*********** PTASSAMj00 ******** FILEIN user.vek ../../CSA/PIK_SPRITE/ ULMN 3 3uao_o00 PUTATIVE ISOCHORISMATASE user 1 3 # 1 A 29 ASP A 165 ASP^? 19.82 MG MG B 701 A 117 LYS A 172 LYS~? 6.12 MG MG B 701 A 150 CYH A 150 CYH^? 20.80 MG MG B 701 coo 37.97 47.82 5.46 38.65 48.02 7.40 49.47 0.04 38.38 48.02 -0.73 39.68 coo 41.02 51.33 13.36 40.18 47.06 9.99 50.20 -3.67 28.72 53.15 -8.47 28.45 coo 39.17 42.30 8.54 40.94 44.26 7.78 54.05 4.31 36.56 55.14 4.53 39.16 ULMN 3 3uao_o00 PUTATIVE ISOCHORISMATASE user 2 3 # 2 A 29 ASP A 165 ASP^? 19.82 MG MG B 701 A 117 LYS A 175 LYS~? 16.95 MG MG B 701 A 150 CYH A 150 CYH^? 20.80 MG MG B 701 coo 37.97 47.82 5.46 38.65 48.02 7.40 49.47 0.04 38.38 48.02 -0.73 39.68 coo 41.02 51.33 13.36 40.18 47.06 9.99 54.19 -7.18 37.22 54.81 -12.82 38.86 coo 39.17 42.30 8.54 40.94 44.26 7.78 54.05 4.31 36.56 55.14 4.53 39.16 ULMN 3 3uao_o00 PUTATIVE ISOCHORISMATASE user 3 3 # 3 A 29 ASP B 165 ASP^? 26.59 MG MG B 701 A 117 LYS B 172 LYS~? 42.28 MG MG B 701 A 150 CYH B 150 CYH^? 29.89 MG MG B 701 coo 37.97 47.82 5.46 38.65 48.02 7.40 71.61 -6.68 45.38 69.65 -6.30 44.66 coo 41.02 51.33 13.36 40.18 47.06 9.99 75.30 -2.84 54.33 79.74 -2.40 56.36 coo 39.17 42.30 8.54 40.94 44.26 7.78 77.46 -9.77 45.05 77.37 -9.94 42.24 ULMN 3 3uao_o00 PUTATIVE ISOCHORISMATASE user 4 3 # 4 A 29 ASP B 165 ASP^? 26.59 MG MG B 701 A 117 LYS B 175 LYS~? 34.92 MG MG B 701 A 150 CYH B 150 CYH^? 29.89 MG MG B 701 coo 37.97 47.82 5.46 38.65 48.02 7.40 71.61 -6.68 45.38 69.65 -6.30 44.66 coo 41.02 51.33 13.36 40.18 47.06 9.99 75.00 1.45 45.20 75.48 7.65 46.06 coo 39.17 42.30 8.54 40.94 44.26 7.78 77.46 -9.77 45.05 77.37 -9.94 42.24 3uao_o00 source 3UAO PUTATIVE ISOCHORISMATASE : 4 hits 3uao_o00 naa= 3 ULMN 4 1c17_c11 ATP SYNTHASE SUBUNIT C user 1 4 # 1 A 61 ASP B 221 ASP~? 37.75 MG MG B 701 M 206 SER B 79 SER~? 34.99 MG MG B 701 M 210 ARG B 89 ARG~? 39.23 MG MG B 701 M 214 ASN B 90 ASN~? 42.88 MG MG B 701 coo 2.15 -17.14 -6.89 2.91 -15.59 -8.10 87.06 -12.52 38.62 87.72 -12.86 40.65 coo -2.55 -23.32 19.81 -3.48 -21.59 18.38 65.87 -9.61 54.86 67.18 -7.64 55.36 coo 1.98 -17.11 17.69 1.79 -15.15 15.33 70.16 -17.97 55.88 70.89 -15.54 57.64 coo 8.13 -16.73 20.92 6.75 -15.93 19.51 72.19 -20.15 61.00 72.72 -18.20 60.27 1c17_c11 source 1c17 ATP SYNTHASE SUBUNIT C : 1 hits 1c17_c11 naa= 4 ULMN 4 1i8t_c02 UDP-GALACTOPYRANOSE MUTASE user 1 4 # 1 A 170 ARG A 122 ARG~? 29.12 MG MG B 701 A 278 ARG A 126 ARG^? 30.85 MG MG B 701 A 298 GLU A 134 GLU^? 30.91 MG MG B 701 A 348 ASP A 221 ASP~? 23.86 MG MG B 701 coo -23.99 -12.72 0.77 -26.03 -13.46 2.92 57.02 18.56 28.04 58.98 19.78 30.13 coo -18.98 -3.88 -14.05 -18.01 -5.56 -11.69 48.08 15.54 42.27 50.77 14.42 43.32 coo -18.09 -5.55 -18.88 -17.66 -5.99 -16.85 46.08 11.35 43.50 47.51 12.29 44.66 coo -11.04 -13.38 -5.15 -13.10 -12.92 -5.14 63.27 9.05 38.25 62.91 9.80 36.26 ULMN 4 1i8t_c02 UDP-GALACTOPYRANOSE MUTASE user 2 4 # 2 A 170 ARG A 163 ARG^? 22.70 MG MG B 701 A 278 ARG A 184 ARG~? 36.26 MG MG B 701 A 298 GLU A 186 GLU~? 38.23 MG MG B 701 A 348 ASP A 177 ASP~? 19.64 MG MG B 701 coo -23.99 -12.72 0.77 -26.03 -13.46 2.92 45.39 -0.99 44.51 45.45 -0.07 41.63 coo -18.98 -3.88 -14.05 -18.01 -5.56 -11.69 59.62 -7.21 56.11 59.92 -9.15 58.50 coo -18.09 -5.55 -18.88 -17.66 -5.99 -16.85 60.82 -4.60 59.58 62.03 -6.27 60.12 coo -11.04 -13.38 -5.15 -13.10 -12.92 -5.14 57.48 -8.32 42.16 55.62 -9.31 42.19 ULMN 4 1i8t_c02 UDP-GALACTOPYRANOSE MUTASE user 3 4 # 3 A 170 ARG B 138 ARG^? 35.64 MG MG B 701 A 278 ARG B 89 ARG~? 39.23 MG MG B 701 A 298 GLU B 78 GLU~? 38.64 MG MG B 701 A 348 ASP B 165 ASP^? 26.59 MG MG B 701 coo -23.99 -12.72 0.77 -26.03 -13.46 2.92 81.28 -15.50 42.88 84.08 -15.53 41.69 coo -18.98 -3.88 -14.05 -18.01 -5.56 -11.69 70.16 -17.97 55.88 70.89 -15.54 57.64 coo -18.09 -5.55 -18.88 -17.66 -5.99 -16.85 64.90 -13.57 57.96 63.80 -14.17 59.70 coo -11.04 -13.38 -5.15 -13.10 -12.92 -5.14 71.61 -6.68 45.38 69.65 -6.30 44.66 ULMN 4 1i8t_c02 UDP-GALACTOPYRANOSE MUTASE user 4 4 # 4 A 170 ARG B 163 ARG^? 22.33 MG MG B 701 A 278 ARG B 184 ARG~? 19.31 MG MG B 701 A 298 GLU B 186 GLU~? 15.37 MG MG B 701 A 348 ASP B 177 ASP~? 29.47 MG MG B 701 coo -23.99 -12.72 0.77 -26.03 -13.46 2.92 66.22 -8.44 41.95 64.50 -6.02 42.66 coo -18.98 -3.88 -14.05 -18.01 -5.56 -11.69 70.96 1.73 26.45 71.21 2.29 23.40 coo -18.09 -5.55 -18.88 -17.66 -5.99 -16.85 69.45 -0.46 21.54 67.97 0.05 22.96 coo -11.04 -13.38 -5.15 -13.10 -12.92 -5.14 75.29 2.41 39.09 75.08 4.12 40.31 1i8t_c02 source 1i8t UDP-GALACTOPYRANOSE MUTASE : 4 hits 1i8t_c02 naa= 4 ULMN 4 1i8t_c03 UDP-GALACTOPYRANOSE MUTASE user 1 4 # 1 B 170 ARG A 163 ARG^? 22.70 MG MG B 701 B 278 ARG A 184 ARG~? 36.26 MG MG B 701 B 298 GLU A 186 GLU~? 38.23 MG MG B 701 B 348 ASP A 177 ASP~? 19.64 MG MG B 701 coo -8.10 23.98 3.08 -8.58 21.04 2.27 45.39 -0.99 44.51 45.45 -0.07 41.63 coo -19.09 15.00 16.26 -16.38 15.21 14.84 59.62 -7.21 56.11 59.92 -9.15 58.50 coo -19.42 16.58 21.15 -18.01 16.20 19.59 60.82 -4.60 59.58 62.03 -6.27 60.12 coo -3.61 14.95 13.27 -5.31 15.62 12.23 57.48 -8.32 42.16 55.62 -9.31 42.19 ULMN 4 1i8t_c03 UDP-GALACTOPYRANOSE MUTASE user 2 4 # 2 B 170 ARG A 178 ARG~? 13.19 MG MG B 701 B 278 ARG A 184 ARG~? 36.26 MG MG B 701 B 298 GLU A 186 GLU~? 38.23 MG MG B 701 B 348 ASP B 165 ASP^? 26.59 MG MG B 701 coo -8.10 23.98 3.08 -8.58 21.04 2.27 60.75 -6.17 35.55 62.65 -6.30 33.15 coo -19.09 15.00 16.26 -16.38 15.21 14.84 59.62 -7.21 56.11 59.92 -9.15 58.50 coo -19.42 16.58 21.15 -18.01 16.20 19.59 60.82 -4.60 59.58 62.03 -6.27 60.12 coo -3.61 14.95 13.27 -5.31 15.62 12.23 71.61 -6.68 45.38 69.65 -6.30 44.66 1i8t_c03 source 1i8t UDP-GALACTOPYRANOSE MUTASE : 2 hits 1i8t_c03 naa= 4 ULMN 4 1pix_c00 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 1 4 # 1 A 151 VAL A 116 VAL^? 31.84 MG MG B 701 A 194 GLY A 114 GLY~? 35.29 MG MG B 701 A 417 ILE A 243 ILE~? 51.92 MG MG B 701 A 457 ALA A 241 ALA~? 47.31 MG MG B 701 coo 60.43 93.31 8.03 62.16 94.30 8.93 36.93 14.51 38.31 37.32 12.69 37.11 coo 59.34 89.99 13.88 59.24 89.18 13.73 31.24 11.76 39.70 31.09 12.06 39.00 coo 39.61 128.90 22.54 40.04 128.24 23.80 58.72 4.12 72.49 58.28 3.32 73.59 coo 43.27 124.32 20.47 43.79 125.29 21.53 53.60 3.48 69.42 52.47 3.64 68.38 ULMN 4 1pix_c00 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 2 4 # 2 A 151 VAL A 116 VAL^? 31.84 MG MG B 701 A 194 GLY A 114 GLY~? 35.29 MG MG B 701 A 417 ILE A 243 ILE~? 51.92 MG MG B 701 A 457 ALA A 242 ALA~? 50.36 MG MG B 701 coo 60.43 93.31 8.03 62.16 94.30 8.93 36.93 14.51 38.31 37.32 12.69 37.11 coo 59.34 89.99 13.88 59.24 89.18 13.73 31.24 11.76 39.70 31.09 12.06 39.00 coo 39.61 128.90 22.54 40.04 128.24 23.80 58.72 4.12 72.49 58.28 3.32 73.59 coo 43.27 124.32 20.47 43.79 125.29 21.53 55.65 6.69 69.54 55.28 7.96 70.34 1pix_c00 source 1pix GLUTACONYL-COA DECARBOXYLASE A SUBUNIT : 2 hits 1pix_c00 naa= 4 ULMN 4 1qtn_c00 ACETYL-ILE-GLU-THR-ASP-ALDEHYDE user 1 4 # 1 A 258 ARG A 71 ARG~? 17.45 MG MG B 701 A 317 HIS A 98 HIS~? 27.68 MG MG B 701 A 318 GLY A 97 GLY~? 31.08 MG MG B 701 A 360 CYH A 93 CYH~? 25.81 MG MG B 701 coo -8.98 40.59 45.04 -10.51 39.37 47.39 52.94 11.11 20.93 55.28 9.38 22.01 coo -8.43 39.80 36.26 -8.18 39.59 38.31 50.40 19.60 21.83 50.19 18.76 19.91 coo -11.14 38.10 31.61 -11.46 38.10 32.37 45.97 21.69 23.70 46.00 21.22 24.47 coo -11.95 34.09 34.07 -11.89 34.73 36.80 42.80 17.19 26.05 43.95 14.89 27.02 ULMN 4 1qtn_c00 ACETYL-ILE-GLU-THR-ASP-ALDEHYDE user 2 4 # 2 A 258 ARG A 122 ARG~? 29.12 MG MG B 701 A 317 HIS A 98 HIS~? 27.68 MG MG B 701 A 318 GLY A 97 GLY~? 31.08 MG MG B 701 A 360 CYH A 93 CYH~? 25.81 MG MG B 701 coo -8.98 40.59 45.04 -10.51 39.37 47.39 57.02 18.56 28.04 58.98 19.78 30.13 coo -8.43 39.80 36.26 -8.18 39.59 38.31 50.40 19.60 21.83 50.19 18.76 19.91 coo -11.14 38.10 31.61 -11.46 38.10 32.37 45.97 21.69 23.70 46.00 21.22 24.47 coo -11.95 34.09 34.07 -11.89 34.73 36.80 42.80 17.19 26.05 43.95 14.89 27.02 1qtn_c00 source 1qtn ACETYL-ILE-GLU-THR-ASP-ALDEHYDE : 2 hits 1qtn_c00 naa= 4 ULMN 4 2nmt_c00 MYRISTOYL-COA:PROTEIN N-MYRISTOYLTRAuser 1 4 # 1 A 169 ASN A 121 ASN^? 29.95 MG MG B 701 A 170 PHE A 124 PHE^? 29.34 MG MG B 701 A 171 LEU A 69 LEU~? 21.39 MG MG B 701 A 455 LEU A 119 LEU^? 32.66 MG MG B 701 coo 29.34 24.41 78.19 29.76 25.72 76.57 52.20 18.76 34.12 54.15 19.63 34.02 coo 30.60 22.78 74.02 32.69 24.70 74.02 53.10 15.90 36.97 52.63 18.53 37.74 coo 23.47 21.19 75.19 21.55 20.19 75.05 53.23 11.80 29.89 52.24 11.34 31.75 coo 34.24 28.84 77.53 36.19 29.18 78.46 47.11 18.54 37.83 46.73 19.95 39.44 ULMN 4 2nmt_c00 MYRISTOYL-COA:PROTEIN N-MYRISTOYLTRAuser 2 4 # 2 A 169 ASN A 121 ASN^? 29.95 MG MG B 701 A 170 PHE A 124 PHE^? 29.34 MG MG B 701 A 171 LEU A 119 LEU^? 32.66 MG MG B 701 A 455 LEU A 69 LEU~? 21.39 MG MG B 701 coo 29.34 24.41 78.19 29.76 25.72 76.57 52.20 18.76 34.12 54.15 19.63 34.02 coo 30.60 22.78 74.02 32.69 24.70 74.02 53.10 15.90 36.97 52.63 18.53 37.74 coo 23.47 21.19 75.19 21.55 20.19 75.05 47.11 18.54 37.83 46.73 19.95 39.44 coo 34.24 28.84 77.53 36.19 29.18 78.46 53.23 11.80 29.89 52.24 11.34 31.75 ULMN 4 2nmt_c00 MYRISTOYL-COA:PROTEIN N-MYRISTOYLTRAuser 3 4 # 3 A 169 ASN B 121 ASN~? 40.01 MG MG B 701 A 170 PHE B 124 PHE~? 35.62 MG MG B 701 A 171 LEU B 69 LEU~? 39.10 MG MG B 701 A 455 LEU B 119 LEU^? 34.76 MG MG B 701 coo 29.34 24.41 78.19 29.76 25.72 76.57 80.51 -24.09 47.29 82.46 -24.55 46.48 coo 30.60 22.78 74.02 32.69 24.70 74.02 79.51 -21.13 44.47 79.25 -23.80 43.75 coo 23.47 21.19 75.19 21.55 20.19 75.05 81.55 -17.18 51.26 79.78 -16.99 49.97 coo 34.24 28.84 77.53 36.19 29.18 78.46 74.33 -25.47 46.06 73.42 -26.96 44.69 ULMN 4 2nmt_c00 MYRISTOYL-COA:PROTEIN N-MYRISTOYLTRAuser 4 4 # 4 A 169 ASN B 121 ASN~? 40.01 MG MG B 701 A 170 PHE B 124 PHE~? 35.62 MG MG B 701 A 171 LEU B 119 LEU^? 34.76 MG MG B 701 A 455 LEU B 69 LEU~? 39.10 MG MG B 701 coo 29.34 24.41 78.19 29.76 25.72 76.57 80.51 -24.09 47.29 82.46 -24.55 46.48 coo 30.60 22.78 74.02 32.69 24.70 74.02 79.51 -21.13 44.47 79.25 -23.80 43.75 coo 23.47 21.19 75.19 21.55 20.19 75.05 74.33 -25.47 46.06 73.42 -26.96 44.69 coo 34.24 28.84 77.53 36.19 29.18 78.46 81.55 -17.18 51.26 79.78 -16.99 49.97 2nmt_c00 source 2nmt MYRISTOYL-COA:PROTEIN N-MYRISTOYLTRANSFERASE : 4 hits 2nmt_c00 naa= 4 ULMN 3 12as_c00 ASPARAGINE SYNTHETASE user 1 3 # 1 A 46 ASP A 187 ASP~? 34.25 MG MG B 701 A 100 ARG A 184 ARG~? 36.26 MG MG B 701 A 116 GLN A 181 GLN~? 27.30 MG MG B 701 coo 32.24 20.09 5.34 30.38 19.04 5.27 61.00 -0.38 56.45 61.66 -2.23 55.67 coo 26.40 25.34 6.28 26.15 22.33 7.25 59.62 -7.21 56.11 59.92 -9.15 58.50 coo 26.74 21.94 13.78 27.57 20.97 12.08 60.16 -5.59 48.31 61.94 -6.68 48.94 ULMN 3 12as_c00 ASPARAGINE SYNTHETASE user 2 3 # 2 A 46 ASP A 187 ASP~? 34.25 MG MG B 701 A 100 ARG A 184 ARG~? 36.26 MG MG B 701 A 116 GLN A 182 GLN~? 28.14 MG MG B 701 coo 32.24 20.09 5.34 30.38 19.04 5.27 61.00 -0.38 56.45 61.66 -2.23 55.67 coo 26.40 25.34 6.28 26.15 22.33 7.25 59.62 -7.21 56.11 59.92 -9.15 58.50 coo 26.74 21.94 13.78 27.57 20.97 12.08 54.30 -2.44 50.45 53.46 -0.63 49.70 ULMN 3 12as_c00 ASPARAGINE SYNTHETASE user 3 3 # 3 A 46 ASP A 194 ASP~? 51.94 MG MG B 701 A 100 ARG A 195 ARG~? 43.32 MG MG B 701 A 116 GLN A 201 GLN~? 52.08 MG MG B 701 coo 32.24 20.09 5.34 30.38 19.04 5.27 62.72 -3.55 72.77 62.75 -5.34 73.88 coo 26.40 25.34 6.28 26.15 22.33 7.25 61.44 -7.15 66.34 63.04 -4.84 65.03 coo 26.74 21.94 13.78 27.57 20.97 12.08 55.05 -7.81 73.07 56.09 -8.90 74.66 ULMN 3 12as_c00 ASPARAGINE SYNTHETASE user 4 3 # 4 A 46 ASP B 161 ASP^? 15.44 MG MG B 701 A 100 ARG A 178 ARG~? 13.19 MG MG B 701 A 116 GLN B 182 GLN~? 19.32 MG MG B 701 coo 32.24 20.09 5.34 30.38 19.04 5.27 63.88 -11.38 34.74 64.49 -9.36 34.64 coo 26.40 25.34 6.28 26.15 22.33 7.25 60.75 -6.17 35.55 62.65 -6.30 33.15 coo 26.74 21.94 13.78 27.57 20.97 12.08 70.28 -3.80 33.26 70.35 -5.77 34.00 ULMN 3 12as_c00 ASPARAGINE SYNTHETASE user 5 3 # 5 A 46 ASP B 165 ASP^? 26.59 MG MG B 701 A 100 ARG A 258 ARG~? 19.65 MG MG B 701 A 116 GLN A 181 GLN~? 27.30 MG MG B 701 coo 32.24 20.09 5.34 30.38 19.04 5.27 71.61 -6.68 45.38 69.65 -6.30 44.66 coo 26.40 25.34 6.28 26.15 22.33 7.25 65.98 -2.88 40.97 66.14 -4.57 38.35 coo 26.74 21.94 13.78 27.57 20.97 12.08 60.16 -5.59 48.31 61.94 -6.68 48.94 ULMN 3 12as_c00 ASPARAGINE SYNTHETASE user 6 3 # 6 A 46 ASP B 165 ASP^? 26.59 MG MG B 701 A 100 ARG B 163 ARG^? 22.33 MG MG B 701 A 116 GLN A 181 GLN~? 27.30 MG MG B 701 coo 32.24 20.09 5.34 30.38 19.04 5.27 71.61 -6.68 45.38 69.65 -6.30 44.66 coo 26.40 25.34 6.28 26.15 22.33 7.25 66.22 -8.44 41.95 64.50 -6.02 42.66 coo 26.74 21.94 13.78 27.57 20.97 12.08 60.16 -5.59 48.31 61.94 -6.68 48.94 ULMN 3 12as_c00 ASPARAGINE SYNTHETASE user 7 3 # 7 A 46 ASP B 187 ASP~? 20.66 MG MG B 701 A 100 ARG B 184 ARG~? 19.31 MG MG B 701 A 116 GLN B 182 GLN~? 19.32 MG MG B 701 coo 32.24 20.09 5.34 30.38 19.04 5.27 74.06 -4.33 24.81 74.57 -2.40 25.55 coo 26.40 25.34 6.28 26.15 22.33 7.25 70.96 1.73 26.45 71.21 2.29 23.40 coo 26.74 21.94 13.78 27.57 20.97 12.08 70.28 -3.80 33.26 70.35 -5.77 34.00 ULMN 3 12as_c00 ASPARAGINE SYNTHETASE user 8 3 # 8 A 46 ASP B 194 ASP~? 20.07 MG MG B 701 A 100 ARG B 195 ARG~? 17.65 MG MG B 701 A 116 GLN B 201 GLN~? 14.81 MG MG B 701 coo 32.24 20.09 5.34 30.38 19.04 5.27 67.87 -2.29 9.08 66.66 -1.03 7.91 coo 26.40 25.34 6.28 26.15 22.33 7.25 67.86 1.55 15.86 69.38 1.19 18.53 coo 26.74 21.94 13.78 27.57 20.97 12.08 59.67 -0.46 11.60 59.85 1.48 12.40 12as_c00 source 12as ASPARAGINE SYNTHETASE : 8 hits 12as_c00 naa= 3 ULMN 3 12as_c01 ASPARAGINE SYNTHETASE user 1 3 # 1 B 46 ASP A 161 ASP^? 31.32 MG MG B 701 B 100 ARG A 226 ARG^? 38.22 MG MG B 701 B 116 GLN A 227 GLN^? 40.32 MG MG B 701 coo 32.18 48.37 12.48 33.96 49.46 12.97 45.91 2.65 51.66 46.91 0.77 51.57 coo 39.04 43.25 11.37 38.30 45.35 13.56 52.39 10.28 54.33 53.57 13.12 54.39 coo 37.43 42.63 19.41 36.76 44.08 17.97 54.41 4.39 59.17 53.11 5.19 60.64 ULMN 3 12as_c01 ASPARAGINE SYNTHETASE user 2 3 # 2 B 46 ASP A 187 ASP~? 34.25 MG MG B 701 B 100 ARG A 184 ARG~? 36.26 MG MG B 701 B 116 GLN A 181 GLN~? 27.30 MG MG B 701 coo 32.18 48.37 12.48 33.96 49.46 12.97 61.00 -0.38 56.45 61.66 -2.23 55.67 coo 39.04 43.25 11.37 38.30 45.35 13.56 59.62 -7.21 56.11 59.92 -9.15 58.50 coo 37.43 42.63 19.41 36.76 44.08 17.97 60.16 -5.59 48.31 61.94 -6.68 48.94 ULMN 3 12as_c01 ASPARAGINE SYNTHETASE user 3 3 # 3 B 46 ASP A 187 ASP~? 34.25 MG MG B 701 B 100 ARG A 184 ARG~? 36.26 MG MG B 701 B 116 GLN A 182 GLN~? 28.14 MG MG B 701 coo 32.18 48.37 12.48 33.96 49.46 12.97 61.00 -0.38 56.45 61.66 -2.23 55.67 coo 39.04 43.25 11.37 38.30 45.35 13.56 59.62 -7.21 56.11 59.92 -9.15 58.50 coo 37.43 42.63 19.41 36.76 44.08 17.97 54.30 -2.44 50.45 53.46 -0.63 49.70 ULMN 3 12as_c01 ASPARAGINE SYNTHETASE user 4 3 # 4 B 46 ASP A 194 ASP~? 51.94 MG MG B 701 B 100 ARG A 195 ARG~? 43.32 MG MG B 701 B 116 GLN A 201 GLN~? 52.08 MG MG B 701 coo 32.18 48.37 12.48 33.96 49.46 12.97 62.72 -3.55 72.77 62.75 -5.34 73.88 coo 39.04 43.25 11.37 38.30 45.35 13.56 61.44 -7.15 66.34 63.04 -4.84 65.03 coo 37.43 42.63 19.41 36.76 44.08 17.97 55.05 -7.81 73.07 56.09 -8.90 74.66 ULMN 3 12as_c01 ASPARAGINE SYNTHETASE user 5 3 # 5 B 46 ASP B 165 ASP^? 26.59 MG MG B 701 B 100 ARG A 258 ARG~? 19.65 MG MG B 701 B 116 GLN A 181 GLN~? 27.30 MG MG B 701 coo 32.18 48.37 12.48 33.96 49.46 12.97 71.61 -6.68 45.38 69.65 -6.30 44.66 coo 39.04 43.25 11.37 38.30 45.35 13.56 65.98 -2.88 40.97 66.14 -4.57 38.35 coo 37.43 42.63 19.41 36.76 44.08 17.97 60.16 -5.59 48.31 61.94 -6.68 48.94 ULMN 3 12as_c01 ASPARAGINE SYNTHETASE user 6 3 # 6 B 46 ASP B 165 ASP^? 26.59 MG MG B 701 B 100 ARG B 163 ARG^? 22.33 MG MG B 701 B 116 GLN A 181 GLN~? 27.30 MG MG B 701 coo 32.18 48.37 12.48 33.96 49.46 12.97 71.61 -6.68 45.38 69.65 -6.30 44.66 coo 39.04 43.25 11.37 38.30 45.35 13.56 66.22 -8.44 41.95 64.50 -6.02 42.66 coo 37.43 42.63 19.41 36.76 44.08 17.97 60.16 -5.59 48.31 61.94 -6.68 48.94 ULMN 3 12as_c01 ASPARAGINE SYNTHETASE user 7 3 # 7 B 46 ASP B 187 ASP~? 20.66 MG MG B 701 B 100 ARG B 184 ARG~? 19.31 MG MG B 701 B 116 GLN B 182 GLN~? 19.32 MG MG B 701 coo 32.18 48.37 12.48 33.96 49.46 12.97 74.06 -4.33 24.81 74.57 -2.40 25.55 coo 39.04 43.25 11.37 38.30 45.35 13.56 70.96 1.73 26.45 71.21 2.29 23.40 coo 37.43 42.63 19.41 36.76 44.08 17.97 70.28 -3.80 33.26 70.35 -5.77 34.00 ULMN 3 12as_c01 ASPARAGINE SYNTHETASE user 8 3 # 8 B 46 ASP B 194 ASP~? 20.07 MG MG B 701 B 100 ARG B 195 ARG~? 17.65 MG MG B 701 B 116 GLN B 201 GLN~? 14.81 MG MG B 701 coo 32.18 48.37 12.48 33.96 49.46 12.97 67.87 -2.29 9.08 66.66 -1.03 7.91 coo 39.04 43.25 11.37 38.30 45.35 13.56 67.86 1.55 15.86 69.38 1.19 18.53 coo 37.43 42.63 19.41 36.76 44.08 17.97 59.67 -0.46 11.60 59.85 1.48 12.40 12as_c01 source 12as ASPARAGINE SYNTHETASE : 8 hits 12as_c01 naa= 3 ULMN 3 1a05_c01 3-ISOPROPYLMALATE DEHYDROGENASE user 1 3 # 1 A 190 LYS A 175 LYS~? 16.95 MG MG B 701 A 222 ASP A 177 ASP~? 19.64 MG MG B 701 B 140 TYR B 211 TYR~? 10.12 MG MG B 701 coo -4.61 20.12 30.34 -2.74 22.65 25.95 54.19 -7.18 37.22 54.81 -12.82 38.86 coo -1.04 26.60 27.37 -2.94 25.93 26.69 57.48 -8.32 42.16 55.62 -9.31 42.19 coo 1.51 16.60 24.17 0.82 19.23 24.79 61.93 -10.14 30.57 59.39 -9.09 31.01 1a05_c01 source 1a05 3-ISOPROPYLMALATE DEHYDROGENASE : 1 hits 1a05_c01 naa= 3 ULMN 3 1a41_c01 TOPOISOMERASE I user 1 3 # 1 223 ARG A 195 ARG~? 43.32 MG MG B 701 265 HIS A 192 HIS~? 50.82 MG MG B 701 274 TYR A 198 TYR~? 56.67 MG MG B 701 coo -15.18 55.46 8.55 -14.82 52.98 10.38 61.44 -7.15 66.34 63.04 -4.84 65.03 coo -14.48 45.59 11.18 -14.02 47.49 10.42 68.48 1.80 70.19 70.40 2.63 70.21 coo 0.94 52.26 9.16 1.95 54.78 9.91 53.82 -3.08 78.46 51.29 -3.39 79.56 ULMN 3 1a41_c01 TOPOISOMERASE I user 2 3 # 2 223 ARG B 195 ARG~? 17.65 MG MG B 701 265 HIS B 192 HIS~? 26.17 MG MG B 701 274 TYR B 198 TYR~? 14.53 MG MG B 701 coo -15.18 55.46 8.55 -14.82 52.98 10.38 67.86 1.55 15.86 69.38 1.19 18.53 coo -14.48 45.59 11.18 -14.02 47.49 10.42 76.10 -2.97 9.85 78.15 -2.61 9.73 coo 0.94 52.26 9.16 1.95 54.78 9.91 57.70 -5.58 8.01 55.21 -6.68 8.56 1a41_c01 source 1a41 TOPOISOMERASE I : 2 hits 1a41_c01 naa= 3 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 1 3 # 1 22 ASN A 90 ASN~? 26.35 MG MG B 701 63 ARG A 89 ARG~? 21.03 MG MG B 701 255 ARG A 95 ARG~? 33.62 MG MG B 701 coo 42.10 13.02 11.14 41.85 11.12 10.23 39.76 12.43 23.01 37.74 11.92 22.68 coo 44.36 11.24 3.39 41.81 12.78 4.00 41.91 10.07 29.06 41.51 7.36 27.58 coo 38.40 3.83 10.26 40.02 6.30 9.25 36.90 22.02 26.51 36.19 19.35 27.93 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 2 3 # 2 22 ASN A 121 ASN^? 29.95 MG MG B 701 63 ARG A 122 ARG~? 29.12 MG MG B 701 255 ARG A 138 ARG^? 25.45 MG MG B 701 coo 42.10 13.02 11.14 41.85 11.12 10.23 52.20 18.76 34.12 54.15 19.63 34.02 coo 44.36 11.24 3.39 41.81 12.78 4.00 57.02 18.56 28.04 58.98 19.78 30.13 coo 38.40 3.83 10.26 40.02 6.30 9.25 56.09 11.79 37.51 58.92 12.66 36.83 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 3 3 # 3 22 ASN A 121 ASN^? 29.95 MG MG B 701 63 ARG A 126 ARG^? 30.85 MG MG B 701 255 ARG A 138 ARG^? 25.45 MG MG B 701 coo 42.10 13.02 11.14 41.85 11.12 10.23 52.20 18.76 34.12 54.15 19.63 34.02 coo 44.36 11.24 3.39 41.81 12.78 4.00 48.08 15.54 42.27 50.77 14.42 43.32 coo 38.40 3.83 10.26 40.02 6.30 9.25 56.09 11.79 37.51 58.92 12.66 36.83 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 4 3 # 4 22 ASN A 121 ASN^? 29.95 MG MG B 701 63 ARG A 138 ARG^? 25.45 MG MG B 701 255 ARG A 126 ARG^? 30.85 MG MG B 701 coo 42.10 13.02 11.14 41.85 11.12 10.23 52.20 18.76 34.12 54.15 19.63 34.02 coo 44.36 11.24 3.39 41.81 12.78 4.00 56.09 11.79 37.51 58.92 12.66 36.83 coo 38.40 3.83 10.26 40.02 6.30 9.25 48.08 15.54 42.27 50.77 14.42 43.32 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 5 3 # 5 22 ASN B 121 ASN~? 40.01 MG MG B 701 63 ARG B 122 ARG~? 47.68 MG MG B 701 255 ARG B 138 ARG^? 35.64 MG MG B 701 coo 42.10 13.02 11.14 41.85 11.12 10.23 80.51 -24.09 47.29 82.46 -24.55 46.48 coo 44.36 11.24 3.39 41.81 12.78 4.00 87.17 -22.65 51.01 87.65 -22.59 54.06 coo 38.40 3.83 10.26 40.02 6.30 9.25 81.28 -15.50 42.88 84.08 -15.53 41.69 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 6 3 # 6 22 ASN B 121 ASN~? 40.01 MG MG B 701 63 ARG B 126 ARG^? 29.16 MG MG B 701 255 ARG B 138 ARG^? 35.64 MG MG B 701 coo 42.10 13.02 11.14 41.85 11.12 10.23 80.51 -24.09 47.29 82.46 -24.55 46.48 coo 44.36 11.24 3.39 41.81 12.78 4.00 72.93 -22.54 42.02 74.52 -21.06 39.83 coo 38.40 3.83 10.26 40.02 6.30 9.25 81.28 -15.50 42.88 84.08 -15.53 41.69 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 7 3 # 7 22 ASN B 121 ASN~? 40.01 MG MG B 701 63 ARG B 138 ARG^? 35.64 MG MG B 701 255 ARG B 126 ARG^? 29.16 MG MG B 701 coo 42.10 13.02 11.14 41.85 11.12 10.23 80.51 -24.09 47.29 82.46 -24.55 46.48 coo 44.36 11.24 3.39 41.81 12.78 4.00 81.28 -15.50 42.88 84.08 -15.53 41.69 coo 38.40 3.83 10.26 40.02 6.30 9.25 72.93 -22.54 42.02 74.52 -21.06 39.83 1aj0_c00 source 1aj0 DIHYDROPTEROATE SYNTHASE : 7 hits 1aj0_c00 naa= 3 ULMN 3 1akd_c01 CYTOCHROME P450CAM user 1 3 # 1 252 THR A 153 THR^? 24.82 MG MG B 701 350 PHE A 166 PHE^? 17.85 MG MG B 701 357 CYH A 150 CYH^? 20.80 MG MG B 701 coo 17.85 20.47 14.62 16.85 19.84 12.80 46.49 5.28 42.88 44.97 4.49 41.56 coo 7.92 21.96 13.27 8.57 20.30 15.42 55.48 -0.21 37.25 56.90 1.01 39.28 coo 8.82 20.77 7.90 10.59 19.75 9.80 54.05 4.31 36.56 55.14 4.53 39.16 ULMN 3 1akd_c01 CYTOCHROME P450CAM user 2 3 # 2 252 THR A 169 THR~? 12.09 MG MG B 701 350 PHE A 166 PHE^? 17.85 MG MG B 701 357 CYH A 150 CYH^? 20.80 MG MG B 701 coo 17.85 20.47 14.62 16.85 19.84 12.80 53.69 2.67 26.96 55.61 3.43 26.29 coo 7.92 21.96 13.27 8.57 20.30 15.42 55.48 -0.21 37.25 56.90 1.01 39.28 coo 8.82 20.77 7.90 10.59 19.75 9.80 54.05 4.31 36.56 55.14 4.53 39.16 ULMN 3 1akd_c01 CYTOCHROME P450CAM user 3 3 # 3 252 THR B 85 THR~? 40.29 MG MG B 701 350 PHE B 73 PHE~? 38.23 MG MG B 701 357 CYH B 93 CYH~? 42.85 MG MG B 701 coo 17.85 20.47 14.62 16.85 19.84 12.80 64.58 -17.53 59.23 63.29 -18.66 60.55 coo 7.92 21.96 13.27 8.57 20.30 15.42 75.10 -18.32 54.35 72.78 -19.57 53.51 coo 8.82 20.77 7.90 10.59 19.75 9.80 74.48 -24.31 57.35 76.42 -22.43 56.76 ULMN 3 1akd_c01 CYTOCHROME P450CAM user 4 3 # 4 252 THR B 85 THR~? 40.29 MG MG B 701 350 PHE B 118 PHE^? 36.09 MG MG B 701 357 CYH B 93 CYH~? 42.85 MG MG B 701 coo 17.85 20.47 14.62 16.85 19.84 12.80 64.58 -17.53 59.23 63.29 -18.66 60.55 coo 7.92 21.96 13.27 8.57 20.30 15.42 70.13 -23.91 51.57 68.23 -22.26 52.74 coo 8.82 20.77 7.90 10.59 19.75 9.80 74.48 -24.31 57.35 76.42 -22.43 56.76 ULMN 3 1akd_c01 CYTOCHROME P450CAM user 5 3 # 5 252 THR B 103 THR~? 38.15 MG MG B 701 350 PHE B 118 PHE^? 36.09 MG MG B 701 357 CYH B 93 CYH~? 42.85 MG MG B 701 coo 17.85 20.47 14.62 16.85 19.84 12.80 79.49 -28.27 47.31 78.51 -27.23 45.65 coo 7.92 21.96 13.27 8.57 20.30 15.42 70.13 -23.91 51.57 68.23 -22.26 52.74 coo 8.82 20.77 7.90 10.59 19.75 9.80 74.48 -24.31 57.35 76.42 -22.43 56.76 ULMN 3 1akd_c01 CYTOCHROME P450CAM user 6 3 # 6 252 THR B 153 THR^? 25.01 MG MG B 701 350 PHE B 166 PHE^? 30.39 MG MG B 701 357 CYH B 150 CYH^? 29.89 MG MG B 701 coo 17.85 20.47 14.62 16.85 19.84 12.80 68.50 -12.99 42.25 67.26 -12.32 43.93 coo 7.92 21.96 13.27 8.57 20.30 15.42 77.21 -5.09 44.06 77.80 -6.03 41.49 coo 8.82 20.77 7.90 10.59 19.75 9.80 77.46 -9.77 45.05 77.37 -9.94 42.24 ULMN 3 1akd_c01 CYTOCHROME P450CAM user 7 3 # 7 252 THR B 169 THR~? 41.74 MG MG B 701 350 PHE B 166 PHE^? 30.39 MG MG B 701 357 CYH B 150 CYH^? 29.89 MG MG B 701 coo 17.85 20.47 14.62 16.85 19.84 12.80 80.90 -7.97 53.82 83.02 -8.15 53.47 coo 7.92 21.96 13.27 8.57 20.30 15.42 77.21 -5.09 44.06 77.80 -6.03 41.49 coo 8.82 20.77 7.90 10.59 19.75 9.80 77.46 -9.77 45.05 77.37 -9.94 42.24 1akd_c01 source 1akd CYTOCHROME P450CAM : 7 hits 1akd_c01 naa= 3 ULMN 3 1amy_c05 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 1 3 # 1 179 ASP B 187 ASP~? 20.66 MG MG B 701 204 GLU B 186 GLU~? 15.37 MG MG B 701 289 ASP A 144 ASP~? 20.24 MG MG B 701 coo -0.62 65.95 29.97 0.31 67.47 31.05 74.06 -4.33 24.81 74.57 -2.40 25.55 coo 4.34 62.44 32.05 4.22 64.48 32.53 69.45 -0.46 21.54 67.97 0.05 22.96 coo 9.42 68.07 30.27 7.35 68.27 30.10 69.22 6.09 27.43 70.24 4.65 26.30 1amy_c05 source 1amy ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE (ALPHA-AMY: 1 hits 1amy_c05 naa= 3 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 1 3 # 1 A 194 SER A 210 SER~? 36.07 MG MG B 701 A 292 ASP A 194 ASP~? 51.94 MG MG B 701 A 322 HIS A 157 HIS~? 39.61 MG MG B 701 coo 36.34 32.23 39.60 36.43 34.62 39.93 49.99 -1.69 57.23 51.51 -3.29 58.19 coo 19.73 19.18 41.39 21.50 18.65 40.34 62.72 -3.55 72.77 62.75 -5.34 73.88 coo 41.69 45.14 46.60 41.78 47.19 46.18 38.94 10.29 53.24 39.70 12.18 53.73 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 2 3 # 2 A 194 SER B 210 SER~? 12.60 MG MG B 701 A 292 ASP B 194 ASP~? 20.07 MG MG B 701 A 322 HIS B 157 HIS~? 18.79 MG MG B 701 coo 36.34 32.23 39.60 36.43 34.62 39.93 63.63 -6.43 28.51 65.51 -5.02 28.70 coo 19.73 19.18 41.39 21.50 18.65 40.34 67.87 -2.29 9.08 66.66 -1.03 7.91 coo 41.69 45.14 46.60 41.78 47.19 46.18 58.96 -20.41 35.42 60.06 -22.12 34.89 1aql_c02 source 1aql BILE-SALT ACTIVATED LIPASE : 2 hits 1aql_c02 naa= 3 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 1 3 # 1 B 194 SER A 210 SER~? 36.07 MG MG B 701 B 292 ASP A 194 ASP~? 51.94 MG MG B 701 B 322 HIS A 157 HIS~? 39.61 MG MG B 701 coo 35.42 71.28 22.94 36.24 69.06 22.37 49.99 -1.69 57.23 51.51 -3.29 58.19 coo 24.74 78.07 5.59 24.32 79.03 7.46 62.72 -3.55 72.77 62.75 -5.34 73.88 coo 48.81 64.16 26.34 49.30 62.16 26.73 38.94 10.29 53.24 39.70 12.18 53.73 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 2 3 # 2 B 194 SER B 210 SER~? 12.60 MG MG B 701 B 292 ASP B 194 ASP~? 20.07 MG MG B 701 B 322 HIS B 157 HIS~? 18.79 MG MG B 701 coo 35.42 71.28 22.94 36.24 69.06 22.37 63.63 -6.43 28.51 65.51 -5.02 28.70 coo 24.74 78.07 5.59 24.32 79.03 7.46 67.87 -2.29 9.08 66.66 -1.03 7.91 coo 48.81 64.16 26.34 49.30 62.16 26.73 58.96 -20.41 35.42 60.06 -22.12 34.89 1aql_c03 source 1aql BILE-SALT ACTIVATED LIPASE : 2 hits 1aql_c03 naa= 3 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 1 3 # 1 B 325 ARG A 138 ARG^? 25.45 MG MG B 701 B 342 ASP A 165 ASP^? 19.82 MG MG B 701 B 531 ARG A 126 ARG^? 30.85 MG MG B 701 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 56.09 11.79 37.51 58.92 12.66 36.83 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 49.47 0.04 38.38 48.02 -0.73 39.68 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 48.08 15.54 42.27 50.77 14.42 43.32 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 2 3 # 2 B 325 ARG A 253 ARG^? 30.10 MG MG B 701 B 342 ASP B 177 ASP~? 29.47 MG MG B 701 B 531 ARG A 261 ARG^? 35.46 MG MG B 701 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 68.27 8.63 43.05 70.75 9.38 41.34 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 75.29 2.41 39.09 75.08 4.12 40.31 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 64.47 3.15 51.80 64.61 3.05 54.85 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 3 3 # 3 B 325 ARG A 258 ARG~? 19.65 MG MG B 701 B 342 ASP A 177 ASP~? 19.64 MG MG B 701 B 531 ARG A 261 ARG^? 35.46 MG MG B 701 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 65.98 -2.88 40.97 66.14 -4.57 38.35 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 57.48 -8.32 42.16 55.62 -9.31 42.19 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 64.47 3.15 51.80 64.61 3.05 54.85 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 4 3 # 4 B 325 ARG A 258 ARG~? 19.65 MG MG B 701 B 342 ASP A 221 ASP~? 23.86 MG MG B 701 B 531 ARG A 261 ARG^? 35.46 MG MG B 701 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 65.98 -2.88 40.97 66.14 -4.57 38.35 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 63.27 9.05 38.25 62.91 9.80 36.26 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 64.47 3.15 51.80 64.61 3.05 54.85 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 5 3 # 5 B 325 ARG A 258 ARG~? 19.65 MG MG B 701 B 342 ASP B 177 ASP~? 29.47 MG MG B 701 B 531 ARG A 261 ARG^? 35.46 MG MG B 701 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 65.98 -2.88 40.97 66.14 -4.57 38.35 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 75.29 2.41 39.09 75.08 4.12 40.31 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 64.47 3.15 51.80 64.61 3.05 54.85 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 6 3 # 6 B 325 ARG A 261 ARG^? 35.46 MG MG B 701 B 342 ASP B 165 ASP^? 26.59 MG MG B 701 B 531 ARG A 184 ARG~? 36.26 MG MG B 701 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 64.47 3.15 51.80 64.61 3.05 54.85 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 71.61 -6.68 45.38 69.65 -6.30 44.66 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 59.62 -7.21 56.11 59.92 -9.15 58.50 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 7 3 # 7 B 325 ARG A 261 ARG^? 35.46 MG MG B 701 B 342 ASP B 165 ASP^? 26.59 MG MG B 701 B 531 ARG A 253 ARG^? 30.10 MG MG B 701 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 64.47 3.15 51.80 64.61 3.05 54.85 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 71.61 -6.68 45.38 69.65 -6.30 44.66 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 68.27 8.63 43.05 70.75 9.38 41.34 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 8 3 # 8 B 325 ARG B 138 ARG^? 35.64 MG MG B 701 B 342 ASP B 165 ASP^? 26.59 MG MG B 701 B 531 ARG B 126 ARG^? 29.16 MG MG B 701 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 81.28 -15.50 42.88 84.08 -15.53 41.69 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 71.61 -6.68 45.38 69.65 -6.30 44.66 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 72.93 -22.54 42.02 74.52 -21.06 39.83 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 9 3 # 9 B 325 ARG B 178 ARG~? 37.59 MG MG B 701 B 342 ASP B 165 ASP^? 26.59 MG MG B 701 B 531 ARG A 253 ARG^? 30.10 MG MG B 701 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 79.48 2.47 45.22 81.37 1.59 47.51 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 71.61 -6.68 45.38 69.65 -6.30 44.66 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 68.27 8.63 43.05 70.75 9.38 41.34 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 10 3 # 10 B 325 ARG B 178 ARG~? 37.59 MG MG B 701 B 342 ASP B 165 ASP^? 26.59 MG MG B 701 B 531 ARG B 258 ARG^? 33.01 MG MG B 701 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 79.48 2.47 45.22 81.37 1.59 47.51 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 71.61 -6.68 45.38 69.65 -6.30 44.66 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 83.96 -0.40 36.39 82.47 1.91 37.80 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 11 3 # 11 B 325 ARG B 184 ARG~? 19.31 MG MG B 701 B 342 ASP B 177 ASP~? 29.47 MG MG B 701 B 531 ARG B 261 ARG^? 24.22 MG MG B 701 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 70.96 1.73 26.45 71.21 2.29 23.40 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 75.29 2.41 39.09 75.08 4.12 40.31 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 79.96 -6.70 27.13 79.05 -6.72 24.18 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 12 3 # 12 B 325 ARG B 258 ARG^? 33.01 MG MG B 701 B 342 ASP B 221 ASP~? 37.75 MG MG B 701 B 531 ARG B 261 ARG^? 24.22 MG MG B 701 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 83.96 -0.40 36.39 82.47 1.91 37.80 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 87.06 -12.52 38.62 87.72 -12.86 40.65 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 79.96 -6.70 27.13 79.05 -6.72 24.18 1asy_c00 source 1asy TRANSFER RIBONUCLEIC ACID (TRNAASP) : 12 hits 1asy_c00 naa= 3 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 1 3 # 1 A 325 ARG A 138 ARG^? 25.45 MG MG B 701 A 342 ASP A 165 ASP^? 19.82 MG MG B 701 A 531 ARG A 126 ARG^? 30.85 MG MG B 701 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 56.09 11.79 37.51 58.92 12.66 36.83 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 49.47 0.04 38.38 48.02 -0.73 39.68 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 48.08 15.54 42.27 50.77 14.42 43.32 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 2 3 # 2 A 325 ARG A 184 ARG~? 36.26 MG MG B 701 A 342 ASP A 177 ASP~? 19.64 MG MG B 701 A 531 ARG A 261 ARG^? 35.46 MG MG B 701 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 59.62 -7.21 56.11 59.92 -9.15 58.50 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 57.48 -8.32 42.16 55.62 -9.31 42.19 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 64.47 3.15 51.80 64.61 3.05 54.85 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 3 3 # 3 A 325 ARG A 258 ARG~? 19.65 MG MG B 701 A 342 ASP A 221 ASP~? 23.86 MG MG B 701 A 531 ARG A 261 ARG^? 35.46 MG MG B 701 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 65.98 -2.88 40.97 66.14 -4.57 38.35 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 63.27 9.05 38.25 62.91 9.80 36.26 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 64.47 3.15 51.80 64.61 3.05 54.85 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 4 3 # 4 A 325 ARG A 261 ARG^? 35.46 MG MG B 701 A 342 ASP B 165 ASP^? 26.59 MG MG B 701 A 531 ARG A 184 ARG~? 36.26 MG MG B 701 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 64.47 3.15 51.80 64.61 3.05 54.85 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 71.61 -6.68 45.38 69.65 -6.30 44.66 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 59.62 -7.21 56.11 59.92 -9.15 58.50 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 5 3 # 5 A 325 ARG A 261 ARG^? 35.46 MG MG B 701 A 342 ASP B 165 ASP^? 26.59 MG MG B 701 A 531 ARG A 253 ARG^? 30.10 MG MG B 701 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 64.47 3.15 51.80 64.61 3.05 54.85 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 71.61 -6.68 45.38 69.65 -6.30 44.66 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 68.27 8.63 43.05 70.75 9.38 41.34 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 6 3 # 6 A 325 ARG B 138 ARG^? 35.64 MG MG B 701 A 342 ASP B 165 ASP^? 26.59 MG MG B 701 A 531 ARG B 126 ARG^? 29.16 MG MG B 701 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 81.28 -15.50 42.88 84.08 -15.53 41.69 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 71.61 -6.68 45.38 69.65 -6.30 44.66 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 72.93 -22.54 42.02 74.52 -21.06 39.83 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 7 3 # 7 A 325 ARG B 178 ARG~? 37.59 MG MG B 701 A 342 ASP B 165 ASP^? 26.59 MG MG B 701 A 531 ARG A 253 ARG^? 30.10 MG MG B 701 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 79.48 2.47 45.22 81.37 1.59 47.51 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 71.61 -6.68 45.38 69.65 -6.30 44.66 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 68.27 8.63 43.05 70.75 9.38 41.34 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 8 3 # 8 A 325 ARG B 178 ARG~? 37.59 MG MG B 701 A 342 ASP B 165 ASP^? 26.59 MG MG B 701 A 531 ARG B 258 ARG^? 33.01 MG MG B 701 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 79.48 2.47 45.22 81.37 1.59 47.51 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 71.61 -6.68 45.38 69.65 -6.30 44.66 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 83.96 -0.40 36.39 82.47 1.91 37.80 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 9 3 # 9 A 325 ARG B 184 ARG~? 19.31 MG MG B 701 A 342 ASP B 177 ASP~? 29.47 MG MG B 701 A 531 ARG B 261 ARG^? 24.22 MG MG B 701 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 70.96 1.73 26.45 71.21 2.29 23.40 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 75.29 2.41 39.09 75.08 4.12 40.31 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 79.96 -6.70 27.13 79.05 -6.72 24.18 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 10 3 # 10 A 325 ARG B 258 ARG^? 33.01 MG MG B 701 A 342 ASP B 221 ASP~? 37.75 MG MG B 701 A 531 ARG B 261 ARG^? 24.22 MG MG B 701 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 83.96 -0.40 36.39 82.47 1.91 37.80 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 87.06 -12.52 38.62 87.72 -12.86 40.65 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 79.96 -6.70 27.13 79.05 -6.72 24.18 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 11 3 # 11 A 325 ARG B 261 ARG^? 24.22 MG MG B 701 A 342 ASP B 221 ASP~? 37.75 MG MG B 701 A 531 ARG B 264 ARG~? 37.47 MG MG B 701 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 79.96 -6.70 27.13 79.05 -6.72 24.18 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 87.06 -12.52 38.62 87.72 -12.86 40.65 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 89.36 -12.56 22.42 91.87 -14.25 23.18 1asy_c01 source 1asy TRANSFER RIBONUCLEIC ACID (TRNAASP) : 11 hits 1asy_c01 naa= 3 ULMN 3 1b02_c02 THYMIDYLATE SYNTHASE user 1 3 # 1 A 71 GLU A 88 GLU~? 31.24 MG MG B 701 A 161 CYH A 93 CYH~? 25.81 MG MG B 701 A 192 ASN A 90 ASN~? 26.35 MG MG B 701 coo 1.71 48.67 0.56 0.18 47.85 1.75 33.25 12.86 29.05 32.48 12.06 30.82 coo -2.78 50.68 10.78 -4.68 50.49 8.71 42.80 17.19 26.05 43.95 14.89 27.02 coo -0.10 43.44 8.03 -1.33 45.05 7.36 39.76 12.43 23.01 37.74 11.92 22.68 1b02_c02 source 1b02 THYMIDYLATE SYNTHASE : 1 hits 1b02_c02 naa= 3 ULMN 3 1b2m_c00 5'-R(*GP*(CH2)U)-3' user 1 3 # 1 A 40 HIS A 98 HIS~? 27.68 MG MG B 701 A 58 GLU A 70 GLU~? 25.37 MG MG B 701 A 92 HIS A 104 HIS^? 33.98 MG MG B 701 coo 12.70 27.74 1.76 10.77 27.11 1.24 50.40 19.60 21.83 50.19 18.76 19.91 coo 11.38 23.30 3.20 9.27 23.34 3.13 49.68 14.74 24.80 49.71 16.74 24.08 coo 2.67 19.36 1.56 3.51 21.24 1.94 45.13 22.80 31.21 43.22 23.40 30.59 ULMN 3 1b2m_c00 5'-R(*GP*(CH2)U)-3' user 2 3 # 2 A 40 HIS B 98 HIS~? 50.51 MG MG B 701 A 58 GLU B 70 GLU~? 46.48 MG MG B 701 A 92 HIS B 104 HIS^? 43.18 MG MG B 701 coo 12.70 27.74 1.76 10.77 27.11 1.24 84.18 -25.10 59.33 84.20 -24.17 61.22 coo 11.38 23.30 3.20 9.27 23.34 3.13 80.85 -20.85 57.05 81.87 -22.62 57.55 coo 2.67 19.36 1.56 3.51 21.24 1.94 76.52 -29.94 52.39 75.18 -30.89 53.68 1b2m_c00 source 1b2m 5'-R(*GP*(CH2)U)-3' : 2 hits 1b2m_c00 naa= 3 ULMN 3 1b5d_c04 DEOXYCYTIDYLATE HYDROXYMETHYLASE user 1 3 # 1 A 60 GLU A 219 GLU~? 34.01 MG MG B 701 A 148 CYH A 150 CYH^? 20.80 MG MG B 701 A 179 ASP A 221 ASP~? 23.86 MG MG B 701 coo 20.47 15.77 27.32 19.04 14.27 26.94 59.27 18.40 40.08 59.60 20.33 40.74 coo 21.87 3.71 21.27 20.32 3.55 23.64 54.05 4.31 36.56 55.14 4.53 39.16 coo 17.09 11.24 20.19 17.85 10.05 21.76 63.27 9.05 38.25 62.91 9.80 36.26 1b5d_c04 source 1b5d DEOXYCYTIDYLATE HYDROXYMETHYLASE : 1 hits 1b5d_c04 naa= 3 ULMN 3 1b5d_c05 DEOXYCYTIDYLATE HYDROXYMETHYLASE user 1 3 # 1 B 60 GLU A 87 GLU~? 27.37 MG MG B 701 B 148 CYH A 93 CYH~? 25.81 MG MG B 701 B 179 ASP A 91 ASP~? 30.86 MG MG B 701 coo 34.11 -11.05 -1.22 32.89 -9.54 -2.05 33.74 9.75 22.88 32.80 8.03 23.69 coo 30.30 0.93 3.58 31.01 1.18 0.88 42.80 17.19 26.05 43.95 14.89 27.02 coo 26.42 -6.51 0.59 28.13 -5.32 0.24 36.10 16.42 24.55 35.02 15.53 22.85 ULMN 3 1b5d_c05 DEOXYCYTIDYLATE HYDROXYMETHYLASE user 2 3 # 2 B 60 GLU A 219 GLU~? 34.01 MG MG B 701 B 148 CYH A 150 CYH^? 20.80 MG MG B 701 B 179 ASP A 221 ASP~? 23.86 MG MG B 701 coo 34.11 -11.05 -1.22 32.89 -9.54 -2.05 59.27 18.40 40.08 59.60 20.33 40.74 coo 30.30 0.93 3.58 31.01 1.18 0.88 54.05 4.31 36.56 55.14 4.53 39.16 coo 26.42 -6.51 0.59 28.13 -5.32 0.24 63.27 9.05 38.25 62.91 9.80 36.26 1b5d_c05 source 1b5d DEOXYCYTIDYLATE HYDROXYMETHYLASE : 2 hits 1b5d_c05 naa= 3 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 1 3 # 1 A 137 ARG A 122 ARG~? 29.12 MG MG B 701 A 141 THR A 103 THR~? 32.91 MG MG B 701 A 235 ASP A 221 ASP~? 23.86 MG MG B 701 coo 6.21 93.81 36.58 4.58 96.33 37.17 57.02 18.56 28.04 58.98 19.78 30.13 coo 6.80 92.87 28.33 4.91 92.74 27.40 50.29 22.50 34.59 50.45 21.47 36.44 coo 12.98 90.36 47.57 11.26 89.62 46.62 63.27 9.05 38.25 62.91 9.80 36.26 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 2 3 # 2 A 137 ARG A 163 ARG^? 22.70 MG MG B 701 A 141 THR A 154 THR^? 30.24 MG MG B 701 A 235 ASP A 177 ASP~? 19.64 MG MG B 701 coo 6.21 93.81 36.58 4.58 96.33 37.17 45.39 -0.99 44.51 45.45 -0.07 41.63 coo 6.80 92.87 28.33 4.91 92.74 27.40 45.72 6.38 46.40 47.33 7.44 47.44 coo 12.98 90.36 47.57 11.26 89.62 46.62 57.48 -8.32 42.16 55.62 -9.31 42.19 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 3 3 # 3 A 137 ARG A 178 ARG~? 13.19 MG MG B 701 A 141 THR B 208 THR~? 10.07 MG MG B 701 A 235 ASP B 165 ASP^? 26.59 MG MG B 701 coo 6.21 93.81 36.58 4.58 96.33 37.17 60.75 -6.17 35.55 62.65 -6.30 33.15 coo 6.80 92.87 28.33 4.91 92.74 27.40 60.49 -3.20 26.65 60.84 -1.10 26.85 coo 12.98 90.36 47.57 11.26 89.62 46.62 71.61 -6.68 45.38 69.65 -6.30 44.66 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 4 3 # 4 A 137 ARG B 163 ARG^? 22.33 MG MG B 701 A 141 THR B 154 THR^? 21.42 MG MG B 701 A 235 ASP B 177 ASP~? 29.47 MG MG B 701 coo 6.21 93.81 36.58 4.58 96.33 37.17 66.22 -8.44 41.95 64.50 -6.02 42.66 coo 6.80 92.87 28.33 4.91 92.74 27.40 66.76 -14.70 39.39 67.99 -15.56 37.81 coo 12.98 90.36 47.57 11.26 89.62 46.62 75.29 2.41 39.09 75.08 4.12 40.31 1bd3_c00 source 1bd3 URACIL PHOSPHORIBOSYLTRANSFERASE : 4 hits 1bd3_c00 naa= 3 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 1 3 # 1 D 137 ARG A 122 ARG~? 29.12 MG MG B 701 D 141 THR A 103 THR~? 32.91 MG MG B 701 D 235 ASP A 221 ASP~? 23.86 MG MG B 701 coo -8.33 92.80 100.06 -7.71 95.33 98.44 57.02 18.56 28.04 58.98 19.78 30.13 coo -9.24 93.49 108.77 -7.37 94.21 109.61 50.29 22.50 34.59 50.45 21.47 36.44 coo -14.64 87.74 89.51 -12.89 87.43 90.65 63.27 9.05 38.25 62.91 9.80 36.26 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 2 3 # 2 D 137 ARG A 163 ARG^? 22.70 MG MG B 701 D 141 THR A 154 THR^? 30.24 MG MG B 701 D 235 ASP A 177 ASP~? 19.64 MG MG B 701 coo -8.33 92.80 100.06 -7.71 95.33 98.44 45.39 -0.99 44.51 45.45 -0.07 41.63 coo -9.24 93.49 108.77 -7.37 94.21 109.61 45.72 6.38 46.40 47.33 7.44 47.44 coo -14.64 87.74 89.51 -12.89 87.43 90.65 57.48 -8.32 42.16 55.62 -9.31 42.19 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 3 3 # 3 D 137 ARG A 178 ARG~? 13.19 MG MG B 701 D 141 THR B 208 THR~? 10.07 MG MG B 701 D 235 ASP B 165 ASP^? 26.59 MG MG B 701 coo -8.33 92.80 100.06 -7.71 95.33 98.44 60.75 -6.17 35.55 62.65 -6.30 33.15 coo -9.24 93.49 108.77 -7.37 94.21 109.61 60.49 -3.20 26.65 60.84 -1.10 26.85 coo -14.64 87.74 89.51 -12.89 87.43 90.65 71.61 -6.68 45.38 69.65 -6.30 44.66 1bd3_c01 source 1bd3 URACIL PHOSPHORIBOSYLTRANSFERASE : 3 hits 1bd3_c01 naa= 3 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 1 3 # 1 C 137 ARG A 122 ARG~? 29.12 MG MG B 701 C 141 THR A 103 THR~? 32.91 MG MG B 701 C 235 ASP A 221 ASP~? 23.86 MG MG B 701 coo -5.79 67.26 36.83 -4.57 64.58 37.74 57.02 18.56 28.04 58.98 19.78 30.13 coo -6.81 68.31 28.28 -4.82 68.47 27.57 50.29 22.50 34.59 50.45 21.47 36.44 coo -13.01 70.96 47.58 -11.44 71.65 46.34 63.27 9.05 38.25 62.91 9.80 36.26 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 2 3 # 2 C 137 ARG A 163 ARG^? 22.70 MG MG B 701 C 141 THR A 154 THR^? 30.24 MG MG B 701 C 235 ASP A 177 ASP~? 19.64 MG MG B 701 coo -5.79 67.26 36.83 -4.57 64.58 37.74 45.39 -0.99 44.51 45.45 -0.07 41.63 coo -6.81 68.31 28.28 -4.82 68.47 27.57 45.72 6.38 46.40 47.33 7.44 47.44 coo -13.01 70.96 47.58 -11.44 71.65 46.34 57.48 -8.32 42.16 55.62 -9.31 42.19 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 3 3 # 3 C 137 ARG A 178 ARG~? 13.19 MG MG B 701 C 141 THR B 208 THR~? 10.07 MG MG B 701 C 235 ASP B 165 ASP^? 26.59 MG MG B 701 coo -5.79 67.26 36.83 -4.57 64.58 37.74 60.75 -6.17 35.55 62.65 -6.30 33.15 coo -6.81 68.31 28.28 -4.82 68.47 27.57 60.49 -3.20 26.65 60.84 -1.10 26.85 coo -13.01 70.96 47.58 -11.44 71.65 46.34 71.61 -6.68 45.38 69.65 -6.30 44.66 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 4 3 # 4 C 137 ARG B 163 ARG^? 22.33 MG MG B 701 C 141 THR B 154 THR^? 21.42 MG MG B 701 C 235 ASP B 177 ASP~? 29.47 MG MG B 701 coo -5.79 67.26 36.83 -4.57 64.58 37.74 66.22 -8.44 41.95 64.50 -6.02 42.66 coo -6.81 68.31 28.28 -4.82 68.47 27.57 66.76 -14.70 39.39 67.99 -15.56 37.81 coo -13.01 70.96 47.58 -11.44 71.65 46.34 75.29 2.41 39.09 75.08 4.12 40.31 1bd3_c02 source 1bd3 URACIL PHOSPHORIBOSYLTRANSFERASE : 4 hits 1bd3_c02 naa= 3 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 1 3 # 1 B 137 ARG A 89 ARG~? 21.03 MG MG B 701 B 141 THR A 85 THR~? 28.58 MG MG B 701 B 235 ASP A 165 ASP^? 19.82 MG MG B 701 coo 8.13 67.41 100.27 7.18 68.35 97.45 41.91 10.07 29.06 41.51 7.36 27.58 coo 8.28 67.78 108.81 6.22 67.65 109.43 34.76 8.28 28.95 32.79 9.05 28.47 coo 14.55 73.52 89.47 12.81 73.95 90.56 49.47 0.04 38.38 48.02 -0.73 39.68 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 2 3 # 2 B 137 ARG A 163 ARG^? 22.70 MG MG B 701 B 141 THR A 154 THR^? 30.24 MG MG B 701 B 235 ASP A 177 ASP~? 19.64 MG MG B 701 coo 8.13 67.41 100.27 7.18 68.35 97.45 45.39 -0.99 44.51 45.45 -0.07 41.63 coo 8.28 67.78 108.81 6.22 67.65 109.43 45.72 6.38 46.40 47.33 7.44 47.44 coo 14.55 73.52 89.47 12.81 73.95 90.56 57.48 -8.32 42.16 55.62 -9.31 42.19 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 3 3 # 3 B 137 ARG A 178 ARG~? 13.19 MG MG B 701 B 141 THR B 208 THR~? 10.07 MG MG B 701 B 235 ASP B 165 ASP^? 26.59 MG MG B 701 coo 8.13 67.41 100.27 7.18 68.35 97.45 60.75 -6.17 35.55 62.65 -6.30 33.15 coo 8.28 67.78 108.81 6.22 67.65 109.43 60.49 -3.20 26.65 60.84 -1.10 26.85 coo 14.55 73.52 89.47 12.81 73.95 90.56 71.61 -6.68 45.38 69.65 -6.30 44.66 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 4 3 # 4 B 137 ARG A 258 ARG~? 19.65 MG MG B 701 B 141 THR B 153 THR^? 25.01 MG MG B 701 B 235 ASP A 221 ASP~? 23.86 MG MG B 701 coo 8.13 67.41 100.27 7.18 68.35 97.45 65.98 -2.88 40.97 66.14 -4.57 38.35 coo 8.28 67.78 108.81 6.22 67.65 109.43 68.50 -12.99 42.25 67.26 -12.32 43.93 coo 14.55 73.52 89.47 12.81 73.95 90.56 63.27 9.05 38.25 62.91 9.80 36.26 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 5 3 # 5 B 137 ARG B 163 ARG^? 22.33 MG MG B 701 B 141 THR B 154 THR^? 21.42 MG MG B 701 B 235 ASP B 177 ASP~? 29.47 MG MG B 701 coo 8.13 67.41 100.27 7.18 68.35 97.45 66.22 -8.44 41.95 64.50 -6.02 42.66 coo 8.28 67.78 108.81 6.22 67.65 109.43 66.76 -14.70 39.39 67.99 -15.56 37.81 coo 14.55 73.52 89.47 12.81 73.95 90.56 75.29 2.41 39.09 75.08 4.12 40.31 1bd3_c03 source 1bd3 URACIL PHOSPHORIBOSYLTRANSFERASE : 5 hits 1bd3_c03 naa= 3 ULMN 3 1bf2_c00 ISOAMYLASE user 1 3 # 1 375 ASP B 187 ASP~? 20.66 MG MG B 701 435 GLU B 186 GLU~? 15.37 MG MG B 701 510 ASP A 144 ASP~? 20.24 MG MG B 701 coo 88.62 69.90 41.16 89.05 70.67 43.04 74.06 -4.33 24.81 74.57 -2.40 25.55 coo 89.52 76.11 40.17 89.01 75.16 41.97 69.45 -0.46 21.54 67.97 0.05 22.96 coo 84.89 77.60 46.67 85.63 75.79 46.03 69.22 6.09 27.43 70.24 4.65 26.30 1bf2_c00 source 1bf2 ISOAMYLASE : 1 hits 1bf2_c00 naa= 3 ULMN 3 1bfd_c00 BENZOYLFORMATE DECARBOXYLASE user 1 3 # 1 28 GLU A 70 GLU~? 25.37 MG MG B 701 70 HIS A 98 HIS~? 27.68 MG MG B 701 281 HIS B 192 HIS~? 26.17 MG MG B 701 coo 66.09 46.17 155.81 66.77 48.19 155.70 49.68 14.74 24.80 49.71 16.74 24.08 coo 69.05 50.55 157.03 68.00 52.29 156.51 50.40 19.60 21.83 50.19 18.76 19.91 coo 100.93 36.73 156.02 100.47 38.42 157.18 76.10 -2.97 9.85 78.15 -2.61 9.73 1bfd_c00 source 1bfd BENZOYLFORMATE DECARBOXYLASE : 1 hits 1bfd_c00 naa= 3 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 1 3 # 1 A 382 ARG A 89 ARG~? 21.03 MG MG B 701 A 451 GLU A 78 GLU~? 24.76 MG MG B 701 A 540 GLU A 88 GLU~? 31.24 MG MG B 701 coo 79.04 80.20 80.81 79.58 81.40 83.63 41.91 10.07 29.06 41.51 7.36 27.58 coo 81.34 87.29 87.22 82.36 86.09 88.61 36.42 4.32 29.08 34.55 4.86 28.21 coo 79.94 80.46 88.84 81.11 81.36 87.27 33.25 12.86 29.05 32.48 12.06 30.82 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 2 3 # 2 A 382 ARG A 89 ARG~? 21.03 MG MG B 701 A 451 GLU A 87 GLU~? 27.37 MG MG B 701 A 540 GLU A 78 GLU~? 24.76 MG MG B 701 coo 79.04 80.20 80.81 79.58 81.40 83.63 41.91 10.07 29.06 41.51 7.36 27.58 coo 81.34 87.29 87.22 82.36 86.09 88.61 33.74 9.75 22.88 32.80 8.03 23.69 coo 79.94 80.46 88.84 81.11 81.36 87.27 36.42 4.32 29.08 34.55 4.86 28.21 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 3 3 # 3 A 382 ARG A 89 ARG~? 21.03 MG MG B 701 A 451 GLU A 87 GLU~? 27.37 MG MG B 701 A 540 GLU A 88 GLU~? 31.24 MG MG B 701 coo 79.04 80.20 80.81 79.58 81.40 83.63 41.91 10.07 29.06 41.51 7.36 27.58 coo 81.34 87.29 87.22 82.36 86.09 88.61 33.74 9.75 22.88 32.80 8.03 23.69 coo 79.94 80.46 88.84 81.11 81.36 87.27 33.25 12.86 29.05 32.48 12.06 30.82 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 4 3 # 4 A 382 ARG A 89 ARG~? 21.03 MG MG B 701 A 451 GLU A 88 GLU~? 31.24 MG MG B 701 A 540 GLU A 78 GLU~? 24.76 MG MG B 701 coo 79.04 80.20 80.81 79.58 81.40 83.63 41.91 10.07 29.06 41.51 7.36 27.58 coo 81.34 87.29 87.22 82.36 86.09 88.61 33.25 12.86 29.05 32.48 12.06 30.82 coo 79.94 80.46 88.84 81.11 81.36 87.27 36.42 4.32 29.08 34.55 4.86 28.21 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 5 3 # 5 A 382 ARG A 122 ARG~? 29.12 MG MG B 701 A 451 GLU A 68 GLU~? 16.08 MG MG B 701 A 540 GLU A 70 GLU~? 25.37 MG MG B 701 coo 79.04 80.20 80.81 79.58 81.40 83.63 57.02 18.56 28.04 58.98 19.78 30.13 coo 81.34 87.29 87.22 82.36 86.09 88.61 56.21 8.51 25.84 57.91 7.36 26.07 coo 79.94 80.46 88.84 81.11 81.36 87.27 49.68 14.74 24.80 49.71 16.74 24.08 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 6 3 # 6 A 382 ARG B 89 ARG~? 39.23 MG MG B 701 A 451 GLU B 87 GLU~? 47.03 MG MG B 701 A 540 GLU B 88 GLU~? 39.12 MG MG B 701 coo 79.04 80.20 80.81 79.58 81.40 83.63 70.16 -17.97 55.88 70.89 -15.54 57.64 coo 81.34 87.29 87.22 82.36 86.09 88.61 66.89 -21.09 64.87 65.61 -20.97 66.54 coo 79.94 80.46 88.84 81.11 81.36 87.27 64.81 -21.91 58.58 62.70 -21.80 58.39 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 7 3 # 7 A 382 ARG B 138 ARG^? 35.64 MG MG B 701 A 451 GLU B 219 GLU~? 39.54 MG MG B 701 A 540 GLU B 218 GLU~? 32.37 MG MG B 701 coo 79.04 80.20 80.81 79.58 81.40 83.63 81.28 -15.50 42.88 84.08 -15.53 41.69 coo 81.34 87.29 87.22 82.36 86.09 88.61 85.46 -21.90 40.90 85.71 -22.21 42.97 coo 79.94 80.46 88.84 81.11 81.36 87.27 79.74 -21.86 40.41 79.27 -22.32 38.45 1bhg_c04 source 1bhg BETA-GLUCURONIDASE : 7 hits 1bhg_c04 naa= 3 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 1 3 # 1 B 382 ARG A 89 ARG~? 21.03 MG MG B 701 B 451 GLU A 87 GLU~? 27.37 MG MG B 701 B 540 GLU A 78 GLU~? 24.76 MG MG B 701 coo 82.21 41.07 119.14 83.95 40.66 116.59 41.91 10.07 29.06 41.51 7.36 27.58 coo 86.52 35.28 112.74 87.08 36.38 110.99 33.74 9.75 22.88 32.80 8.03 23.69 coo 83.38 41.19 112.55 85.47 40.59 112.72 36.42 4.32 29.08 34.55 4.86 28.21 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 2 3 # 2 B 382 ARG A 138 ARG^? 25.45 MG MG B 701 B 451 GLU A 219 GLU~? 34.01 MG MG B 701 B 540 GLU A 218 GLU~? 32.55 MG MG B 701 coo 82.21 41.07 119.14 83.95 40.66 116.59 56.09 11.79 37.51 58.92 12.66 36.83 coo 86.52 35.28 112.74 87.08 36.38 110.99 59.27 18.40 40.08 59.60 20.33 40.74 coo 83.38 41.19 112.55 85.47 40.59 112.72 54.56 16.53 40.79 53.76 18.19 41.81 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 3 3 # 3 B 382 ARG B 89 ARG~? 39.23 MG MG B 701 B 451 GLU B 87 GLU~? 47.03 MG MG B 701 B 540 GLU B 88 GLU~? 39.12 MG MG B 701 coo 82.21 41.07 119.14 83.95 40.66 116.59 70.16 -17.97 55.88 70.89 -15.54 57.64 coo 86.52 35.28 112.74 87.08 36.38 110.99 66.89 -21.09 64.87 65.61 -20.97 66.54 coo 83.38 41.19 112.55 85.47 40.59 112.72 64.81 -21.91 58.58 62.70 -21.80 58.39 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 4 3 # 4 B 382 ARG B 138 ARG^? 35.64 MG MG B 701 B 451 GLU B 219 GLU~? 39.54 MG MG B 701 B 540 GLU B 218 GLU~? 32.37 MG MG B 701 coo 82.21 41.07 119.14 83.95 40.66 116.59 81.28 -15.50 42.88 84.08 -15.53 41.69 coo 86.52 35.28 112.74 87.08 36.38 110.99 85.46 -21.90 40.90 85.71 -22.21 42.97 coo 83.38 41.19 112.55 85.47 40.59 112.72 79.74 -21.86 40.41 79.27 -22.32 38.45 1bhg_c05 source 1bhg BETA-GLUCURONIDASE : 4 hits 1bhg_c05 naa= 3 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 1 3 # 1 118 ARG A 163 ARG^? 22.70 MG MG B 701 183 LYS A 175 LYS~? 16.95 MG MG B 701 317 ARG A 261 ARG^? 35.46 MG MG B 701 coo 76.57 109.19 73.41 73.86 110.26 72.16 45.39 -0.99 44.51 45.45 -0.07 41.63 coo 82.09 117.51 66.37 80.60 114.32 71.44 54.19 -7.18 37.22 54.81 -12.82 38.86 coo 65.21 120.62 58.76 63.62 123.14 59.66 64.47 3.15 51.80 64.61 3.05 54.85 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 2 3 # 2 118 ARG A 258 ARG~? 19.65 MG MG B 701 183 LYS B 175 LYS~? 34.92 MG MG B 701 317 ARG B 138 ARG^? 35.64 MG MG B 701 coo 76.57 109.19 73.41 73.86 110.26 72.16 65.98 -2.88 40.97 66.14 -4.57 38.35 coo 82.09 117.51 66.37 80.60 114.32 71.44 75.00 1.45 45.20 75.48 7.65 46.06 coo 65.21 120.62 58.76 63.62 123.14 59.66 81.28 -15.50 42.88 84.08 -15.53 41.69 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 3 3 # 3 118 ARG A 258 ARG~? 19.65 MG MG B 701 183 LYS B 175 LYS~? 34.92 MG MG B 701 317 ARG B 261 ARG^? 24.22 MG MG B 701 coo 76.57 109.19 73.41 73.86 110.26 72.16 65.98 -2.88 40.97 66.14 -4.57 38.35 coo 82.09 117.51 66.37 80.60 114.32 71.44 75.00 1.45 45.20 75.48 7.65 46.06 coo 65.21 120.62 58.76 63.62 123.14 59.66 79.96 -6.70 27.13 79.05 -6.72 24.18 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 4 3 # 4 118 ARG B 163 ARG^? 22.33 MG MG B 701 183 LYS A 175 LYS~? 16.95 MG MG B 701 317 ARG A 138 ARG^? 25.45 MG MG B 701 coo 76.57 109.19 73.41 73.86 110.26 72.16 66.22 -8.44 41.95 64.50 -6.02 42.66 coo 82.09 117.51 66.37 80.60 114.32 71.44 54.19 -7.18 37.22 54.81 -12.82 38.86 coo 65.21 120.62 58.76 63.62 123.14 59.66 56.09 11.79 37.51 58.92 12.66 36.83 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 5 3 # 5 118 ARG B 163 ARG^? 22.33 MG MG B 701 183 LYS B 175 LYS~? 34.92 MG MG B 701 317 ARG B 261 ARG^? 24.22 MG MG B 701 coo 76.57 109.19 73.41 73.86 110.26 72.16 66.22 -8.44 41.95 64.50 -6.02 42.66 coo 82.09 117.51 66.37 80.60 114.32 71.44 75.00 1.45 45.20 75.48 7.65 46.06 coo 65.21 120.62 58.76 63.62 123.14 59.66 79.96 -6.70 27.13 79.05 -6.72 24.18 1bib_c00 source 1bib BIRA BIFUNCTIONAL PROTEIN (ACTS AS BIOTIN OPER: 5 hits 1bib_c00 naa= 3 ULMN 3 1bqc_c01 BETA-MANNANASE user 1 3 # 1 A 50 ARG A 138 ARG^? 25.45 MG MG B 701 A 128 GLU A 219 GLU~? 34.01 MG MG B 701 A 225 GLU A 218 GLU~? 32.55 MG MG B 701 coo 38.56 19.11 14.83 37.12 21.00 16.76 56.09 11.79 37.51 58.92 12.66 36.83 coo 36.48 24.43 22.02 36.86 26.34 21.13 59.27 18.40 40.08 59.60 20.33 40.74 coo 40.16 23.71 17.01 38.52 24.96 17.40 54.56 16.53 40.79 53.76 18.19 41.81 ULMN 3 1bqc_c01 BETA-MANNANASE user 2 3 # 2 A 50 ARG B 89 ARG~? 39.23 MG MG B 701 A 128 GLU B 87 GLU~? 47.03 MG MG B 701 A 225 GLU B 88 GLU~? 39.12 MG MG B 701 coo 38.56 19.11 14.83 37.12 21.00 16.76 70.16 -17.97 55.88 70.89 -15.54 57.64 coo 36.48 24.43 22.02 36.86 26.34 21.13 66.89 -21.09 64.87 65.61 -20.97 66.54 coo 40.16 23.71 17.01 38.52 24.96 17.40 64.81 -21.91 58.58 62.70 -21.80 58.39 ULMN 3 1bqc_c01 BETA-MANNANASE user 3 3 # 3 A 50 ARG B 138 ARG^? 35.64 MG MG B 701 A 128 GLU B 219 GLU~? 39.54 MG MG B 701 A 225 GLU B 218 GLU~? 32.37 MG MG B 701 coo 38.56 19.11 14.83 37.12 21.00 16.76 81.28 -15.50 42.88 84.08 -15.53 41.69 coo 36.48 24.43 22.02 36.86 26.34 21.13 85.46 -21.90 40.90 85.71 -22.21 42.97 coo 40.16 23.71 17.01 38.52 24.96 17.40 79.74 -21.86 40.41 79.27 -22.32 38.45 1bqc_c01 source 1bqc BETA-MANNANASE : 3 hits 1bqc_c01 naa= 3 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 1 3 # 1 A 109 PHE A 73 PHE~? 23.31 MG MG B 701 A 205 ASP A 165 ASP^? 19.82 MG MG B 701 A 236 LYS A 172 LYS~? 6.12 MG MG B 701 coo 4.14 2.10 36.34 6.69 3.08 36.92 46.15 11.22 29.51 44.01 12.03 31.08 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 49.47 0.04 38.38 48.02 -0.73 39.68 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 50.20 -3.67 28.72 53.15 -8.47 28.45 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 2 3 # 2 A 109 PHE A 142 PHE~? 13.47 MG MG B 701 A 205 ASP A 165 ASP^? 19.82 MG MG B 701 A 236 LYS A 172 LYS~? 6.12 MG MG B 701 coo 4.14 2.10 36.34 6.69 3.08 36.92 62.78 -0.55 30.89 63.67 -3.12 31.49 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 49.47 0.04 38.38 48.02 -0.73 39.68 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 50.20 -3.67 28.72 53.15 -8.47 28.45 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 3 3 # 3 A 109 PHE A 259 PHE^? 23.41 MG MG B 701 A 205 ASP B 161 ASP^? 15.44 MG MG B 701 A 236 LYS A 175 LYS~? 16.95 MG MG B 701 coo 4.14 2.10 36.34 6.69 3.08 36.92 60.86 3.12 42.58 59.55 5.17 41.16 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 63.88 -11.38 34.74 64.49 -9.36 34.64 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 54.19 -7.18 37.22 54.81 -12.82 38.86 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 4 3 # 4 A 109 PHE B 73 PHE~? 38.23 MG MG B 701 A 205 ASP B 165 ASP^? 26.59 MG MG B 701 A 236 LYS B 172 LYS~? 42.28 MG MG B 701 coo 4.14 2.10 36.34 6.69 3.08 36.92 75.10 -18.32 54.35 72.78 -19.57 53.51 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 71.61 -6.68 45.38 69.65 -6.30 44.66 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 75.30 -2.84 54.33 79.74 -2.40 56.36 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 5 3 # 5 A 109 PHE B 142 PHE~? 39.32 MG MG B 701 A 205 ASP B 165 ASP^? 26.59 MG MG B 701 A 236 LYS B 172 LYS~? 42.28 MG MG B 701 coo 4.14 2.10 36.34 6.69 3.08 36.92 86.08 -2.81 46.36 85.54 -0.20 45.70 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 71.61 -6.68 45.38 69.65 -6.30 44.66 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 75.30 -2.84 54.33 79.74 -2.40 56.36 1bs0_c01 source 1bs0 8-AMINO-7-OXONANOATE SYNTHASE : 5 hits 1bs0_c01 naa= 3 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 1 3 # 1 A 50 GLN A 213 GLN~? 34.86 MG MG B 701 A 91 LEU A 156 LEU~? 35.04 MG MG B 701 A 133 GLU A 231 GLU~? 40.57 MG MG B 701 coo 43.58 43.67 66.73 42.32 42.78 68.15 49.72 8.72 50.78 48.64 10.39 51.50 coo 38.58 45.09 70.44 38.28 45.21 72.59 42.21 10.50 50.11 43.44 11.59 48.63 coo 44.05 36.87 70.65 43.15 38.64 69.97 46.37 8.02 59.96 46.65 9.30 58.33 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 2 3 # 2 A 50 GLN A 227 GLN^? 40.32 MG MG B 701 A 91 LEU A 245 LEU~? 43.05 MG MG B 701 A 133 GLU A 231 GLU~? 40.57 MG MG B 701 coo 43.58 43.67 66.73 42.32 42.78 68.15 54.41 4.39 59.17 53.11 5.19 60.64 coo 38.58 45.09 70.44 38.28 45.21 72.59 55.41 3.40 65.10 54.46 2.65 63.31 coo 44.05 36.87 70.65 43.15 38.64 69.97 46.37 8.02 59.96 46.65 9.30 58.33 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 3 3 # 3 A 50 GLN A 227 GLN^? 40.32 MG MG B 701 A 91 LEU A 245 LEU~? 43.05 MG MG B 701 A 133 GLU A 248 GLU~? 42.11 MG MG B 701 coo 43.58 43.67 66.73 42.32 42.78 68.15 54.41 4.39 59.17 53.11 5.19 60.64 coo 38.58 45.09 70.44 38.28 45.21 72.59 55.41 3.40 65.10 54.46 2.65 63.31 coo 44.05 36.87 70.65 43.15 38.64 69.97 61.57 10.69 58.38 61.15 12.75 58.68 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 4 3 # 4 A 50 GLN B 213 GLN~? 19.92 MG MG B 701 A 91 LEU B 156 LEU~? 20.91 MG MG B 701 A 133 GLU B 134 GLU^? 26.11 MG MG B 701 coo 43.58 43.67 66.73 42.32 42.78 68.15 69.29 -16.23 33.49 68.51 -18.13 33.12 coo 38.58 45.09 70.44 38.28 45.21 72.59 62.90 -19.58 37.07 65.03 -20.26 37.42 coo 44.05 36.87 70.65 43.15 38.64 69.97 69.63 -18.91 41.63 70.61 -19.62 39.97 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 5 3 # 5 A 50 GLN B 227 GLN^? 12.88 MG MG B 701 A 91 LEU B 245 LEU~? 12.21 MG MG B 701 A 133 GLU B 231 GLU~? 14.47 MG MG B 701 coo 43.58 43.67 66.73 42.32 42.78 68.15 68.72 -11.20 24.26 67.08 -12.21 23.35 coo 38.58 45.09 70.44 38.28 45.21 72.59 66.89 -9.70 18.93 66.65 -9.22 21.07 coo 44.05 36.87 70.65 43.15 38.64 69.97 63.35 -17.79 25.44 64.18 -18.11 27.34 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 6 3 # 6 A 50 GLN B 227 GLN^? 12.88 MG MG B 701 A 91 LEU B 245 LEU~? 12.21 MG MG B 701 A 133 GLU B 248 GLU~? 22.62 MG MG B 701 coo 43.58 43.67 66.73 42.32 42.78 68.15 68.72 -11.20 24.26 67.08 -12.21 23.35 coo 38.58 45.09 70.44 38.28 45.21 72.59 66.89 -9.70 18.93 66.65 -9.22 21.07 coo 44.05 36.87 70.65 43.15 38.64 69.97 75.57 -15.61 20.16 75.32 -17.65 20.76 1bs4_c00 source 1bs4 PEPTIDE DEFORMYLASE : 6 hits 1bs4_c00 naa= 3 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 1 3 # 1 B 550 GLN A 213 GLN~? 34.86 MG MG B 701 B 591 LEU A 156 LEU~? 35.04 MG MG B 701 B 633 GLU A 231 GLU~? 40.57 MG MG B 701 coo 88.06 44.34 57.19 89.06 45.53 55.74 49.72 8.72 50.78 48.64 10.39 51.50 coo 86.70 48.66 52.61 87.15 48.69 50.51 42.21 10.50 50.11 43.44 11.59 48.63 coo 95.42 44.52 54.43 93.46 45.31 54.70 46.37 8.02 59.96 46.65 9.30 58.33 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 2 3 # 2 B 550 GLN A 227 GLN^? 40.32 MG MG B 701 B 591 LEU A 245 LEU~? 43.05 MG MG B 701 B 633 GLU A 231 GLU~? 40.57 MG MG B 701 coo 88.06 44.34 57.19 89.06 45.53 55.74 54.41 4.39 59.17 53.11 5.19 60.64 coo 86.70 48.66 52.61 87.15 48.69 50.51 55.41 3.40 65.10 54.46 2.65 63.31 coo 95.42 44.52 54.43 93.46 45.31 54.70 46.37 8.02 59.96 46.65 9.30 58.33 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 3 3 # 3 B 550 GLN A 227 GLN^? 40.32 MG MG B 701 B 591 LEU A 245 LEU~? 43.05 MG MG B 701 B 633 GLU A 248 GLU~? 42.11 MG MG B 701 coo 88.06 44.34 57.19 89.06 45.53 55.74 54.41 4.39 59.17 53.11 5.19 60.64 coo 86.70 48.66 52.61 87.15 48.69 50.51 55.41 3.40 65.10 54.46 2.65 63.31 coo 95.42 44.52 54.43 93.46 45.31 54.70 61.57 10.69 58.38 61.15 12.75 58.68 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 4 3 # 4 B 550 GLN B 213 GLN~? 19.92 MG MG B 701 B 591 LEU B 156 LEU~? 20.91 MG MG B 701 B 633 GLU B 134 GLU^? 26.11 MG MG B 701 coo 88.06 44.34 57.19 89.06 45.53 55.74 69.29 -16.23 33.49 68.51 -18.13 33.12 coo 86.70 48.66 52.61 87.15 48.69 50.51 62.90 -19.58 37.07 65.03 -20.26 37.42 coo 95.42 44.52 54.43 93.46 45.31 54.70 69.63 -18.91 41.63 70.61 -19.62 39.97 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 5 3 # 5 B 550 GLN B 227 GLN^? 12.88 MG MG B 701 B 591 LEU B 245 LEU~? 12.21 MG MG B 701 B 633 GLU B 231 GLU~? 14.47 MG MG B 701 coo 88.06 44.34 57.19 89.06 45.53 55.74 68.72 -11.20 24.26 67.08 -12.21 23.35 coo 86.70 48.66 52.61 87.15 48.69 50.51 66.89 -9.70 18.93 66.65 -9.22 21.07 coo 95.42 44.52 54.43 93.46 45.31 54.70 63.35 -17.79 25.44 64.18 -18.11 27.34 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 6 3 # 6 B 550 GLN B 227 GLN^? 12.88 MG MG B 701 B 591 LEU B 245 LEU~? 12.21 MG MG B 701 B 633 GLU B 248 GLU~? 22.62 MG MG B 701 coo 88.06 44.34 57.19 89.06 45.53 55.74 68.72 -11.20 24.26 67.08 -12.21 23.35 coo 86.70 48.66 52.61 87.15 48.69 50.51 66.89 -9.70 18.93 66.65 -9.22 21.07 coo 95.42 44.52 54.43 93.46 45.31 54.70 75.57 -15.61 20.16 75.32 -17.65 20.76 1bs4_c01 source 1bs4 PEPTIDE DEFORMYLASE : 6 hits 1bs4_c01 naa= 3 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 1 3 # 1 C1050 GLN A 213 GLN~? 34.86 MG MG B 701 C1091 LEU A 156 LEU~? 35.04 MG MG B 701 C1133 GLU A 231 GLU~? 40.57 MG MG B 701 coo 68.29 34.44 43.03 66.67 34.74 44.37 49.72 8.72 50.78 48.64 10.39 51.50 coo 65.83 38.95 47.05 65.46 38.90 49.20 42.21 10.50 50.11 43.44 11.59 48.63 coo 63.14 29.39 46.25 63.84 31.31 45.74 46.37 8.02 59.96 46.65 9.30 58.33 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 2 3 # 2 C1050 GLN A 227 GLN^? 40.32 MG MG B 701 C1091 LEU A 245 LEU~? 43.05 MG MG B 701 C1133 GLU A 231 GLU~? 40.57 MG MG B 701 coo 68.29 34.44 43.03 66.67 34.74 44.37 54.41 4.39 59.17 53.11 5.19 60.64 coo 65.83 38.95 47.05 65.46 38.90 49.20 55.41 3.40 65.10 54.46 2.65 63.31 coo 63.14 29.39 46.25 63.84 31.31 45.74 46.37 8.02 59.96 46.65 9.30 58.33 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 3 3 # 3 C1050 GLN A 227 GLN^? 40.32 MG MG B 701 C1091 LEU A 245 LEU~? 43.05 MG MG B 701 C1133 GLU A 248 GLU~? 42.11 MG MG B 701 coo 68.29 34.44 43.03 66.67 34.74 44.37 54.41 4.39 59.17 53.11 5.19 60.64 coo 65.83 38.95 47.05 65.46 38.90 49.20 55.41 3.40 65.10 54.46 2.65 63.31 coo 63.14 29.39 46.25 63.84 31.31 45.74 61.57 10.69 58.38 61.15 12.75 58.68 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 4 3 # 4 C1050 GLN B 213 GLN~? 19.92 MG MG B 701 C1091 LEU B 156 LEU~? 20.91 MG MG B 701 C1133 GLU B 134 GLU^? 26.11 MG MG B 701 coo 68.29 34.44 43.03 66.67 34.74 44.37 69.29 -16.23 33.49 68.51 -18.13 33.12 coo 65.83 38.95 47.05 65.46 38.90 49.20 62.90 -19.58 37.07 65.03 -20.26 37.42 coo 63.14 29.39 46.25 63.84 31.31 45.74 69.63 -18.91 41.63 70.61 -19.62 39.97 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 5 3 # 5 C1050 GLN B 227 GLN^? 12.88 MG MG B 701 C1091 LEU B 245 LEU~? 12.21 MG MG B 701 C1133 GLU B 231 GLU~? 14.47 MG MG B 701 coo 68.29 34.44 43.03 66.67 34.74 44.37 68.72 -11.20 24.26 67.08 -12.21 23.35 coo 65.83 38.95 47.05 65.46 38.90 49.20 66.89 -9.70 18.93 66.65 -9.22 21.07 coo 63.14 29.39 46.25 63.84 31.31 45.74 63.35 -17.79 25.44 64.18 -18.11 27.34 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 6 3 # 6 C1050 GLN B 227 GLN^? 12.88 MG MG B 701 C1091 LEU B 245 LEU~? 12.21 MG MG B 701 C1133 GLU B 248 GLU~? 22.62 MG MG B 701 coo 68.29 34.44 43.03 66.67 34.74 44.37 68.72 -11.20 24.26 67.08 -12.21 23.35 coo 65.83 38.95 47.05 65.46 38.90 49.20 66.89 -9.70 18.93 66.65 -9.22 21.07 coo 63.14 29.39 46.25 63.84 31.31 45.74 75.57 -15.61 20.16 75.32 -17.65 20.76 1bs4_c02 source 1bs4 PEPTIDE DEFORMYLASE : 6 hits 1bs4_c02 naa= 3 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 1 3 # 1 A 50 GLN A 213 GLN~? 34.86 MG MG B 701 A 91 LEU A 156 LEU~? 35.04 MG MG B 701 A 133 GLU A 231 GLU~? 40.57 MG MG B 701 coo 38.23 53.34 67.59 38.84 53.87 69.56 49.72 8.72 50.78 48.64 10.39 51.50 coo 35.40 53.22 73.30 35.37 54.87 74.74 42.21 10.50 50.11 43.44 11.59 48.63 coo 45.08 56.04 70.60 43.15 55.19 70.77 46.37 8.02 59.96 46.65 9.30 58.33 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 2 3 # 2 A 50 GLN A 227 GLN^? 40.32 MG MG B 701 A 91 LEU A 245 LEU~? 43.05 MG MG B 701 A 133 GLU A 231 GLU~? 40.57 MG MG B 701 coo 38.23 53.34 67.59 38.84 53.87 69.56 54.41 4.39 59.17 53.11 5.19 60.64 coo 35.40 53.22 73.30 35.37 54.87 74.74 55.41 3.40 65.10 54.46 2.65 63.31 coo 45.08 56.04 70.60 43.15 55.19 70.77 46.37 8.02 59.96 46.65 9.30 58.33 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 3 3 # 3 A 50 GLN A 227 GLN^? 40.32 MG MG B 701 A 91 LEU A 245 LEU~? 43.05 MG MG B 701 A 133 GLU A 248 GLU~? 42.11 MG MG B 701 coo 38.23 53.34 67.59 38.84 53.87 69.56 54.41 4.39 59.17 53.11 5.19 60.64 coo 35.40 53.22 73.30 35.37 54.87 74.74 55.41 3.40 65.10 54.46 2.65 63.31 coo 45.08 56.04 70.60 43.15 55.19 70.77 61.57 10.69 58.38 61.15 12.75 58.68 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 4 3 # 4 A 50 GLN B 227 GLN^? 12.88 MG MG B 701 A 91 LEU B 245 LEU~? 12.21 MG MG B 701 A 133 GLU B 231 GLU~? 14.47 MG MG B 701 coo 38.23 53.34 67.59 38.84 53.87 69.56 68.72 -11.20 24.26 67.08 -12.21 23.35 coo 35.40 53.22 73.30 35.37 54.87 74.74 66.89 -9.70 18.93 66.65 -9.22 21.07 coo 45.08 56.04 70.60 43.15 55.19 70.77 63.35 -17.79 25.44 64.18 -18.11 27.34 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 5 3 # 5 A 50 GLN B 227 GLN^? 12.88 MG MG B 701 A 91 LEU B 245 LEU~? 12.21 MG MG B 701 A 133 GLU B 248 GLU~? 22.62 MG MG B 701 coo 38.23 53.34 67.59 38.84 53.87 69.56 68.72 -11.20 24.26 67.08 -12.21 23.35 coo 35.40 53.22 73.30 35.37 54.87 74.74 66.89 -9.70 18.93 66.65 -9.22 21.07 coo 45.08 56.04 70.60 43.15 55.19 70.77 75.57 -15.61 20.16 75.32 -17.65 20.76 1bsj_c00 source 1bsj PEPTIDE DEFORMYLASE : 5 hits 1bsj_c00 naa= 3 ULMN 3 1bu7_c02 CYTOCHROME P450 user 1 3 # 1 A 268 THR A 169 THR~? 12.09 MG MG B 701 A 393 PHE A 166 PHE^? 17.85 MG MG B 701 A 400 CYH A 150 CYH^? 20.80 MG MG B 701 coo 45.81 71.19 43.26 47.70 70.19 43.25 53.69 2.67 26.96 55.61 3.43 26.29 coo 48.54 63.17 48.16 46.74 64.99 49.22 55.48 -0.21 37.25 56.90 1.01 39.28 coo 53.76 64.39 46.87 52.06 66.55 47.33 54.05 4.31 36.56 55.14 4.53 39.16 ULMN 3 1bu7_c02 CYTOCHROME P450 user 2 3 # 2 A 268 THR B 85 THR~? 40.29 MG MG B 701 A 393 PHE B 73 PHE~? 38.23 MG MG B 701 A 400 CYH B 93 CYH~? 42.85 MG MG B 701 coo 45.81 71.19 43.26 47.70 70.19 43.25 64.58 -17.53 59.23 63.29 -18.66 60.55 coo 48.54 63.17 48.16 46.74 64.99 49.22 75.10 -18.32 54.35 72.78 -19.57 53.51 coo 53.76 64.39 46.87 52.06 66.55 47.33 74.48 -24.31 57.35 76.42 -22.43 56.76 ULMN 3 1bu7_c02 CYTOCHROME P450 user 3 3 # 3 A 268 THR B 85 THR~? 40.29 MG MG B 701 A 393 PHE B 118 PHE^? 36.09 MG MG B 701 A 400 CYH B 93 CYH~? 42.85 MG MG B 701 coo 45.81 71.19 43.26 47.70 70.19 43.25 64.58 -17.53 59.23 63.29 -18.66 60.55 coo 48.54 63.17 48.16 46.74 64.99 49.22 70.13 -23.91 51.57 68.23 -22.26 52.74 coo 53.76 64.39 46.87 52.06 66.55 47.33 74.48 -24.31 57.35 76.42 -22.43 56.76 ULMN 3 1bu7_c02 CYTOCHROME P450 user 4 3 # 4 A 268 THR B 103 THR~? 38.15 MG MG B 701 A 393 PHE B 118 PHE^? 36.09 MG MG B 701 A 400 CYH B 93 CYH~? 42.85 MG MG B 701 coo 45.81 71.19 43.26 47.70 70.19 43.25 79.49 -28.27 47.31 78.51 -27.23 45.65 coo 48.54 63.17 48.16 46.74 64.99 49.22 70.13 -23.91 51.57 68.23 -22.26 52.74 coo 53.76 64.39 46.87 52.06 66.55 47.33 74.48 -24.31 57.35 76.42 -22.43 56.76 ULMN 3 1bu7_c02 CYTOCHROME P450 user 5 3 # 5 A 268 THR B 169 THR~? 41.74 MG MG B 701 A 393 PHE B 166 PHE^? 30.39 MG MG B 701 A 400 CYH B 150 CYH^? 29.89 MG MG B 701 coo 45.81 71.19 43.26 47.70 70.19 43.25 80.90 -7.97 53.82 83.02 -8.15 53.47 coo 48.54 63.17 48.16 46.74 64.99 49.22 77.21 -5.09 44.06 77.80 -6.03 41.49 coo 53.76 64.39 46.87 52.06 66.55 47.33 77.46 -9.77 45.05 77.37 -9.94 42.24 1bu7_c02 source 1bu7 CYTOCHROME P450 : 5 hits 1bu7_c02 naa= 3 ULMN 3 1bu7_c03 CYTOCHROME P450 user 1 3 # 1 B 268 THR A 168 THR^? 7.86 MG MG B 701 B 393 PHE A 166 PHE^? 17.85 MG MG B 701 B 400 CYH A 150 CYH^? 20.80 MG MG B 701 coo 37.20 116.32 52.00 35.18 117.07 52.13 54.22 -0.54 28.99 53.77 -2.31 27.85 coo 33.81 121.65 59.26 35.49 119.55 59.81 55.48 -0.21 37.25 56.90 1.01 39.28 coo 28.79 121.15 57.00 30.51 118.99 56.70 54.05 4.31 36.56 55.14 4.53 39.16 ULMN 3 1bu7_c03 CYTOCHROME P450 user 2 3 # 2 B 268 THR A 169 THR~? 12.09 MG MG B 701 B 393 PHE A 166 PHE^? 17.85 MG MG B 701 B 400 CYH A 150 CYH^? 20.80 MG MG B 701 coo 37.20 116.32 52.00 35.18 117.07 52.13 53.69 2.67 26.96 55.61 3.43 26.29 coo 33.81 121.65 59.26 35.49 119.55 59.81 55.48 -0.21 37.25 56.90 1.01 39.28 coo 28.79 121.15 57.00 30.51 118.99 56.70 54.05 4.31 36.56 55.14 4.53 39.16 ULMN 3 1bu7_c03 CYTOCHROME P450 user 3 3 # 3 B 268 THR B 85 THR~? 40.29 MG MG B 701 B 393 PHE B 118 PHE^? 36.09 MG MG B 701 B 400 CYH B 93 CYH~? 42.85 MG MG B 701 coo 37.20 116.32 52.00 35.18 117.07 52.13 64.58 -17.53 59.23 63.29 -18.66 60.55 coo 33.81 121.65 59.26 35.49 119.55 59.81 70.13 -23.91 51.57 68.23 -22.26 52.74 coo 28.79 121.15 57.00 30.51 118.99 56.70 74.48 -24.31 57.35 76.42 -22.43 56.76 ULMN 3 1bu7_c03 CYTOCHROME P450 user 4 3 # 4 B 268 THR B 103 THR~? 38.15 MG MG B 701 B 393 PHE B 118 PHE^? 36.09 MG MG B 701 B 400 CYH B 93 CYH~? 42.85 MG MG B 701 coo 37.20 116.32 52.00 35.18 117.07 52.13 79.49 -28.27 47.31 78.51 -27.23 45.65 coo 33.81 121.65 59.26 35.49 119.55 59.81 70.13 -23.91 51.57 68.23 -22.26 52.74 coo 28.79 121.15 57.00 30.51 118.99 56.70 74.48 -24.31 57.35 76.42 -22.43 56.76 ULMN 3 1bu7_c03 CYTOCHROME P450 user 5 3 # 5 B 268 THR B 168 THR^? 39.79 MG MG B 701 B 393 PHE B 166 PHE^? 30.39 MG MG B 701 B 400 CYH B 150 CYH^? 29.89 MG MG B 701 coo 37.20 116.32 52.00 35.18 117.07 52.13 79.61 -4.74 52.17 79.36 -3.15 53.62 coo 33.81 121.65 59.26 35.49 119.55 59.81 77.21 -5.09 44.06 77.80 -6.03 41.49 coo 28.79 121.15 57.00 30.51 118.99 56.70 77.46 -9.77 45.05 77.37 -9.94 42.24 ULMN 3 1bu7_c03 CYTOCHROME P450 user 6 3 # 6 B 268 THR B 169 THR~? 41.74 MG MG B 701 B 393 PHE B 166 PHE^? 30.39 MG MG B 701 B 400 CYH B 150 CYH^? 29.89 MG MG B 701 coo 37.20 116.32 52.00 35.18 117.07 52.13 80.90 -7.97 53.82 83.02 -8.15 53.47 coo 33.81 121.65 59.26 35.49 119.55 59.81 77.21 -5.09 44.06 77.80 -6.03 41.49 coo 28.79 121.15 57.00 30.51 118.99 56.70 77.46 -9.77 45.05 77.37 -9.94 42.24 1bu7_c03 source 1bu7 CYTOCHROME P450 : 6 hits 1bu7_c03 naa= 3 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 1 3 # 1 A 325 ASP B 187 ASP~? 20.66 MG MG B 701 A 354 GLU B 186 GLU~? 15.37 MG MG B 701 A 421 ASP A 144 ASP~? 20.24 MG MG B 701 coo 31.05 49.37 64.51 31.97 51.11 63.85 74.06 -4.33 24.81 74.57 -2.40 25.55 coo 29.07 50.42 58.36 29.02 52.18 59.49 69.45 -0.46 21.54 67.97 0.05 22.96 coo 30.82 59.76 58.47 31.12 59.02 60.40 69.22 6.09 27.43 70.24 4.65 26.30 1bvz_c08 source 1bvz ALPHA-AMYLASE II : 1 hits 1bvz_c08 naa= 3 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 1 3 # 1 B 325 ASP B 187 ASP~? 20.66 MG MG B 701 B 354 GLU B 186 GLU~? 15.37 MG MG B 701 B 421 ASP A 144 ASP~? 20.24 MG MG B 701 coo 25.90 8.19 53.87 25.36 6.97 52.29 74.06 -4.33 24.81 74.57 -2.40 25.55 coo 27.87 10.66 47.95 27.82 8.60 48.27 69.45 -0.46 21.54 67.97 0.05 22.96 coo 26.02 1.87 43.38 25.90 1.97 45.49 69.22 6.09 27.43 70.24 4.65 26.30 1bvz_c09 source 1bvz ALPHA-AMYLASE II : 1 hits 1bvz_c09 naa= 3 ULMN 3 1bzc_c00 PROTEIN-TYROSINE-PHOSPHATASE user 1 3 # 1 A 181 ASP A 91 ASP~? 30.86 MG MG B 701 A 215 CYH A 93 CYH~? 25.81 MG MG B 701 A 221 ARG A 94 ARG~? 29.54 MG MG B 701 coo -20.67 62.35 15.68 -20.16 63.09 17.59 36.10 16.42 24.55 35.02 15.53 22.85 coo -17.06 60.65 8.77 -19.43 59.04 8.89 42.80 17.19 26.05 43.95 14.89 27.02 coo -21.54 63.29 10.68 -19.32 62.77 12.69 39.43 19.06 19.67 38.29 16.27 20.39 ULMN 3 1bzc_c00 PROTEIN-TYROSINE-PHOSPHATASE user 2 3 # 2 A 181 ASP B 91 ASP~? 46.73 MG MG B 701 A 215 CYH B 93 CYH~? 42.85 MG MG B 701 A 221 ARG B 94 ARG~? 47.57 MG MG B 701 coo -20.67 62.35 15.68 -20.16 63.09 17.59 69.68 -24.93 62.08 69.33 -24.21 64.01 coo -17.06 60.65 8.77 -19.43 59.04 8.89 74.48 -24.31 57.35 76.42 -22.43 56.76 coo -21.54 63.29 10.68 -19.32 62.77 12.69 76.29 -23.20 63.54 75.68 -20.19 63.65 1bzc_c00 source 1bzc PROTEIN-TYROSINE-PHOSPHATASE : 2 hits 1bzc_c00 naa= 3 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 1 3 # 1 A 198 GLY A 257 GLY~? 18.38 MG MG B 701 A 228 SER A 143 SER~? 15.64 MG MG B 701 A 549 ASP A 144 ASP~? 20.24 MG MG B 701 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 64.56 0.21 35.89 64.86 0.29 36.62 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 66.42 2.53 29.16 66.03 2.11 26.82 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 69.22 6.09 27.43 70.24 4.65 26.30 1cjy_c00 source 1cjy CYTOSOLIC PHOSPHOLIPASE A2 : 1 hits 1cjy_c00 naa= 3 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 1 3 # 1 B1198 GLY A 257 GLY~? 18.38 MG MG B 701 B1228 SER A 143 SER~? 15.64 MG MG B 701 B1549 ASP A 144 ASP~? 20.24 MG MG B 701 coo 126.34 72.75 125.66 125.95 73.27 126.11 64.56 0.21 35.89 64.86 0.29 36.62 coo 131.65 74.68 129.41 130.31 72.73 128.82 66.42 2.53 29.16 66.03 2.11 26.82 coo 134.72 69.43 130.42 133.03 70.65 130.08 69.22 6.09 27.43 70.24 4.65 26.30 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 2 3 # 2 B1198 GLY B 257 GLY~? 36.89 MG MG B 701 B1228 SER B 143 SER~? 44.45 MG MG B 701 B1549 ASP B 144 ASP~? 48.42 MG MG B 701 coo 126.34 72.75 125.66 125.95 73.27 126.11 86.35 -3.07 41.26 86.22 -3.12 40.48 coo 131.65 74.68 129.41 130.31 72.73 128.82 90.48 -3.13 47.60 89.69 -2.19 49.67 coo 134.72 69.43 130.42 133.03 70.65 130.08 94.61 -4.13 49.96 95.84 -4.32 48.22 1cjy_c01 source 1cjy CYTOSOLIC PHOSPHOLIPASE A2 : 2 hits 1cjy_c01 naa= 3 ULMN 3 1cns_c00 CHITINASE user 1 3 # 1 A 67 GLU A 88 GLU~? 31.24 MG MG B 701 A 89 GLU A 109 GLU~? 38.68 MG MG B 701 A 120 SER A 107 SER^? 37.91 MG MG B 701 coo -24.35 9.53 67.64 -25.07 11.29 68.60 33.25 12.86 29.05 32.48 12.06 30.82 coo -31.18 6.91 75.60 -32.39 8.51 74.91 29.40 16.91 37.45 28.08 15.31 37.76 coo -34.73 8.57 68.21 -33.63 9.08 70.28 37.40 19.71 36.06 36.29 21.61 37.11 ULMN 3 1cns_c00 CHITINASE user 2 3 # 2 A 67 GLU A 134 GLU^? 30.91 MG MG B 701 A 89 GLU A 218 GLU~? 32.55 MG MG B 701 A 120 SER A 215 SER~? 31.75 MG MG B 701 coo -24.35 9.53 67.64 -25.07 11.29 68.60 46.08 11.35 43.50 47.51 12.29 44.66 coo -31.18 6.91 75.60 -32.39 8.51 74.91 54.56 16.53 40.79 53.76 18.19 41.81 coo -34.73 8.57 68.21 -33.63 9.08 70.28 53.96 10.22 46.63 54.01 12.63 46.67 ULMN 3 1cns_c00 CHITINASE user 3 3 # 3 A 67 GLU A 170 GLU~? 8.58 MG MG B 701 A 89 GLU A 68 GLU~? 16.08 MG MG B 701 A 120 SER A 146 SER~? 13.04 MG MG B 701 coo -24.35 9.53 67.64 -25.07 11.29 68.60 52.41 0.03 22.89 54.38 0.44 23.67 coo -31.18 6.91 75.60 -32.39 8.51 74.91 56.21 8.51 25.84 57.91 7.36 26.07 coo -34.73 8.57 68.21 -33.63 9.08 70.28 62.43 3.35 26.06 63.03 1.20 26.92 ULMN 3 1cns_c00 CHITINASE user 4 3 # 4 A 67 GLU A 170 GLU~? 8.58 MG MG B 701 A 89 GLU A 68 GLU~? 16.08 MG MG B 701 A 120 SER A 147 SER^? 16.30 MG MG B 701 coo -24.35 9.53 67.64 -25.07 11.29 68.60 52.41 0.03 22.89 54.38 0.44 23.67 coo -31.18 6.91 75.60 -32.39 8.51 74.91 56.21 8.51 25.84 57.91 7.36 26.07 coo -34.73 8.57 68.21 -33.63 9.08 70.28 59.94 3.92 28.83 60.06 6.29 28.37 ULMN 3 1cns_c00 CHITINASE user 5 3 # 5 A 67 GLU A 218 GLU~? 32.55 MG MG B 701 A 89 GLU A 134 GLU^? 30.91 MG MG B 701 A 120 SER A 215 SER~? 31.75 MG MG B 701 coo -24.35 9.53 67.64 -25.07 11.29 68.60 54.56 16.53 40.79 53.76 18.19 41.81 coo -31.18 6.91 75.60 -32.39 8.51 74.91 46.08 11.35 43.50 47.51 12.29 44.66 coo -34.73 8.57 68.21 -33.63 9.08 70.28 53.96 10.22 46.63 54.01 12.63 46.67 ULMN 3 1cns_c00 CHITINASE user 6 3 # 6 A 67 GLU B 68 GLU~? 43.73 MG MG B 701 A 89 GLU B 170 GLU~? 43.78 MG MG B 701 A 120 SER B 146 SER~? 44.57 MG MG B 701 coo -24.35 9.53 67.64 -25.07 11.29 68.60 85.21 -13.08 54.11 86.12 -11.45 53.05 coo -31.18 6.91 75.60 -32.39 8.51 74.91 80.92 -5.65 58.14 82.41 -5.69 56.60 coo -34.73 8.57 68.21 -33.63 9.08 70.28 87.67 -4.57 51.59 87.26 -2.47 52.75 ULMN 3 1cns_c00 CHITINASE user 7 3 # 7 A 67 GLU B 88 GLU~? 39.12 MG MG B 701 A 89 GLU B 109 GLU^? 35.66 MG MG B 701 A 120 SER B 107 SER^? 37.85 MG MG B 701 coo -24.35 9.53 67.64 -25.07 11.29 68.60 64.81 -21.91 58.58 62.70 -21.80 58.39 coo -31.18 6.91 75.60 -32.39 8.51 74.91 59.57 -29.27 53.23 59.54 -28.97 51.11 coo -34.73 8.57 68.21 -33.63 9.08 70.28 67.06 -28.86 51.54 65.90 -30.87 50.74 ULMN 3 1cns_c00 CHITINASE user 8 3 # 8 A 67 GLU B 88 GLU~? 39.12 MG MG B 701 A 89 GLU B 109 GLU^? 35.66 MG MG B 701 A 120 SER B 111 SER~? 36.45 MG MG B 701 coo -24.35 9.53 67.64 -25.07 11.29 68.60 64.81 -21.91 58.58 62.70 -21.80 58.39 coo -31.18 6.91 75.60 -32.39 8.51 74.91 59.57 -29.27 53.23 59.54 -28.97 51.11 coo -34.73 8.57 68.21 -33.63 9.08 70.28 56.74 -22.11 55.96 57.39 -19.94 56.97 ULMN 3 1cns_c00 CHITINASE user 9 3 # 9 A 67 GLU B 134 GLU^? 26.11 MG MG B 701 A 89 GLU B 218 GLU~? 32.37 MG MG B 701 A 120 SER B 215 SER~? 26.70 MG MG B 701 coo -24.35 9.53 67.64 -25.07 11.29 68.60 69.63 -18.91 41.63 70.61 -19.62 39.97 coo -31.18 6.91 75.60 -32.39 8.51 74.91 79.74 -21.86 40.41 79.27 -22.32 38.45 coo -34.73 8.57 68.21 -33.63 9.08 70.28 75.07 -16.26 35.49 76.05 -18.46 35.16 ULMN 3 1cns_c00 CHITINASE user 10 3 # 10 A 67 GLU B 170 GLU~? 43.78 MG MG B 701 A 89 GLU B 68 GLU~? 43.73 MG MG B 701 A 120 SER B 146 SER~? 44.57 MG MG B 701 coo -24.35 9.53 67.64 -25.07 11.29 68.60 80.92 -5.65 58.14 82.41 -5.69 56.60 coo -31.18 6.91 75.60 -32.39 8.51 74.91 85.21 -13.08 54.11 86.12 -11.45 53.05 coo -34.73 8.57 68.21 -33.63 9.08 70.28 87.67 -4.57 51.59 87.26 -2.47 52.75 ULMN 3 1cns_c00 CHITINASE user 11 3 # 11 A 67 GLU B 170 GLU~? 43.78 MG MG B 701 A 89 GLU B 68 GLU~? 43.73 MG MG B 701 A 120 SER B 147 SER^? 42.22 MG MG B 701 coo -24.35 9.53 67.64 -25.07 11.29 68.60 80.92 -5.65 58.14 82.41 -5.69 56.60 coo -31.18 6.91 75.60 -32.39 8.51 74.91 85.21 -13.08 54.11 86.12 -11.45 53.05 coo -34.73 8.57 68.21 -33.63 9.08 70.28 85.67 -7.01 49.55 87.33 -8.74 49.65 ULMN 3 1cns_c00 CHITINASE user 12 3 # 12 A 67 GLU B 218 GLU~? 32.37 MG MG B 701 A 89 GLU B 134 GLU^? 26.11 MG MG B 701 A 120 SER B 215 SER~? 26.70 MG MG B 701 coo -24.35 9.53 67.64 -25.07 11.29 68.60 79.74 -21.86 40.41 79.27 -22.32 38.45 coo -31.18 6.91 75.60 -32.39 8.51 74.91 69.63 -18.91 41.63 70.61 -19.62 39.97 coo -34.73 8.57 68.21 -33.63 9.08 70.28 75.07 -16.26 35.49 76.05 -18.46 35.16 1cns_c00 source 1cns CHITINASE : 12 hits 1cns_c00 naa= 3 ULMN 3 1cns_c01 CHITINASE user 1 3 # 1 B 67 GLU A 88 GLU~? 31.24 MG MG B 701 B 89 GLU A 109 GLU~? 38.68 MG MG B 701 B 120 SER A 107 SER^? 37.91 MG MG B 701 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 33.25 12.86 29.05 32.48 12.06 30.82 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 29.40 16.91 37.45 28.08 15.31 37.76 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 37.40 19.71 36.06 36.29 21.61 37.11 ULMN 3 1cns_c01 CHITINASE user 2 3 # 2 B 67 GLU A 170 GLU~? 8.58 MG MG B 701 B 89 GLU A 68 GLU~? 16.08 MG MG B 701 B 120 SER A 146 SER~? 13.04 MG MG B 701 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 52.41 0.03 22.89 54.38 0.44 23.67 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 56.21 8.51 25.84 57.91 7.36 26.07 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 62.43 3.35 26.06 63.03 1.20 26.92 ULMN 3 1cns_c01 CHITINASE user 3 3 # 3 B 67 GLU A 231 GLU~? 40.57 MG MG B 701 B 89 GLU A 237 GLU~? 48.86 MG MG B 701 B 120 SER A 206 SER~? 45.83 MG MG B 701 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 46.37 8.02 59.96 46.65 9.30 58.33 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 46.26 1.98 71.28 45.32 1.01 69.65 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 47.28 -2.73 65.33 45.89 -1.90 67.11 ULMN 3 1cns_c01 CHITINASE user 4 3 # 4 B 67 GLU B 88 GLU~? 39.12 MG MG B 701 B 89 GLU B 109 GLU^? 35.66 MG MG B 701 B 120 SER B 107 SER^? 37.85 MG MG B 701 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 64.81 -21.91 58.58 62.70 -21.80 58.39 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 59.57 -29.27 53.23 59.54 -28.97 51.11 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 67.06 -28.86 51.54 65.90 -30.87 50.74 1cns_c01 source 1cns CHITINASE : 4 hits 1cns_c01 naa= 3 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 101 TYR B 252 TYR^? 25.41 MG MG B 701 A 173 ASP B 187 ASP~? 20.66 MG MG B 701 C 48 ARG B 258 ARG^? 33.01 MG MG B 701 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 79.70 -7.64 31.83 77.94 -6.02 30.43 coo 24.35 4.55 25.11 25.94 3.23 25.53 74.06 -4.33 24.81 74.57 -2.40 25.55 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 83.96 -0.40 36.39 82.47 1.91 37.80 1cs1_c00 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1cs1_c00 naa= 3 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 48 ARG B 258 ARG^? 33.01 MG MG B 701 D 101 TYR B 252 TYR^? 25.41 MG MG B 701 D 173 ASP B 187 ASP~? 20.66 MG MG B 701 coo 69.08 8.58 32.60 69.70 10.81 30.58 83.96 -0.40 36.39 82.47 1.91 37.80 coo 71.77 11.86 24.26 70.23 12.22 26.56 79.70 -7.64 31.83 77.94 -6.02 30.43 coo 71.60 6.14 19.25 70.26 6.87 20.69 74.06 -4.33 24.81 74.57 -2.40 25.55 1cs1_c02 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1cs1_c02 naa= 3 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 101 TYR B 252 TYR^? 25.41 MG MG B 701 B 173 ASP B 187 ASP~? 20.66 MG MG B 701 D 48 ARG B 258 ARG^? 33.01 MG MG B 701 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 79.70 -7.64 31.83 77.94 -6.02 30.43 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 74.06 -4.33 24.81 74.57 -2.40 25.55 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 83.96 -0.40 36.39 82.47 1.91 37.80 1cs1_c03 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1cs1_c03 naa= 3 ULMN 3 1ctn_c00 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 1 3 # 1 313 ASP A 187 ASP~? 34.25 MG MG B 701 315 GLU A 186 GLU~? 38.23 MG MG B 701 390 TYR A 200 TYR~? 45.60 MG MG B 701 coo 32.46 99.13 19.34 30.94 100.38 20.07 61.00 -0.38 56.45 61.66 -2.23 55.67 coo 32.04 94.22 18.23 30.57 94.75 16.88 60.82 -4.60 59.58 62.03 -6.27 60.12 coo 21.10 94.74 18.36 23.09 96.71 18.59 56.79 -4.41 69.25 56.84 -5.83 66.87 1ctn_c00 source 1ctn CHITINASE A (E.C.3.2.1.14) (PH 5.5, 4 DEGREES : 1 hits 1ctn_c00 naa= 3 ULMN 3 1cwy_c00 AMYLOMALTASE user 1 3 # 1 A 293 ASP B 187 ASP~? 20.66 MG MG B 701 A 340 GLU B 186 GLU~? 15.37 MG MG B 701 A 395 ASP A 144 ASP~? 20.24 MG MG B 701 coo -48.00 -26.48 6.86 -46.51 -25.94 5.49 74.06 -4.33 24.81 74.57 -2.40 25.55 coo -43.58 -29.03 7.13 -42.45 -27.34 7.75 69.45 -0.46 21.54 67.97 0.05 22.96 coo -42.28 -26.47 -1.32 -44.06 -25.60 -0.58 69.22 6.09 27.43 70.24 4.65 26.30 1cwy_c00 source 1cwy AMYLOMALTASE : 1 hits 1cwy_c00 naa= 3 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 1 3 # 1 A 37 ASP A 194 ASP~? 51.94 MG MG B 701 A 56 ILE A 203 ILE~? 47.39 MG MG B 701 A 82 TYR A 204 TYR~? 43.42 MG MG B 701 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 62.72 -3.55 72.77 62.75 -5.34 73.88 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 51.36 -0.95 69.21 50.48 0.06 69.21 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 52.40 -7.49 67.00 53.03 -9.24 64.93 1d6o_c00 source 1d6o FK506-BINDING PROTEIN : 1 hits 1d6o_c00 naa= 3 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 1 3 # 1 B 37 ASP A 194 ASP~? 51.94 MG MG B 701 B 56 ILE A 203 ILE~? 47.39 MG MG B 701 B 82 TYR A 204 TYR~? 43.42 MG MG B 701 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 62.72 -3.55 72.77 62.75 -5.34 73.88 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 51.36 -0.95 69.21 50.48 0.06 69.21 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 52.40 -7.49 67.00 53.03 -9.24 64.93 1d6o_c01 source 1d6o FK506-BINDING PROTEIN : 1 hits 1d6o_c01 naa= 3 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 1 3 # 1 A 173 TYR B 200 TYR~? 13.23 MG MG B 701 A 243 ASP B 161 ASP^? 15.44 MG MG B 701 A 272 LYS A 175 LYS~? 16.95 MG MG B 701 coo 2.03 68.31 21.46 0.66 68.36 23.90 64.00 -2.37 14.81 64.76 -0.92 17.07 coo 16.93 55.67 9.65 17.16 54.23 11.19 63.88 -11.38 34.74 64.49 -9.36 34.64 coo 14.13 45.79 13.40 14.25 49.41 18.30 54.19 -7.18 37.22 54.81 -12.82 38.86 1d7r_c02 source 1d7r 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYRUVATE) : 1 hits 1d7r_c02 naa= 3 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 1 3 # 1 A 145 LYS A 238 LYS~? 48.13 MG MG B 701 A 177 GLU A 231 GLU~? 40.57 MG MG B 701 A 201 LEU A 233 LEU~? 46.15 MG MG B 701 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 49.71 6.68 70.26 45.99 10.01 66.31 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 46.37 8.02 59.96 46.65 9.30 58.33 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 47.05 4.25 66.96 48.61 2.87 66.43 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 2 3 # 2 A 145 LYS B 238 LYS~? 10.43 MG MG B 701 A 177 GLU B 231 GLU~? 14.47 MG MG B 701 A 201 LEU B 233 LEU~? 6.36 MG MG B 701 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 60.37 -14.95 16.47 59.84 -17.17 21.39 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 63.35 -17.79 25.44 64.18 -18.11 27.34 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 58.66 -13.18 20.71 59.84 -11.35 20.53 1daa_c00 source 1daa D-AMINO ACID AMINOTRANSFERASE : 2 hits 1daa_c00 naa= 3 ULMN 3 1db3_c01 GDP-MANNOSE 4,6-DEHYDRATASE user 1 3 # 1 A 132 THR A 169 THR~? 12.09 MG MG B 701 A 156 TYR A 167 TYR^? 14.87 MG MG B 701 A 160 LYS A 172 LYS~? 6.12 MG MG B 701 coo 10.50 56.87 17.73 11.24 57.93 19.43 53.69 2.67 26.96 55.61 3.43 26.29 coo 11.64 63.07 23.95 11.76 62.47 21.20 50.02 0.16 32.66 47.75 0.13 34.22 coo 5.78 61.30 21.65 8.04 62.89 17.54 50.20 -3.67 28.72 53.15 -8.47 28.45 ULMN 3 1db3_c01 GDP-MANNOSE 4,6-DEHYDRATASE user 2 3 # 2 A 132 THR B 169 THR~? 41.74 MG MG B 701 A 156 TYR B 167 TYR^? 33.00 MG MG B 701 A 160 LYS B 172 LYS~? 42.28 MG MG B 701 coo 10.50 56.87 17.73 11.24 57.93 19.43 80.90 -7.97 53.82 83.02 -8.15 53.47 coo 11.64 63.07 23.95 11.76 62.47 21.20 74.51 -6.62 50.39 71.88 -7.09 49.71 coo 5.78 61.30 21.65 8.04 62.89 17.54 75.30 -2.84 54.33 79.74 -2.40 56.36 1db3_c01 source 1db3 GDP-MANNOSE 4,6-DEHYDRATASE : 2 hits 1db3_c01 naa= 3 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 A 57 GLU A 134 GLU^? 30.91 MG MG B 701 A 226 THR A 230 THR~? 44.21 MG MG B 701 A 229 LYS A 238 LYS~? 48.13 MG MG B 701 coo 9.66 102.78 70.07 9.79 101.18 71.42 46.08 11.35 43.50 47.51 12.29 44.66 coo 7.24 97.46 49.60 8.11 95.69 48.80 49.84 5.84 63.31 51.56 6.85 64.09 coo 10.53 97.56 43.71 9.33 93.71 47.17 49.71 6.68 70.26 45.99 10.01 66.31 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 A 57 GLU A 219 GLU~? 34.01 MG MG B 701 A 226 THR A 168 THR^? 7.86 MG MG B 701 A 229 LYS A 172 LYS~? 6.12 MG MG B 701 coo 9.66 102.78 70.07 9.79 101.18 71.42 59.27 18.40 40.08 59.60 20.33 40.74 coo 7.24 97.46 49.60 8.11 95.69 48.80 54.22 -0.54 28.99 53.77 -2.31 27.85 coo 10.53 97.56 43.71 9.33 93.71 47.17 50.20 -3.67 28.72 53.15 -8.47 28.45 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 3 3 # 3 A 57 GLU A 219 GLU~? 34.01 MG MG B 701 A 226 THR A 169 THR~? 12.09 MG MG B 701 A 229 LYS A 172 LYS~? 6.12 MG MG B 701 coo 9.66 102.78 70.07 9.79 101.18 71.42 59.27 18.40 40.08 59.60 20.33 40.74 coo 7.24 97.46 49.60 8.11 95.69 48.80 53.69 2.67 26.96 55.61 3.43 26.29 coo 10.53 97.56 43.71 9.33 93.71 47.17 50.20 -3.67 28.72 53.15 -8.47 28.45 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 4 3 # 4 A 57 GLU B 134 GLU^? 26.11 MG MG B 701 A 226 THR B 230 THR~? 11.71 MG MG B 701 A 229 LYS B 238 LYS~? 10.43 MG MG B 701 coo 9.66 102.78 70.07 9.79 101.18 71.42 69.63 -18.91 41.63 70.61 -19.62 39.97 coo 7.24 97.46 49.60 8.11 95.69 48.80 63.14 -13.74 22.31 64.62 -14.39 20.89 coo 10.53 97.56 43.71 9.33 93.71 47.17 60.37 -14.95 16.47 59.84 -17.17 21.39 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 5 3 # 5 A 57 GLU B 219 GLU~? 39.54 MG MG B 701 A 226 THR B 168 THR^? 39.79 MG MG B 701 A 229 LYS B 172 LYS~? 42.28 MG MG B 701 coo 9.66 102.78 70.07 9.79 101.18 71.42 85.46 -21.90 40.90 85.71 -22.21 42.97 coo 7.24 97.46 49.60 8.11 95.69 48.80 79.61 -4.74 52.17 79.36 -3.15 53.62 coo 10.53 97.56 43.71 9.33 93.71 47.17 75.30 -2.84 54.33 79.74 -2.40 56.36 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 6 3 # 6 A 57 GLU B 219 GLU~? 39.54 MG MG B 701 A 226 THR B 169 THR~? 41.74 MG MG B 701 A 229 LYS B 172 LYS~? 42.28 MG MG B 701 coo 9.66 102.78 70.07 9.79 101.18 71.42 85.46 -21.90 40.90 85.71 -22.21 42.97 coo 7.24 97.46 49.60 8.11 95.69 48.80 80.90 -7.97 53.82 83.02 -8.15 53.47 coo 10.53 97.56 43.71 9.33 93.71 47.17 75.30 -2.84 54.33 79.74 -2.40 56.36 1dfo_c04 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 6 hits 1dfo_c04 naa= 3 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 B 57 GLU A 134 GLU^? 30.91 MG MG B 701 B 226 THR A 230 THR~? 44.21 MG MG B 701 B 229 LYS A 238 LYS~? 48.13 MG MG B 701 coo 15.90 87.61 49.61 13.92 86.96 49.36 46.08 11.35 43.50 47.51 12.29 44.66 coo 20.74 95.78 68.68 19.29 96.84 69.83 49.84 5.84 63.31 51.56 6.85 64.09 coo 22.32 101.61 71.64 17.89 98.63 71.55 49.71 6.68 70.26 45.99 10.01 66.31 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 B 57 GLU A 219 GLU~? 34.01 MG MG B 701 B 226 THR A 168 THR^? 7.86 MG MG B 701 B 229 LYS A 172 LYS~? 6.12 MG MG B 701 coo 15.90 87.61 49.61 13.92 86.96 49.36 59.27 18.40 40.08 59.60 20.33 40.74 coo 20.74 95.78 68.68 19.29 96.84 69.83 54.22 -0.54 28.99 53.77 -2.31 27.85 coo 22.32 101.61 71.64 17.89 98.63 71.55 50.20 -3.67 28.72 53.15 -8.47 28.45 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 3 3 # 3 B 57 GLU A 219 GLU~? 34.01 MG MG B 701 B 226 THR A 169 THR~? 12.09 MG MG B 701 B 229 LYS A 172 LYS~? 6.12 MG MG B 701 coo 15.90 87.61 49.61 13.92 86.96 49.36 59.27 18.40 40.08 59.60 20.33 40.74 coo 20.74 95.78 68.68 19.29 96.84 69.83 53.69 2.67 26.96 55.61 3.43 26.29 coo 22.32 101.61 71.64 17.89 98.63 71.55 50.20 -3.67 28.72 53.15 -8.47 28.45 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 4 3 # 4 B 57 GLU B 134 GLU^? 26.11 MG MG B 701 B 226 THR B 230 THR~? 11.71 MG MG B 701 B 229 LYS B 238 LYS~? 10.43 MG MG B 701 coo 15.90 87.61 49.61 13.92 86.96 49.36 69.63 -18.91 41.63 70.61 -19.62 39.97 coo 20.74 95.78 68.68 19.29 96.84 69.83 63.14 -13.74 22.31 64.62 -14.39 20.89 coo 22.32 101.61 71.64 17.89 98.63 71.55 60.37 -14.95 16.47 59.84 -17.17 21.39 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 5 3 # 5 B 57 GLU B 219 GLU~? 39.54 MG MG B 701 B 226 THR B 168 THR^? 39.79 MG MG B 701 B 229 LYS B 172 LYS~? 42.28 MG MG B 701 coo 15.90 87.61 49.61 13.92 86.96 49.36 85.46 -21.90 40.90 85.71 -22.21 42.97 coo 20.74 95.78 68.68 19.29 96.84 69.83 79.61 -4.74 52.17 79.36 -3.15 53.62 coo 22.32 101.61 71.64 17.89 98.63 71.55 75.30 -2.84 54.33 79.74 -2.40 56.36 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 6 3 # 6 B 57 GLU B 219 GLU~? 39.54 MG MG B 701 B 226 THR B 169 THR~? 41.74 MG MG B 701 B 229 LYS B 172 LYS~? 42.28 MG MG B 701 coo 15.90 87.61 49.61 13.92 86.96 49.36 85.46 -21.90 40.90 85.71 -22.21 42.97 coo 20.74 95.78 68.68 19.29 96.84 69.83 80.90 -7.97 53.82 83.02 -8.15 53.47 coo 22.32 101.61 71.64 17.89 98.63 71.55 75.30 -2.84 54.33 79.74 -2.40 56.36 1dfo_c05 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 6 hits 1dfo_c05 naa= 3 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 C 57 GLU A 134 GLU^? 30.91 MG MG B 701 C 226 THR A 230 THR~? 44.21 MG MG B 701 C 229 LYS A 238 LYS~? 48.13 MG MG B 701 coo 5.43 40.40 61.63 4.27 41.99 60.90 46.08 11.35 43.50 47.51 12.29 44.66 coo 22.16 45.88 73.63 23.23 47.70 73.25 49.84 5.84 63.31 51.56 6.85 64.09 coo 28.90 45.91 73.55 25.22 49.72 72.97 49.71 6.68 70.26 45.99 10.01 66.31 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 C 57 GLU A 219 GLU~? 34.01 MG MG B 701 C 226 THR A 168 THR^? 7.86 MG MG B 701 C 229 LYS A 172 LYS~? 6.12 MG MG B 701 coo 5.43 40.40 61.63 4.27 41.99 60.90 59.27 18.40 40.08 59.60 20.33 40.74 coo 22.16 45.88 73.63 23.23 47.70 73.25 54.22 -0.54 28.99 53.77 -2.31 27.85 coo 28.90 45.91 73.55 25.22 49.72 72.97 50.20 -3.67 28.72 53.15 -8.47 28.45 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 3 3 # 3 C 57 GLU A 219 GLU~? 34.01 MG MG B 701 C 226 THR A 169 THR~? 12.09 MG MG B 701 C 229 LYS A 172 LYS~? 6.12 MG MG B 701 coo 5.43 40.40 61.63 4.27 41.99 60.90 59.27 18.40 40.08 59.60 20.33 40.74 coo 22.16 45.88 73.63 23.23 47.70 73.25 53.69 2.67 26.96 55.61 3.43 26.29 coo 28.90 45.91 73.55 25.22 49.72 72.97 50.20 -3.67 28.72 53.15 -8.47 28.45 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 4 3 # 4 C 57 GLU B 134 GLU^? 26.11 MG MG B 701 C 226 THR B 230 THR~? 11.71 MG MG B 701 C 229 LYS B 238 LYS~? 10.43 MG MG B 701 coo 5.43 40.40 61.63 4.27 41.99 60.90 69.63 -18.91 41.63 70.61 -19.62 39.97 coo 22.16 45.88 73.63 23.23 47.70 73.25 63.14 -13.74 22.31 64.62 -14.39 20.89 coo 28.90 45.91 73.55 25.22 49.72 72.97 60.37 -14.95 16.47 59.84 -17.17 21.39 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 5 3 # 5 C 57 GLU B 219 GLU~? 39.54 MG MG B 701 C 226 THR B 168 THR^? 39.79 MG MG B 701 C 229 LYS B 172 LYS~? 42.28 MG MG B 701 coo 5.43 40.40 61.63 4.27 41.99 60.90 85.46 -21.90 40.90 85.71 -22.21 42.97 coo 22.16 45.88 73.63 23.23 47.70 73.25 79.61 -4.74 52.17 79.36 -3.15 53.62 coo 28.90 45.91 73.55 25.22 49.72 72.97 75.30 -2.84 54.33 79.74 -2.40 56.36 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 6 3 # 6 C 57 GLU B 219 GLU~? 39.54 MG MG B 701 C 226 THR B 169 THR~? 41.74 MG MG B 701 C 229 LYS B 172 LYS~? 42.28 MG MG B 701 coo 5.43 40.40 61.63 4.27 41.99 60.90 85.46 -21.90 40.90 85.71 -22.21 42.97 coo 22.16 45.88 73.63 23.23 47.70 73.25 80.90 -7.97 53.82 83.02 -8.15 53.47 coo 28.90 45.91 73.55 25.22 49.72 72.97 75.30 -2.84 54.33 79.74 -2.40 56.36 1dfo_c06 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 6 hits 1dfo_c06 naa= 3 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 D 57 GLU A 134 GLU^? 30.91 MG MG B 701 D 226 THR A 230 THR~? 44.21 MG MG B 701 D 229 LYS A 238 LYS~? 48.13 MG MG B 701 coo 26.07 55.89 66.14 25.33 56.50 68.01 46.08 11.35 43.50 47.51 12.29 44.66 coo 11.79 47.62 52.67 10.10 46.51 53.39 49.84 5.84 63.31 51.56 6.85 64.09 coo 10.05 41.79 49.80 7.94 44.71 53.76 49.71 6.68 70.26 45.99 10.01 66.31 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 D 57 GLU A 219 GLU~? 34.01 MG MG B 701 D 226 THR A 168 THR^? 7.86 MG MG B 701 D 229 LYS A 172 LYS~? 6.12 MG MG B 701 coo 26.07 55.89 66.14 25.33 56.50 68.01 59.27 18.40 40.08 59.60 20.33 40.74 coo 11.79 47.62 52.67 10.10 46.51 53.39 54.22 -0.54 28.99 53.77 -2.31 27.85 coo 10.05 41.79 49.80 7.94 44.71 53.76 50.20 -3.67 28.72 53.15 -8.47 28.45 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 3 3 # 3 D 57 GLU A 219 GLU~? 34.01 MG MG B 701 D 226 THR A 169 THR~? 12.09 MG MG B 701 D 229 LYS A 172 LYS~? 6.12 MG MG B 701 coo 26.07 55.89 66.14 25.33 56.50 68.01 59.27 18.40 40.08 59.60 20.33 40.74 coo 11.79 47.62 52.67 10.10 46.51 53.39 53.69 2.67 26.96 55.61 3.43 26.29 coo 10.05 41.79 49.80 7.94 44.71 53.76 50.20 -3.67 28.72 53.15 -8.47 28.45 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 4 3 # 4 D 57 GLU B 134 GLU^? 26.11 MG MG B 701 D 226 THR B 230 THR~? 11.71 MG MG B 701 D 229 LYS B 238 LYS~? 10.43 MG MG B 701 coo 26.07 55.89 66.14 25.33 56.50 68.01 69.63 -18.91 41.63 70.61 -19.62 39.97 coo 11.79 47.62 52.67 10.10 46.51 53.39 63.14 -13.74 22.31 64.62 -14.39 20.89 coo 10.05 41.79 49.80 7.94 44.71 53.76 60.37 -14.95 16.47 59.84 -17.17 21.39 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 5 3 # 5 D 57 GLU B 219 GLU~? 39.54 MG MG B 701 D 226 THR B 168 THR^? 39.79 MG MG B 701 D 229 LYS B 172 LYS~? 42.28 MG MG B 701 coo 26.07 55.89 66.14 25.33 56.50 68.01 85.46 -21.90 40.90 85.71 -22.21 42.97 coo 11.79 47.62 52.67 10.10 46.51 53.39 79.61 -4.74 52.17 79.36 -3.15 53.62 coo 10.05 41.79 49.80 7.94 44.71 53.76 75.30 -2.84 54.33 79.74 -2.40 56.36 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 6 3 # 6 D 57 GLU B 219 GLU~? 39.54 MG MG B 701 D 226 THR B 169 THR~? 41.74 MG MG B 701 D 229 LYS B 172 LYS~? 42.28 MG MG B 701 coo 26.07 55.89 66.14 25.33 56.50 68.01 85.46 -21.90 40.90 85.71 -22.21 42.97 coo 11.79 47.62 52.67 10.10 46.51 53.39 80.90 -7.97 53.82 83.02 -8.15 53.47 coo 10.05 41.79 49.80 7.94 44.71 53.76 75.30 -2.84 54.33 79.74 -2.40 56.36 1dfo_c07 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 6 hits 1dfo_c07 naa= 3 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 1 3 # 1 A 44 THR A 168 THR^? 7.86 MG MG B 701 A 45 THR A 169 THR~? 12.09 MG MG B 701 A 161 LYS A 175 LYS~? 16.95 MG MG B 701 coo 26.16 88.25 79.16 25.22 89.47 80.71 54.22 -0.54 28.99 53.77 -2.31 27.85 coo 27.73 89.90 76.08 29.24 91.46 75.95 53.69 2.67 26.96 55.61 3.43 26.29 coo 33.83 91.15 88.62 31.07 91.06 83.02 54.19 -7.18 37.22 54.81 -12.82 38.86 1dhp_c02 source 1dhp DIHYDRODIPICOLINATE SYNTHASE : 1 hits 1dhp_c02 naa= 3 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 1 3 # 1 B 44 THR A 168 THR^? 7.86 MG MG B 701 B 45 THR A 169 THR~? 12.09 MG MG B 701 B 161 LYS A 175 LYS~? 16.95 MG MG B 701 coo 7.39 128.28 94.56 8.34 126.36 94.79 54.22 -0.54 28.99 53.77 -2.31 27.85 coo 5.75 129.25 91.25 4.29 128.16 90.07 53.69 2.67 26.96 55.61 3.43 26.29 coo -0.17 119.75 99.65 2.51 123.83 95.70 54.19 -7.18 37.22 54.81 -12.82 38.86 1dhp_c03 source 1dhp DIHYDRODIPICOLINATE SYNTHASE : 1 hits 1dhp_c03 naa= 3 ULMN 3 1dub_c13 2-ENOYL-COA HYDRATASE user 1 3 # 1 B 141 GLY A 67 GLY~? 22.64 MG MG B 701 B 144 GLU A 68 GLU~? 16.08 MG MG B 701 B 164 GLU A 70 GLU~? 25.37 MG MG B 701 coo 88.87 114.43 152.30 88.45 115.15 152.32 55.37 14.48 24.73 54.63 14.21 24.44 coo 85.20 111.99 152.05 86.60 110.89 150.91 56.21 8.51 25.84 57.91 7.36 26.07 coo 88.14 113.46 145.73 86.79 113.92 147.30 49.68 14.74 24.80 49.71 16.74 24.08 ULMN 3 1dub_c13 2-ENOYL-COA HYDRATASE user 2 3 # 2 B 141 GLY A 67 GLY~? 22.64 MG MG B 701 B 144 GLU A 70 GLU~? 25.37 MG MG B 701 B 164 GLU A 68 GLU~? 16.08 MG MG B 701 coo 88.87 114.43 152.30 88.45 115.15 152.32 55.37 14.48 24.73 54.63 14.21 24.44 coo 85.20 111.99 152.05 86.60 110.89 150.91 49.68 14.74 24.80 49.71 16.74 24.08 coo 88.14 113.46 145.73 86.79 113.92 147.30 56.21 8.51 25.84 57.91 7.36 26.07 1dub_c13 source 1dub 2-ENOYL-COA HYDRATASE : 2 hits 1dub_c13 naa= 3 ULMN 3 1dub_c17 2-ENOYL-COA HYDRATASE user 1 3 # 1 F 141 GLY A 67 GLY~? 22.64 MG MG B 701 F 144 GLU A 68 GLU~? 16.08 MG MG B 701 F 164 GLU A 70 GLU~? 25.37 MG MG B 701 coo 57.12 70.68 155.10 57.52 69.95 155.02 55.37 14.48 24.73 54.63 14.21 24.44 coo 60.62 73.13 154.21 59.05 74.26 153.35 56.21 8.51 25.84 57.91 7.36 26.07 coo 56.75 71.71 148.46 58.44 71.01 149.54 49.68 14.74 24.80 49.71 16.74 24.08 ULMN 3 1dub_c17 2-ENOYL-COA HYDRATASE user 2 3 # 2 F 141 GLY A 67 GLY~? 22.64 MG MG B 701 F 144 GLU A 70 GLU~? 25.37 MG MG B 701 F 164 GLU A 68 GLU~? 16.08 MG MG B 701 coo 57.12 70.68 155.10 57.52 69.95 155.02 55.37 14.48 24.73 54.63 14.21 24.44 coo 60.62 73.13 154.21 59.05 74.26 153.35 49.68 14.74 24.80 49.71 16.74 24.08 coo 56.75 71.71 148.46 58.44 71.01 149.54 56.21 8.51 25.84 57.91 7.36 26.07 1dub_c17 source 1dub 2-ENOYL-COA HYDRATASE : 2 hits 1dub_c17 naa= 3 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 1 3 # 1 A 229 ALA A 202 ALA~? 52.00 MG MG B 701 A 257 ALA A 199 ALA~? 51.88 MG MG B 701 A 328 ASP A 194 ASP~? 51.94 MG MG B 701 coo 39.84 24.12 8.44 38.50 24.23 9.11 50.44 -3.80 73.05 50.45 -2.68 74.13 coo 43.22 26.73 5.37 41.81 27.09 5.79 54.75 -0.85 73.97 55.62 0.40 73.78 coo 38.17 34.10 6.67 37.72 32.06 6.84 62.72 -3.55 72.77 62.75 -5.34 73.88 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 2 3 # 2 A 229 ALA A 241 ALA~? 47.31 MG MG B 701 A 257 ALA A 199 ALA~? 51.88 MG MG B 701 A 328 ASP A 194 ASP~? 51.94 MG MG B 701 coo 39.84 24.12 8.44 38.50 24.23 9.11 53.60 3.48 69.42 52.47 3.64 68.38 coo 43.22 26.73 5.37 41.81 27.09 5.79 54.75 -0.85 73.97 55.62 0.40 73.78 coo 38.17 34.10 6.67 37.72 32.06 6.84 62.72 -3.55 72.77 62.75 -5.34 73.88 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 3 3 # 3 A 229 ALA B 241 ALA~? 10.01 MG MG B 701 A 257 ALA B 199 ALA~? 13.57 MG MG B 701 A 328 ASP B 194 ASP~? 20.07 MG MG B 701 coo 39.84 24.12 8.44 38.50 24.23 9.11 63.24 -10.78 15.96 62.74 -11.32 17.28 coo 43.22 26.73 5.37 41.81 27.09 5.79 61.06 -6.74 11.45 62.28 -7.68 11.21 coo 38.17 34.10 6.67 37.72 32.06 6.84 67.87 -2.29 9.08 66.66 -1.03 7.91 1eo7_c00 source 1eo7 CYCLODEXTRIN GLYCOSYLTRANSFERASE : 3 hits 1eo7_c00 naa= 3 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 1 3 # 1 A 112 PHE A 142 PHE~? 13.47 MG MG B 701 A 210 ASP B 161 ASP^? 15.44 MG MG B 701 A 244 LYS A 175 LYS~? 16.95 MG MG B 701 coo 9.23 46.77 25.11 11.48 48.39 24.76 62.78 -0.55 30.89 63.67 -3.12 31.49 coo 10.51 37.86 19.71 9.07 39.38 20.04 63.88 -11.38 34.74 64.49 -9.36 34.64 coo -1.20 42.34 17.67 3.19 45.13 19.06 54.19 -7.18 37.22 54.81 -12.82 38.86 1fc4_c02 source 1fc4 2-AMINO-3-KETOBUTYRATE CONENZYME A LIGASE : 1 hits 1fc4_c02 naa= 3 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 1 3 # 1 B 112 PHE A 142 PHE~? 13.47 MG MG B 701 B 210 ASP B 161 ASP^? 15.44 MG MG B 701 B 244 LYS A 175 LYS~? 16.95 MG MG B 701 coo 8.76 47.85 34.91 11.08 46.36 35.41 62.78 -0.55 30.89 63.67 -3.12 31.49 coo 9.06 56.85 40.30 7.71 55.27 39.90 63.88 -11.38 34.74 64.49 -9.36 34.64 coo -2.38 51.82 41.62 2.07 49.19 40.42 54.19 -7.18 37.22 54.81 -12.82 38.86 1fc4_c03 source 1fc4 2-AMINO-3-KETOBUTYRATE CONENZYME A LIGASE : 1 hits 1fc4_c03 naa= 3 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 A 137 TYR A 167 TYR^? 14.87 MG MG B 701 A 142 LEU A 81 LEU~? 21.91 MG MG B 701 A 165 LYS A 172 LYS~? 6.12 MG MG B 701 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 50.02 0.16 32.66 47.75 0.13 34.22 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 42.12 4.62 33.97 42.77 5.70 35.72 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 50.20 -3.67 28.72 53.15 -8.47 28.45 1fdy_c00 source 1fdy N-ACETYLNEURAMINATE LYASE : 1 hits 1fdy_c00 naa= 3 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 B 137 TYR A 167 TYR^? 14.87 MG MG B 701 B 142 LEU A 81 LEU~? 21.91 MG MG B 701 B 165 LYS A 172 LYS~? 6.12 MG MG B 701 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 50.02 0.16 32.66 47.75 0.13 34.22 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 42.12 4.62 33.97 42.77 5.70 35.72 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 50.20 -3.67 28.72 53.15 -8.47 28.45 1fdy_c01 source 1fdy N-ACETYLNEURAMINATE LYASE : 1 hits 1fdy_c01 naa= 3 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 C 137 TYR A 167 TYR^? 14.87 MG MG B 701 C 142 LEU A 81 LEU~? 21.91 MG MG B 701 C 165 LYS A 172 LYS~? 6.12 MG MG B 701 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 50.02 0.16 32.66 47.75 0.13 34.22 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 42.12 4.62 33.97 42.77 5.70 35.72 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 50.20 -3.67 28.72 53.15 -8.47 28.45 1fdy_c02 source 1fdy N-ACETYLNEURAMINATE LYASE : 1 hits 1fdy_c02 naa= 3 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 D 137 TYR A 167 TYR^? 14.87 MG MG B 701 D 142 LEU A 81 LEU~? 21.91 MG MG B 701 D 165 LYS A 172 LYS~? 6.12 MG MG B 701 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 50.02 0.16 32.66 47.75 0.13 34.22 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 42.12 4.62 33.97 42.77 5.70 35.72 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 50.20 -3.67 28.72 53.15 -8.47 28.45 1fdy_c03 source 1fdy N-ACETYLNEURAMINATE LYASE : 1 hits 1fdy_c03 naa= 3 ULMN 3 1fdy_c04 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 A 47 SER A 206 SER~? 45.83 MG MG B 701 A 48 THR A 208 THR~? 38.19 MG MG B 701 A 165 LYS A 238 LYS~? 48.13 MG MG B 701 coo -39.09 -83.21 -19.79 -37.33 -83.94 -21.38 47.28 -2.73 65.33 45.89 -1.90 67.11 coo -41.85 -80.60 -20.11 -42.94 -79.78 -21.77 48.48 -4.56 60.28 49.36 -6.54 60.36 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 49.71 6.68 70.26 45.99 10.01 66.31 ULMN 3 1fdy_c04 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 A 47 SER B 210 SER~? 12.60 MG MG B 701 A 48 THR B 208 THR~? 10.07 MG MG B 701 A 165 LYS A 175 LYS~? 16.95 MG MG B 701 coo -39.09 -83.21 -19.79 -37.33 -83.94 -21.38 63.63 -6.43 28.51 65.51 -5.02 28.70 coo -41.85 -80.60 -20.11 -42.94 -79.78 -21.77 60.49 -3.20 26.65 60.84 -1.10 26.85 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 54.19 -7.18 37.22 54.81 -12.82 38.86 1fdy_c04 source 1fdy N-ACETYLNEURAMINATE LYASE : 2 hits 1fdy_c04 naa= 3 ULMN 3 1fdy_c05 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 B 47 SER A 206 SER~? 45.83 MG MG B 701 B 48 THR A 208 THR~? 38.19 MG MG B 701 B 165 LYS A 238 LYS~? 48.13 MG MG B 701 coo 0.74 -71.26 -35.87 -0.36 -73.34 -35.30 47.28 -2.73 65.33 45.89 -1.90 67.11 coo 2.65 -68.72 -33.78 3.66 -68.93 -31.87 48.48 -4.56 60.28 49.36 -6.54 60.36 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 49.71 6.68 70.26 45.99 10.01 66.31 ULMN 3 1fdy_c05 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 B 47 SER B 210 SER~? 12.60 MG MG B 701 B 48 THR B 208 THR~? 10.07 MG MG B 701 B 165 LYS A 175 LYS~? 16.95 MG MG B 701 coo 0.74 -71.26 -35.87 -0.36 -73.34 -35.30 63.63 -6.43 28.51 65.51 -5.02 28.70 coo 2.65 -68.72 -33.78 3.66 -68.93 -31.87 60.49 -3.20 26.65 60.84 -1.10 26.85 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 54.19 -7.18 37.22 54.81 -12.82 38.86 1fdy_c05 source 1fdy N-ACETYLNEURAMINATE LYASE : 2 hits 1fdy_c05 naa= 3 ULMN 3 1fdy_c06 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 C 47 SER A 206 SER~? 45.83 MG MG B 701 C 48 THR A 208 THR~? 38.19 MG MG B 701 C 165 LYS A 238 LYS~? 48.13 MG MG B 701 coo -15.18 -75.37 -50.42 -16.12 -74.55 -48.34 47.28 -2.73 65.33 45.89 -1.90 67.11 coo -16.57 -77.65 -53.15 -18.61 -78.18 -53.63 48.48 -4.56 60.28 49.36 -6.54 60.36 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 49.71 6.68 70.26 45.99 10.01 66.31 ULMN 3 1fdy_c06 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 C 47 SER B 210 SER~? 12.60 MG MG B 701 C 48 THR B 208 THR~? 10.07 MG MG B 701 C 165 LYS A 175 LYS~? 16.95 MG MG B 701 coo -15.18 -75.37 -50.42 -16.12 -74.55 -48.34 63.63 -6.43 28.51 65.51 -5.02 28.70 coo -16.57 -77.65 -53.15 -18.61 -78.18 -53.63 60.49 -3.20 26.65 60.84 -1.10 26.85 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 54.19 -7.18 37.22 54.81 -12.82 38.86 1fdy_c06 source 1fdy N-ACETYLNEURAMINATE LYASE : 2 hits 1fdy_c06 naa= 3 ULMN 3 1fdy_c07 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 D 47 SER A 206 SER~? 45.83 MG MG B 701 D 48 THR A 208 THR~? 38.19 MG MG B 701 D 165 LYS A 238 LYS~? 48.13 MG MG B 701 coo -21.69 -90.39 -8.89 -21.07 -88.29 -10.03 47.28 -2.73 65.33 45.89 -1.90 67.11 coo -19.38 -93.32 -7.98 -17.24 -93.31 -7.67 48.48 -4.56 60.28 49.36 -6.54 60.36 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 49.71 6.68 70.26 45.99 10.01 66.31 ULMN 3 1fdy_c07 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 D 47 SER B 162 SER^? 20.48 MG MG B 701 D 48 THR B 154 THR^? 21.42 MG MG B 701 D 165 LYS A 175 LYS~? 16.95 MG MG B 701 coo -21.69 -90.39 -8.89 -21.07 -88.29 -10.03 67.92 -11.32 37.08 69.18 -13.29 36.33 coo -19.38 -93.32 -7.98 -17.24 -93.31 -7.67 66.76 -14.70 39.39 67.99 -15.56 37.81 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 54.19 -7.18 37.22 54.81 -12.82 38.86 ULMN 3 1fdy_c07 N-ACETYLNEURAMINATE LYASE user 3 3 # 3 D 47 SER B 206 SER~? -2.06 MG MG B 701s D 48 THR B 208 THR~? 10.07 MG MG B 701 D 165 LYS B 238 LYS~? 10.43 MG MG B 701 coo -21.69 -90.39 -8.89 -21.07 -88.29 -10.03 58.11 -6.07 22.68 56.48 -7.41 21.42 coo -19.38 -93.32 -7.98 -17.24 -93.31 -7.67 60.49 -3.20 26.65 60.84 -1.10 26.85 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 60.37 -14.95 16.47 59.84 -17.17 21.39 ULMN 3 1fdy_c07 N-ACETYLNEURAMINATE LYASE user 4 3 # 4 D 47 SER B 210 SER~? 12.60 MG MG B 701 D 48 THR B 208 THR~? 10.07 MG MG B 701 D 165 LYS A 175 LYS~? 16.95 MG MG B 701 coo -21.69 -90.39 -8.89 -21.07 -88.29 -10.03 63.63 -6.43 28.51 65.51 -5.02 28.70 coo -19.38 -93.32 -7.98 -17.24 -93.31 -7.67 60.49 -3.20 26.65 60.84 -1.10 26.85 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 54.19 -7.18 37.22 54.81 -12.82 38.86 1fdy_c07 source 1fdy N-ACETYLNEURAMINATE LYASE : 4 hits 1fdy_c07 naa= 3 ULMN 3 1fhl_c00 BETA-1,4-GALACTANASE user 1 3 # 1 A 45 ARG A 126 ARG^? 30.85 MG MG B 701 A 136 GLU A 219 GLU~? 34.01 MG MG B 701 A 246 GLU A 218 GLU~? 32.55 MG MG B 701 coo 13.48 30.30 107.06 11.75 30.99 109.44 48.08 15.54 42.27 50.77 14.42 43.32 coo 9.46 32.37 115.82 8.50 34.20 115.47 59.27 18.40 40.08 59.60 20.33 40.74 coo 11.99 34.33 109.92 10.08 34.19 110.77 54.56 16.53 40.79 53.76 18.19 41.81 ULMN 3 1fhl_c00 BETA-1,4-GALACTANASE user 2 3 # 2 A 45 ARG B 89 ARG~? 39.23 MG MG B 701 A 136 GLU B 87 GLU~? 47.03 MG MG B 701 A 246 GLU B 88 GLU~? 39.12 MG MG B 701 coo 13.48 30.30 107.06 11.75 30.99 109.44 70.16 -17.97 55.88 70.89 -15.54 57.64 coo 9.46 32.37 115.82 8.50 34.20 115.47 66.89 -21.09 64.87 65.61 -20.97 66.54 coo 11.99 34.33 109.92 10.08 34.19 110.77 64.81 -21.91 58.58 62.70 -21.80 58.39 1fhl_c00 source 1fhl BETA-1,4-GALACTANASE : 2 hits 1fhl_c00 naa= 3 ULMN 3 1fnb_c00 FERREDOXIN:NADP+ OXIDOREDUCTASE (FERuser 1 3 # 1 96 SER A 147 SER^? 16.30 MG MG B 701 272 CYH A 72 CYH~? 15.35 MG MG B 701 312 GLU A 68 GLU~? 16.08 MG MG B 701 coo 27.57 5.78 14.13 25.30 6.31 13.99 59.94 3.92 28.83 60.06 6.29 28.37 coo 18.48 7.50 15.98 21.17 6.92 15.38 49.96 7.59 26.24 52.51 6.56 26.61 coo 22.30 10.15 12.52 24.07 9.52 13.47 56.21 8.51 25.84 57.91 7.36 26.07 1fnb_c00 source 1fnb FERREDOXIN:NADP+ OXIDOREDUCTASE (FERREDOXIN RE: 1 hits 1fnb_c00 naa= 3 ULMN 3 1fob_c00 BETA-1,4-GALACTANASE user 1 3 # 1 A 45 ARG A 126 ARG^? 30.85 MG MG B 701 A 136 GLU A 219 GLU~? 34.01 MG MG B 701 A 246 GLU A 218 GLU~? 32.55 MG MG B 701 coo 13.94 29.84 106.80 11.67 30.40 108.79 48.08 15.54 42.27 50.77 14.42 43.32 coo 9.52 31.97 115.23 8.45 33.74 114.72 59.27 18.40 40.08 59.60 20.33 40.74 coo 11.92 33.82 109.35 10.10 33.50 110.39 54.56 16.53 40.79 53.76 18.19 41.81 ULMN 3 1fob_c00 BETA-1,4-GALACTANASE user 2 3 # 2 A 45 ARG B 138 ARG^? 35.64 MG MG B 701 A 136 GLU B 219 GLU~? 39.54 MG MG B 701 A 246 GLU B 218 GLU~? 32.37 MG MG B 701 coo 13.94 29.84 106.80 11.67 30.40 108.79 81.28 -15.50 42.88 84.08 -15.53 41.69 coo 9.52 31.97 115.23 8.45 33.74 114.72 85.46 -21.90 40.90 85.71 -22.21 42.97 coo 11.92 33.82 109.35 10.10 33.50 110.39 79.74 -21.86 40.41 79.27 -22.32 38.45 1fob_c00 source 1fob BETA-1,4-GALACTANASE : 2 hits 1fob_c00 naa= 3 ULMN 3 1fr8_c00 BETA 1,4 GALACTOSYLTRANSFERASE user 1 3 # 1 A 317 GLU A 87 GLU~? 27.37 MG MG B 701 A 319 ASP A 91 ASP~? 30.86 MG MG B 701 A 359 ARG A 94 ARG~? 29.54 MG MG B 701 coo 14.41 12.40 16.42 12.92 13.74 15.71 33.74 9.75 22.88 32.80 8.03 23.69 coo 12.25 13.04 23.85 11.56 15.02 23.93 36.10 16.42 24.55 35.02 15.53 22.85 coo 10.89 14.95 28.28 12.39 12.53 29.31 39.43 19.06 19.67 38.29 16.27 20.39 ULMN 3 1fr8_c00 BETA 1,4 GALACTOSYLTRANSFERASE user 2 3 # 2 A 317 GLU A 87 GLU~? 27.37 MG MG B 701 A 319 ASP A 91 ASP~? 30.86 MG MG B 701 A 359 ARG A 95 ARG~? 33.62 MG MG B 701 coo 14.41 12.40 16.42 12.92 13.74 15.71 33.74 9.75 22.88 32.80 8.03 23.69 coo 12.25 13.04 23.85 11.56 15.02 23.93 36.10 16.42 24.55 35.02 15.53 22.85 coo 10.89 14.95 28.28 12.39 12.53 29.31 36.90 22.02 26.51 36.19 19.35 27.93 ULMN 3 1fr8_c00 BETA 1,4 GALACTOSYLTRANSFERASE user 3 3 # 3 A 317 GLU A 88 GLU~? 31.24 MG MG B 701 A 319 ASP A 91 ASP~? 30.86 MG MG B 701 A 359 ARG A 94 ARG~? 29.54 MG MG B 701 coo 14.41 12.40 16.42 12.92 13.74 15.71 33.25 12.86 29.05 32.48 12.06 30.82 coo 12.25 13.04 23.85 11.56 15.02 23.93 36.10 16.42 24.55 35.02 15.53 22.85 coo 10.89 14.95 28.28 12.39 12.53 29.31 39.43 19.06 19.67 38.29 16.27 20.39 ULMN 3 1fr8_c00 BETA 1,4 GALACTOSYLTRANSFERASE user 4 3 # 4 A 317 GLU B 88 GLU~? 39.12 MG MG B 701 A 319 ASP B 91 ASP~? 46.73 MG MG B 701 A 359 ARG B 94 ARG~? 47.57 MG MG B 701 coo 14.41 12.40 16.42 12.92 13.74 15.71 64.81 -21.91 58.58 62.70 -21.80 58.39 coo 12.25 13.04 23.85 11.56 15.02 23.93 69.68 -24.93 62.08 69.33 -24.21 64.01 coo 10.89 14.95 28.28 12.39 12.53 29.31 76.29 -23.20 63.54 75.68 -20.19 63.65 ULMN 3 1fr8_c00 BETA 1,4 GALACTOSYLTRANSFERASE user 5 3 # 5 A 317 GLU B 88 GLU~? 39.12 MG MG B 701 A 319 ASP B 91 ASP~? 46.73 MG MG B 701 A 359 ARG B 95 ARG~? 44.55 MG MG B 701 coo 14.41 12.40 16.42 12.92 13.74 15.71 64.81 -21.91 58.58 62.70 -21.80 58.39 coo 12.25 13.04 23.85 11.56 15.02 23.93 69.68 -24.93 62.08 69.33 -24.21 64.01 coo 10.89 14.95 28.28 12.39 12.53 29.31 71.08 -30.47 60.44 68.82 -28.47 59.67 ULMN 3 1fr8_c00 BETA 1,4 GALACTOSYLTRANSFERASE user 6 3 # 6 A 317 GLU B 186 GLU~? 15.37 MG MG B 701 A 319 ASP B 187 ASP~? 20.66 MG MG B 701 A 359 ARG B 261 ARG^? 24.22 MG MG B 701 coo 14.41 12.40 16.42 12.92 13.74 15.71 69.45 -0.46 21.54 67.97 0.05 22.96 coo 12.25 13.04 23.85 11.56 15.02 23.93 74.06 -4.33 24.81 74.57 -2.40 25.55 coo 10.89 14.95 28.28 12.39 12.53 29.31 79.96 -6.70 27.13 79.05 -6.72 24.18 1fr8_c00 source 1fr8 BETA 1,4 GALACTOSYLTRANSFERASE : 6 hits 1fr8_c00 naa= 3 ULMN 3 1fr8_c01 BETA 1,4 GALACTOSYLTRANSFERASE user 1 3 # 1 B 317 GLU A 87 GLU~? 27.37 MG MG B 701 B 319 ASP A 91 ASP~? 30.86 MG MG B 701 B 359 ARG A 94 ARG~? 29.54 MG MG B 701 coo 10.77 13.13 40.94 11.03 14.73 39.51 33.74 9.75 22.88 32.80 8.03 23.69 coo 3.77 12.64 38.21 3.35 14.53 37.39 36.10 16.42 24.55 35.02 15.53 22.85 coo -1.16 15.32 35.60 -3.32 13.56 36.98 39.43 19.06 19.67 38.29 16.27 20.39 ULMN 3 1fr8_c01 BETA 1,4 GALACTOSYLTRANSFERASE user 2 3 # 2 B 317 GLU A 87 GLU~? 27.37 MG MG B 701 B 319 ASP A 91 ASP~? 30.86 MG MG B 701 B 359 ARG A 95 ARG~? 33.62 MG MG B 701 coo 10.77 13.13 40.94 11.03 14.73 39.51 33.74 9.75 22.88 32.80 8.03 23.69 coo 3.77 12.64 38.21 3.35 14.53 37.39 36.10 16.42 24.55 35.02 15.53 22.85 coo -1.16 15.32 35.60 -3.32 13.56 36.98 36.90 22.02 26.51 36.19 19.35 27.93 ULMN 3 1fr8_c01 BETA 1,4 GALACTOSYLTRANSFERASE user 3 3 # 3 B 317 GLU A 88 GLU~? 31.24 MG MG B 701 B 319 ASP A 91 ASP~? 30.86 MG MG B 701 B 359 ARG A 94 ARG~? 29.54 MG MG B 701 coo 10.77 13.13 40.94 11.03 14.73 39.51 33.25 12.86 29.05 32.48 12.06 30.82 coo 3.77 12.64 38.21 3.35 14.53 37.39 36.10 16.42 24.55 35.02 15.53 22.85 coo -1.16 15.32 35.60 -3.32 13.56 36.98 39.43 19.06 19.67 38.29 16.27 20.39 ULMN 3 1fr8_c01 BETA 1,4 GALACTOSYLTRANSFERASE user 4 3 # 4 B 317 GLU B 88 GLU~? 39.12 MG MG B 701 B 319 ASP B 91 ASP~? 46.73 MG MG B 701 B 359 ARG B 94 ARG~? 47.57 MG MG B 701 coo 10.77 13.13 40.94 11.03 14.73 39.51 64.81 -21.91 58.58 62.70 -21.80 58.39 coo 3.77 12.64 38.21 3.35 14.53 37.39 69.68 -24.93 62.08 69.33 -24.21 64.01 coo -1.16 15.32 35.60 -3.32 13.56 36.98 76.29 -23.20 63.54 75.68 -20.19 63.65 ULMN 3 1fr8_c01 BETA 1,4 GALACTOSYLTRANSFERASE user 5 3 # 5 B 317 GLU B 186 GLU~? 15.37 MG MG B 701 B 319 ASP B 187 ASP~? 20.66 MG MG B 701 B 359 ARG B 261 ARG^? 24.22 MG MG B 701 coo 10.77 13.13 40.94 11.03 14.73 39.51 69.45 -0.46 21.54 67.97 0.05 22.96 coo 3.77 12.64 38.21 3.35 14.53 37.39 74.06 -4.33 24.81 74.57 -2.40 25.55 coo -1.16 15.32 35.60 -3.32 13.56 36.98 79.96 -6.70 27.13 79.05 -6.72 24.18 1fr8_c01 source 1fr8 BETA 1,4 GALACTOSYLTRANSFERASE : 5 hits 1fr8_c01 naa= 3 ULMN 3 1gim_c00 ADENYLOSUCCINATE SYNTHETASE user 1 3 # 1 13 ASP A 161 ASP^? 31.32 MG MG B 701 41 HIS A 157 HIS~? 39.61 MG MG B 701 224 GLN A 213 GLN~? 34.86 MG MG B 701 coo -3.80 50.71 49.48 -5.59 51.85 49.27 45.91 2.65 51.66 46.91 0.77 51.57 coo -6.45 47.32 41.99 -8.32 46.87 42.83 38.94 10.29 53.24 39.70 12.18 53.73 coo -12.35 49.13 49.89 -13.38 48.89 48.03 49.72 8.72 50.78 48.64 10.39 51.50 ULMN 3 1gim_c00 ADENYLOSUCCINATE SYNTHETASE user 2 3 # 2 13 ASP B 161 ASP^? 15.44 MG MG B 701 41 HIS B 157 HIS~? 18.79 MG MG B 701 224 GLN B 213 GLN~? 19.92 MG MG B 701 coo -3.80 50.71 49.48 -5.59 51.85 49.27 63.88 -11.38 34.74 64.49 -9.36 34.64 coo -6.45 47.32 41.99 -8.32 46.87 42.83 58.96 -20.41 35.42 60.06 -22.12 34.89 coo -12.35 49.13 49.89 -13.38 48.89 48.03 69.29 -16.23 33.49 68.51 -18.13 33.12 1gim_c00 source 1gim ADENYLOSUCCINATE SYNTHETASE : 2 hits 1gim_c00 naa= 3 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 1 3 # 1 A 189 PHE A 179 PHE~? 15.24 MG MG B 701 A 298 ASP A 165 ASP^? 19.82 MG MG B 701 A 329 LYS A 172 LYS~? 6.12 MG MG B 701 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 59.12 -2.16 37.53 58.98 -3.05 34.90 coo 2.59 0.29 25.55 4.65 0.18 25.07 49.47 0.04 38.38 48.02 -0.73 39.68 coo 12.42 6.10 23.27 9.95 1.57 20.16 50.20 -3.67 28.72 53.15 -8.47 28.45 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 2 3 # 2 A 189 PHE B 179 PHE~? 33.79 MG MG B 701 A 298 ASP B 165 ASP^? 26.59 MG MG B 701 A 329 LYS B 172 LYS~? 42.28 MG MG B 701 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 80.09 -2.55 42.63 80.83 -1.68 45.20 coo 2.59 0.29 25.55 4.65 0.18 25.07 71.61 -6.68 45.38 69.65 -6.30 44.66 coo 12.42 6.10 23.27 9.95 1.57 20.16 75.30 -2.84 54.33 79.74 -2.40 56.36 1gtx_c00 source 1gtx 4-AMINOBUTYRATE AMINOTRANSFERASE : 2 hits 1gtx_c00 naa= 3 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 1 3 # 1 B 189 PHE A 179 PHE~? 15.24 MG MG B 701 B 298 ASP A 165 ASP^? 19.82 MG MG B 701 B 329 LYS A 172 LYS~? 6.12 MG MG B 701 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 59.12 -2.16 37.53 58.98 -3.05 34.90 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 49.47 0.04 38.38 48.02 -0.73 39.68 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 50.20 -3.67 28.72 53.15 -8.47 28.45 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 2 3 # 2 B 189 PHE B 179 PHE~? 33.79 MG MG B 701 B 298 ASP B 165 ASP^? 26.59 MG MG B 701 B 329 LYS B 172 LYS~? 42.28 MG MG B 701 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 80.09 -2.55 42.63 80.83 -1.68 45.20 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 71.61 -6.68 45.38 69.65 -6.30 44.66 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 75.30 -2.84 54.33 79.74 -2.40 56.36 1gtx_c01 source 1gtx 4-AMINOBUTYRATE AMINOTRANSFERASE : 2 hits 1gtx_c01 naa= 3 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 1 3 # 1 C 189 PHE A 179 PHE~? 15.24 MG MG B 701 C 298 ASP A 165 ASP^? 19.82 MG MG B 701 C 329 LYS A 172 LYS~? 6.12 MG MG B 701 coo 17.41 60.57 64.39 18.40 58.12 65.34 59.12 -2.16 37.53 58.98 -3.05 34.90 coo 24.10 66.43 63.33 24.18 64.30 63.40 49.47 0.04 38.38 48.02 -0.73 39.68 coo 27.64 56.61 58.17 22.18 57.92 60.36 50.20 -3.67 28.72 53.15 -8.47 28.45 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 2 3 # 2 C 189 PHE B 179 PHE~? 33.79 MG MG B 701 C 298 ASP B 165 ASP^? 26.59 MG MG B 701 C 329 LYS B 172 LYS~? 42.28 MG MG B 701 coo 17.41 60.57 64.39 18.40 58.12 65.34 80.09 -2.55 42.63 80.83 -1.68 45.20 coo 24.10 66.43 63.33 24.18 64.30 63.40 71.61 -6.68 45.38 69.65 -6.30 44.66 coo 27.64 56.61 58.17 22.18 57.92 60.36 75.30 -2.84 54.33 79.74 -2.40 56.36 1gtx_c02 source 1gtx 4-AMINOBUTYRATE AMINOTRANSFERASE : 2 hits 1gtx_c02 naa= 3 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 1 3 # 1 D 189 PHE A 179 PHE~? 15.24 MG MG B 701 D 298 ASP A 165 ASP^? 19.82 MG MG B 701 D 329 LYS A 172 LYS~? 6.12 MG MG B 701 coo 35.44 53.35 83.81 35.65 54.53 81.28 59.12 -2.16 37.53 58.98 -3.05 34.90 coo 29.72 46.46 83.60 30.79 47.36 81.99 49.47 0.04 38.38 48.02 -0.73 39.68 coo 36.89 44.91 74.55 37.33 48.94 79.01 50.20 -3.67 28.72 53.15 -8.47 28.45 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 2 3 # 2 D 189 PHE B 179 PHE~? 33.79 MG MG B 701 D 298 ASP B 165 ASP^? 26.59 MG MG B 701 D 329 LYS B 172 LYS~? 42.28 MG MG B 701 coo 35.44 53.35 83.81 35.65 54.53 81.28 80.09 -2.55 42.63 80.83 -1.68 45.20 coo 29.72 46.46 83.60 30.79 47.36 81.99 71.61 -6.68 45.38 69.65 -6.30 44.66 coo 36.89 44.91 74.55 37.33 48.94 79.01 75.30 -2.84 54.33 79.74 -2.40 56.36 1gtx_c03 source 1gtx 4-AMINOBUTYRATE AMINOTRANSFERASE : 2 hits 1gtx_c03 naa= 3 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 1 3 # 1 A 50 ASP A 194 ASP~? 51.94 MG MG B 701 A 327 GLU B 231 GLU~? 14.47 MG MG B 701 A 339 ARG B 226 ARG^? 21.45 MG MG B 701 coo 85.81 57.99 116.01 86.03 55.86 115.89 62.72 -3.55 72.77 62.75 -5.34 73.88 coo 75.11 41.01 160.30 76.65 40.06 161.41 63.35 -17.79 25.44 64.18 -18.11 27.34 coo 82.23 40.35 159.87 85.09 40.67 161.01 70.51 -17.10 28.75 72.04 -19.70 28.19 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 2 3 # 2 A 50 ASP B 91 ASP~? 46.73 MG MG B 701 A 327 GLU A 218 GLU~? 32.55 MG MG B 701 A 339 ARG A 138 ARG^? 25.45 MG MG B 701 coo 85.81 57.99 116.01 86.03 55.86 115.89 69.68 -24.93 62.08 69.33 -24.21 64.01 coo 75.11 41.01 160.30 76.65 40.06 161.41 54.56 16.53 40.79 53.76 18.19 41.81 coo 82.23 40.35 159.87 85.09 40.67 161.01 56.09 11.79 37.51 58.92 12.66 36.83 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 3 3 # 3 A 50 ASP B 91 ASP~? 46.73 MG MG B 701 A 327 GLU A 219 GLU~? 34.01 MG MG B 701 A 339 ARG A 138 ARG^? 25.45 MG MG B 701 coo 85.81 57.99 116.01 86.03 55.86 115.89 69.68 -24.93 62.08 69.33 -24.21 64.01 coo 75.11 41.01 160.30 76.65 40.06 161.41 59.27 18.40 40.08 59.60 20.33 40.74 coo 82.23 40.35 159.87 85.09 40.67 161.01 56.09 11.79 37.51 58.92 12.66 36.83 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 4 3 # 4 A 50 ASP B 194 ASP~? 20.07 MG MG B 701 A 327 GLU B 78 GLU~? 38.64 MG MG B 701 A 339 ARG A 184 ARG~? 36.26 MG MG B 701 coo 85.81 57.99 116.01 86.03 55.86 115.89 67.87 -2.29 9.08 66.66 -1.03 7.91 coo 75.11 41.01 160.30 76.65 40.06 161.41 64.90 -13.57 57.96 63.80 -14.17 59.70 coo 82.23 40.35 159.87 85.09 40.67 161.01 59.62 -7.21 56.11 59.92 -9.15 58.50 1hto_c00 source 1hto GLUTAMINE SYNTHETASE : 4 hits 1hto_c00 naa= 3 ULMN 3 1ig8_c00 HEXOKINASE PII user 1 3 # 1 A 158 SER A 143 SER~? 15.64 MG MG B 701 A 173 ARG A 178 ARG~? 13.19 MG MG B 701 A 211 ASP A 144 ASP~? 20.24 MG MG B 701 coo 22.72 76.24 0.23 24.60 76.86 -1.25 66.42 2.53 29.16 66.03 2.11 26.82 coo 18.77 77.82 11.69 20.55 80.22 10.73 60.75 -6.17 35.55 62.65 -6.30 33.15 coo 26.87 77.59 -3.91 27.39 79.28 -2.83 69.22 6.09 27.43 70.24 4.65 26.30 ULMN 3 1ig8_c00 HEXOKINASE PII user 2 3 # 2 A 158 SER A 143 SER~? 15.64 MG MG B 701 A 173 ARG A 258 ARG~? 19.65 MG MG B 701 A 211 ASP A 144 ASP~? 20.24 MG MG B 701 coo 22.72 76.24 0.23 24.60 76.86 -1.25 66.42 2.53 29.16 66.03 2.11 26.82 coo 18.77 77.82 11.69 20.55 80.22 10.73 65.98 -2.88 40.97 66.14 -4.57 38.35 coo 26.87 77.59 -3.91 27.39 79.28 -2.83 69.22 6.09 27.43 70.24 4.65 26.30 ULMN 3 1ig8_c00 HEXOKINASE PII user 3 3 # 3 A 158 SER A 146 SER~? 13.04 MG MG B 701 A 173 ARG A 71 ARG~? 17.45 MG MG B 701 A 211 ASP A 144 ASP~? 20.24 MG MG B 701 coo 22.72 76.24 0.23 24.60 76.86 -1.25 62.43 3.35 26.06 63.03 1.20 26.92 coo 18.77 77.82 11.69 20.55 80.22 10.73 52.94 11.11 20.93 55.28 9.38 22.01 coo 26.87 77.59 -3.91 27.39 79.28 -2.83 69.22 6.09 27.43 70.24 4.65 26.30 ULMN 3 1ig8_c00 HEXOKINASE PII user 4 3 # 4 A 158 SER A 146 SER~? 13.04 MG MG B 701 A 173 ARG A 178 ARG~? 13.19 MG MG B 701 A 211 ASP A 144 ASP~? 20.24 MG MG B 701 coo 22.72 76.24 0.23 24.60 76.86 -1.25 62.43 3.35 26.06 63.03 1.20 26.92 coo 18.77 77.82 11.69 20.55 80.22 10.73 60.75 -6.17 35.55 62.65 -6.30 33.15 coo 26.87 77.59 -3.91 27.39 79.28 -2.83 69.22 6.09 27.43 70.24 4.65 26.30 ULMN 3 1ig8_c00 HEXOKINASE PII user 5 3 # 5 A 158 SER A 162 SER^? 29.38 MG MG B 701 A 173 ARG A 126 ARG^? 30.85 MG MG B 701 A 211 ASP A 161 ASP^? 31.32 MG MG B 701 coo 22.72 76.24 0.23 24.60 76.86 -1.25 48.41 3.59 47.69 49.51 5.75 47.96 coo 18.77 77.82 11.69 20.55 80.22 10.73 48.08 15.54 42.27 50.77 14.42 43.32 coo 26.87 77.59 -3.91 27.39 79.28 -2.83 45.91 2.65 51.66 46.91 0.77 51.57 ULMN 3 1ig8_c00 HEXOKINASE PII user 6 3 # 6 A 158 SER A 256 SER~? 22.42 MG MG B 701 A 173 ARG A 178 ARG~? 13.19 MG MG B 701 A 211 ASP B 177 ASP~? 29.47 MG MG B 701 coo 22.72 76.24 0.23 24.60 76.86 -1.25 68.19 1.16 36.27 69.40 -0.26 37.83 coo 18.77 77.82 11.69 20.55 80.22 10.73 60.75 -6.17 35.55 62.65 -6.30 33.15 coo 26.87 77.59 -3.91 27.39 79.28 -2.83 75.29 2.41 39.09 75.08 4.12 40.31 ULMN 3 1ig8_c00 HEXOKINASE PII user 7 3 # 7 A 158 SER B 143 SER~? 44.45 MG MG B 701 A 173 ARG B 178 ARG~? 37.59 MG MG B 701 A 211 ASP B 144 ASP~? 48.42 MG MG B 701 coo 22.72 76.24 0.23 24.60 76.86 -1.25 90.48 -3.13 47.60 89.69 -2.19 49.67 coo 18.77 77.82 11.69 20.55 80.22 10.73 79.48 2.47 45.22 81.37 1.59 47.51 coo 26.87 77.59 -3.91 27.39 79.28 -2.83 94.61 -4.13 49.96 95.84 -4.32 48.22 ULMN 3 1ig8_c00 HEXOKINASE PII user 8 3 # 8 A 158 SER B 143 SER~? 44.45 MG MG B 701 A 173 ARG B 258 ARG^? 33.01 MG MG B 701 A 211 ASP B 144 ASP~? 48.42 MG MG B 701 coo 22.72 76.24 0.23 24.60 76.86 -1.25 90.48 -3.13 47.60 89.69 -2.19 49.67 coo 18.77 77.82 11.69 20.55 80.22 10.73 83.96 -0.40 36.39 82.47 1.91 37.80 coo 26.87 77.59 -3.91 27.39 79.28 -2.83 94.61 -4.13 49.96 95.84 -4.32 48.22 ULMN 3 1ig8_c00 HEXOKINASE PII user 9 3 # 9 A 158 SER B 146 SER~? 44.57 MG MG B 701 A 173 ARG B 178 ARG~? 37.59 MG MG B 701 A 211 ASP B 144 ASP~? 48.42 MG MG B 701 coo 22.72 76.24 0.23 24.60 76.86 -1.25 87.67 -4.57 51.59 87.26 -2.47 52.75 coo 18.77 77.82 11.69 20.55 80.22 10.73 79.48 2.47 45.22 81.37 1.59 47.51 coo 26.87 77.59 -3.91 27.39 79.28 -2.83 94.61 -4.13 49.96 95.84 -4.32 48.22 ULMN 3 1ig8_c00 HEXOKINASE PII user 10 3 # 10 A 158 SER B 162 SER^? 20.48 MG MG B 701 A 173 ARG B 126 ARG^? 29.16 MG MG B 701 A 211 ASP B 161 ASP^? 15.44 MG MG B 701 coo 22.72 76.24 0.23 24.60 76.86 -1.25 67.92 -11.32 37.08 69.18 -13.29 36.33 coo 18.77 77.82 11.69 20.55 80.22 10.73 72.93 -22.54 42.02 74.52 -21.06 39.83 coo 26.87 77.59 -3.91 27.39 79.28 -2.83 63.88 -11.38 34.74 64.49 -9.36 34.64 ULMN 3 1ig8_c00 HEXOKINASE PII user 11 3 # 11 A 158 SER B 210 SER~? 12.60 MG MG B 701 A 173 ARG B 184 ARG~? 19.31 MG MG B 701 A 211 ASP B 161 ASP^? 15.44 MG MG B 701 coo 22.72 76.24 0.23 24.60 76.86 -1.25 63.63 -6.43 28.51 65.51 -5.02 28.70 coo 18.77 77.82 11.69 20.55 80.22 10.73 70.96 1.73 26.45 71.21 2.29 23.40 coo 26.87 77.59 -3.91 27.39 79.28 -2.83 63.88 -11.38 34.74 64.49 -9.36 34.64 1ig8_c00 source 1ig8 HEXOKINASE PII : 11 hits 1ig8_c00 naa= 3 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 1 3 # 1 54 ASP B 165 ASP^? 26.59 MG MG B 701 158 THR B 153 THR^? 25.01 MG MG B 701 317 ASP A 177 ASP~? 19.64 MG MG B 701 coo -2.63 8.40 35.07 -3.66 9.81 36.17 71.61 -6.68 45.38 69.65 -6.30 44.66 coo -5.30 12.75 41.86 -4.34 13.05 39.99 68.50 -12.99 42.25 67.26 -12.32 43.93 coo -12.63 17.64 33.66 -10.65 17.90 34.40 57.48 -8.32 42.16 55.62 -9.31 42.19 1inp_c02 source 1inp INOSITOL POLYPHOSPHATE 1-PHOSPHATASE (1-PTASE): 1 hits 1inp_c02 naa= 3 ULMN 3 1itx_c00 GLYCOSYL HYDROLASE user 1 3 # 1 A 202 ASP A 187 ASP~? 34.25 MG MG B 701 A 204 GLU A 186 GLU~? 38.23 MG MG B 701 A 279 TYR A 200 TYR~? 45.60 MG MG B 701 coo 5.85 5.60 30.32 5.00 7.49 29.88 61.00 -0.38 56.45 61.66 -2.23 55.67 coo 7.79 1.83 27.81 9.08 3.25 26.92 60.82 -4.60 59.58 62.03 -6.27 60.12 coo 8.22 7.77 18.64 7.58 8.47 21.28 56.79 -4.41 69.25 56.84 -5.83 66.87 1itx_c00 source 1itx GLYCOSYL HYDROLASE : 1 hits 1itx_c00 naa= 3 ULMN 3 1j7g_c00 D-TYROSYL-TRNA(TYR) DEACYLASE user 1 3 # 1 A 78 GLN A 128 GLN^? 32.89 MG MG B 701 A 79 PHE A 118 PHE^? 29.09 MG MG B 701 A 80 THR A 117 THR^? 34.97 MG MG B 701 coo 18.18 6.97 -1.14 17.20 5.70 -2.56 42.53 15.36 43.07 43.83 14.09 44.24 coo 24.87 4.39 -2.11 26.74 2.89 -0.67 41.62 15.66 34.45 39.96 13.55 33.81 coo 21.26 8.65 -4.24 19.54 7.67 -5.04 39.68 17.15 38.48 39.65 17.82 40.51 ULMN 3 1j7g_c00 D-TYROSYL-TRNA(TYR) DEACYLASE user 2 3 # 2 A 78 GLN B 128 GLN^? 30.14 MG MG B 701 A 79 PHE B 118 PHE^? 36.09 MG MG B 701 A 80 THR B 117 THR^? 33.70 MG MG B 701 coo 18.18 6.97 -1.14 17.20 5.70 -2.56 68.67 -23.51 43.42 69.56 -25.25 42.57 coo 24.87 4.39 -2.11 26.74 2.89 -0.67 70.13 -23.91 51.57 68.23 -22.26 52.74 coo 21.26 8.65 -4.24 19.54 7.67 -5.04 67.56 -26.21 48.19 67.67 -27.81 46.75 1j7g_c00 source 1j7g D-TYROSYL-TRNA(TYR) DEACYLASE : 2 hits 1j7g_c00 naa= 3 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 1 3 # 1 A 396 ARG B 253 ARG^? 38.87 MG MG B 701 A 581 ARG B 258 ARG^? 33.01 MG MG B 701 A 713 ARG B 261 ARG^? 24.22 MG MG B 701 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 89.00 -9.67 33.53 91.76 -9.21 34.95 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 83.96 -0.40 36.39 82.47 1.91 37.80 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 79.96 -6.70 27.13 79.05 -6.72 24.18 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 2 3 # 2 A 396 ARG B 253 ARG^? 38.87 MG MG B 701 A 581 ARG B 261 ARG^? 24.22 MG MG B 701 A 713 ARG B 258 ARG^? 33.01 MG MG B 701 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 89.00 -9.67 33.53 91.76 -9.21 34.95 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 79.96 -6.70 27.13 79.05 -6.72 24.18 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 83.96 -0.40 36.39 82.47 1.91 37.80 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 3 3 # 3 A 396 ARG B 253 ARG^? 38.87 MG MG B 701 A 581 ARG B 261 ARG^? 24.22 MG MG B 701 A 713 ARG B 264 ARG~? 37.47 MG MG B 701 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 89.00 -9.67 33.53 91.76 -9.21 34.95 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 79.96 -6.70 27.13 79.05 -6.72 24.18 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 89.36 -12.56 22.42 91.87 -14.25 23.18 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 4 3 # 4 A 396 ARG B 253 ARG^? 38.87 MG MG B 701 A 581 ARG B 264 ARG~? 37.47 MG MG B 701 A 713 ARG B 261 ARG^? 24.22 MG MG B 701 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 89.00 -9.67 33.53 91.76 -9.21 34.95 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 89.36 -12.56 22.42 91.87 -14.25 23.18 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 79.96 -6.70 27.13 79.05 -6.72 24.18 1jqn_c01 source 1jqn PHOSPHOENOLPYRUVATE CARBOXYLASE : 4 hits 1jqn_c01 naa= 3 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 1 3 # 1 A 2 GLU A 170 GLU~? 8.58 MG MG B 701 A 56 LYS A 172 LYS~? 6.12 MG MG B 701 A 258 ARG A 71 ARG~? 17.45 MG MG B 701 coo 42.33 1.56 26.99 42.38 2.91 28.66 52.41 0.03 22.89 54.38 0.44 23.67 coo 38.45 -0.44 19.89 37.36 0.90 25.90 50.20 -3.67 28.72 53.15 -8.47 28.45 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 52.94 11.11 20.93 55.28 9.38 22.01 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 2 3 # 2 A 2 GLU B 170 GLU~? 43.78 MG MG B 701 A 56 LYS B 172 LYS~? 42.28 MG MG B 701 A 258 ARG B 71 ARG~? 47.78 MG MG B 701 coo 42.33 1.56 26.99 42.38 2.91 28.66 80.92 -5.65 58.14 82.41 -5.69 56.60 coo 38.45 -0.44 19.89 37.36 0.90 25.90 75.30 -2.84 54.33 79.74 -2.40 56.36 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 84.61 -16.28 59.56 86.63 -14.84 57.69 1k82_c00 source 1k82 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE : 2 hits 1k82_c00 naa= 3 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 1 3 # 1 B 2 GLU A 170 GLU~? 8.58 MG MG B 701 B 56 LYS A 172 LYS~? 6.12 MG MG B 701 B 258 ARG A 71 ARG~? 17.45 MG MG B 701 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 52.41 0.03 22.89 54.38 0.44 23.67 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 50.20 -3.67 28.72 53.15 -8.47 28.45 coo 2.64 1.83 34.81 1.56 1.13 32.02 52.94 11.11 20.93 55.28 9.38 22.01 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 2 3 # 2 B 2 GLU B 170 GLU~? 43.78 MG MG B 701 B 56 LYS B 172 LYS~? 42.28 MG MG B 701 B 258 ARG B 71 ARG~? 47.78 MG MG B 701 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 80.92 -5.65 58.14 82.41 -5.69 56.60 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 75.30 -2.84 54.33 79.74 -2.40 56.36 coo 2.64 1.83 34.81 1.56 1.13 32.02 84.61 -16.28 59.56 86.63 -14.84 57.69 1k82_c01 source 1k82 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE : 2 hits 1k82_c01 naa= 3 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 1 3 # 1 C 2 GLU A 170 GLU~? 8.58 MG MG B 701 C 56 LYS A 172 LYS~? 6.12 MG MG B 701 C 258 ARG A 71 ARG~? 17.45 MG MG B 701 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 52.41 0.03 22.89 54.38 0.44 23.67 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 50.20 -3.67 28.72 53.15 -8.47 28.45 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 52.94 11.11 20.93 55.28 9.38 22.01 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 2 3 # 2 C 2 GLU B 170 GLU~? 43.78 MG MG B 701 C 56 LYS B 172 LYS~? 42.28 MG MG B 701 C 258 ARG B 71 ARG~? 47.78 MG MG B 701 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 80.92 -5.65 58.14 82.41 -5.69 56.60 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 75.30 -2.84 54.33 79.74 -2.40 56.36 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 84.61 -16.28 59.56 86.63 -14.84 57.69 1k82_c02 source 1k82 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE : 2 hits 1k82_c02 naa= 3 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 1 3 # 1 D 2 GLU A 170 GLU~? 8.58 MG MG B 701 D 56 LYS A 172 LYS~? 6.12 MG MG B 701 D 258 ARG A 71 ARG~? 17.45 MG MG B 701 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 52.41 0.03 22.89 54.38 0.44 23.67 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 50.20 -3.67 28.72 53.15 -8.47 28.45 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 52.94 11.11 20.93 55.28 9.38 22.01 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 2 3 # 2 D 2 GLU B 170 GLU~? 43.78 MG MG B 701 D 56 LYS B 172 LYS~? 42.28 MG MG B 701 D 258 ARG B 71 ARG~? 47.78 MG MG B 701 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 80.92 -5.65 58.14 82.41 -5.69 56.60 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 75.30 -2.84 54.33 79.74 -2.40 56.36 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 84.61 -16.28 59.56 86.63 -14.84 57.69 1k82_c03 source 1k82 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE : 2 hits 1k82_c03 naa= 3 ULMN 3 1kim_c00 THYMIDINE KINASE user 1 3 # 1 A 83 GLU A 186 GLU~? 38.23 MG MG B 701 A 163 ARG A 184 ARG~? 36.26 MG MG B 701 A 222 ARG A 195 ARG~? 43.32 MG MG B 701 coo 51.27 81.34 48.31 51.67 80.79 50.28 60.82 -4.60 59.58 62.03 -6.27 60.12 coo 48.06 78.22 50.94 48.51 78.27 53.98 59.62 -7.21 56.11 59.92 -9.15 58.50 coo 54.85 84.16 52.60 54.26 81.23 53.34 61.44 -7.15 66.34 63.04 -4.84 65.03 ULMN 3 1kim_c00 THYMIDINE KINASE user 2 3 # 2 A 83 GLU A 218 GLU~? 32.55 MG MG B 701 A 163 ARG A 126 ARG^? 30.85 MG MG B 701 A 222 ARG A 138 ARG^? 25.45 MG MG B 701 coo 51.27 81.34 48.31 51.67 80.79 50.28 54.56 16.53 40.79 53.76 18.19 41.81 coo 48.06 78.22 50.94 48.51 78.27 53.98 48.08 15.54 42.27 50.77 14.42 43.32 coo 54.85 84.16 52.60 54.26 81.23 53.34 56.09 11.79 37.51 58.92 12.66 36.83 ULMN 3 1kim_c00 THYMIDINE KINASE user 3 3 # 3 A 83 GLU A 218 GLU~? 32.55 MG MG B 701 A 163 ARG A 138 ARG^? 25.45 MG MG B 701 A 222 ARG A 126 ARG^? 30.85 MG MG B 701 coo 51.27 81.34 48.31 51.67 80.79 50.28 54.56 16.53 40.79 53.76 18.19 41.81 coo 48.06 78.22 50.94 48.51 78.27 53.98 56.09 11.79 37.51 58.92 12.66 36.83 coo 54.85 84.16 52.60 54.26 81.23 53.34 48.08 15.54 42.27 50.77 14.42 43.32 ULMN 3 1kim_c00 THYMIDINE KINASE user 4 3 # 4 A 83 GLU B 186 GLU~? 15.37 MG MG B 701 A 163 ARG B 184 ARG~? 19.31 MG MG B 701 A 222 ARG B 195 ARG~? 17.65 MG MG B 701 coo 51.27 81.34 48.31 51.67 80.79 50.28 69.45 -0.46 21.54 67.97 0.05 22.96 coo 48.06 78.22 50.94 48.51 78.27 53.98 70.96 1.73 26.45 71.21 2.29 23.40 coo 54.85 84.16 52.60 54.26 81.23 53.34 67.86 1.55 15.86 69.38 1.19 18.53 ULMN 3 1kim_c00 THYMIDINE KINASE user 5 3 # 5 A 83 GLU B 186 GLU~? 15.37 MG MG B 701 A 163 ARG B 195 ARG~? 17.65 MG MG B 701 A 222 ARG B 184 ARG~? 19.31 MG MG B 701 coo 51.27 81.34 48.31 51.67 80.79 50.28 69.45 -0.46 21.54 67.97 0.05 22.96 coo 48.06 78.22 50.94 48.51 78.27 53.98 67.86 1.55 15.86 69.38 1.19 18.53 coo 54.85 84.16 52.60 54.26 81.23 53.34 70.96 1.73 26.45 71.21 2.29 23.40 ULMN 3 1kim_c00 THYMIDINE KINASE user 6 3 # 6 A 83 GLU B 218 GLU~? 32.37 MG MG B 701 A 163 ARG B 126 ARG^? 29.16 MG MG B 701 A 222 ARG B 138 ARG^? 35.64 MG MG B 701 coo 51.27 81.34 48.31 51.67 80.79 50.28 79.74 -21.86 40.41 79.27 -22.32 38.45 coo 48.06 78.22 50.94 48.51 78.27 53.98 72.93 -22.54 42.02 74.52 -21.06 39.83 coo 54.85 84.16 52.60 54.26 81.23 53.34 81.28 -15.50 42.88 84.08 -15.53 41.69 ULMN 3 1kim_c00 THYMIDINE KINASE user 7 3 # 7 A 83 GLU B 218 GLU~? 32.37 MG MG B 701 A 163 ARG B 138 ARG^? 35.64 MG MG B 701 A 222 ARG B 126 ARG^? 29.16 MG MG B 701 coo 51.27 81.34 48.31 51.67 80.79 50.28 79.74 -21.86 40.41 79.27 -22.32 38.45 coo 48.06 78.22 50.94 48.51 78.27 53.98 81.28 -15.50 42.88 84.08 -15.53 41.69 coo 54.85 84.16 52.60 54.26 81.23 53.34 72.93 -22.54 42.02 74.52 -21.06 39.83 1kim_c00 source 1kim THYMIDINE KINASE : 7 hits 1kim_c00 naa= 3 ULMN 3 1lcb_c02 THYMIDYLATE SYNTHASE user 1 3 # 1 60 GLU B 78 GLU~? 38.64 MG MG B 701 198 CYH B 72 CYH~? 41.54 MG MG B 701 229 ASN B 90 ASN~? 42.88 MG MG B 701 coo 11.57 50.45 -41.48 12.95 49.39 -42.73 64.90 -13.57 57.96 63.80 -14.17 59.70 coo 9.92 49.50 -53.84 12.48 47.89 -53.69 79.11 -13.84 55.95 80.97 -12.20 54.68 coo 9.79 43.22 -47.74 11.15 44.81 -48.24 72.19 -20.15 61.00 72.72 -18.20 60.27 1lcb_c02 source 1lcb THYMIDYLATE SYNTHASE : 1 hits 1lcb_c02 naa= 3 ULMN 3 1lci_c00 LUCIFERASE user 1 3 # 1 218 ARG A 122 ARG~? 29.12 MG MG B 701 245 HIS A 104 HIS^? 33.98 MG MG B 701 343 THR A 103 THR~? 32.91 MG MG B 701 coo 18.11 85.25 41.19 18.04 83.33 43.59 57.02 18.56 28.04 58.98 19.78 30.13 coo 5.34 86.23 43.48 6.16 87.26 45.12 45.13 22.80 31.21 43.22 23.40 30.59 coo 9.06 92.76 42.80 7.04 92.63 42.14 50.29 22.50 34.59 50.45 21.47 36.44 ULMN 3 1lci_c00 LUCIFERASE user 2 3 # 2 218 ARG A 126 ARG^? 30.85 MG MG B 701 245 HIS A 104 HIS^? 33.98 MG MG B 701 343 THR A 103 THR~? 32.91 MG MG B 701 coo 18.11 85.25 41.19 18.04 83.33 43.59 48.08 15.54 42.27 50.77 14.42 43.32 coo 5.34 86.23 43.48 6.16 87.26 45.12 45.13 22.80 31.21 43.22 23.40 30.59 coo 9.06 92.76 42.80 7.04 92.63 42.14 50.29 22.50 34.59 50.45 21.47 36.44 ULMN 3 1lci_c00 LUCIFERASE user 3 3 # 3 218 ARG B 122 ARG~? 47.68 MG MG B 701 245 HIS B 104 HIS^? 43.18 MG MG B 701 343 THR B 103 THR~? 38.15 MG MG B 701 coo 18.11 85.25 41.19 18.04 83.33 43.59 87.17 -22.65 51.01 87.65 -22.59 54.06 coo 5.34 86.23 43.48 6.16 87.26 45.12 76.52 -29.94 52.39 75.18 -30.89 53.68 coo 9.06 92.76 42.80 7.04 92.63 42.14 79.49 -28.27 47.31 78.51 -27.23 45.65 ULMN 3 1lci_c00 LUCIFERASE user 4 3 # 4 218 ARG B 126 ARG^? 29.16 MG MG B 701 245 HIS B 104 HIS^? 43.18 MG MG B 701 343 THR B 103 THR~? 38.15 MG MG B 701 coo 18.11 85.25 41.19 18.04 83.33 43.59 72.93 -22.54 42.02 74.52 -21.06 39.83 coo 5.34 86.23 43.48 6.16 87.26 45.12 76.52 -29.94 52.39 75.18 -30.89 53.68 coo 9.06 92.76 42.80 7.04 92.63 42.14 79.49 -28.27 47.31 78.51 -27.23 45.65 1lci_c00 source 1lci LUCIFERASE : 4 hits 1lci_c00 naa= 3 ULMN 3 1m53_c03 ISOMALTULOSE SYNTHASE user 1 3 # 1 A 241 ASP B 187 ASP~? 20.66 MG MG B 701 A 295 GLU B 186 GLU~? 15.37 MG MG B 701 A 369 ASP A 144 ASP~? 20.24 MG MG B 701 coo 11.74 38.14 80.19 10.63 36.40 80.65 74.06 -4.33 24.81 74.57 -2.40 25.55 coo 16.11 33.72 80.99 14.10 33.54 81.63 69.45 -0.46 21.54 67.97 0.05 22.96 coo 12.19 31.08 87.29 11.13 32.66 86.38 69.22 6.09 27.43 70.24 4.65 26.30 1m53_c03 source 1m53 ISOMALTULOSE SYNTHASE : 1 hits 1m53_c03 naa= 3 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 1 3 # 1 A 241 ASP B 161 ASP^? 15.44 MG MG B 701 A 279 GLU B 235 GLU~? 13.13 MG MG B 701 A 369 ASP A 177 ASP~? 19.64 MG MG B 701 coo 11.74 38.14 80.19 10.63 36.40 80.65 63.88 -11.38 34.74 64.49 -9.36 34.64 coo 16.54 46.37 63.94 14.77 45.79 62.95 55.24 -20.07 18.27 57.27 -20.40 18.80 coo 12.19 31.08 87.29 11.13 32.66 86.38 57.48 -8.32 42.16 55.62 -9.31 42.19 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 2 3 # 2 A 241 ASP B 161 ASP^? 15.44 MG MG B 701 A 279 GLU B 248 GLU~? 22.62 MG MG B 701 A 369 ASP A 177 ASP~? 19.64 MG MG B 701 coo 11.74 38.14 80.19 10.63 36.40 80.65 63.88 -11.38 34.74 64.49 -9.36 34.64 coo 16.54 46.37 63.94 14.77 45.79 62.95 75.57 -15.61 20.16 75.32 -17.65 20.76 coo 12.19 31.08 87.29 11.13 32.66 86.38 57.48 -8.32 42.16 55.62 -9.31 42.19 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 3 3 # 3 A 241 ASP B 165 ASP^? 26.59 MG MG B 701 A 279 GLU B 70 GLU~? 46.48 MG MG B 701 A 369 ASP B 177 ASP~? 29.47 MG MG B 701 coo 11.74 38.14 80.19 10.63 36.40 80.65 71.61 -6.68 45.38 69.65 -6.30 44.66 coo 16.54 46.37 63.94 14.77 45.79 62.95 80.85 -20.85 57.05 81.87 -22.62 57.55 coo 12.19 31.08 87.29 11.13 32.66 86.38 75.29 2.41 39.09 75.08 4.12 40.31 1m53_c06 source 1m53 ISOMALTULOSE SYNTHASE : 3 hits 1m53_c06 naa= 3 ULMN 3 1mbb_c00 URIDINE DIPHOSPHO-N-ACETYLENOLPYRUVYuser 1 3 # 1 159 ARG B 184 ARG~? 19.31 MG MG B 701 229 SER A 145 SER~? 15.87 MG MG B 701 325 GLU B 186 GLU~? 15.37 MG MG B 701 coo 2.54 15.84 18.57 3.24 17.85 16.30 70.96 1.73 26.45 71.21 2.29 23.40 coo 10.17 13.48 15.92 9.61 15.76 15.27 65.62 4.84 24.49 66.57 2.65 23.80 coo 5.42 13.04 19.75 5.74 13.81 17.79 69.45 -0.46 21.54 67.97 0.05 22.96 1mbb_c00 source 1mbb URIDINE DIPHOSPHO-N-ACETYLENOLPYRUVYLGLUCOSAMI: 1 hits 1mbb_c00 naa= 3 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 1 3 # 1 A 465 GLY A 101 GLY~? 31.96 MG MG B 701 A 501 ASP A 91 ASP~? 30.86 MG MG B 701 B 367 TYR A 252 TYR^? 28.98 MG MG B 701 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 55.62 22.57 31.69 54.92 22.90 31.49 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 36.10 16.42 24.55 35.02 15.53 22.85 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 62.00 3.47 47.74 61.53 1.51 49.69 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 2 3 # 2 A 465 GLY B 101 GLY~? 43.78 MG MG B 701 A 501 ASP B 91 ASP~? 46.73 MG MG B 701 B 367 TYR B 252 TYR^? 25.41 MG MG B 701 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 85.46 -26.82 47.74 85.02 -27.36 48.17 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 69.68 -24.93 62.08 69.33 -24.21 64.01 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 79.70 -7.64 31.83 77.94 -6.02 30.43 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 3 3 # 3 A 465 GLY B 114 GLY~? 31.92 MG MG B 701 A 501 ASP B 161 ASP^? 15.44 MG MG B 701 B 367 TYR A 200 TYR~? 45.60 MG MG B 701 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 57.80 -24.83 49.60 58.36 -24.34 49.94 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 63.88 -11.38 34.74 64.49 -9.36 34.64 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 56.79 -4.41 69.25 56.84 -5.83 66.87 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 4 3 # 4 A 465 GLY B 133 GLY^? 23.40 MG MG B 701 A 501 ASP A 187 ASP~? 34.25 MG MG B 701 B 367 TYR B 204 TYR~? 10.93 MG MG B 701 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 63.80 -18.70 41.45 63.81 -19.34 41.96 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 61.00 -0.38 56.45 61.66 -2.23 55.67 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 60.36 -0.30 19.04 61.29 1.75 20.68 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 5 3 # 5 A 465 GLY B 133 GLY^? 23.40 MG MG B 701 A 501 ASP B 221 ASP~? 37.75 MG MG B 701 B 367 TYR B 204 TYR~? 10.93 MG MG B 701 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 63.80 -18.70 41.45 63.81 -19.34 41.96 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 87.06 -12.52 38.62 87.72 -12.86 40.65 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 60.36 -0.30 19.04 61.29 1.75 20.68 1mro_c00 source 1mro METHYL-COENZYME M REDUCTASE : 5 hits 1mro_c00 naa= 3 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 1 3 # 1 D 465 GLY A 101 GLY~? 31.96 MG MG B 701 D 501 ASP A 91 ASP~? 30.86 MG MG B 701 E 367 TYR A 252 TYR^? 28.98 MG MG B 701 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 55.62 22.57 31.69 54.92 22.90 31.49 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 36.10 16.42 24.55 35.02 15.53 22.85 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 62.00 3.47 47.74 61.53 1.51 49.69 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 2 3 # 2 D 465 GLY B 101 GLY~? 43.78 MG MG B 701 D 501 ASP B 91 ASP~? 46.73 MG MG B 701 E 367 TYR B 252 TYR^? 25.41 MG MG B 701 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 85.46 -26.82 47.74 85.02 -27.36 48.17 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 69.68 -24.93 62.08 69.33 -24.21 64.01 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 79.70 -7.64 31.83 77.94 -6.02 30.43 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 3 3 # 3 D 465 GLY B 114 GLY~? 31.92 MG MG B 701 D 501 ASP B 161 ASP^? 15.44 MG MG B 701 E 367 TYR A 200 TYR~? 45.60 MG MG B 701 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 57.80 -24.83 49.60 58.36 -24.34 49.94 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 63.88 -11.38 34.74 64.49 -9.36 34.64 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 56.79 -4.41 69.25 56.84 -5.83 66.87 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 4 3 # 4 D 465 GLY B 133 GLY^? 23.40 MG MG B 701 D 501 ASP A 187 ASP~? 34.25 MG MG B 701 E 367 TYR B 204 TYR~? 10.93 MG MG B 701 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 63.80 -18.70 41.45 63.81 -19.34 41.96 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 61.00 -0.38 56.45 61.66 -2.23 55.67 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 60.36 -0.30 19.04 61.29 1.75 20.68 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 5 3 # 5 D 465 GLY B 133 GLY^? 23.40 MG MG B 701 D 501 ASP B 221 ASP~? 37.75 MG MG B 701 E 367 TYR B 204 TYR~? 10.93 MG MG B 701 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 63.80 -18.70 41.45 63.81 -19.34 41.96 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 87.06 -12.52 38.62 87.72 -12.86 40.65 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 60.36 -0.30 19.04 61.29 1.75 20.68 1mro_c01 source 1mro METHYL-COENZYME M REDUCTASE : 5 hits 1mro_c01 naa= 3 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 1 3 # 1 A 114 HIS A 192 HIS~? 50.82 MG MG B 701 A 197 ASP A 194 ASP~? 51.94 MG MG B 701 A 223 ALA A 241 ALA~? 47.31 MG MG B 701 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 68.48 1.80 70.19 70.40 2.63 70.21 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 62.72 -3.55 72.77 62.75 -5.34 73.88 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 53.60 3.48 69.42 52.47 3.64 68.38 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 2 3 # 2 A 114 HIS A 192 HIS~? 50.82 MG MG B 701 A 197 ASP A 194 ASP~? 51.94 MG MG B 701 A 223 ALA A 242 ALA~? 50.36 MG MG B 701 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 68.48 1.80 70.19 70.40 2.63 70.21 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 62.72 -3.55 72.77 62.75 -5.34 73.88 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 55.65 6.69 69.54 55.28 7.96 70.34 1n2t_c02 source 1n2t L-CYSTEINE-CYSTINE LYASE C-DES : 2 hits 1n2t_c02 naa= 3 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 1 3 # 1 B 114 HIS A 192 HIS~? 50.82 MG MG B 701 B 197 ASP A 194 ASP~? 51.94 MG MG B 701 B 223 ALA A 241 ALA~? 47.31 MG MG B 701 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 68.48 1.80 70.19 70.40 2.63 70.21 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 62.72 -3.55 72.77 62.75 -5.34 73.88 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 53.60 3.48 69.42 52.47 3.64 68.38 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 2 3 # 2 B 114 HIS A 192 HIS~? 50.82 MG MG B 701 B 197 ASP A 194 ASP~? 51.94 MG MG B 701 B 223 ALA A 242 ALA~? 50.36 MG MG B 701 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 68.48 1.80 70.19 70.40 2.63 70.21 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 62.72 -3.55 72.77 62.75 -5.34 73.88 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 55.65 6.69 69.54 55.28 7.96 70.34 1n2t_c03 source 1n2t L-CYSTEINE-CYSTINE LYASE C-DES : 2 hits 1n2t_c03 naa= 3 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 1 3 # 1 549 LYS A 175 LYS~? 16.95 MG MG B 701 631 LYS B 175 LYS~? 34.92 MG MG B 701 708 LYS A 172 LYS~? 6.12 MG MG B 701 coo 8.61 33.06 11.15 10.12 29.19 8.82 54.19 -7.18 37.22 54.81 -12.82 38.86 coo -11.99 27.40 17.14 -13.60 24.52 11.71 75.00 1.45 45.20 75.48 7.65 46.06 coo 18.16 32.86 9.85 16.06 28.20 13.56 50.20 -3.67 28.72 53.15 -8.47 28.45 1nsf_c00 source 1nsf N-ETHYLMALEIMIDE SENSITIVE FACTOR : 1 hits 1nsf_c00 naa= 3 ULMN 3 1nu3_c00 LIMONENE-1,2-EPOXIDE HYDROLASE user 1 3 # 1 A 99 ARG A 178 ARG~? 13.19 MG MG B 701 A 101 ASP A 177 ASP~? 19.64 MG MG B 701 A 132 ASP B 161 ASP^? 15.44 MG MG B 701 coo 11.61 22.83 17.30 14.06 21.71 15.78 60.75 -6.17 35.55 62.65 -6.30 33.15 coo 11.37 24.94 11.48 12.48 24.45 13.28 57.48 -8.32 42.16 55.62 -9.31 42.19 coo 16.14 18.17 13.37 15.92 19.81 14.71 63.88 -11.38 34.74 64.49 -9.36 34.64 ULMN 3 1nu3_c00 LIMONENE-1,2-EPOXIDE HYDROLASE user 2 3 # 2 A 99 ARG A 178 ARG~? 13.19 MG MG B 701 A 101 ASP B 161 ASP^? 15.44 MG MG B 701 A 132 ASP A 177 ASP~? 19.64 MG MG B 701 coo 11.61 22.83 17.30 14.06 21.71 15.78 60.75 -6.17 35.55 62.65 -6.30 33.15 coo 11.37 24.94 11.48 12.48 24.45 13.28 63.88 -11.38 34.74 64.49 -9.36 34.64 coo 16.14 18.17 13.37 15.92 19.81 14.71 57.48 -8.32 42.16 55.62 -9.31 42.19 ULMN 3 1nu3_c00 LIMONENE-1,2-EPOXIDE HYDROLASE user 3 3 # 3 A 99 ARG B 163 ARG^? 22.33 MG MG B 701 A 101 ASP B 161 ASP^? 15.44 MG MG B 701 A 132 ASP A 177 ASP~? 19.64 MG MG B 701 coo 11.61 22.83 17.30 14.06 21.71 15.78 66.22 -8.44 41.95 64.50 -6.02 42.66 coo 11.37 24.94 11.48 12.48 24.45 13.28 63.88 -11.38 34.74 64.49 -9.36 34.64 coo 16.14 18.17 13.37 15.92 19.81 14.71 57.48 -8.32 42.16 55.62 -9.31 42.19 1nu3_c00 source 1nu3 LIMONENE-1,2-EPOXIDE HYDROLASE : 3 hits 1nu3_c00 naa= 3 ULMN 3 1nu3_c01 LIMONENE-1,2-EPOXIDE HYDROLASE user 1 3 # 1 B 99 ARG A 178 ARG~? 13.19 MG MG B 701 B 101 ASP A 177 ASP~? 19.64 MG MG B 701 B 132 ASP B 161 ASP^? 15.44 MG MG B 701 coo 11.61 3.43 18.38 9.11 4.29 16.86 60.75 -6.17 35.55 62.65 -6.30 33.15 coo 11.74 0.51 12.98 10.75 1.32 14.67 57.48 -8.32 42.16 55.62 -9.31 42.19 coo 6.93 7.52 14.08 7.18 6.08 15.65 63.88 -11.38 34.74 64.49 -9.36 34.64 ULMN 3 1nu3_c01 LIMONENE-1,2-EPOXIDE HYDROLASE user 2 3 # 2 B 99 ARG A 178 ARG~? 13.19 MG MG B 701 B 101 ASP B 161 ASP^? 15.44 MG MG B 701 B 132 ASP A 177 ASP~? 19.64 MG MG B 701 coo 11.61 3.43 18.38 9.11 4.29 16.86 60.75 -6.17 35.55 62.65 -6.30 33.15 coo 11.74 0.51 12.98 10.75 1.32 14.67 63.88 -11.38 34.74 64.49 -9.36 34.64 coo 6.93 7.52 14.08 7.18 6.08 15.65 57.48 -8.32 42.16 55.62 -9.31 42.19 1nu3_c01 source 1nu3 LIMONENE-1,2-EPOXIDE HYDROLASE : 2 hits 1nu3_c01 naa= 3 ULMN 3 1nww_c02 LIMONENE-1,2-EPOXIDE HYDROLASE user 1 3 # 1 A 99 ARG A 178 ARG~? 13.19 MG MG B 701 A 101 ASP A 177 ASP~? 19.64 MG MG B 701 A 132 ASP B 161 ASP^? 15.44 MG MG B 701 coo 11.50 22.77 17.24 14.00 21.62 15.86 60.75 -6.17 35.55 62.65 -6.30 33.15 coo 11.19 25.00 11.76 12.16 24.45 13.59 57.48 -8.32 42.16 55.62 -9.31 42.19 coo 16.04 18.11 13.43 15.88 19.70 14.83 63.88 -11.38 34.74 64.49 -9.36 34.64 ULMN 3 1nww_c02 LIMONENE-1,2-EPOXIDE HYDROLASE user 2 3 # 2 A 99 ARG A 178 ARG~? 13.19 MG MG B 701 A 101 ASP B 161 ASP^? 15.44 MG MG B 701 A 132 ASP A 177 ASP~? 19.64 MG MG B 701 coo 11.50 22.77 17.24 14.00 21.62 15.86 60.75 -6.17 35.55 62.65 -6.30 33.15 coo 11.19 25.00 11.76 12.16 24.45 13.59 63.88 -11.38 34.74 64.49 -9.36 34.64 coo 16.04 18.11 13.43 15.88 19.70 14.83 57.48 -8.32 42.16 55.62 -9.31 42.19 1nww_c02 source 1nww LIMONENE-1,2-EPOXIDE HYDROLASE : 2 hits 1nww_c02 naa= 3 ULMN 3 1nww_c03 LIMONENE-1,2-EPOXIDE HYDROLASE user 1 3 # 1 B 99 ARG A 178 ARG~? 13.19 MG MG B 701 B 101 ASP A 177 ASP~? 19.64 MG MG B 701 B 132 ASP B 161 ASP^? 15.44 MG MG B 701 coo 11.48 3.09 18.25 9.01 4.07 16.77 60.75 -6.17 35.55 62.65 -6.30 33.15 coo 11.83 0.33 13.01 10.88 1.04 14.81 57.48 -8.32 42.16 55.62 -9.31 42.19 coo 6.85 7.33 14.07 7.10 5.88 15.60 63.88 -11.38 34.74 64.49 -9.36 34.64 ULMN 3 1nww_c03 LIMONENE-1,2-EPOXIDE HYDROLASE user 2 3 # 2 B 99 ARG A 178 ARG~? 13.19 MG MG B 701 B 101 ASP B 161 ASP^? 15.44 MG MG B 701 B 132 ASP A 177 ASP~? 19.64 MG MG B 701 coo 11.48 3.09 18.25 9.01 4.07 16.77 60.75 -6.17 35.55 62.65 -6.30 33.15 coo 11.83 0.33 13.01 10.88 1.04 14.81 63.88 -11.38 34.74 64.49 -9.36 34.64 coo 6.85 7.33 14.07 7.10 5.88 15.60 57.48 -8.32 42.16 55.62 -9.31 42.19 1nww_c03 source 1nww LIMONENE-1,2-EPOXIDE HYDROLASE : 2 hits 1nww_c03 naa= 3 ULMN 3 1o98_c00 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT user 1 3 # 1 A 62 SER A 162 SER^? 29.38 MG MG B 701 A 154 ASP A 165 ASP^? 19.82 MG MG B 701 A 261 ARG A 163 ARG^? 22.70 MG MG B 701 coo 16.10 74.10 3.11 17.18 73.52 5.20 48.41 3.59 47.69 49.51 5.75 47.96 coo 16.07 84.71 8.14 15.20 82.81 8.14 49.47 0.04 38.38 48.02 -0.73 39.68 coo 10.59 77.85 4.81 13.09 76.36 5.76 45.39 -0.99 44.51 45.45 -0.07 41.63 ULMN 3 1o98_c00 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT user 2 3 # 2 A 62 SER A 215 SER~? 31.75 MG MG B 701 A 154 ASP A 161 ASP^? 31.32 MG MG B 701 A 261 ARG A 226 ARG^? 38.22 MG MG B 701 coo 16.10 74.10 3.11 17.18 73.52 5.20 53.96 10.22 46.63 54.01 12.63 46.67 coo 16.07 84.71 8.14 15.20 82.81 8.14 45.91 2.65 51.66 46.91 0.77 51.57 coo 10.59 77.85 4.81 13.09 76.36 5.76 52.39 10.28 54.33 53.57 13.12 54.39 ULMN 3 1o98_c00 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT user 3 3 # 3 A 62 SER A 256 SER~? 22.42 MG MG B 701 A 154 ASP B 161 ASP^? 15.44 MG MG B 701 A 261 ARG A 258 ARG~? 19.65 MG MG B 701 coo 16.10 74.10 3.11 17.18 73.52 5.20 68.19 1.16 36.27 69.40 -0.26 37.83 coo 16.07 84.71 8.14 15.20 82.81 8.14 63.88 -11.38 34.74 64.49 -9.36 34.64 coo 10.59 77.85 4.81 13.09 76.36 5.76 65.98 -2.88 40.97 66.14 -4.57 38.35 ULMN 3 1o98_c00 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT user 4 3 # 4 A 62 SER A 256 SER~? 22.42 MG MG B 701 A 154 ASP B 165 ASP^? 26.59 MG MG B 701 A 261 ARG A 258 ARG~? 19.65 MG MG B 701 coo 16.10 74.10 3.11 17.18 73.52 5.20 68.19 1.16 36.27 69.40 -0.26 37.83 coo 16.07 84.71 8.14 15.20 82.81 8.14 71.61 -6.68 45.38 69.65 -6.30 44.66 coo 10.59 77.85 4.81 13.09 76.36 5.76 65.98 -2.88 40.97 66.14 -4.57 38.35 ULMN 3 1o98_c00 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT user 5 3 # 5 A 62 SER B 162 SER^? 20.48 MG MG B 701 A 154 ASP A 177 ASP~? 19.64 MG MG B 701 A 261 ARG B 163 ARG^? 22.33 MG MG B 701 coo 16.10 74.10 3.11 17.18 73.52 5.20 67.92 -11.32 37.08 69.18 -13.29 36.33 coo 16.07 84.71 8.14 15.20 82.81 8.14 57.48 -8.32 42.16 55.62 -9.31 42.19 coo 10.59 77.85 4.81 13.09 76.36 5.76 66.22 -8.44 41.95 64.50 -6.02 42.66 ULMN 3 1o98_c00 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT user 6 3 # 6 A 62 SER B 215 SER~? 26.70 MG MG B 701 A 154 ASP B 161 ASP^? 15.44 MG MG B 701 A 261 ARG B 226 ARG^? 21.45 MG MG B 701 coo 16.10 74.10 3.11 17.18 73.52 5.20 75.07 -16.26 35.49 76.05 -18.46 35.16 coo 16.07 84.71 8.14 15.20 82.81 8.14 63.88 -11.38 34.74 64.49 -9.36 34.64 coo 10.59 77.85 4.81 13.09 76.36 5.76 70.51 -17.10 28.75 72.04 -19.70 28.19 1o98_c00 source 1o98 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT PHOSPHOGLY: 6 hits 1o98_c00 naa= 3 ULMN 3 1p7m_c00 DNA-3-METHYLADENINE GLYCOSYLASE I user 1 3 # 1 A 16 TYR A 167 TYR^? 14.87 MG MG B 701 A 38 GLU A 68 GLU~? 16.08 MG MG B 701 A 46 TRP A 171 TRP~? 14.96 MG MG B 701 coo 141.05 24.62 -1.85 142.62 22.60 -2.97 50.02 0.16 32.66 47.75 0.13 34.22 coo 142.20 14.40 -6.46 142.04 16.49 -6.62 56.21 8.51 25.84 57.91 7.36 26.07 coo 137.32 22.45 -5.52 140.17 20.39 -3.63 48.02 3.02 27.05 48.23 4.36 30.74 ULMN 3 1p7m_c00 DNA-3-METHYLADENINE GLYCOSYLASE I user 2 3 # 2 A 16 TYR B 167 TYR^? 33.00 MG MG B 701 A 38 GLU B 68 GLU~? 43.73 MG MG B 701 A 46 TRP B 171 TRP~? 37.92 MG MG B 701 coo 141.05 24.62 -1.85 142.62 22.60 -2.97 74.51 -6.62 50.39 71.88 -7.09 49.71 coo 142.20 14.40 -6.46 142.04 16.49 -6.62 85.21 -13.08 54.11 86.12 -11.45 53.05 coo 137.32 22.45 -5.52 140.17 20.39 -3.63 75.95 -9.87 56.13 75.11 -11.27 52.54 1p7m_c00 source 1p7m DNA-3-METHYLADENINE GLYCOSYLASE I : 2 hits 1p7m_c00 naa= 3 ULMN 3 1pd2_c02 HEMATOPOIETIC PROSTAGLADIN D SYNTHASuser 1 3 # 1 1 8 TYR A 252 TYR^? 28.98 MG MG B 701 1 14 ARG A 253 ARG^? 30.10 MG MG B 701 1 104 TRP A 254 TRP^? 19.98 MG MG B 701 coo -6.26 36.66 22.35 -5.62 38.66 24.20 62.00 3.47 47.74 61.53 1.51 49.69 coo -1.84 42.97 23.45 -1.37 45.90 22.68 68.27 8.63 43.05 70.75 9.38 41.34 coo -2.17 45.44 30.78 -5.80 46.76 31.55 63.78 5.04 36.79 61.29 2.03 37.17 ULMN 3 1pd2_c02 HEMATOPOIETIC PROSTAGLADIN D SYNTHASuser 2 3 # 2 1 8 TYR B 252 TYR^? 25.41 MG MG B 701 1 14 ARG B 253 ARG^? 38.87 MG MG B 701 1 104 TRP B 254 TRP^? 35.06 MG MG B 701 coo -6.26 36.66 22.35 -5.62 38.66 24.20 79.70 -7.64 31.83 77.94 -6.02 30.43 coo -1.84 42.97 23.45 -1.37 45.90 22.68 89.00 -9.67 33.53 91.76 -9.21 34.95 coo -2.17 45.44 30.78 -5.80 46.76 31.55 86.14 -8.57 40.83 83.12 -6.13 41.56 ULMN 3 1pd2_c02 HEMATOPOIETIC PROSTAGLADIN D SYNTHASuser 3 3 # 3 1 8 TYR B 252 TYR^? 25.41 MG MG B 701 1 14 ARG B 258 ARG^? 33.01 MG MG B 701 1 104 TRP B 254 TRP^? 35.06 MG MG B 701 coo -6.26 36.66 22.35 -5.62 38.66 24.20 79.70 -7.64 31.83 77.94 -6.02 30.43 coo -1.84 42.97 23.45 -1.37 45.90 22.68 83.96 -0.40 36.39 82.47 1.91 37.80 coo -2.17 45.44 30.78 -5.80 46.76 31.55 86.14 -8.57 40.83 83.12 -6.13 41.56 1pd2_c02 source 1pd2 HEMATOPOIETIC PROSTAGLADIN D SYNTHASE : 3 hits 1pd2_c02 naa= 3 ULMN 3 1pd2_c03 HEMATOPOIETIC PROSTAGLADIN D SYNTHASuser 1 3 # 1 2 8 TYR A 252 TYR^? 28.98 MG MG B 701 2 14 ARG A 253 ARG^? 30.10 MG MG B 701 2 104 TRP A 254 TRP^? 19.98 MG MG B 701 coo 14.82 62.39 20.28 14.73 60.21 22.02 62.00 3.47 47.74 61.53 1.51 49.69 coo 10.81 55.96 22.08 10.04 53.12 21.26 68.27 8.63 43.05 70.75 9.38 41.34 coo 13.42 52.88 28.75 17.04 51.48 28.24 63.78 5.04 36.79 61.29 2.03 37.17 ULMN 3 1pd2_c03 HEMATOPOIETIC PROSTAGLADIN D SYNTHASuser 2 3 # 2 2 8 TYR B 252 TYR^? 25.41 MG MG B 701 2 14 ARG B 253 ARG^? 38.87 MG MG B 701 2 104 TRP B 254 TRP^? 35.06 MG MG B 701 coo 14.82 62.39 20.28 14.73 60.21 22.02 79.70 -7.64 31.83 77.94 -6.02 30.43 coo 10.81 55.96 22.08 10.04 53.12 21.26 89.00 -9.67 33.53 91.76 -9.21 34.95 coo 13.42 52.88 28.75 17.04 51.48 28.24 86.14 -8.57 40.83 83.12 -6.13 41.56 ULMN 3 1pd2_c03 HEMATOPOIETIC PROSTAGLADIN D SYNTHASuser 3 3 # 3 2 8 TYR B 252 TYR^? 25.41 MG MG B 701 2 14 ARG B 258 ARG^? 33.01 MG MG B 701 2 104 TRP B 254 TRP^? 35.06 MG MG B 701 coo 14.82 62.39 20.28 14.73 60.21 22.02 79.70 -7.64 31.83 77.94 -6.02 30.43 coo 10.81 55.96 22.08 10.04 53.12 21.26 83.96 -0.40 36.39 82.47 1.91 37.80 coo 13.42 52.88 28.75 17.04 51.48 28.24 86.14 -8.57 40.83 83.12 -6.13 41.56 1pd2_c03 source 1pd2 HEMATOPOIETIC PROSTAGLADIN D SYNTHASE : 3 hits 1pd2_c03 naa= 3 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 1 3 # 1 A 70 ALA A 75 ALA~? 16.29 MG MG B 701 A 126 LEU A 74 LEU~? 22.11 MG MG B 701 A 158 GLU A 70 GLU~? 25.37 MG MG B 701 coo -2.29 37.66 144.73 -1.46 37.12 145.87 45.58 6.48 23.74 46.73 6.03 22.86 coo -4.62 32.83 147.14 -5.50 32.85 149.12 45.85 10.99 23.70 45.70 13.12 23.34 coo -0.83 29.57 149.77 -0.39 31.47 148.95 49.68 14.74 24.80 49.71 16.74 24.08 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 2 3 # 2 A 70 ALA A 96 ALA~? 30.94 MG MG B 701 A 126 LEU A 99 LEU~? 26.86 MG MG B 701 A 158 GLU A 70 GLU~? 25.37 MG MG B 701 coo -2.29 37.66 144.73 -1.46 37.12 145.87 43.90 21.81 26.90 44.37 20.58 27.66 coo -4.62 32.83 147.14 -5.50 32.85 149.12 50.61 18.05 28.30 48.66 17.16 28.74 coo -0.83 29.57 149.77 -0.39 31.47 148.95 49.68 14.74 24.80 49.71 16.74 24.08 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 3 3 # 3 A 70 ALA A 199 ALA~? 51.88 MG MG B 701 A 126 LEU A 240 LEU~? 52.77 MG MG B 701 A 158 GLU A 237 GLU~? 48.86 MG MG B 701 coo -2.29 37.66 144.73 -1.46 37.12 145.87 54.75 -0.85 73.97 55.62 0.40 73.78 coo -4.62 32.83 147.14 -5.50 32.85 149.12 52.19 2.32 73.37 51.41 1.66 75.25 coo -0.83 29.57 149.77 -0.39 31.47 148.95 46.26 1.98 71.28 45.32 1.01 69.65 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 4 3 # 4 A 70 ALA A 241 ALA~? 47.31 MG MG B 701 A 126 LEU A 233 LEU~? 46.15 MG MG B 701 A 158 GLU A 237 GLU~? 48.86 MG MG B 701 coo -2.29 37.66 144.73 -1.46 37.12 145.87 53.60 3.48 69.42 52.47 3.64 68.38 coo -4.62 32.83 147.14 -5.50 32.85 149.12 47.05 4.25 66.96 48.61 2.87 66.43 coo -0.83 29.57 149.77 -0.39 31.47 148.95 46.26 1.98 71.28 45.32 1.01 69.65 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 5 3 # 5 A 70 ALA A 241 ALA~? 47.31 MG MG B 701 A 126 LEU A 240 LEU~? 52.77 MG MG B 701 A 158 GLU A 237 GLU~? 48.86 MG MG B 701 coo -2.29 37.66 144.73 -1.46 37.12 145.87 53.60 3.48 69.42 52.47 3.64 68.38 coo -4.62 32.83 147.14 -5.50 32.85 149.12 52.19 2.32 73.37 51.41 1.66 75.25 coo -0.83 29.57 149.77 -0.39 31.47 148.95 46.26 1.98 71.28 45.32 1.01 69.65 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 6 3 # 6 A 70 ALA A 242 ALA~? 50.36 MG MG B 701 A 126 LEU A 240 LEU~? 52.77 MG MG B 701 A 158 GLU A 237 GLU~? 48.86 MG MG B 701 coo -2.29 37.66 144.73 -1.46 37.12 145.87 55.65 6.69 69.54 55.28 7.96 70.34 coo -4.62 32.83 147.14 -5.50 32.85 149.12 52.19 2.32 73.37 51.41 1.66 75.25 coo -0.83 29.57 149.77 -0.39 31.47 148.95 46.26 1.98 71.28 45.32 1.01 69.65 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 7 3 # 7 A 70 ALA B 75 ALA~? 43.51 MG MG B 701 A 126 LEU B 74 LEU~? 44.78 MG MG B 701 A 158 GLU B 70 GLU~? 46.48 MG MG B 701 coo -2.29 37.66 144.73 -1.46 37.12 145.87 75.83 -13.23 59.70 77.14 -12.38 59.76 coo -4.62 32.83 147.14 -5.50 32.85 149.12 76.89 -17.71 59.97 77.15 -19.85 60.11 coo -0.83 29.57 149.77 -0.39 31.47 148.95 80.85 -20.85 57.05 81.87 -22.62 57.55 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 8 3 # 8 A 70 ALA B 96 ALA~? 44.52 MG MG B 701 A 126 LEU B 99 LEU~? 42.90 MG MG B 701 A 158 GLU B 70 GLU~? 46.48 MG MG B 701 coo -2.29 37.66 144.73 -1.46 37.12 145.87 77.10 -29.00 56.84 77.04 -27.87 55.77 coo -4.62 32.83 147.14 -5.50 32.85 149.12 81.39 -23.82 53.26 79.24 -23.51 53.65 coo -0.83 29.57 149.77 -0.39 31.47 148.95 80.85 -20.85 57.05 81.87 -22.62 57.55 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 9 3 # 9 A 70 ALA B 106 ALA^? 40.55 MG MG B 701 A 126 LEU B 108 LEU^? 38.32 MG MG B 701 A 158 GLU B 109 GLU^? 35.66 MG MG B 701 coo -2.29 37.66 144.73 -1.46 37.12 145.87 70.76 -29.74 51.68 71.32 -29.23 53.03 coo -4.62 32.83 147.14 -5.50 32.85 149.12 64.83 -26.80 55.02 64.92 -24.61 55.22 coo -0.83 29.57 149.77 -0.39 31.47 148.95 59.57 -29.27 53.23 59.54 -28.97 51.11 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 10 3 # 10 A 70 ALA B 199 ALA~? 13.57 MG MG B 701 A 126 LEU B 240 LEU~? 11.40 MG MG B 701 A 158 GLU B 237 GLU~? 4.20 MG MG B 701 coo -2.29 37.66 144.73 -1.46 37.12 145.87 61.06 -6.74 11.45 62.28 -7.68 11.21 coo -4.62 32.83 147.14 -5.50 32.85 149.12 59.94 -10.41 13.04 58.48 -10.02 11.48 coo -0.83 29.57 149.77 -0.39 31.47 148.95 55.73 -11.24 17.28 55.11 -10.45 19.16 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 11 3 # 11 A 70 ALA B 241 ALA~? 10.01 MG MG B 701 A 126 LEU B 233 LEU~? 6.36 MG MG B 701 A 158 GLU B 237 GLU~? 4.20 MG MG B 701 coo -2.29 37.66 144.73 -1.46 37.12 145.87 63.24 -10.78 15.96 62.74 -11.32 17.28 coo -4.62 32.83 147.14 -5.50 32.85 149.12 58.66 -13.18 20.71 59.84 -11.35 20.53 coo -0.83 29.57 149.77 -0.39 31.47 148.95 55.73 -11.24 17.28 55.11 -10.45 19.16 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 12 3 # 12 A 70 ALA B 241 ALA~? 10.01 MG MG B 701 A 126 LEU B 240 LEU~? 11.40 MG MG B 701 A 158 GLU B 237 GLU~? 4.20 MG MG B 701 coo -2.29 37.66 144.73 -1.46 37.12 145.87 63.24 -10.78 15.96 62.74 -11.32 17.28 coo -4.62 32.83 147.14 -5.50 32.85 149.12 59.94 -10.41 13.04 58.48 -10.02 11.48 coo -0.83 29.57 149.77 -0.39 31.47 148.95 55.73 -11.24 17.28 55.11 -10.45 19.16 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 13 3 # 13 A 70 ALA B 242 ALA~? 15.16 MG MG B 701 A 126 LEU B 240 LEU~? 11.40 MG MG B 701 A 158 GLU B 237 GLU~? 4.20 MG MG B 701 coo -2.29 37.66 144.73 -1.46 37.12 145.87 65.94 -13.15 14.66 65.70 -14.54 14.15 coo -4.62 32.83 147.14 -5.50 32.85 149.12 59.94 -10.41 13.04 58.48 -10.02 11.48 coo -0.83 29.57 149.77 -0.39 31.47 148.95 55.73 -11.24 17.28 55.11 -10.45 19.16 1pjh_c00 source 1pjh ENOYL-COA ISOMERASE; ECI1P : 13 hits 1pjh_c00 naa= 3 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 1 3 # 1 B 70 ALA A 75 ALA~? 16.29 MG MG B 701 B 126 LEU A 74 LEU~? 22.11 MG MG B 701 B 158 GLU A 70 GLU~? 25.37 MG MG B 701 coo -39.79 4.61 147.27 -39.61 5.56 148.47 45.58 6.48 23.74 46.73 6.03 22.86 coo -34.22 5.06 149.25 -33.65 4.24 151.15 45.85 10.99 23.70 45.70 13.12 23.34 coo -33.03 9.93 151.71 -34.98 9.38 151.11 49.68 14.74 24.80 49.71 16.74 24.08 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 2 3 # 2 B 70 ALA A 96 ALA~? 30.94 MG MG B 701 B 126 LEU A 99 LEU~? 26.86 MG MG B 701 B 158 GLU A 70 GLU~? 25.37 MG MG B 701 coo -39.79 4.61 147.27 -39.61 5.56 148.47 43.90 21.81 26.90 44.37 20.58 27.66 coo -34.22 5.06 149.25 -33.65 4.24 151.15 50.61 18.05 28.30 48.66 17.16 28.74 coo -33.03 9.93 151.71 -34.98 9.38 151.11 49.68 14.74 24.80 49.71 16.74 24.08 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 3 3 # 3 B 70 ALA A 199 ALA~? 51.88 MG MG B 701 B 126 LEU A 240 LEU~? 52.77 MG MG B 701 B 158 GLU A 237 GLU~? 48.86 MG MG B 701 coo -39.79 4.61 147.27 -39.61 5.56 148.47 54.75 -0.85 73.97 55.62 0.40 73.78 coo -34.22 5.06 149.25 -33.65 4.24 151.15 52.19 2.32 73.37 51.41 1.66 75.25 coo -33.03 9.93 151.71 -34.98 9.38 151.11 46.26 1.98 71.28 45.32 1.01 69.65 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 4 3 # 4 B 70 ALA A 241 ALA~? 47.31 MG MG B 701 B 126 LEU A 233 LEU~? 46.15 MG MG B 701 B 158 GLU A 237 GLU~? 48.86 MG MG B 701 coo -39.79 4.61 147.27 -39.61 5.56 148.47 53.60 3.48 69.42 52.47 3.64 68.38 coo -34.22 5.06 149.25 -33.65 4.24 151.15 47.05 4.25 66.96 48.61 2.87 66.43 coo -33.03 9.93 151.71 -34.98 9.38 151.11 46.26 1.98 71.28 45.32 1.01 69.65 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 5 3 # 5 B 70 ALA A 241 ALA~? 47.31 MG MG B 701 B 126 LEU A 240 LEU~? 52.77 MG MG B 701 B 158 GLU A 237 GLU~? 48.86 MG MG B 701 coo -39.79 4.61 147.27 -39.61 5.56 148.47 53.60 3.48 69.42 52.47 3.64 68.38 coo -34.22 5.06 149.25 -33.65 4.24 151.15 52.19 2.32 73.37 51.41 1.66 75.25 coo -33.03 9.93 151.71 -34.98 9.38 151.11 46.26 1.98 71.28 45.32 1.01 69.65 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 6 3 # 6 B 70 ALA A 242 ALA~? 50.36 MG MG B 701 B 126 LEU A 240 LEU~? 52.77 MG MG B 701 B 158 GLU A 237 GLU~? 48.86 MG MG B 701 coo -39.79 4.61 147.27 -39.61 5.56 148.47 55.65 6.69 69.54 55.28 7.96 70.34 coo -34.22 5.06 149.25 -33.65 4.24 151.15 52.19 2.32 73.37 51.41 1.66 75.25 coo -33.03 9.93 151.71 -34.98 9.38 151.11 46.26 1.98 71.28 45.32 1.01 69.65 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 7 3 # 7 B 70 ALA B 75 ALA~? 43.51 MG MG B 701 B 126 LEU B 74 LEU~? 44.78 MG MG B 701 B 158 GLU B 70 GLU~? 46.48 MG MG B 701 coo -39.79 4.61 147.27 -39.61 5.56 148.47 75.83 -13.23 59.70 77.14 -12.38 59.76 coo -34.22 5.06 149.25 -33.65 4.24 151.15 76.89 -17.71 59.97 77.15 -19.85 60.11 coo -33.03 9.93 151.71 -34.98 9.38 151.11 80.85 -20.85 57.05 81.87 -22.62 57.55 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 8 3 # 8 B 70 ALA B 96 ALA~? 44.52 MG MG B 701 B 126 LEU B 99 LEU~? 42.90 MG MG B 701 B 158 GLU B 70 GLU~? 46.48 MG MG B 701 coo -39.79 4.61 147.27 -39.61 5.56 148.47 77.10 -29.00 56.84 77.04 -27.87 55.77 coo -34.22 5.06 149.25 -33.65 4.24 151.15 81.39 -23.82 53.26 79.24 -23.51 53.65 coo -33.03 9.93 151.71 -34.98 9.38 151.11 80.85 -20.85 57.05 81.87 -22.62 57.55 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 9 3 # 9 B 70 ALA B 106 ALA^? 40.55 MG MG B 701 B 126 LEU B 108 LEU^? 38.32 MG MG B 701 B 158 GLU B 109 GLU^? 35.66 MG MG B 701 coo -39.79 4.61 147.27 -39.61 5.56 148.47 70.76 -29.74 51.68 71.32 -29.23 53.03 coo -34.22 5.06 149.25 -33.65 4.24 151.15 64.83 -26.80 55.02 64.92 -24.61 55.22 coo -33.03 9.93 151.71 -34.98 9.38 151.11 59.57 -29.27 53.23 59.54 -28.97 51.11 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 10 3 # 10 B 70 ALA B 199 ALA~? 13.57 MG MG B 701 B 126 LEU B 240 LEU~? 11.40 MG MG B 701 B 158 GLU B 237 GLU~? 4.20 MG MG B 701 coo -39.79 4.61 147.27 -39.61 5.56 148.47 61.06 -6.74 11.45 62.28 -7.68 11.21 coo -34.22 5.06 149.25 -33.65 4.24 151.15 59.94 -10.41 13.04 58.48 -10.02 11.48 coo -33.03 9.93 151.71 -34.98 9.38 151.11 55.73 -11.24 17.28 55.11 -10.45 19.16 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 11 3 # 11 B 70 ALA B 242 ALA~? 15.16 MG MG B 701 B 126 LEU B 240 LEU~? 11.40 MG MG B 701 B 158 GLU B 237 GLU~? 4.20 MG MG B 701 coo -39.79 4.61 147.27 -39.61 5.56 148.47 65.94 -13.15 14.66 65.70 -14.54 14.15 coo -34.22 5.06 149.25 -33.65 4.24 151.15 59.94 -10.41 13.04 58.48 -10.02 11.48 coo -33.03 9.93 151.71 -34.98 9.38 151.11 55.73 -11.24 17.28 55.11 -10.45 19.16 1pjh_c01 source 1pjh ENOYL-COA ISOMERASE; ECI1P : 11 hits 1pjh_c01 naa= 3 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 1 3 # 1 C 70 ALA A 75 ALA~? 16.29 MG MG B 701 C 126 LEU A 74 LEU~? 22.11 MG MG B 701 C 158 GLU A 70 GLU~? 25.37 MG MG B 701 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 45.58 6.48 23.74 46.73 6.03 22.86 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 45.85 10.99 23.70 45.70 13.12 23.34 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 49.68 14.74 24.80 49.71 16.74 24.08 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 2 3 # 2 C 70 ALA A 160 ALA~? 35.52 MG MG B 701 C 126 LEU A 156 LEU~? 35.04 MG MG B 701 C 158 GLU A 134 GLU^? 30.91 MG MG B 701 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 45.30 6.87 52.88 46.13 8.16 52.95 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 42.21 10.50 50.11 43.44 11.59 48.63 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 46.08 11.35 43.50 47.51 12.29 44.66 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 3 3 # 3 C 70 ALA A 199 ALA~? 51.88 MG MG B 701 C 126 LEU A 240 LEU~? 52.77 MG MG B 701 C 158 GLU A 237 GLU~? 48.86 MG MG B 701 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 54.75 -0.85 73.97 55.62 0.40 73.78 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 52.19 2.32 73.37 51.41 1.66 75.25 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 46.26 1.98 71.28 45.32 1.01 69.65 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 4 3 # 4 C 70 ALA A 241 ALA~? 47.31 MG MG B 701 C 126 LEU A 233 LEU~? 46.15 MG MG B 701 C 158 GLU A 237 GLU~? 48.86 MG MG B 701 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 53.60 3.48 69.42 52.47 3.64 68.38 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 47.05 4.25 66.96 48.61 2.87 66.43 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 46.26 1.98 71.28 45.32 1.01 69.65 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 5 3 # 5 C 70 ALA A 241 ALA~? 47.31 MG MG B 701 C 126 LEU A 240 LEU~? 52.77 MG MG B 701 C 158 GLU A 237 GLU~? 48.86 MG MG B 701 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 53.60 3.48 69.42 52.47 3.64 68.38 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 52.19 2.32 73.37 51.41 1.66 75.25 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 46.26 1.98 71.28 45.32 1.01 69.65 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 6 3 # 6 C 70 ALA A 242 ALA~? 50.36 MG MG B 701 C 126 LEU A 240 LEU~? 52.77 MG MG B 701 C 158 GLU A 237 GLU~? 48.86 MG MG B 701 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 55.65 6.69 69.54 55.28 7.96 70.34 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 52.19 2.32 73.37 51.41 1.66 75.25 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 46.26 1.98 71.28 45.32 1.01 69.65 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 7 3 # 7 C 70 ALA B 75 ALA~? 43.51 MG MG B 701 C 126 LEU B 74 LEU~? 44.78 MG MG B 701 C 158 GLU B 70 GLU~? 46.48 MG MG B 701 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 75.83 -13.23 59.70 77.14 -12.38 59.76 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 76.89 -17.71 59.97 77.15 -19.85 60.11 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 80.85 -20.85 57.05 81.87 -22.62 57.55 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 8 3 # 8 C 70 ALA B 96 ALA~? 44.52 MG MG B 701 C 126 LEU B 99 LEU~? 42.90 MG MG B 701 C 158 GLU B 70 GLU~? 46.48 MG MG B 701 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 77.10 -29.00 56.84 77.04 -27.87 55.77 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 81.39 -23.82 53.26 79.24 -23.51 53.65 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 80.85 -20.85 57.05 81.87 -22.62 57.55 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 9 3 # 9 C 70 ALA B 106 ALA^? 40.55 MG MG B 701 C 126 LEU B 108 LEU^? 38.32 MG MG B 701 C 158 GLU B 109 GLU^? 35.66 MG MG B 701 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 70.76 -29.74 51.68 71.32 -29.23 53.03 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 64.83 -26.80 55.02 64.92 -24.61 55.22 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 59.57 -29.27 53.23 59.54 -28.97 51.11 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 10 3 # 10 C 70 ALA B 199 ALA~? 13.57 MG MG B 701 C 126 LEU B 240 LEU~? 11.40 MG MG B 701 C 158 GLU B 237 GLU~? 4.20 MG MG B 701 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 61.06 -6.74 11.45 62.28 -7.68 11.21 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 59.94 -10.41 13.04 58.48 -10.02 11.48 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 55.73 -11.24 17.28 55.11 -10.45 19.16 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 11 3 # 11 C 70 ALA B 241 ALA~? 10.01 MG MG B 701 C 126 LEU B 233 LEU~? 6.36 MG MG B 701 C 158 GLU B 237 GLU~? 4.20 MG MG B 701 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 63.24 -10.78 15.96 62.74 -11.32 17.28 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 58.66 -13.18 20.71 59.84 -11.35 20.53 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 55.73 -11.24 17.28 55.11 -10.45 19.16 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 12 3 # 12 C 70 ALA B 241 ALA~? 10.01 MG MG B 701 C 126 LEU B 240 LEU~? 11.40 MG MG B 701 C 158 GLU B 237 GLU~? 4.20 MG MG B 701 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 63.24 -10.78 15.96 62.74 -11.32 17.28 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 59.94 -10.41 13.04 58.48 -10.02 11.48 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 55.73 -11.24 17.28 55.11 -10.45 19.16 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 13 3 # 13 C 70 ALA B 242 ALA~? 15.16 MG MG B 701 C 126 LEU B 240 LEU~? 11.40 MG MG B 701 C 158 GLU B 237 GLU~? 4.20 MG MG B 701 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 65.94 -13.15 14.66 65.70 -14.54 14.15 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 59.94 -10.41 13.04 58.48 -10.02 11.48 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 55.73 -11.24 17.28 55.11 -10.45 19.16 1pjh_c02 source 1pjh ENOYL-COA ISOMERASE; ECI1P : 13 hits 1pjh_c02 naa= 3 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 1 3 # 1 A 248 ASP A 165 ASP^? 19.82 MG MG B 701 A 270 LYS A 175 LYS~? 16.95 MG MG B 701 A 382 MET A 76 MET?? 19.37 MG MG B 701 coo -27.63 121.99 45.48 -26.66 123.86 45.68 49.47 0.04 38.38 48.02 -0.73 39.68 coo -32.20 115.91 49.56 -31.37 121.03 53.12 54.19 -7.18 37.22 54.81 -12.82 38.86 coo -23.75 127.89 58.42 -26.02 128.79 55.12 44.86 4.90 27.16 44.80 5.97 31.31 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 2 3 # 2 A 248 ASP B 165 ASP^? 26.59 MG MG B 701 A 270 LYS B 175 LYS~? 34.92 MG MG B 701 A 382 MET B 76 MET?? 35.51 MG MG B 701 coo -27.63 121.99 45.48 -26.66 123.86 45.68 71.61 -6.68 45.38 69.65 -6.30 44.66 coo -32.20 115.91 49.56 -31.37 121.03 53.12 75.00 1.45 45.20 75.48 7.65 46.06 coo -23.75 127.89 58.42 -26.02 128.79 55.12 73.39 -12.45 56.87 72.36 -13.86 52.98 1pjq_c02 source 1pjq SIROHEME SYNTHASE : 2 hits 1pjq_c02 naa= 3 ULMN 3 1pjq_c03 SIROHEME SYNTHASE user 1 3 # 1 B 248 ASP A 177 ASP~? 19.64 MG MG B 701 B 270 LYS A 175 LYS~? 16.95 MG MG B 701 B 382 MET B 212 MET?? 16.58 MG MG B 701 coo -11.82 154.51 43.38 -12.86 152.74 43.79 57.48 -8.32 42.16 55.62 -9.31 42.19 coo -5.09 158.39 43.41 -0.74 158.80 47.15 54.19 -7.18 37.22 54.81 -12.82 38.86 coo -2.79 145.52 50.38 -5.75 148.14 51.66 67.90 -10.80 31.00 69.79 -7.11 29.87 1pjq_c03 source 1pjq SIROHEME SYNTHASE : 1 hits 1pjq_c03 naa= 3 ULMN 3 1pmi_c00 PHOSPHOMANNOSE ISOMERASE user 1 3 # 1 111 GLN A 227 GLN^? 40.32 MG MG B 701 294 GLU A 186 GLU~? 38.23 MG MG B 701 304 ARG A 226 ARG^? 38.22 MG MG B 701 coo 15.89 18.45 46.53 15.82 16.91 48.02 54.41 4.39 59.17 53.11 5.19 60.64 coo 22.84 13.44 52.91 20.84 13.18 52.38 60.82 -4.60 59.58 62.03 -6.27 60.12 coo 8.71 17.11 46.51 7.23 17.64 49.20 52.39 10.28 54.33 53.57 13.12 54.39 1pmi_c00 source 1pmi PHOSPHOMANNOSE ISOMERASE : 1 hits 1pmi_c00 naa= 3 ULMN 3 1pow_c02 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 1 3 # 1 A 264 ARG A 126 ARG^? 30.85 MG MG B 701 A 479 PHE A 124 PHE^? 29.34 MG MG B 701 A 483 GLU A 218 GLU~? 32.55 MG MG B 701 coo 17.33 52.29 2.24 18.71 54.03 0.18 48.08 15.54 42.27 50.77 14.42 43.32 coo 20.06 57.44 1.28 18.39 56.19 3.12 53.10 15.90 36.97 52.63 18.53 37.74 coo 17.33 54.96 -3.04 16.34 56.76 -2.51 54.56 16.53 40.79 53.76 18.19 41.81 ULMN 3 1pow_c02 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 2 3 # 2 A 264 ARG A 126 ARG^? 30.85 MG MG B 701 A 479 PHE A 136 PHE^? 26.98 MG MG B 701 A 483 GLU A 134 GLU^? 30.91 MG MG B 701 coo 17.33 52.29 2.24 18.71 54.03 0.18 48.08 15.54 42.27 50.77 14.42 43.32 coo 20.06 57.44 1.28 18.39 56.19 3.12 51.01 11.36 40.52 53.20 13.02 39.90 coo 17.33 54.96 -3.04 16.34 56.76 -2.51 46.08 11.35 43.50 47.51 12.29 44.66 ULMN 3 1pow_c02 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 3 3 # 3 A 264 ARG A 126 ARG^? 30.85 MG MG B 701 A 479 PHE A 136 PHE^? 26.98 MG MG B 701 A 483 GLU A 218 GLU~? 32.55 MG MG B 701 coo 17.33 52.29 2.24 18.71 54.03 0.18 48.08 15.54 42.27 50.77 14.42 43.32 coo 20.06 57.44 1.28 18.39 56.19 3.12 51.01 11.36 40.52 53.20 13.02 39.90 coo 17.33 54.96 -3.04 16.34 56.76 -2.51 54.56 16.53 40.79 53.76 18.19 41.81 ULMN 3 1pow_c02 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 4 3 # 4 A 264 ARG A 138 ARG^? 25.45 MG MG B 701 A 479 PHE A 124 PHE^? 29.34 MG MG B 701 A 483 GLU A 218 GLU~? 32.55 MG MG B 701 coo 17.33 52.29 2.24 18.71 54.03 0.18 56.09 11.79 37.51 58.92 12.66 36.83 coo 20.06 57.44 1.28 18.39 56.19 3.12 53.10 15.90 36.97 52.63 18.53 37.74 coo 17.33 54.96 -3.04 16.34 56.76 -2.51 54.56 16.53 40.79 53.76 18.19 41.81 ULMN 3 1pow_c02 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 5 3 # 5 A 264 ARG A 138 ARG^? 25.45 MG MG B 701 A 479 PHE A 124 PHE^? 29.34 MG MG B 701 A 483 GLU A 219 GLU~? 34.01 MG MG B 701 coo 17.33 52.29 2.24 18.71 54.03 0.18 56.09 11.79 37.51 58.92 12.66 36.83 coo 20.06 57.44 1.28 18.39 56.19 3.12 53.10 15.90 36.97 52.63 18.53 37.74 coo 17.33 54.96 -3.04 16.34 56.76 -2.51 59.27 18.40 40.08 59.60 20.33 40.74 ULMN 3 1pow_c02 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 6 3 # 6 A 264 ARG A 138 ARG^? 25.45 MG MG B 701 A 479 PHE A 136 PHE^? 26.98 MG MG B 701 A 483 GLU A 218 GLU~? 32.55 MG MG B 701 coo 17.33 52.29 2.24 18.71 54.03 0.18 56.09 11.79 37.51 58.92 12.66 36.83 coo 20.06 57.44 1.28 18.39 56.19 3.12 51.01 11.36 40.52 53.20 13.02 39.90 coo 17.33 54.96 -3.04 16.34 56.76 -2.51 54.56 16.53 40.79 53.76 18.19 41.81 ULMN 3 1pow_c02 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 7 3 # 7 A 264 ARG A 195 ARG~? 43.32 MG MG B 701 A 479 PHE A 189 PHE~? 41.84 MG MG B 701 A 483 GLU A 186 GLU~? 38.23 MG MG B 701 coo 17.33 52.29 2.24 18.71 54.03 0.18 61.44 -7.15 66.34 63.04 -4.84 65.03 coo 20.06 57.44 1.28 18.39 56.19 3.12 59.77 -0.70 63.73 57.68 -2.54 63.82 coo 17.33 54.96 -3.04 16.34 56.76 -2.51 60.82 -4.60 59.58 62.03 -6.27 60.12 ULMN 3 1pow_c02 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 8 3 # 8 A 264 ARG B 126 ARG^? 29.16 MG MG B 701 A 479 PHE B 124 PHE~? 35.62 MG MG B 701 A 483 GLU B 218 GLU~? 32.37 MG MG B 701 coo 17.33 52.29 2.24 18.71 54.03 0.18 72.93 -22.54 42.02 74.52 -21.06 39.83 coo 20.06 57.44 1.28 18.39 56.19 3.12 79.51 -21.13 44.47 79.25 -23.80 43.75 coo 17.33 54.96 -3.04 16.34 56.76 -2.51 79.74 -21.86 40.41 79.27 -22.32 38.45 ULMN 3 1pow_c02 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 9 3 # 9 A 264 ARG B 126 ARG^? 29.16 MG MG B 701 A 479 PHE B 136 PHE^? 30.83 MG MG B 701 A 483 GLU B 134 GLU^? 26.11 MG MG B 701 coo 17.33 52.29 2.24 18.71 54.03 0.18 72.93 -22.54 42.02 74.52 -21.06 39.83 coo 20.06 57.44 1.28 18.39 56.19 3.12 75.25 -17.57 42.31 77.88 -18.52 41.97 coo 17.33 54.96 -3.04 16.34 56.76 -2.51 69.63 -18.91 41.63 70.61 -19.62 39.97 ULMN 3 1pow_c02 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 10 3 # 10 A 264 ARG B 126 ARG^? 29.16 MG MG B 701 A 479 PHE B 136 PHE^? 30.83 MG MG B 701 A 483 GLU B 218 GLU~? 32.37 MG MG B 701 coo 17.33 52.29 2.24 18.71 54.03 0.18 72.93 -22.54 42.02 74.52 -21.06 39.83 coo 20.06 57.44 1.28 18.39 56.19 3.12 75.25 -17.57 42.31 77.88 -18.52 41.97 coo 17.33 54.96 -3.04 16.34 56.76 -2.51 79.74 -21.86 40.41 79.27 -22.32 38.45 ULMN 3 1pow_c02 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 11 3 # 11 A 264 ARG B 138 ARG^? 35.64 MG MG B 701 A 479 PHE B 124 PHE~? 35.62 MG MG B 701 A 483 GLU B 218 GLU~? 32.37 MG MG B 701 coo 17.33 52.29 2.24 18.71 54.03 0.18 81.28 -15.50 42.88 84.08 -15.53 41.69 coo 20.06 57.44 1.28 18.39 56.19 3.12 79.51 -21.13 44.47 79.25 -23.80 43.75 coo 17.33 54.96 -3.04 16.34 56.76 -2.51 79.74 -21.86 40.41 79.27 -22.32 38.45 ULMN 3 1pow_c02 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 12 3 # 12 A 264 ARG B 138 ARG^? 35.64 MG MG B 701 A 479 PHE B 124 PHE~? 35.62 MG MG B 701 A 483 GLU B 219 GLU~? 39.54 MG MG B 701 coo 17.33 52.29 2.24 18.71 54.03 0.18 81.28 -15.50 42.88 84.08 -15.53 41.69 coo 20.06 57.44 1.28 18.39 56.19 3.12 79.51 -21.13 44.47 79.25 -23.80 43.75 coo 17.33 54.96 -3.04 16.34 56.76 -2.51 85.46 -21.90 40.90 85.71 -22.21 42.97 ULMN 3 1pow_c02 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 13 3 # 13 A 264 ARG B 138 ARG^? 35.64 MG MG B 701 A 479 PHE B 136 PHE^? 30.83 MG MG B 701 A 483 GLU B 218 GLU~? 32.37 MG MG B 701 coo 17.33 52.29 2.24 18.71 54.03 0.18 81.28 -15.50 42.88 84.08 -15.53 41.69 coo 20.06 57.44 1.28 18.39 56.19 3.12 75.25 -17.57 42.31 77.88 -18.52 41.97 coo 17.33 54.96 -3.04 16.34 56.76 -2.51 79.74 -21.86 40.41 79.27 -22.32 38.45 ULMN 3 1pow_c02 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 14 3 # 14 A 264 ARG B 195 ARG~? 17.65 MG MG B 701 A 479 PHE B 189 PHE~? 14.75 MG MG B 701 A 483 GLU B 186 GLU~? 15.37 MG MG B 701 coo 17.33 52.29 2.24 18.71 54.03 0.18 67.86 1.55 15.86 69.38 1.19 18.53 coo 20.06 57.44 1.28 18.39 56.19 3.12 69.85 -4.50 18.58 67.45 -3.45 19.57 coo 17.33 54.96 -3.04 16.34 56.76 -2.51 69.45 -0.46 21.54 67.97 0.05 22.96 1pow_c02 source 1pow PYRUVATE OXIDASE (E.C.1.2.3.3) (WILD TYPE) : 14 hits 1pow_c02 naa= 3 ULMN 3 1pow_c03 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 1 3 # 1 B 264 ARG A 126 ARG^? 30.85 MG MG B 701 B 479 PHE A 124 PHE^? 29.34 MG MG B 701 B 483 GLU A 218 GLU~? 32.55 MG MG B 701 coo -26.72 93.28 20.13 -28.02 93.55 17.39 48.08 15.54 42.27 50.77 14.42 43.32 coo -29.34 90.48 15.69 -27.62 89.95 17.80 53.10 15.90 36.97 52.63 18.53 37.74 coo -26.63 95.49 14.65 -25.77 93.77 13.77 54.56 16.53 40.79 53.76 18.19 41.81 ULMN 3 1pow_c03 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 2 3 # 2 B 264 ARG A 126 ARG^? 30.85 MG MG B 701 B 479 PHE A 136 PHE^? 26.98 MG MG B 701 B 483 GLU A 134 GLU^? 30.91 MG MG B 701 coo -26.72 93.28 20.13 -28.02 93.55 17.39 48.08 15.54 42.27 50.77 14.42 43.32 coo -29.34 90.48 15.69 -27.62 89.95 17.80 51.01 11.36 40.52 53.20 13.02 39.90 coo -26.63 95.49 14.65 -25.77 93.77 13.77 46.08 11.35 43.50 47.51 12.29 44.66 ULMN 3 1pow_c03 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 3 3 # 3 B 264 ARG A 126 ARG^? 30.85 MG MG B 701 B 479 PHE A 136 PHE^? 26.98 MG MG B 701 B 483 GLU A 218 GLU~? 32.55 MG MG B 701 coo -26.72 93.28 20.13 -28.02 93.55 17.39 48.08 15.54 42.27 50.77 14.42 43.32 coo -29.34 90.48 15.69 -27.62 89.95 17.80 51.01 11.36 40.52 53.20 13.02 39.90 coo -26.63 95.49 14.65 -25.77 93.77 13.77 54.56 16.53 40.79 53.76 18.19 41.81 ULMN 3 1pow_c03 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 4 3 # 4 B 264 ARG A 138 ARG^? 25.45 MG MG B 701 B 479 PHE A 124 PHE^? 29.34 MG MG B 701 B 483 GLU A 218 GLU~? 32.55 MG MG B 701 coo -26.72 93.28 20.13 -28.02 93.55 17.39 56.09 11.79 37.51 58.92 12.66 36.83 coo -29.34 90.48 15.69 -27.62 89.95 17.80 53.10 15.90 36.97 52.63 18.53 37.74 coo -26.63 95.49 14.65 -25.77 93.77 13.77 54.56 16.53 40.79 53.76 18.19 41.81 ULMN 3 1pow_c03 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 5 3 # 5 B 264 ARG A 138 ARG^? 25.45 MG MG B 701 B 479 PHE A 124 PHE^? 29.34 MG MG B 701 B 483 GLU A 219 GLU~? 34.01 MG MG B 701 coo -26.72 93.28 20.13 -28.02 93.55 17.39 56.09 11.79 37.51 58.92 12.66 36.83 coo -29.34 90.48 15.69 -27.62 89.95 17.80 53.10 15.90 36.97 52.63 18.53 37.74 coo -26.63 95.49 14.65 -25.77 93.77 13.77 59.27 18.40 40.08 59.60 20.33 40.74 ULMN 3 1pow_c03 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 6 3 # 6 B 264 ARG A 138 ARG^? 25.45 MG MG B 701 B 479 PHE A 136 PHE^? 26.98 MG MG B 701 B 483 GLU A 218 GLU~? 32.55 MG MG B 701 coo -26.72 93.28 20.13 -28.02 93.55 17.39 56.09 11.79 37.51 58.92 12.66 36.83 coo -29.34 90.48 15.69 -27.62 89.95 17.80 51.01 11.36 40.52 53.20 13.02 39.90 coo -26.63 95.49 14.65 -25.77 93.77 13.77 54.56 16.53 40.79 53.76 18.19 41.81 ULMN 3 1pow_c03 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 7 3 # 7 B 264 ARG A 195 ARG~? 43.32 MG MG B 701 B 479 PHE A 189 PHE~? 41.84 MG MG B 701 B 483 GLU A 186 GLU~? 38.23 MG MG B 701 coo -26.72 93.28 20.13 -28.02 93.55 17.39 61.44 -7.15 66.34 63.04 -4.84 65.03 coo -29.34 90.48 15.69 -27.62 89.95 17.80 59.77 -0.70 63.73 57.68 -2.54 63.82 coo -26.63 95.49 14.65 -25.77 93.77 13.77 60.82 -4.60 59.58 62.03 -6.27 60.12 ULMN 3 1pow_c03 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 8 3 # 8 B 264 ARG B 126 ARG^? 29.16 MG MG B 701 B 479 PHE B 124 PHE~? 35.62 MG MG B 701 B 483 GLU B 218 GLU~? 32.37 MG MG B 701 coo -26.72 93.28 20.13 -28.02 93.55 17.39 72.93 -22.54 42.02 74.52 -21.06 39.83 coo -29.34 90.48 15.69 -27.62 89.95 17.80 79.51 -21.13 44.47 79.25 -23.80 43.75 coo -26.63 95.49 14.65 -25.77 93.77 13.77 79.74 -21.86 40.41 79.27 -22.32 38.45 ULMN 3 1pow_c03 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 9 3 # 9 B 264 ARG B 126 ARG^? 29.16 MG MG B 701 B 479 PHE B 136 PHE^? 30.83 MG MG B 701 B 483 GLU B 134 GLU^? 26.11 MG MG B 701 coo -26.72 93.28 20.13 -28.02 93.55 17.39 72.93 -22.54 42.02 74.52 -21.06 39.83 coo -29.34 90.48 15.69 -27.62 89.95 17.80 75.25 -17.57 42.31 77.88 -18.52 41.97 coo -26.63 95.49 14.65 -25.77 93.77 13.77 69.63 -18.91 41.63 70.61 -19.62 39.97 ULMN 3 1pow_c03 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 10 3 # 10 B 264 ARG B 126 ARG^? 29.16 MG MG B 701 B 479 PHE B 136 PHE^? 30.83 MG MG B 701 B 483 GLU B 218 GLU~? 32.37 MG MG B 701 coo -26.72 93.28 20.13 -28.02 93.55 17.39 72.93 -22.54 42.02 74.52 -21.06 39.83 coo -29.34 90.48 15.69 -27.62 89.95 17.80 75.25 -17.57 42.31 77.88 -18.52 41.97 coo -26.63 95.49 14.65 -25.77 93.77 13.77 79.74 -21.86 40.41 79.27 -22.32 38.45 ULMN 3 1pow_c03 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 11 3 # 11 B 264 ARG B 138 ARG^? 35.64 MG MG B 701 B 479 PHE B 124 PHE~? 35.62 MG MG B 701 B 483 GLU B 218 GLU~? 32.37 MG MG B 701 coo -26.72 93.28 20.13 -28.02 93.55 17.39 81.28 -15.50 42.88 84.08 -15.53 41.69 coo -29.34 90.48 15.69 -27.62 89.95 17.80 79.51 -21.13 44.47 79.25 -23.80 43.75 coo -26.63 95.49 14.65 -25.77 93.77 13.77 79.74 -21.86 40.41 79.27 -22.32 38.45 ULMN 3 1pow_c03 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 12 3 # 12 B 264 ARG B 138 ARG^? 35.64 MG MG B 701 B 479 PHE B 124 PHE~? 35.62 MG MG B 701 B 483 GLU B 219 GLU~? 39.54 MG MG B 701 coo -26.72 93.28 20.13 -28.02 93.55 17.39 81.28 -15.50 42.88 84.08 -15.53 41.69 coo -29.34 90.48 15.69 -27.62 89.95 17.80 79.51 -21.13 44.47 79.25 -23.80 43.75 coo -26.63 95.49 14.65 -25.77 93.77 13.77 85.46 -21.90 40.90 85.71 -22.21 42.97 ULMN 3 1pow_c03 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 13 3 # 13 B 264 ARG B 138 ARG^? 35.64 MG MG B 701 B 479 PHE B 136 PHE^? 30.83 MG MG B 701 B 483 GLU B 218 GLU~? 32.37 MG MG B 701 coo -26.72 93.28 20.13 -28.02 93.55 17.39 81.28 -15.50 42.88 84.08 -15.53 41.69 coo -29.34 90.48 15.69 -27.62 89.95 17.80 75.25 -17.57 42.31 77.88 -18.52 41.97 coo -26.63 95.49 14.65 -25.77 93.77 13.77 79.74 -21.86 40.41 79.27 -22.32 38.45 ULMN 3 1pow_c03 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 14 3 # 14 B 264 ARG B 195 ARG~? 17.65 MG MG B 701 B 479 PHE B 189 PHE~? 14.75 MG MG B 701 B 483 GLU B 186 GLU~? 15.37 MG MG B 701 coo -26.72 93.28 20.13 -28.02 93.55 17.39 67.86 1.55 15.86 69.38 1.19 18.53 coo -29.34 90.48 15.69 -27.62 89.95 17.80 69.85 -4.50 18.58 67.45 -3.45 19.57 coo -26.63 95.49 14.65 -25.77 93.77 13.77 69.45 -0.46 21.54 67.97 0.05 22.96 1pow_c03 source 1pow PYRUVATE OXIDASE (E.C.1.2.3.3) (WILD TYPE) : 14 hits 1pow_c03 naa= 3 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 1 3 # 1 A 67 ASP A 161 ASP^? 31.32 MG MG B 701 A 68 ALA A 160 ALA~? 35.52 MG MG B 701 A 72 LEU A 156 LEU~? 35.04 MG MG B 701 coo 46.76 7.59 18.65 45.27 6.01 18.52 45.91 2.65 51.66 46.91 0.77 51.57 coo 48.88 4.35 16.59 48.73 5.09 15.20 45.30 6.87 52.88 46.13 8.16 52.95 coo 53.89 6.25 15.09 52.88 7.92 14.14 42.21 10.50 50.11 43.44 11.59 48.63 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 2 3 # 2 A 67 ASP B 161 ASP^? 15.44 MG MG B 701 A 68 ALA B 160 ALA~? 17.20 MG MG B 701 A 72 LEU B 156 LEU~? 20.91 MG MG B 701 coo 46.76 7.59 18.65 45.27 6.01 18.52 63.88 -11.38 34.74 64.49 -9.36 34.64 coo 48.88 4.35 16.59 48.73 5.09 15.20 64.13 -15.84 33.51 65.33 -16.77 33.15 coo 53.89 6.25 15.09 52.88 7.92 14.14 62.90 -19.58 37.07 65.03 -20.26 37.42 1q6l_c05 source 1q6l 3-KETO-L-GULONATE 6-PHOSPHATE DECARBOXYLASE : 2 hits 1q6l_c05 naa= 3 ULMN 3 1qe3_c00 PARA-NITROBENZYL ESTERASE user 1 3 # 1 A 189 SER A 100 SER~? 32.62 MG MG B 701 A 310 GLU A 70 GLU~? 25.37 MG MG B 701 A 399 HIS A 98 HIS~? 27.68 MG MG B 701 coo 2.67 37.96 55.23 1.78 40.01 56.16 53.58 21.63 28.64 52.67 23.81 29.19 coo 6.61 38.44 63.61 6.69 38.31 61.50 49.68 14.74 24.80 49.71 16.74 24.08 coo 4.95 41.82 59.53 3.85 40.70 58.14 50.40 19.60 21.83 50.19 18.76 19.91 ULMN 3 1qe3_c00 PARA-NITROBENZYL ESTERASE user 2 3 # 2 A 189 SER B 100 SER~? 45.77 MG MG B 701 A 310 GLU B 70 GLU~? 46.48 MG MG B 701 A 399 HIS B 98 HIS~? 50.51 MG MG B 701 coo 2.67 37.96 55.23 1.78 40.01 56.16 84.70 -26.50 51.42 84.08 -28.81 51.12 coo 6.61 38.44 63.61 6.69 38.31 61.50 80.85 -20.85 57.05 81.87 -22.62 57.55 coo 4.95 41.82 59.53 3.85 40.70 58.14 84.18 -25.10 59.33 84.20 -24.17 61.22 1qe3_c00 source 1qe3 PARA-NITROBENZYL ESTERASE : 2 hits 1qe3_c00 naa= 3 ULMN 3 1qgn_c00 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 155 HIS A 157 HIS~? 39.61 MG MG B 701 A 236 ASP A 165 ASP^? 19.82 MG MG B 701 A 261 LYS A 172 LYS~? 6.12 MG MG B 701 coo 55.45 46.76 42.08 57.34 46.16 42.75 38.94 10.29 53.24 39.70 12.18 53.73 coo 48.87 29.19 44.63 49.10 27.34 43.63 49.47 0.04 38.38 48.02 -0.73 39.68 coo 47.58 17.35 41.83 51.40 20.85 40.83 50.20 -3.67 28.72 53.15 -8.47 28.45 1qgn_c00 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1qgn_c00 naa= 3 ULMN 3 1qgn_c03 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 D 155 HIS A 157 HIS~? 39.61 MG MG B 701 D 236 ASP A 165 ASP^? 19.82 MG MG B 701 D 261 LYS A 172 LYS~? 6.12 MG MG B 701 coo 21.65 -31.73 40.91 19.91 -31.10 41.91 38.94 10.29 53.24 39.70 12.18 53.73 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 49.47 0.04 38.38 48.02 -0.73 39.68 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 50.20 -3.67 28.72 53.15 -8.47 28.45 1qgn_c03 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1qgn_c03 naa= 3 ULMN 3 1qgn_c04 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 E 155 HIS A 157 HIS~? 39.61 MG MG B 701 E 236 ASP A 165 ASP^? 19.82 MG MG B 701 E 261 LYS A 172 LYS~? 6.12 MG MG B 701 coo 76.61 -27.00 -35.69 75.87 -28.77 -34.87 38.94 10.29 53.24 39.70 12.18 53.73 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 49.47 0.04 38.38 48.02 -0.73 39.68 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 50.20 -3.67 28.72 53.15 -8.47 28.45 1qgn_c04 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1qgn_c04 naa= 3 ULMN 3 1qgn_c07 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 H 155 HIS A 157 HIS~? 39.61 MG MG B 701 H 236 ASP A 165 ASP^? 19.82 MG MG B 701 H 261 LYS A 172 LYS~? 6.12 MG MG B 701 coo 0.50 11.68 -36.58 0.99 13.43 -35.52 38.94 10.29 53.24 39.70 12.18 53.73 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 49.47 0.04 38.38 48.02 -0.73 39.68 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 50.20 -3.67 28.72 53.15 -8.47 28.45 1qgn_c07 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1qgn_c07 naa= 3 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 110 ARG B 258 ARG^? 33.01 MG MG B 701 C 163 TYR B 252 TYR^? 25.41 MG MG B 701 C 236 ASP B 187 ASP~? 20.66 MG MG B 701 coo 39.01 29.77 22.02 37.48 31.30 19.84 83.96 -0.40 36.39 82.47 1.91 37.80 coo 39.51 34.34 13.63 37.63 32.61 14.79 79.70 -7.64 31.83 77.94 -6.02 30.43 coo 45.78 31.11 9.51 44.25 30.06 10.53 74.06 -4.33 24.81 74.57 -2.40 25.55 1qgn_c16 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1qgn_c16 naa= 3 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 110 ARG B 258 ARG^? 33.01 MG MG B 701 D 163 TYR B 252 TYR^? 25.41 MG MG B 701 D 236 ASP B 187 ASP~? 20.66 MG MG B 701 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 83.96 -0.40 36.39 82.47 1.91 37.80 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 79.70 -7.64 31.83 77.94 -6.02 30.43 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 74.06 -4.33 24.81 74.57 -2.40 25.55 1qgn_c17 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1qgn_c17 naa= 3 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 163 TYR B 252 TYR^? 25.41 MG MG B 701 A 236 ASP B 187 ASP~? 20.66 MG MG B 701 C 110 ARG B 258 ARG^? 33.01 MG MG B 701 coo 55.48 26.51 40.65 55.39 23.99 39.43 79.70 -7.64 31.83 77.94 -6.02 30.43 coo 48.87 29.19 44.63 49.10 27.34 43.63 74.06 -4.33 24.81 74.57 -2.40 25.55 coo 52.39 23.42 32.10 54.51 23.27 34.29 83.96 -0.40 36.39 82.47 1.91 37.80 1qgn_c18 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1qgn_c18 naa= 3 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 163 TYR B 252 TYR^? 25.41 MG MG B 701 B 236 ASP B 187 ASP~? 20.66 MG MG B 701 D 110 ARG B 258 ARG^? 33.01 MG MG B 701 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 79.70 -7.64 31.83 77.94 -6.02 30.43 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 74.06 -4.33 24.81 74.57 -2.40 25.55 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 83.96 -0.40 36.39 82.47 1.91 37.80 1qgn_c19 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1qgn_c19 naa= 3 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 E 110 ARG B 258 ARG^? 33.01 MG MG B 701 G 163 TYR B 252 TYR^? 25.41 MG MG B 701 G 236 ASP B 187 ASP~? 20.66 MG MG B 701 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 83.96 -0.40 36.39 82.47 1.91 37.80 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 79.70 -7.64 31.83 77.94 -6.02 30.43 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 74.06 -4.33 24.81 74.57 -2.40 25.55 1qgn_c20 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1qgn_c20 naa= 3 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 F 110 ARG B 258 ARG^? 33.01 MG MG B 701 H 163 TYR B 252 TYR^? 25.41 MG MG B 701 H 236 ASP B 187 ASP~? 20.66 MG MG B 701 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 83.96 -0.40 36.39 82.47 1.91 37.80 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 79.70 -7.64 31.83 77.94 -6.02 30.43 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 74.06 -4.33 24.81 74.57 -2.40 25.55 1qgn_c21 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1qgn_c21 naa= 3 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 E 163 TYR B 252 TYR^? 25.41 MG MG B 701 E 236 ASP B 187 ASP~? 20.66 MG MG B 701 G 110 ARG B 258 ARG^? 33.01 MG MG B 701 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 79.70 -7.64 31.83 77.94 -6.02 30.43 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 74.06 -4.33 24.81 74.57 -2.40 25.55 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 83.96 -0.40 36.39 82.47 1.91 37.80 1qgn_c22 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1qgn_c22 naa= 3 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 F 163 TYR B 252 TYR^? 25.41 MG MG B 701 F 236 ASP B 187 ASP~? 20.66 MG MG B 701 H 110 ARG B 258 ARG^? 33.01 MG MG B 701 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 79.70 -7.64 31.83 77.94 -6.02 30.43 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 74.06 -4.33 24.81 74.57 -2.40 25.55 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 83.96 -0.40 36.39 82.47 1.91 37.80 1qgn_c23 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1qgn_c23 naa= 3 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 1 3 # 1 A 49 ASP A 161 ASP^? 31.32 MG MG B 701 A 147 THR A 154 THR^? 30.24 MG MG B 701 A 294 ASP A 165 ASP^? 19.82 MG MG B 701 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 45.91 2.65 51.66 46.91 0.77 51.57 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 45.72 6.38 46.40 47.33 7.44 47.44 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 49.47 0.04 38.38 48.02 -0.73 39.68 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 2 3 # 2 A 49 ASP B 161 ASP^? 15.44 MG MG B 701 A 147 THR B 154 THR^? 21.42 MG MG B 701 A 294 ASP B 165 ASP^? 26.59 MG MG B 701 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 63.88 -11.38 34.74 64.49 -9.36 34.64 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 66.76 -14.70 39.39 67.99 -15.56 37.81 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 71.61 -6.68 45.38 69.65 -6.30 44.66 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 3 3 # 3 A 49 ASP B 165 ASP^? 26.59 MG MG B 701 A 147 THR B 153 THR^? 25.01 MG MG B 701 A 294 ASP A 177 ASP~? 19.64 MG MG B 701 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 71.61 -6.68 45.38 69.65 -6.30 44.66 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 68.50 -12.99 42.25 67.26 -12.32 43.93 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 57.48 -8.32 42.16 55.62 -9.31 42.19 1qgx_c02 source 1qgx 3',5'-ADENOSINE BISPHOSPHATASE : 3 hits 1qgx_c02 naa= 3 ULMN 3 1qho_c04 ALPHA-AMYLASE user 1 3 # 1 A 228 ASP B 187 ASP~? 20.66 MG MG B 701 A 256 GLU B 186 GLU~? 15.37 MG MG B 701 A 329 ASP A 144 ASP~? 20.24 MG MG B 701 coo 28.46 69.88 26.74 30.40 70.70 26.53 74.06 -4.33 24.81 74.57 -2.40 25.55 coo 30.54 71.65 32.58 31.73 72.26 30.92 69.45 -0.46 21.54 67.97 0.05 22.96 coo 37.87 70.12 31.80 36.61 69.74 30.15 69.22 6.09 27.43 70.24 4.65 26.30 1qho_c04 source 1qho ALPHA-AMYLASE : 1 hits 1qho_c04 naa= 3 ULMN 3 1qho_c05 ALPHA-AMYLASE user 1 3 # 1 A 228 ASP A 144 ASP~? 20.24 MG MG B 701 A 261 ASP B 161 ASP^? 15.44 MG MG B 701 A 329 ASP B 187 ASP~? 20.66 MG MG B 701 coo 28.46 69.88 26.74 30.40 70.70 26.53 69.22 6.09 27.43 70.24 4.65 26.30 coo 34.02 79.89 42.60 34.73 78.01 41.86 63.88 -11.38 34.74 64.49 -9.36 34.64 coo 37.87 70.12 31.80 36.61 69.74 30.15 74.06 -4.33 24.81 74.57 -2.40 25.55 ULMN 3 1qho_c05 ALPHA-AMYLASE user 2 3 # 2 A 228 ASP A 144 ASP~? 20.24 MG MG B 701 A 261 ASP B 194 ASP~? 20.07 MG MG B 701 A 329 ASP B 187 ASP~? 20.66 MG MG B 701 coo 28.46 69.88 26.74 30.40 70.70 26.53 69.22 6.09 27.43 70.24 4.65 26.30 coo 34.02 79.89 42.60 34.73 78.01 41.86 67.87 -2.29 9.08 66.66 -1.03 7.91 coo 37.87 70.12 31.80 36.61 69.74 30.15 74.06 -4.33 24.81 74.57 -2.40 25.55 ULMN 3 1qho_c05 ALPHA-AMYLASE user 3 3 # 3 A 228 ASP A 165 ASP^? 19.82 MG MG B 701 A 261 ASP A 187 ASP~? 34.25 MG MG B 701 A 329 ASP A 177 ASP~? 19.64 MG MG B 701 coo 28.46 69.88 26.74 30.40 70.70 26.53 49.47 0.04 38.38 48.02 -0.73 39.68 coo 34.02 79.89 42.60 34.73 78.01 41.86 61.00 -0.38 56.45 61.66 -2.23 55.67 coo 37.87 70.12 31.80 36.61 69.74 30.15 57.48 -8.32 42.16 55.62 -9.31 42.19 ULMN 3 1qho_c05 ALPHA-AMYLASE user 4 3 # 4 A 228 ASP A 177 ASP~? 19.64 MG MG B 701 A 261 ASP A 161 ASP^? 31.32 MG MG B 701 A 329 ASP A 165 ASP^? 19.82 MG MG B 701 coo 28.46 69.88 26.74 30.40 70.70 26.53 57.48 -8.32 42.16 55.62 -9.31 42.19 coo 34.02 79.89 42.60 34.73 78.01 41.86 45.91 2.65 51.66 46.91 0.77 51.57 coo 37.87 70.12 31.80 36.61 69.74 30.15 49.47 0.04 38.38 48.02 -0.73 39.68 ULMN 3 1qho_c05 ALPHA-AMYLASE user 5 3 # 5 A 228 ASP A 177 ASP~? 19.64 MG MG B 701 A 261 ASP A 221 ASP~? 23.86 MG MG B 701 A 329 ASP A 165 ASP^? 19.82 MG MG B 701 coo 28.46 69.88 26.74 30.40 70.70 26.53 57.48 -8.32 42.16 55.62 -9.31 42.19 coo 34.02 79.89 42.60 34.73 78.01 41.86 63.27 9.05 38.25 62.91 9.80 36.26 coo 37.87 70.12 31.80 36.61 69.74 30.15 49.47 0.04 38.38 48.02 -0.73 39.68 ULMN 3 1qho_c05 ALPHA-AMYLASE user 6 3 # 6 A 228 ASP B 165 ASP^? 26.59 MG MG B 701 A 261 ASP A 221 ASP~? 23.86 MG MG B 701 A 329 ASP B 177 ASP~? 29.47 MG MG B 701 coo 28.46 69.88 26.74 30.40 70.70 26.53 71.61 -6.68 45.38 69.65 -6.30 44.66 coo 34.02 79.89 42.60 34.73 78.01 41.86 63.27 9.05 38.25 62.91 9.80 36.26 coo 37.87 70.12 31.80 36.61 69.74 30.15 75.29 2.41 39.09 75.08 4.12 40.31 ULMN 3 1qho_c05 ALPHA-AMYLASE user 7 3 # 7 A 228 ASP B 165 ASP^? 26.59 MG MG B 701 A 261 ASP B 187 ASP~? 20.66 MG MG B 701 A 329 ASP B 177 ASP~? 29.47 MG MG B 701 coo 28.46 69.88 26.74 30.40 70.70 26.53 71.61 -6.68 45.38 69.65 -6.30 44.66 coo 34.02 79.89 42.60 34.73 78.01 41.86 74.06 -4.33 24.81 74.57 -2.40 25.55 coo 37.87 70.12 31.80 36.61 69.74 30.15 75.29 2.41 39.09 75.08 4.12 40.31 ULMN 3 1qho_c05 ALPHA-AMYLASE user 8 3 # 8 A 228 ASP B 177 ASP~? 29.47 MG MG B 701 A 261 ASP A 177 ASP~? 19.64 MG MG B 701 A 329 ASP B 165 ASP^? 26.59 MG MG B 701 coo 28.46 69.88 26.74 30.40 70.70 26.53 75.29 2.41 39.09 75.08 4.12 40.31 coo 34.02 79.89 42.60 34.73 78.01 41.86 57.48 -8.32 42.16 55.62 -9.31 42.19 coo 37.87 70.12 31.80 36.61 69.74 30.15 71.61 -6.68 45.38 69.65 -6.30 44.66 ULMN 3 1qho_c05 ALPHA-AMYLASE user 9 3 # 9 A 228 ASP B 177 ASP~? 29.47 MG MG B 701 A 261 ASP B 161 ASP^? 15.44 MG MG B 701 A 329 ASP B 165 ASP^? 26.59 MG MG B 701 coo 28.46 69.88 26.74 30.40 70.70 26.53 75.29 2.41 39.09 75.08 4.12 40.31 coo 34.02 79.89 42.60 34.73 78.01 41.86 63.88 -11.38 34.74 64.49 -9.36 34.64 coo 37.87 70.12 31.80 36.61 69.74 30.15 71.61 -6.68 45.38 69.65 -6.30 44.66 1qho_c05 source 1qho ALPHA-AMYLASE : 9 hits 1qho_c05 naa= 3 ULMN 3 1qho_c07 ALPHA-AMYLASE user 1 3 # 1 A 228 ASP A 177 ASP~? 19.64 MG MG B 701 A 260 ASP B 165 ASP^? 26.59 MG MG B 701 A 329 ASP B 161 ASP^? 15.44 MG MG B 701 coo 28.46 69.88 26.74 30.40 70.70 26.53 57.48 -8.32 42.16 55.62 -9.31 42.19 coo 30.73 81.29 37.61 31.23 82.07 35.69 71.61 -6.68 45.38 69.65 -6.30 44.66 coo 37.87 70.12 31.80 36.61 69.74 30.15 63.88 -11.38 34.74 64.49 -9.36 34.64 ULMN 3 1qho_c07 ALPHA-AMYLASE user 2 3 # 2 A 228 ASP B 161 ASP^? 15.44 MG MG B 701 A 260 ASP B 165 ASP^? 26.59 MG MG B 701 A 329 ASP A 177 ASP~? 19.64 MG MG B 701 coo 28.46 69.88 26.74 30.40 70.70 26.53 63.88 -11.38 34.74 64.49 -9.36 34.64 coo 30.73 81.29 37.61 31.23 82.07 35.69 71.61 -6.68 45.38 69.65 -6.30 44.66 coo 37.87 70.12 31.80 36.61 69.74 30.15 57.48 -8.32 42.16 55.62 -9.31 42.19 ULMN 3 1qho_c07 ALPHA-AMYLASE user 3 3 # 3 A 228 ASP B 187 ASP~? 20.66 MG MG B 701 A 260 ASP B 177 ASP~? 29.47 MG MG B 701 A 329 ASP A 144 ASP~? 20.24 MG MG B 701 coo 28.46 69.88 26.74 30.40 70.70 26.53 74.06 -4.33 24.81 74.57 -2.40 25.55 coo 30.73 81.29 37.61 31.23 82.07 35.69 75.29 2.41 39.09 75.08 4.12 40.31 coo 37.87 70.12 31.80 36.61 69.74 30.15 69.22 6.09 27.43 70.24 4.65 26.30 1qho_c07 source 1qho ALPHA-AMYLASE : 3 hits 1qho_c07 naa= 3 ULMN 3 1qrr_c01 SULFOLIPID BIOSYNTHESIS (SQD1) PROTEuser 1 3 # 1 A 145 THR A 169 THR~? 12.09 MG MG B 701 A 182 TYR A 167 TYR^? 14.87 MG MG B 701 A 186 LYS A 172 LYS~? 6.12 MG MG B 701 coo 69.38 87.38 24.64 71.11 88.47 25.40 53.69 2.67 26.96 55.61 3.43 26.29 coo 73.61 90.42 31.12 71.36 89.66 29.64 50.02 0.16 32.66 47.75 0.13 34.22 coo 73.54 84.00 28.64 69.01 86.68 29.71 50.20 -3.67 28.72 53.15 -8.47 28.45 ULMN 3 1qrr_c01 SULFOLIPID BIOSYNTHESIS (SQD1) PROTEuser 2 3 # 2 A 145 THR B 169 THR~? 41.74 MG MG B 701 A 182 TYR B 167 TYR^? 33.00 MG MG B 701 A 186 LYS B 172 LYS~? 42.28 MG MG B 701 coo 69.38 87.38 24.64 71.11 88.47 25.40 80.90 -7.97 53.82 83.02 -8.15 53.47 coo 73.61 90.42 31.12 71.36 89.66 29.64 74.51 -6.62 50.39 71.88 -7.09 49.71 coo 73.54 84.00 28.64 69.01 86.68 29.71 75.30 -2.84 54.33 79.74 -2.40 56.36 1qrr_c01 source 1qrr SULFOLIPID BIOSYNTHESIS (SQD1) PROTEIN : 2 hits 1qrr_c01 naa= 3 ULMN 3 1qtn_c02 ACETYL-ILE-GLU-THR-ASP-ALDEHYDE user 1 3 # 1 A 317 HIS A 98 HIS~? 27.68 MG MG B 701 A 318 GLY A 97 GLY~? 31.08 MG MG B 701 A 360 CYH A 93 CYH~? 25.81 MG MG B 701 coo -8.43 39.80 36.26 -8.18 39.59 38.31 50.40 19.60 21.83 50.19 18.76 19.91 coo -11.14 38.10 31.61 -11.46 38.10 32.37 45.97 21.69 23.70 46.00 21.22 24.47 coo -11.95 34.09 34.07 -11.89 34.73 36.80 42.80 17.19 26.05 43.95 14.89 27.02 1qtn_c02 source 1qtn ACETYL-ILE-GLU-THR-ASP-ALDEHYDE : 1 hits 1qtn_c02 naa= 3 ULMN 3 1qx3_c00 APOPAIN user 1 3 # 1 A 121 HIS A 98 HIS~? 27.68 MG MG B 701 A 122 GLY A 97 GLY~? 31.08 MG MG B 701 A 163 CYH A 93 CYH~? 25.81 MG MG B 701 coo 2.23 29.11 15.20 1.24 27.27 15.13 50.40 19.60 21.83 50.19 18.76 19.91 coo 2.54 34.86 14.60 1.83 34.53 14.82 45.97 21.69 23.70 46.00 21.22 24.47 coo -1.20 35.13 11.95 -2.11 32.67 12.98 42.80 17.19 26.05 43.95 14.89 27.02 ULMN 3 1qx3_c00 APOPAIN user 2 3 # 2 A 121 HIS A 104 HIS^? 33.98 MG MG B 701 A 122 GLY A 97 GLY~? 31.08 MG MG B 701 A 163 CYH A 93 CYH~? 25.81 MG MG B 701 coo 2.23 29.11 15.20 1.24 27.27 15.13 45.13 22.80 31.21 43.22 23.40 30.59 coo 2.54 34.86 14.60 1.83 34.53 14.82 45.97 21.69 23.70 46.00 21.22 24.47 coo -1.20 35.13 11.95 -2.11 32.67 12.98 42.80 17.19 26.05 43.95 14.89 27.02 1qx3_c00 source 1qx3 APOPAIN : 2 hits 1qx3_c00 naa= 3 ULMN 3 1rtu_c00 RIBONUCLEASE U2 user 1 3 # 1 41 HIS A 98 HIS~? 27.68 MG MG B 701 62 GLU A 70 GLU~? 25.37 MG MG B 701 101 HIS A 104 HIS^? 33.98 MG MG B 701 coo 13.91 26.31 13.70 14.98 27.08 12.06 50.40 19.60 21.83 50.19 18.76 19.91 coo 9.15 26.32 13.85 8.75 28.20 13.02 49.68 14.74 24.80 49.71 16.74 24.08 coo 7.90 34.31 7.89 9.24 33.73 9.42 45.13 22.80 31.21 43.22 23.40 30.59 ULMN 3 1rtu_c00 RIBONUCLEASE U2 user 2 3 # 2 41 HIS B 98 HIS~? 50.51 MG MG B 701 62 GLU B 70 GLU~? 46.48 MG MG B 701 101 HIS B 104 HIS^? 43.18 MG MG B 701 coo 13.91 26.31 13.70 14.98 27.08 12.06 84.18 -25.10 59.33 84.20 -24.17 61.22 coo 9.15 26.32 13.85 8.75 28.20 13.02 80.85 -20.85 57.05 81.87 -22.62 57.55 coo 7.90 34.31 7.89 9.24 33.73 9.42 76.52 -29.94 52.39 75.18 -30.89 53.68 1rtu_c00 source 1rtu RIBONUCLEASE U2 : 2 hits 1rtu_c00 naa= 3 ULMN 3 1t4c_c02 FORMYL-COENZYME A TRANSFERASE user 1 3 # 1 A 261 GLY B 133 GLY^? 23.40 MG MG B 701 B 17 GLN B 213 GLN~? 19.92 MG MG B 701 B 140 GLU B 134 GLU^? 26.11 MG MG B 701 coo 61.49 19.86 5.96 61.52 19.46 5.16 63.80 -18.70 41.45 63.81 -19.34 41.96 coo 63.76 11.90 7.93 65.18 13.07 6.77 69.29 -16.23 33.49 68.51 -18.13 33.12 coo 66.44 19.00 7.38 67.69 17.67 8.37 69.63 -18.91 41.63 70.61 -19.62 39.97 1t4c_c02 source 1t4c FORMYL-COENZYME A TRANSFERASE : 1 hits 1t4c_c02 naa= 3 ULMN 3 1thg_c00 LIPASE (E.C.3.1.1.3) TRIACYLGLYCEROLuser 1 3 # 1 217 SER A 100 SER~? 32.62 MG MG B 701 354 GLU A 70 GLU~? 25.37 MG MG B 701 463 HIS A 98 HIS~? 27.68 MG MG B 701 coo 48.87 13.74 2.81 48.49 11.54 3.93 53.58 21.63 28.64 52.67 23.81 29.19 coo 39.95 14.43 3.01 41.55 14.10 1.63 49.68 14.74 24.80 49.71 16.74 24.08 coo 43.90 10.50 2.81 45.63 11.48 3.27 50.40 19.60 21.83 50.19 18.76 19.91 1thg_c00 source 1thg LIPASE (E.C.3.1.1.3) TRIACYLGLYCEROL HYDROLASE: 1 hits 1thg_c00 naa= 3 ULMN 3 1uf7_c00 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 1 3 # 1 A 46 GLU A 170 GLU~? 8.58 MG MG B 701 A 126 LYS A 172 LYS~? 6.12 MG MG B 701 A 171 ALA B 205 ALA~? 6.01 MG MG B 701 coo 52.87 81.38 -9.32 53.05 81.09 -7.22 52.41 0.03 22.89 54.38 0.44 23.67 coo 51.43 89.29 -7.19 53.08 83.69 -4.74 50.20 -3.67 28.72 53.15 -8.47 28.45 coo 48.80 81.73 -5.45 50.30 81.43 -5.45 57.40 -2.45 21.64 55.93 -2.24 21.43 ULMN 3 1uf7_c00 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 2 3 # 2 A 46 GLU A 235 GLU~? 51.63 MG MG B 701 A 126 LYS A 238 LYS~? 48.13 MG MG B 701 A 171 ALA A 234 ALA~? 50.82 MG MG B 701 coo 52.87 81.38 -9.32 53.05 81.09 -7.22 43.25 10.32 70.63 44.91 11.03 69.52 coo 51.43 89.29 -7.19 53.08 83.69 -4.74 49.71 6.68 70.26 45.99 10.01 66.31 coo 48.80 81.73 -5.45 50.30 81.43 -5.45 43.44 5.14 69.42 42.86 4.18 70.43 ULMN 3 1uf7_c00 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 3 3 # 3 A 46 GLU A 236 GLU~? 53.96 MG MG B 701 A 126 LYS A 238 LYS~? 48.13 MG MG B 701 A 171 ALA A 234 ALA~? 50.82 MG MG B 701 coo 52.87 81.38 -9.32 53.05 81.09 -7.22 44.03 4.05 74.67 42.22 4.37 73.55 coo 51.43 89.29 -7.19 53.08 83.69 -4.74 49.71 6.68 70.26 45.99 10.01 66.31 coo 48.80 81.73 -5.45 50.30 81.43 -5.45 43.44 5.14 69.42 42.86 4.18 70.43 ULMN 3 1uf7_c00 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 4 3 # 4 A 46 GLU B 235 GLU~? 13.13 MG MG B 701 A 126 LYS B 238 LYS~? 10.43 MG MG B 701 A 171 ALA B 234 ALA~? 7.25 MG MG B 701 coo 52.87 81.38 -9.32 53.05 81.09 -7.22 55.24 -20.07 18.27 57.27 -20.40 18.80 coo 51.43 89.29 -7.19 53.08 83.69 -4.74 60.37 -14.95 16.47 59.84 -17.17 21.39 coo 48.80 81.73 -5.45 50.30 81.43 -5.45 54.81 -14.99 19.68 53.67 -14.24 19.03 ULMN 3 1uf7_c00 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 5 3 # 5 A 46 GLU B 236 GLU~? 10.26 MG MG B 701 A 126 LYS B 238 LYS~? 10.43 MG MG B 701 A 171 ALA B 234 ALA~? 7.25 MG MG B 701 coo 52.87 81.38 -9.32 53.05 81.09 -7.22 52.91 -14.17 15.05 51.71 -15.48 16.30 coo 51.43 89.29 -7.19 53.08 83.69 -4.74 60.37 -14.95 16.47 59.84 -17.17 21.39 coo 48.80 81.73 -5.45 50.30 81.43 -5.45 54.81 -14.99 19.68 53.67 -14.24 19.03 1uf7_c00 source 1uf7 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLASE : 5 hits 1uf7_c00 naa= 3 ULMN 3 1uf7_c01 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 1 3 # 1 B 46 GLU A 170 GLU~? 8.58 MG MG B 701 B 126 LYS A 172 LYS~? 6.12 MG MG B 701 B 171 ALA B 205 ALA~? 6.01 MG MG B 701 coo 20.47 87.42 16.54 20.16 87.17 14.45 52.41 0.03 22.89 54.38 0.44 23.67 coo 24.73 94.37 14.59 21.08 89.84 11.98 50.20 -3.67 28.72 53.15 -8.47 28.45 coo 24.38 86.32 12.71 22.88 86.54 12.71 57.40 -2.45 21.64 55.93 -2.24 21.43 ULMN 3 1uf7_c01 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 2 3 # 2 B 46 GLU A 235 GLU~? 51.63 MG MG B 701 B 126 LYS A 238 LYS~? 48.13 MG MG B 701 B 171 ALA A 234 ALA~? 50.82 MG MG B 701 coo 20.47 87.42 16.54 20.16 87.17 14.45 43.25 10.32 70.63 44.91 11.03 69.52 coo 24.73 94.37 14.59 21.08 89.84 11.98 49.71 6.68 70.26 45.99 10.01 66.31 coo 24.38 86.32 12.71 22.88 86.54 12.71 43.44 5.14 69.42 42.86 4.18 70.43 ULMN 3 1uf7_c01 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 3 3 # 3 B 46 GLU A 236 GLU~? 53.96 MG MG B 701 B 126 LYS A 238 LYS~? 48.13 MG MG B 701 B 171 ALA A 234 ALA~? 50.82 MG MG B 701 coo 20.47 87.42 16.54 20.16 87.17 14.45 44.03 4.05 74.67 42.22 4.37 73.55 coo 24.73 94.37 14.59 21.08 89.84 11.98 49.71 6.68 70.26 45.99 10.01 66.31 coo 24.38 86.32 12.71 22.88 86.54 12.71 43.44 5.14 69.42 42.86 4.18 70.43 ULMN 3 1uf7_c01 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 4 3 # 4 B 46 GLU B 235 GLU~? 13.13 MG MG B 701 B 126 LYS B 238 LYS~? 10.43 MG MG B 701 B 171 ALA B 234 ALA~? 7.25 MG MG B 701 coo 20.47 87.42 16.54 20.16 87.17 14.45 55.24 -20.07 18.27 57.27 -20.40 18.80 coo 24.73 94.37 14.59 21.08 89.84 11.98 60.37 -14.95 16.47 59.84 -17.17 21.39 coo 24.38 86.32 12.71 22.88 86.54 12.71 54.81 -14.99 19.68 53.67 -14.24 19.03 ULMN 3 1uf7_c01 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 5 3 # 5 B 46 GLU B 236 GLU~? 10.26 MG MG B 701 B 126 LYS B 238 LYS~? 10.43 MG MG B 701 B 171 ALA B 234 ALA~? 7.25 MG MG B 701 coo 20.47 87.42 16.54 20.16 87.17 14.45 52.91 -14.17 15.05 51.71 -15.48 16.30 coo 24.73 94.37 14.59 21.08 89.84 11.98 60.37 -14.95 16.47 59.84 -17.17 21.39 coo 24.38 86.32 12.71 22.88 86.54 12.71 54.81 -14.99 19.68 53.67 -14.24 19.03 1uf7_c01 source 1uf7 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLASE : 5 hits 1uf7_c01 naa= 3 ULMN 3 1un1_c00 XYLOGLUCAN ENDOTRANSGLYCOSYLASE user 1 3 # 1 A 85 GLU B 88 GLU~? 39.12 MG MG B 701 A 87 ASP B 91 ASP~? 46.73 MG MG B 701 A 89 GLU B 87 GLU~? 47.03 MG MG B 701 coo 22.84 137.30 -8.23 24.70 136.75 -9.08 64.81 -21.91 58.58 62.70 -21.80 58.39 coo 25.07 140.95 -5.73 24.98 139.34 -7.10 69.68 -24.93 62.08 69.33 -24.21 64.01 coo 29.50 140.95 -4.45 30.03 140.88 -6.51 66.89 -21.09 64.87 65.61 -20.97 66.54 1un1_c00 source 1un1 XYLOGLUCAN ENDOTRANSGLYCOSYLASE : 1 hits 1un1_c00 naa= 3 ULMN 3 1un1_c01 XYLOGLUCAN ENDOTRANSGLYCOSYLASE user 1 3 # 1 B 85 GLU B 88 GLU~? 39.12 MG MG B 701 B 87 ASP B 91 ASP~? 46.73 MG MG B 701 B 89 GLU B 87 GLU~? 47.03 MG MG B 701 coo 19.32 178.30 3.72 20.56 176.87 2.77 64.81 -21.91 58.58 62.70 -21.80 58.39 coo 22.91 179.81 6.56 22.10 178.65 5.00 69.68 -24.93 62.08 69.33 -24.21 64.01 coo 26.74 177.55 7.48 27.16 177.47 5.41 66.89 -21.09 64.87 65.61 -20.97 66.54 1un1_c01 source 1un1 XYLOGLUCAN ENDOTRANSGLYCOSYLASE : 1 hits 1un1_c01 naa= 3 ULMN 3 1uok_c03 OLIGO-1,6-GLUCOSIDASE user 1 3 # 1 199 ASP B 187 ASP~? 20.66 MG MG B 701 255 GLU B 186 GLU~? 15.37 MG MG B 701 329 ASP A 144 ASP~? 20.24 MG MG B 701 coo 49.16 35.16 15.19 51.08 34.43 15.65 74.06 -4.33 24.81 74.57 -2.40 25.55 coo 52.57 37.12 10.17 53.37 35.95 11.75 69.45 -0.46 21.54 67.97 0.05 22.96 coo 59.16 37.82 13.95 57.63 37.03 15.12 69.22 6.09 27.43 70.24 4.65 26.30 1uok_c03 source 1uok OLIGO-1,6-GLUCOSIDASE : 1 hits 1uok_c03 naa= 3 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 1 3 # 1 199 ASP A 177 ASP~? 19.64 MG MG B 701 218 GLU B 68 GLU~? 43.73 MG MG B 701 329 ASP B 161 ASP^? 15.44 MG MG B 701 coo 49.16 35.16 15.19 51.08 34.43 15.65 57.48 -8.32 42.16 55.62 -9.31 42.19 coo 70.09 11.71 8.46 70.56 12.89 6.77 85.21 -13.08 54.11 86.12 -11.45 53.05 coo 59.16 37.82 13.95 57.63 37.03 15.12 63.88 -11.38 34.74 64.49 -9.36 34.64 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 2 3 # 2 199 ASP A 177 ASP~? 19.64 MG MG B 701 218 GLU B 70 GLU~? 46.48 MG MG B 701 329 ASP B 161 ASP^? 15.44 MG MG B 701 coo 49.16 35.16 15.19 51.08 34.43 15.65 57.48 -8.32 42.16 55.62 -9.31 42.19 coo 70.09 11.71 8.46 70.56 12.89 6.77 80.85 -20.85 57.05 81.87 -22.62 57.55 coo 59.16 37.82 13.95 57.63 37.03 15.12 63.88 -11.38 34.74 64.49 -9.36 34.64 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 3 3 # 3 199 ASP B 161 ASP^? 15.44 MG MG B 701 218 GLU A 70 GLU~? 25.37 MG MG B 701 329 ASP A 177 ASP~? 19.64 MG MG B 701 coo 49.16 35.16 15.19 51.08 34.43 15.65 63.88 -11.38 34.74 64.49 -9.36 34.64 coo 70.09 11.71 8.46 70.56 12.89 6.77 49.68 14.74 24.80 49.71 16.74 24.08 coo 59.16 37.82 13.95 57.63 37.03 15.12 57.48 -8.32 42.16 55.62 -9.31 42.19 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 4 3 # 4 199 ASP B 161 ASP^? 15.44 MG MG B 701 218 GLU A 78 GLU~? 24.76 MG MG B 701 329 ASP A 177 ASP~? 19.64 MG MG B 701 coo 49.16 35.16 15.19 51.08 34.43 15.65 63.88 -11.38 34.74 64.49 -9.36 34.64 coo 70.09 11.71 8.46 70.56 12.89 6.77 36.42 4.32 29.08 34.55 4.86 28.21 coo 59.16 37.82 13.95 57.63 37.03 15.12 57.48 -8.32 42.16 55.62 -9.31 42.19 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 5 3 # 5 199 ASP B 161 ASP^? 15.44 MG MG B 701 218 GLU A 219 GLU~? 34.01 MG MG B 701 329 ASP A 177 ASP~? 19.64 MG MG B 701 coo 49.16 35.16 15.19 51.08 34.43 15.65 63.88 -11.38 34.74 64.49 -9.36 34.64 coo 70.09 11.71 8.46 70.56 12.89 6.77 59.27 18.40 40.08 59.60 20.33 40.74 coo 59.16 37.82 13.95 57.63 37.03 15.12 57.48 -8.32 42.16 55.62 -9.31 42.19 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 6 3 # 6 199 ASP B 161 ASP^? 15.44 MG MG B 701 218 GLU B 87 GLU~? 47.03 MG MG B 701 329 ASP A 177 ASP~? 19.64 MG MG B 701 coo 49.16 35.16 15.19 51.08 34.43 15.65 63.88 -11.38 34.74 64.49 -9.36 34.64 coo 70.09 11.71 8.46 70.56 12.89 6.77 66.89 -21.09 64.87 65.61 -20.97 66.54 coo 59.16 37.82 13.95 57.63 37.03 15.12 57.48 -8.32 42.16 55.62 -9.31 42.19 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 7 3 # 7 199 ASP B 165 ASP^? 26.59 MG MG B 701 218 GLU A 170 GLU~? 8.58 MG MG B 701 329 ASP B 177 ASP~? 29.47 MG MG B 701 coo 49.16 35.16 15.19 51.08 34.43 15.65 71.61 -6.68 45.38 69.65 -6.30 44.66 coo 70.09 11.71 8.46 70.56 12.89 6.77 52.41 0.03 22.89 54.38 0.44 23.67 coo 59.16 37.82 13.95 57.63 37.03 15.12 75.29 2.41 39.09 75.08 4.12 40.31 1uok_c04 source 1uok OLIGO-1,6-GLUCOSIDASE : 7 hits 1uok_c04 naa= 3 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 1 3 # 1 199 ASP A 144 ASP~? 20.24 MG MG B 701 242 GLU A 70 GLU~? 25.37 MG MG B 701 329 ASP B 187 ASP~? 20.66 MG MG B 701 coo 49.16 35.16 15.19 51.08 34.43 15.65 69.22 6.09 27.43 70.24 4.65 26.30 coo 30.42 34.74 5.00 29.09 35.09 3.38 49.68 14.74 24.80 49.71 16.74 24.08 coo 59.16 37.82 13.95 57.63 37.03 15.12 74.06 -4.33 24.81 74.57 -2.40 25.55 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 2 3 # 2 199 ASP A 144 ASP~? 20.24 MG MG B 701 242 GLU A 219 GLU~? 34.01 MG MG B 701 329 ASP B 187 ASP~? 20.66 MG MG B 701 coo 49.16 35.16 15.19 51.08 34.43 15.65 69.22 6.09 27.43 70.24 4.65 26.30 coo 30.42 34.74 5.00 29.09 35.09 3.38 59.27 18.40 40.08 59.60 20.33 40.74 coo 59.16 37.82 13.95 57.63 37.03 15.12 74.06 -4.33 24.81 74.57 -2.40 25.55 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 3 3 # 3 199 ASP A 165 ASP^? 19.82 MG MG B 701 242 GLU A 70 GLU~? 25.37 MG MG B 701 329 ASP A 177 ASP~? 19.64 MG MG B 701 coo 49.16 35.16 15.19 51.08 34.43 15.65 49.47 0.04 38.38 48.02 -0.73 39.68 coo 30.42 34.74 5.00 29.09 35.09 3.38 49.68 14.74 24.80 49.71 16.74 24.08 coo 59.16 37.82 13.95 57.63 37.03 15.12 57.48 -8.32 42.16 55.62 -9.31 42.19 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 4 3 # 4 199 ASP A 177 ASP~? 19.64 MG MG B 701 242 GLU A 134 GLU^? 30.91 MG MG B 701 329 ASP B 161 ASP^? 15.44 MG MG B 701 coo 49.16 35.16 15.19 51.08 34.43 15.65 57.48 -8.32 42.16 55.62 -9.31 42.19 coo 30.42 34.74 5.00 29.09 35.09 3.38 46.08 11.35 43.50 47.51 12.29 44.66 coo 59.16 37.82 13.95 57.63 37.03 15.12 63.88 -11.38 34.74 64.49 -9.36 34.64 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 5 3 # 5 199 ASP B 165 ASP^? 26.59 MG MG B 701 242 GLU B 70 GLU~? 46.48 MG MG B 701 329 ASP B 177 ASP~? 29.47 MG MG B 701 coo 49.16 35.16 15.19 51.08 34.43 15.65 71.61 -6.68 45.38 69.65 -6.30 44.66 coo 30.42 34.74 5.00 29.09 35.09 3.38 80.85 -20.85 57.05 81.87 -22.62 57.55 coo 59.16 37.82 13.95 57.63 37.03 15.12 75.29 2.41 39.09 75.08 4.12 40.31 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 6 3 # 6 199 ASP B 177 ASP~? 29.47 MG MG B 701 242 GLU A 219 GLU~? 34.01 MG MG B 701 329 ASP B 165 ASP^? 26.59 MG MG B 701 coo 49.16 35.16 15.19 51.08 34.43 15.65 75.29 2.41 39.09 75.08 4.12 40.31 coo 30.42 34.74 5.00 29.09 35.09 3.38 59.27 18.40 40.08 59.60 20.33 40.74 coo 59.16 37.82 13.95 57.63 37.03 15.12 71.61 -6.68 45.38 69.65 -6.30 44.66 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 7 3 # 7 199 ASP B 187 ASP~? 20.66 MG MG B 701 242 GLU B 134 GLU^? 26.11 MG MG B 701 329 ASP A 144 ASP~? 20.24 MG MG B 701 coo 49.16 35.16 15.19 51.08 34.43 15.65 74.06 -4.33 24.81 74.57 -2.40 25.55 coo 30.42 34.74 5.00 29.09 35.09 3.38 69.63 -18.91 41.63 70.61 -19.62 39.97 coo 59.16 37.82 13.95 57.63 37.03 15.12 69.22 6.09 27.43 70.24 4.65 26.30 1uok_c05 source 1uok OLIGO-1,6-GLUCOSIDASE : 7 hits 1uok_c05 naa= 3 ULMN 3 1vom_c00 MYOSIN user 1 3 # 1 233 ASN A 121 ASN^? 29.95 MG MG B 701 457 GLY A 67 GLY~? 22.64 MG MG B 701 459 GLU A 70 GLU~? 25.37 MG MG B 701 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 52.20 18.76 34.12 54.15 19.63 34.02 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 55.37 14.48 24.73 54.63 14.21 24.44 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 49.68 14.74 24.80 49.71 16.74 24.08 ULMN 3 1vom_c00 MYOSIN user 2 3 # 2 233 ASN A 123 ASN~? 26.30 MG MG B 701 457 GLY A 67 GLY~? 22.64 MG MG B 701 459 GLU A 68 GLU~? 16.08 MG MG B 701 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 57.01 15.83 33.37 58.33 16.35 31.78 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 55.37 14.48 24.73 54.63 14.21 24.44 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 56.21 8.51 25.84 57.91 7.36 26.07 ULMN 3 1vom_c00 MYOSIN user 3 3 # 3 233 ASN B 121 ASN~? 40.01 MG MG B 701 457 GLY B 67 GLY~? 46.35 MG MG B 701 459 GLU B 70 GLU~? 46.48 MG MG B 701 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 80.51 -24.09 47.29 82.46 -24.55 46.48 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 86.06 -19.11 55.10 85.43 -19.01 55.62 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 80.85 -20.85 57.05 81.87 -22.62 57.55 ULMN 3 1vom_c00 MYOSIN user 4 3 # 4 233 ASN B 123 ASN~? 41.71 MG MG B 701 457 GLY B 67 GLY~? 46.35 MG MG B 701 459 GLU B 68 GLU~? 43.73 MG MG B 701 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 84.46 -20.26 46.14 86.41 -20.49 46.97 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 86.06 -19.11 55.10 85.43 -19.01 55.62 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 85.21 -13.08 54.11 86.12 -11.45 53.05 1vom_c00 source 1vom MYOSIN : 4 hits 1vom_c00 naa= 3 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 1 3 # 1 A 16 TYR A 252 TYR^? 28.98 MG MG B 701 A 40 ASP A 221 ASP~? 23.86 MG MG B 701 A 103 LEU A 223 LEU^? 27.10 MG MG B 701 coo 12.09 16.13 10.57 11.28 18.80 10.73 62.00 3.47 47.74 61.53 1.51 49.69 coo 7.55 25.51 14.34 9.65 25.73 14.24 63.27 9.05 38.25 62.91 9.80 36.26 coo 11.83 18.73 16.99 10.99 19.71 15.26 58.29 7.44 44.99 58.08 5.33 45.61 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 2 3 # 2 A 16 TYR B 252 TYR^? 25.41 MG MG B 701 A 40 ASP B 221 ASP~? 37.75 MG MG B 701 A 103 LEU B 223 LEU^? 26.75 MG MG B 701 coo 12.09 16.13 10.57 11.28 18.80 10.73 79.70 -7.64 31.83 77.94 -6.02 30.43 coo 7.55 25.51 14.34 9.65 25.73 14.24 87.06 -12.52 38.62 87.72 -12.86 40.65 coo 11.83 18.73 16.99 10.99 19.71 15.26 78.79 -12.35 35.47 77.70 -10.41 35.04 1vzz_c00 source 1vzz STEROID DELTA-ISOMERASE : 2 hits 1vzz_c00 naa= 3 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 1 3 # 1 B 16 TYR A 252 TYR^? 28.98 MG MG B 701 B 40 ASP A 221 ASP~? 23.86 MG MG B 701 B 103 LEU A 223 LEU^? 27.10 MG MG B 701 coo 14.25 20.09 37.35 13.48 17.40 37.38 62.00 3.47 47.74 61.53 1.51 49.69 coo 9.39 10.77 34.53 11.50 10.63 34.41 63.27 9.05 38.25 62.91 9.80 36.26 coo 12.89 17.60 31.13 12.34 16.51 32.90 58.29 7.44 44.99 58.08 5.33 45.61 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 2 3 # 2 B 16 TYR B 252 TYR^? 25.41 MG MG B 701 B 40 ASP B 221 ASP~? 37.75 MG MG B 701 B 103 LEU B 223 LEU^? 26.75 MG MG B 701 coo 14.25 20.09 37.35 13.48 17.40 37.38 79.70 -7.64 31.83 77.94 -6.02 30.43 coo 9.39 10.77 34.53 11.50 10.63 34.41 87.06 -12.52 38.62 87.72 -12.86 40.65 coo 12.89 17.60 31.13 12.34 16.51 32.90 78.79 -12.35 35.47 77.70 -10.41 35.04 1vzz_c01 source 1vzz STEROID DELTA-ISOMERASE : 2 hits 1vzz_c01 naa= 3 ULMN 3 1w1o_c00 CYTOKININ DEHYDROGENASE 1 user 1 3 # 1 A 105 HIS A 104 HIS^? 33.98 MG MG B 701 A 169 ASP A 91 ASP~? 30.86 MG MG B 701 A 288 GLU A 87 GLU~? 27.37 MG MG B 701 coo 67.72 35.99 30.87 69.77 36.13 31.33 45.13 22.80 31.21 43.22 23.40 30.59 coo 73.17 30.66 22.56 72.87 30.30 20.46 36.10 16.42 24.55 35.02 15.53 22.85 coo 74.06 28.51 15.92 73.77 29.56 17.73 33.74 9.75 22.88 32.80 8.03 23.69 ULMN 3 1w1o_c00 CYTOKININ DEHYDROGENASE 1 user 2 3 # 2 A 105 HIS B 104 HIS^? 43.18 MG MG B 701 A 169 ASP B 91 ASP~? 46.73 MG MG B 701 A 288 GLU B 87 GLU~? 47.03 MG MG B 701 coo 67.72 35.99 30.87 69.77 36.13 31.33 76.52 -29.94 52.39 75.18 -30.89 53.68 coo 73.17 30.66 22.56 72.87 30.30 20.46 69.68 -24.93 62.08 69.33 -24.21 64.01 coo 74.06 28.51 15.92 73.77 29.56 17.73 66.89 -21.09 64.87 65.61 -20.97 66.54 1w1o_c00 source 1w1o CYTOKININ DEHYDROGENASE 1 : 2 hits 1w1o_c00 naa= 3 ULMN 3 1xqd_c02 CYTOCHROME P450 55A1 user 1 3 # 1 A 243 THR B 85 THR~? 40.29 MG MG B 701 A 345 PHE B 73 PHE~? 38.23 MG MG B 701 A 352 CYH B 93 CYH~? 42.85 MG MG B 701 coo 9.58 21.79 21.50 11.25 23.03 20.90 64.58 -17.53 59.23 63.29 -18.66 60.55 coo 19.40 19.75 18.58 17.39 17.81 18.80 75.10 -18.32 54.35 72.78 -19.57 53.51 coo 21.57 22.52 22.79 19.20 21.13 23.26 74.48 -24.31 57.35 76.42 -22.43 56.76 ULMN 3 1xqd_c02 CYTOCHROME P450 55A1 user 2 3 # 2 A 243 THR B 85 THR~? 40.29 MG MG B 701 A 345 PHE B 118 PHE^? 36.09 MG MG B 701 A 352 CYH B 93 CYH~? 42.85 MG MG B 701 coo 9.58 21.79 21.50 11.25 23.03 20.90 64.58 -17.53 59.23 63.29 -18.66 60.55 coo 19.40 19.75 18.58 17.39 17.81 18.80 70.13 -23.91 51.57 68.23 -22.26 52.74 coo 21.57 22.52 22.79 19.20 21.13 23.26 74.48 -24.31 57.35 76.42 -22.43 56.76 ULMN 3 1xqd_c02 CYTOCHROME P450 55A1 user 3 3 # 3 A 243 THR B 103 THR~? 38.15 MG MG B 701 A 345 PHE B 118 PHE^? 36.09 MG MG B 701 A 352 CYH B 93 CYH~? 42.85 MG MG B 701 coo 9.58 21.79 21.50 11.25 23.03 20.90 79.49 -28.27 47.31 78.51 -27.23 45.65 coo 19.40 19.75 18.58 17.39 17.81 18.80 70.13 -23.91 51.57 68.23 -22.26 52.74 coo 21.57 22.52 22.79 19.20 21.13 23.26 74.48 -24.31 57.35 76.42 -22.43 56.76 ULMN 3 1xqd_c02 CYTOCHROME P450 55A1 user 4 3 # 4 A 243 THR B 208 THR~? 10.07 MG MG B 701 A 345 PHE A 166 PHE^? 17.85 MG MG B 701 A 352 CYH A 150 CYH^? 20.80 MG MG B 701 coo 9.58 21.79 21.50 11.25 23.03 20.90 60.49 -3.20 26.65 60.84 -1.10 26.85 coo 19.40 19.75 18.58 17.39 17.81 18.80 55.48 -0.21 37.25 56.90 1.01 39.28 coo 21.57 22.52 22.79 19.20 21.13 23.26 54.05 4.31 36.56 55.14 4.53 39.16 1xqd_c02 source 1xqd CYTOCHROME P450 55A1 : 4 hits 1xqd_c02 naa= 3 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 B 124 ALA A 96 ALA~? 30.94 MG MG B 701 B 126 ARG A 95 ARG~? 33.62 MG MG B 701 B 138 GLU A 70 GLU~? 25.37 MG MG B 701 coo 2.11 4.00 19.31 3.14 4.86 19.99 43.90 21.81 26.90 44.37 20.58 27.66 coo 2.45 5.53 11.28 3.59 7.56 13.29 36.90 22.02 26.51 36.19 19.35 27.93 coo 6.10 2.00 25.24 6.12 1.84 23.13 49.68 14.74 24.80 49.71 16.74 24.08 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 3 # 2 B 124 ALA B 75 ALA~? 43.51 MG MG B 701 B 126 ARG B 89 ARG~? 39.23 MG MG B 701 B 138 GLU B 170 GLU~? 43.78 MG MG B 701 coo 2.11 4.00 19.31 3.14 4.86 19.99 75.83 -13.23 59.70 77.14 -12.38 59.76 coo 2.45 5.53 11.28 3.59 7.56 13.29 70.16 -17.97 55.88 70.89 -15.54 57.64 coo 6.10 2.00 25.24 6.12 1.84 23.13 80.92 -5.65 58.14 82.41 -5.69 56.60 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 3 3 # 3 B 124 ALA B 96 ALA~? 44.52 MG MG B 701 B 126 ARG B 95 ARG~? 44.55 MG MG B 701 B 138 GLU B 70 GLU~? 46.48 MG MG B 701 coo 2.11 4.00 19.31 3.14 4.86 19.99 77.10 -29.00 56.84 77.04 -27.87 55.77 coo 2.45 5.53 11.28 3.59 7.56 13.29 71.08 -30.47 60.44 68.82 -28.47 59.67 coo 6.10 2.00 25.24 6.12 1.84 23.13 80.85 -20.85 57.05 81.87 -22.62 57.55 1xs1_c07 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 3 hits 1xs1_c07 naa= 3 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 C 124 ALA B 75 ALA~? 43.51 MG MG B 701 C 126 ARG B 89 ARG~? 39.23 MG MG B 701 C 138 GLU B 170 GLU~? 43.78 MG MG B 701 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 75.83 -13.23 59.70 77.14 -12.38 59.76 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 70.16 -17.97 55.88 70.89 -15.54 57.64 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 80.92 -5.65 58.14 82.41 -5.69 56.60 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 3 # 2 C 124 ALA B 96 ALA~? 44.52 MG MG B 701 C 126 ARG B 95 ARG~? 44.55 MG MG B 701 C 138 GLU B 70 GLU~? 46.48 MG MG B 701 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 77.10 -29.00 56.84 77.04 -27.87 55.77 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 71.08 -30.47 60.44 68.82 -28.47 59.67 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 80.85 -20.85 57.05 81.87 -22.62 57.55 1xs1_c08 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 2 hits 1xs1_c08 naa= 3 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 D 124 ALA A 96 ALA~? 30.94 MG MG B 701 D 126 ARG A 95 ARG~? 33.62 MG MG B 701 D 138 GLU A 70 GLU~? 25.37 MG MG B 701 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 43.90 21.81 26.90 44.37 20.58 27.66 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 36.90 22.02 26.51 36.19 19.35 27.93 coo 6.23 0.50 57.10 5.93 0.72 59.19 49.68 14.74 24.80 49.71 16.74 24.08 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 3 # 2 D 124 ALA B 75 ALA~? 43.51 MG MG B 701 D 126 ARG B 89 ARG~? 39.23 MG MG B 701 D 138 GLU B 170 GLU~? 43.78 MG MG B 701 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 75.83 -13.23 59.70 77.14 -12.38 59.76 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 70.16 -17.97 55.88 70.89 -15.54 57.64 coo 6.23 0.50 57.10 5.93 0.72 59.19 80.92 -5.65 58.14 82.41 -5.69 56.60 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 3 3 # 3 D 124 ALA B 96 ALA~? 44.52 MG MG B 701 D 126 ARG B 95 ARG~? 44.55 MG MG B 701 D 138 GLU B 70 GLU~? 46.48 MG MG B 701 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 77.10 -29.00 56.84 77.04 -27.87 55.77 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 71.08 -30.47 60.44 68.82 -28.47 59.67 coo 6.23 0.50 57.10 5.93 0.72 59.19 80.85 -20.85 57.05 81.87 -22.62 57.55 1xs1_c09 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 3 hits 1xs1_c09 naa= 3 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 E 124 ALA A 75 ALA~? 16.29 MG MG B 701 E 126 ARG A 89 ARG~? 21.03 MG MG B 701 E 138 GLU A 170 GLU~? 8.58 MG MG B 701 coo -4.56 10.03 62.36 -4.38 11.31 61.55 45.58 6.48 23.74 46.73 6.03 22.86 coo -3.02 12.00 70.07 -1.94 13.84 67.82 41.91 10.07 29.06 41.51 7.36 27.58 coo -8.67 12.22 56.54 -8.68 12.09 58.65 52.41 0.03 22.89 54.38 0.44 23.67 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 3 # 2 E 124 ALA A 96 ALA~? 30.94 MG MG B 701 E 126 ARG A 95 ARG~? 33.62 MG MG B 701 E 138 GLU A 70 GLU~? 25.37 MG MG B 701 coo -4.56 10.03 62.36 -4.38 11.31 61.55 43.90 21.81 26.90 44.37 20.58 27.66 coo -3.02 12.00 70.07 -1.94 13.84 67.82 36.90 22.02 26.51 36.19 19.35 27.93 coo -8.67 12.22 56.54 -8.68 12.09 58.65 49.68 14.74 24.80 49.71 16.74 24.08 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 3 3 # 3 E 124 ALA B 75 ALA~? 43.51 MG MG B 701 E 126 ARG B 89 ARG~? 39.23 MG MG B 701 E 138 GLU B 170 GLU~? 43.78 MG MG B 701 coo -4.56 10.03 62.36 -4.38 11.31 61.55 75.83 -13.23 59.70 77.14 -12.38 59.76 coo -3.02 12.00 70.07 -1.94 13.84 67.82 70.16 -17.97 55.88 70.89 -15.54 57.64 coo -8.67 12.22 56.54 -8.68 12.09 58.65 80.92 -5.65 58.14 82.41 -5.69 56.60 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 4 3 # 4 E 124 ALA B 96 ALA~? 44.52 MG MG B 701 E 126 ARG B 95 ARG~? 44.55 MG MG B 701 E 138 GLU B 70 GLU~? 46.48 MG MG B 701 coo -4.56 10.03 62.36 -4.38 11.31 61.55 77.10 -29.00 56.84 77.04 -27.87 55.77 coo -3.02 12.00 70.07 -1.94 13.84 67.82 71.08 -30.47 60.44 68.82 -28.47 59.67 coo -8.67 12.22 56.54 -8.68 12.09 58.65 80.85 -20.85 57.05 81.87 -22.62 57.55 1xs1_c10 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 4 hits 1xs1_c10 naa= 3 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 F 124 ALA B 75 ALA~? 43.51 MG MG B 701 F 126 ARG B 89 ARG~? 39.23 MG MG B 701 F 138 GLU B 170 GLU~? 43.78 MG MG B 701 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 75.83 -13.23 59.70 77.14 -12.38 59.76 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 70.16 -17.97 55.88 70.89 -15.54 57.64 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 80.92 -5.65 58.14 82.41 -5.69 56.60 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 3 # 2 F 124 ALA B 96 ALA~? 44.52 MG MG B 701 F 126 ARG B 95 ARG~? 44.55 MG MG B 701 F 138 GLU B 70 GLU~? 46.48 MG MG B 701 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 77.10 -29.00 56.84 77.04 -27.87 55.77 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 71.08 -30.47 60.44 68.82 -28.47 59.67 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 80.85 -20.85 57.05 81.87 -22.62 57.55 1xs1_c11 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 2 hits 1xs1_c11 naa= 3 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 1 3 # 1 B 137 GLY B 257 GLY~? 36.89 MG MG B 701 B 175 ARG B 253 ARG^? 38.87 MG MG B 701 B 242 TYR B 252 TYR^? 25.41 MG MG B 701 coo 99.45 58.28 3.33 99.57 58.61 4.10 86.35 -3.07 41.26 86.22 -3.12 40.48 coo 106.37 63.53 0.89 108.02 63.40 -1.62 89.00 -9.67 33.53 91.76 -9.21 34.95 coo 100.93 69.04 4.38 99.52 68.48 2.09 79.70 -7.64 31.83 77.94 -6.02 30.43 1xva_c03 source 1xva GLYCINE N-METHYLTRANSFERASE : 1 hits 1xva_c03 naa= 3 ULMN 3 2ace_c00 ACETYLCHOLINESTERASE user 1 3 # 1 200 SER A 100 SER~? 32.62 MG MG B 701 327 GLU A 70 GLU~? 25.37 MG MG B 701 440 HIS A 98 HIS~? 27.68 MG MG B 701 coo 6.96 64.04 57.84 6.74 63.69 60.26 53.58 21.63 28.64 52.67 23.81 29.19 coo 14.82 64.63 62.37 13.47 65.72 61.17 49.68 14.74 24.80 49.71 16.74 24.08 coo 9.52 66.51 63.07 8.75 65.02 61.81 50.40 19.60 21.83 50.19 18.76 19.91 ULMN 3 2ace_c00 ACETYLCHOLINESTERASE user 2 3 # 2 200 SER B 100 SER~? 45.77 MG MG B 701 327 GLU B 70 GLU~? 46.48 MG MG B 701 440 HIS B 98 HIS~? 50.51 MG MG B 701 coo 6.96 64.04 57.84 6.74 63.69 60.26 84.70 -26.50 51.42 84.08 -28.81 51.12 coo 14.82 64.63 62.37 13.47 65.72 61.17 80.85 -20.85 57.05 81.87 -22.62 57.55 coo 9.52 66.51 63.07 8.75 65.02 61.81 84.18 -25.10 59.33 84.20 -24.17 61.22 2ace_c00 source 2ace ACETYLCHOLINESTERASE : 2 hits 2ace_c00 naa= 3 ULMN 3 2amg_c02 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 1 3 # 1 193 ASP A 144 ASP~? 20.24 MG MG B 701 219 GLU B 186 GLU~? 15.37 MG MG B 701 294 ASP B 187 ASP~? 20.66 MG MG B 701 coo 27.89 102.52 14.98 29.35 101.92 13.57 69.22 6.09 27.43 70.24 4.65 26.30 coo 25.84 105.87 9.06 27.86 105.55 8.74 69.45 -0.46 21.54 67.97 0.05 22.96 coo 33.16 106.80 7.72 33.34 104.87 6.92 74.06 -4.33 24.81 74.57 -2.40 25.55 ULMN 3 2amg_c02 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 2 3 # 2 193 ASP B 187 ASP~? 20.66 MG MG B 701 219 GLU B 186 GLU~? 15.37 MG MG B 701 294 ASP A 144 ASP~? 20.24 MG MG B 701 coo 27.89 102.52 14.98 29.35 101.92 13.57 74.06 -4.33 24.81 74.57 -2.40 25.55 coo 25.84 105.87 9.06 27.86 105.55 8.74 69.45 -0.46 21.54 67.97 0.05 22.96 coo 33.16 106.80 7.72 33.34 104.87 6.92 69.22 6.09 27.43 70.24 4.65 26.30 2amg_c02 source 2amg 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLASE : 2 hits 2amg_c02 naa= 3 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 1 3 # 1 193 ASP A 144 ASP~? 20.24 MG MG B 701 231 ASP A 177 ASP~? 19.64 MG MG B 701 294 ASP B 187 ASP~? 20.66 MG MG B 701 coo 27.89 102.52 14.98 29.35 101.92 13.57 69.22 6.09 27.43 70.24 4.65 26.30 coo 14.74 93.05 -1.00 14.30 94.22 0.73 57.48 -8.32 42.16 55.62 -9.31 42.19 coo 33.16 106.80 7.72 33.34 104.87 6.92 74.06 -4.33 24.81 74.57 -2.40 25.55 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 2 3 # 2 193 ASP B 165 ASP^? 26.59 MG MG B 701 231 ASP A 165 ASP^? 19.82 MG MG B 701 294 ASP B 177 ASP~? 29.47 MG MG B 701 coo 27.89 102.52 14.98 29.35 101.92 13.57 71.61 -6.68 45.38 69.65 -6.30 44.66 coo 14.74 93.05 -1.00 14.30 94.22 0.73 49.47 0.04 38.38 48.02 -0.73 39.68 coo 33.16 106.80 7.72 33.34 104.87 6.92 75.29 2.41 39.09 75.08 4.12 40.31 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 3 3 # 3 193 ASP B 165 ASP^? 26.59 MG MG B 701 231 ASP B 144 ASP~? 48.42 MG MG B 701 294 ASP B 177 ASP~? 29.47 MG MG B 701 coo 27.89 102.52 14.98 29.35 101.92 13.57 71.61 -6.68 45.38 69.65 -6.30 44.66 coo 14.74 93.05 -1.00 14.30 94.22 0.73 94.61 -4.13 49.96 95.84 -4.32 48.22 coo 33.16 106.80 7.72 33.34 104.87 6.92 75.29 2.41 39.09 75.08 4.12 40.31 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 4 3 # 4 193 ASP B 177 ASP~? 29.47 MG MG B 701 231 ASP B 144 ASP~? 48.42 MG MG B 701 294 ASP B 165 ASP^? 26.59 MG MG B 701 coo 27.89 102.52 14.98 29.35 101.92 13.57 75.29 2.41 39.09 75.08 4.12 40.31 coo 14.74 93.05 -1.00 14.30 94.22 0.73 94.61 -4.13 49.96 95.84 -4.32 48.22 coo 33.16 106.80 7.72 33.34 104.87 6.92 71.61 -6.68 45.38 69.65 -6.30 44.66 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 5 3 # 5 193 ASP B 187 ASP~? 20.66 MG MG B 701 231 ASP A 177 ASP~? 19.64 MG MG B 701 294 ASP A 144 ASP~? 20.24 MG MG B 701 coo 27.89 102.52 14.98 29.35 101.92 13.57 74.06 -4.33 24.81 74.57 -2.40 25.55 coo 14.74 93.05 -1.00 14.30 94.22 0.73 57.48 -8.32 42.16 55.62 -9.31 42.19 coo 33.16 106.80 7.72 33.34 104.87 6.92 69.22 6.09 27.43 70.24 4.65 26.30 2amg_c06 source 2amg 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLASE : 5 hits 2amg_c06 naa= 3 ULMN 3 2ayh_c00 1,3-1,4-BETA-D-GLUCAN 4 GLUCANOHYDROuser 1 3 # 1 105 GLU B 88 GLU~? 39.12 MG MG B 701 107 ASP B 91 ASP~? 46.73 MG MG B 701 109 GLU B 87 GLU~? 47.03 MG MG B 701 coo 15.97 13.58 10.29 15.12 15.36 9.48 64.81 -21.91 58.58 62.70 -21.80 58.39 coo 20.07 16.34 11.47 18.03 16.15 11.04 69.68 -24.93 62.08 69.33 -24.21 64.01 coo 20.99 19.84 9.56 19.07 20.34 10.22 66.89 -21.09 64.87 65.61 -20.97 66.54 2ayh_c00 source 2ayh 1,3-1,4-BETA-D-GLUCAN 4 GLUCANOHYDROLASE (E.C.: 1 hits 2ayh_c00 naa= 3 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 1 3 # 1 A 14 ARG A 89 ARG~? 21.03 MG MG B 701 A 161 ASP A 165 ASP^? 19.82 MG MG B 701 A 174 TYR A 167 TYR^? 14.87 MG MG B 701 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 41.91 10.07 29.06 41.51 7.36 27.58 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 49.47 0.04 38.38 48.02 -0.73 39.68 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 50.02 0.16 32.66 47.75 0.13 34.22 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 2 3 # 2 A 14 ARG A 138 ARG^? 25.45 MG MG B 701 A 161 ASP A 165 ASP^? 19.82 MG MG B 701 A 174 TYR A 167 TYR^? 14.87 MG MG B 701 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 56.09 11.79 37.51 58.92 12.66 36.83 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 49.47 0.04 38.38 48.02 -0.73 39.68 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 50.02 0.16 32.66 47.75 0.13 34.22 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 3 3 # 3 A 14 ARG A 184 ARG~? 36.26 MG MG B 701 A 161 ASP B 165 ASP^? 26.59 MG MG B 701 A 174 TYR B 167 TYR^? 33.00 MG MG B 701 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 59.62 -7.21 56.11 59.92 -9.15 58.50 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 71.61 -6.68 45.38 69.65 -6.30 44.66 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 74.51 -6.62 50.39 71.88 -7.09 49.71 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 4 3 # 4 A 14 ARG A 261 ARG^? 35.46 MG MG B 701 A 161 ASP B 165 ASP^? 26.59 MG MG B 701 A 174 TYR B 167 TYR^? 33.00 MG MG B 701 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 64.47 3.15 51.80 64.61 3.05 54.85 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 71.61 -6.68 45.38 69.65 -6.30 44.66 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 74.51 -6.62 50.39 71.88 -7.09 49.71 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 5 3 # 5 A 14 ARG B 89 ARG~? 39.23 MG MG B 701 A 161 ASP B 165 ASP^? 26.59 MG MG B 701 A 174 TYR B 167 TYR^? 33.00 MG MG B 701 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 70.16 -17.97 55.88 70.89 -15.54 57.64 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 71.61 -6.68 45.38 69.65 -6.30 44.66 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 74.51 -6.62 50.39 71.88 -7.09 49.71 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 6 3 # 6 A 14 ARG B 138 ARG^? 35.64 MG MG B 701 A 161 ASP B 165 ASP^? 26.59 MG MG B 701 A 174 TYR B 167 TYR^? 33.00 MG MG B 701 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 81.28 -15.50 42.88 84.08 -15.53 41.69 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 71.61 -6.68 45.38 69.65 -6.30 44.66 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 74.51 -6.62 50.39 71.88 -7.09 49.71 2c7v_c08 source 2c7v PTERIDINE REDUCTASE : 6 hits 2c7v_c08 naa= 3 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 1 3 # 1 B 14 ARG A 89 ARG~? 21.03 MG MG B 701 B 161 ASP A 165 ASP^? 19.82 MG MG B 701 B 174 TYR A 167 TYR^? 14.87 MG MG B 701 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 41.91 10.07 29.06 41.51 7.36 27.58 coo -14.86 10.19 8.14 -14.82 12.31 8.42 49.47 0.04 38.38 48.02 -0.73 39.68 coo -21.46 12.70 8.53 -19.04 12.30 7.24 50.02 0.16 32.66 47.75 0.13 34.22 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 2 3 # 2 B 14 ARG A 138 ARG^? 25.45 MG MG B 701 B 161 ASP A 165 ASP^? 19.82 MG MG B 701 B 174 TYR A 167 TYR^? 14.87 MG MG B 701 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 56.09 11.79 37.51 58.92 12.66 36.83 coo -14.86 10.19 8.14 -14.82 12.31 8.42 49.47 0.04 38.38 48.02 -0.73 39.68 coo -21.46 12.70 8.53 -19.04 12.30 7.24 50.02 0.16 32.66 47.75 0.13 34.22 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 3 3 # 3 B 14 ARG A 184 ARG~? 36.26 MG MG B 701 B 161 ASP B 165 ASP^? 26.59 MG MG B 701 B 174 TYR B 167 TYR^? 33.00 MG MG B 701 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 59.62 -7.21 56.11 59.92 -9.15 58.50 coo -14.86 10.19 8.14 -14.82 12.31 8.42 71.61 -6.68 45.38 69.65 -6.30 44.66 coo -21.46 12.70 8.53 -19.04 12.30 7.24 74.51 -6.62 50.39 71.88 -7.09 49.71 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 4 3 # 4 B 14 ARG A 261 ARG^? 35.46 MG MG B 701 B 161 ASP B 165 ASP^? 26.59 MG MG B 701 B 174 TYR B 167 TYR^? 33.00 MG MG B 701 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 64.47 3.15 51.80 64.61 3.05 54.85 coo -14.86 10.19 8.14 -14.82 12.31 8.42 71.61 -6.68 45.38 69.65 -6.30 44.66 coo -21.46 12.70 8.53 -19.04 12.30 7.24 74.51 -6.62 50.39 71.88 -7.09 49.71 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 5 3 # 5 B 14 ARG B 89 ARG~? 39.23 MG MG B 701 B 161 ASP B 165 ASP^? 26.59 MG MG B 701 B 174 TYR B 167 TYR^? 33.00 MG MG B 701 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 70.16 -17.97 55.88 70.89 -15.54 57.64 coo -14.86 10.19 8.14 -14.82 12.31 8.42 71.61 -6.68 45.38 69.65 -6.30 44.66 coo -21.46 12.70 8.53 -19.04 12.30 7.24 74.51 -6.62 50.39 71.88 -7.09 49.71 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 6 3 # 6 B 14 ARG B 138 ARG^? 35.64 MG MG B 701 B 161 ASP B 165 ASP^? 26.59 MG MG B 701 B 174 TYR B 167 TYR^? 33.00 MG MG B 701 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 81.28 -15.50 42.88 84.08 -15.53 41.69 coo -14.86 10.19 8.14 -14.82 12.31 8.42 71.61 -6.68 45.38 69.65 -6.30 44.66 coo -21.46 12.70 8.53 -19.04 12.30 7.24 74.51 -6.62 50.39 71.88 -7.09 49.71 2c7v_c09 source 2c7v PTERIDINE REDUCTASE : 6 hits 2c7v_c09 naa= 3 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 1 3 # 1 C 14 ARG A 89 ARG~? 21.03 MG MG B 701 C 161 ASP A 165 ASP^? 19.82 MG MG B 701 C 174 TYR A 167 TYR^? 14.87 MG MG B 701 coo 2.84 19.43 40.34 1.59 20.35 37.65 41.91 10.07 29.06 41.51 7.36 27.58 coo -0.62 11.10 28.05 -0.65 13.15 27.46 49.47 0.04 38.38 48.02 -0.73 39.68 coo 5.94 13.28 27.17 3.53 13.05 28.58 50.02 0.16 32.66 47.75 0.13 34.22 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 2 3 # 2 C 14 ARG A 138 ARG^? 25.45 MG MG B 701 C 161 ASP A 165 ASP^? 19.82 MG MG B 701 C 174 TYR A 167 TYR^? 14.87 MG MG B 701 coo 2.84 19.43 40.34 1.59 20.35 37.65 56.09 11.79 37.51 58.92 12.66 36.83 coo -0.62 11.10 28.05 -0.65 13.15 27.46 49.47 0.04 38.38 48.02 -0.73 39.68 coo 5.94 13.28 27.17 3.53 13.05 28.58 50.02 0.16 32.66 47.75 0.13 34.22 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 3 3 # 3 C 14 ARG A 184 ARG~? 36.26 MG MG B 701 C 161 ASP B 165 ASP^? 26.59 MG MG B 701 C 174 TYR B 167 TYR^? 33.00 MG MG B 701 coo 2.84 19.43 40.34 1.59 20.35 37.65 59.62 -7.21 56.11 59.92 -9.15 58.50 coo -0.62 11.10 28.05 -0.65 13.15 27.46 71.61 -6.68 45.38 69.65 -6.30 44.66 coo 5.94 13.28 27.17 3.53 13.05 28.58 74.51 -6.62 50.39 71.88 -7.09 49.71 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 4 3 # 4 C 14 ARG A 261 ARG^? 35.46 MG MG B 701 C 161 ASP B 165 ASP^? 26.59 MG MG B 701 C 174 TYR B 167 TYR^? 33.00 MG MG B 701 coo 2.84 19.43 40.34 1.59 20.35 37.65 64.47 3.15 51.80 64.61 3.05 54.85 coo -0.62 11.10 28.05 -0.65 13.15 27.46 71.61 -6.68 45.38 69.65 -6.30 44.66 coo 5.94 13.28 27.17 3.53 13.05 28.58 74.51 -6.62 50.39 71.88 -7.09 49.71 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 5 3 # 5 C 14 ARG B 89 ARG~? 39.23 MG MG B 701 C 161 ASP B 165 ASP^? 26.59 MG MG B 701 C 174 TYR B 167 TYR^? 33.00 MG MG B 701 coo 2.84 19.43 40.34 1.59 20.35 37.65 70.16 -17.97 55.88 70.89 -15.54 57.64 coo -0.62 11.10 28.05 -0.65 13.15 27.46 71.61 -6.68 45.38 69.65 -6.30 44.66 coo 5.94 13.28 27.17 3.53 13.05 28.58 74.51 -6.62 50.39 71.88 -7.09 49.71 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 6 3 # 6 C 14 ARG B 138 ARG^? 35.64 MG MG B 701 C 161 ASP B 165 ASP^? 26.59 MG MG B 701 C 174 TYR B 167 TYR^? 33.00 MG MG B 701 coo 2.84 19.43 40.34 1.59 20.35 37.65 81.28 -15.50 42.88 84.08 -15.53 41.69 coo -0.62 11.10 28.05 -0.65 13.15 27.46 71.61 -6.68 45.38 69.65 -6.30 44.66 coo 5.94 13.28 27.17 3.53 13.05 28.58 74.51 -6.62 50.39 71.88 -7.09 49.71 2c7v_c10 source 2c7v PTERIDINE REDUCTASE : 6 hits 2c7v_c10 naa= 3 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 1 3 # 1 D 14 ARG A 89 ARG~? 21.03 MG MG B 701 D 161 ASP A 165 ASP^? 19.82 MG MG B 701 D 174 TYR A 167 TYR^? 14.87 MG MG B 701 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 41.91 10.07 29.06 41.51 7.36 27.58 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 49.47 0.04 38.38 48.02 -0.73 39.68 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 50.02 0.16 32.66 47.75 0.13 34.22 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 2 3 # 2 D 14 ARG A 138 ARG^? 25.45 MG MG B 701 D 161 ASP A 165 ASP^? 19.82 MG MG B 701 D 174 TYR A 167 TYR^? 14.87 MG MG B 701 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 56.09 11.79 37.51 58.92 12.66 36.83 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 49.47 0.04 38.38 48.02 -0.73 39.68 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 50.02 0.16 32.66 47.75 0.13 34.22 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 3 3 # 3 D 14 ARG A 184 ARG~? 36.26 MG MG B 701 D 161 ASP B 165 ASP^? 26.59 MG MG B 701 D 174 TYR B 167 TYR^? 33.00 MG MG B 701 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 59.62 -7.21 56.11 59.92 -9.15 58.50 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 71.61 -6.68 45.38 69.65 -6.30 44.66 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 74.51 -6.62 50.39 71.88 -7.09 49.71 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 4 3 # 4 D 14 ARG A 261 ARG^? 35.46 MG MG B 701 D 161 ASP B 165 ASP^? 26.59 MG MG B 701 D 174 TYR B 167 TYR^? 33.00 MG MG B 701 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 64.47 3.15 51.80 64.61 3.05 54.85 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 71.61 -6.68 45.38 69.65 -6.30 44.66 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 74.51 -6.62 50.39 71.88 -7.09 49.71 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 5 3 # 5 D 14 ARG B 89 ARG~? 39.23 MG MG B 701 D 161 ASP B 165 ASP^? 26.59 MG MG B 701 D 174 TYR B 167 TYR^? 33.00 MG MG B 701 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 70.16 -17.97 55.88 70.89 -15.54 57.64 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 71.61 -6.68 45.38 69.65 -6.30 44.66 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 74.51 -6.62 50.39 71.88 -7.09 49.71 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 6 3 # 6 D 14 ARG B 138 ARG^? 35.64 MG MG B 701 D 161 ASP B 165 ASP^? 26.59 MG MG B 701 D 174 TYR B 167 TYR^? 33.00 MG MG B 701 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 81.28 -15.50 42.88 84.08 -15.53 41.69 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 71.61 -6.68 45.38 69.65 -6.30 44.66 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 74.51 -6.62 50.39 71.88 -7.09 49.71 2c7v_c11 source 2c7v PTERIDINE REDUCTASE : 6 hits 2c7v_c11 naa= 3 ULMN 3 2cnd_c01 NADH-DEPENDENT NITRATE REDUCTASE (CYuser 1 3 # 1 65 THR A 169 THR~? 12.09 MG MG B 701 242 CYH A 150 CYH^? 20.80 MG MG B 701 270 PHE A 166 PHE^? 17.85 MG MG B 701 coo 12.97 28.35 3.84 11.81 28.07 2.09 53.69 2.67 26.96 55.61 3.43 26.29 coo 8.65 19.49 -2.27 10.50 20.91 -0.59 54.05 4.31 36.56 55.14 4.53 39.16 coo 9.41 24.60 -3.66 7.52 26.57 -4.16 55.48 -0.21 37.25 56.90 1.01 39.28 ULMN 3 2cnd_c01 NADH-DEPENDENT NITRATE REDUCTASE (CYuser 2 3 # 2 65 THR B 105 THR^? 37.87 MG MG B 701 242 CYH B 93 CYH~? 42.85 MG MG B 701 270 PHE B 118 PHE^? 36.09 MG MG B 701 coo 12.97 28.35 3.84 11.81 28.07 2.09 73.55 -30.07 49.09 72.87 -30.65 47.12 coo 8.65 19.49 -2.27 10.50 20.91 -0.59 74.48 -24.31 57.35 76.42 -22.43 56.76 coo 9.41 24.60 -3.66 7.52 26.57 -4.16 70.13 -23.91 51.57 68.23 -22.26 52.74 2cnd_c01 source 2cnd NADH-DEPENDENT NITRATE REDUCTASE (CYTOCHROME B: 2 hits 2cnd_c01 naa= 3 ULMN 3 2esd_c00 1.02.01.0009 user 1 3 # 1 A 154 ASN B 90 ASN~? 42.88 MG MG B 701 A 250 ALA B 106 ALA^? 40.55 MG MG B 701 A 284 CYH B 93 CYH~? 42.85 MG MG B 701 coo -98.31 19.25 26.95 -99.27 21.10 26.57 72.19 -20.15 61.00 72.72 -18.20 60.27 coo -102.90 29.72 23.02 -103.69 28.50 23.43 70.76 -29.74 51.68 71.32 -29.23 53.03 coo -98.59 26.45 29.50 -99.24 25.73 26.84 74.48 -24.31 57.35 76.42 -22.43 56.76 2esd_c00 source 2esd 1.02.01.0009 : 1 hits 2esd_c00 naa= 3 ULMN 3 2esd_c01 1.02.01.0009 user 1 3 # 1 B 154 ASN B 90 ASN~? 42.88 MG MG B 701 B 250 ALA B 106 ALA^? 40.55 MG MG B 701 B 284 CYH B 93 CYH~? 42.85 MG MG B 701 coo -116.62 58.12 2.11 -116.17 56.24 3.01 72.19 -20.15 61.00 72.72 -18.20 60.27 coo -114.20 47.61 7.65 -114.88 48.80 8.33 70.76 -29.74 51.68 71.32 -29.23 53.03 coo -118.73 50.90 1.30 -116.61 51.76 2.87 74.48 -24.31 57.35 76.42 -22.43 56.76 2esd_c01 source 2esd 1.02.01.0009 : 1 hits 2esd_c01 naa= 3 ULMN 3 2esd_c02 1.02.01.0009 user 1 3 # 1 C 154 ASN B 90 ASN~? 42.88 MG MG B 701 C 250 ALA B 106 ALA^? 40.55 MG MG B 701 C 284 CYH B 93 CYH~? 42.85 MG MG B 701 coo -155.36 18.42 28.93 -154.49 20.30 29.39 72.19 -20.15 61.00 72.72 -18.20 60.27 coo -150.95 29.02 32.87 -150.10 27.86 32.40 70.76 -29.74 51.68 71.32 -29.23 53.03 coo -155.22 25.64 26.33 -154.78 25.20 29.09 74.48 -24.31 57.35 76.42 -22.43 56.76 2esd_c02 source 2esd 1.02.01.0009 : 1 hits 2esd_c02 naa= 3 ULMN 3 2esd_c03 1.02.01.0009 user 1 3 # 1 D 154 ASN B 90 ASN~? 42.88 MG MG B 701 D 250 ALA B 106 ALA^? 40.55 MG MG B 701 D 284 CYH B 93 CYH~? 42.85 MG MG B 701 coo -138.05 57.23 54.59 -137.96 55.47 53.43 72.19 -20.15 61.00 72.72 -18.20 60.27 coo -139.97 46.71 48.80 -139.25 47.90 48.19 70.76 -29.74 51.68 71.32 -29.23 53.03 coo -135.22 50.13 55.22 -137.25 50.94 53.65 74.48 -24.31 57.35 76.42 -22.43 56.76 2esd_c03 source 2esd 1.02.01.0009 : 1 hits 2esd_c03 naa= 3 ULMN 3 2f9z_c00 PROTEIN (CHEMOTAXIS METHYLATION PROTuser 1 3 # 1 C 21 THR B 103 THR~? 38.15 MG MG B 701 C 27 CYH B 93 CYH~? 42.85 MG MG B 701 C 44 HIS B 104 HIS^? 43.18 MG MG B 701 coo 31.18 22.40 -15.93 30.94 20.86 -14.44 79.49 -28.27 47.31 78.51 -27.23 45.65 coo 33.52 13.02 -11.58 35.31 14.81 -10.35 74.48 -24.31 57.35 76.42 -22.43 56.76 coo 32.65 18.86 -10.97 34.16 18.23 -12.28 76.52 -29.94 52.39 75.18 -30.89 53.68 ULMN 3 2f9z_c00 PROTEIN (CHEMOTAXIS METHYLATION PROTuser 2 3 # 2 C 21 THR B 105 THR^? 37.87 MG MG B 701 C 27 CYH B 93 CYH~? 42.85 MG MG B 701 C 44 HIS B 104 HIS^? 43.18 MG MG B 701 coo 31.18 22.40 -15.93 30.94 20.86 -14.44 73.55 -30.07 49.09 72.87 -30.65 47.12 coo 33.52 13.02 -11.58 35.31 14.81 -10.35 74.48 -24.31 57.35 76.42 -22.43 56.76 coo 32.65 18.86 -10.97 34.16 18.23 -12.28 76.52 -29.94 52.39 75.18 -30.89 53.68 2f9z_c00 source 2f9z PROTEIN (CHEMOTAXIS METHYLATION PROTEIN) : 2 hits 2f9z_c00 naa= 3 ULMN 3 2f9z_c01 PROTEIN (CHEMOTAXIS METHYLATION PROTuser 1 3 # 1 D 21 THR B 103 THR~? 38.15 MG MG B 701 D 27 CYH B 93 CYH~? 42.85 MG MG B 701 D 44 HIS B 104 HIS^? 43.18 MG MG B 701 coo 8.10 8.69 -37.60 9.58 7.79 -38.92 79.49 -28.27 47.31 78.51 -27.23 45.65 coo 15.06 1.75 -41.51 12.66 0.75 -42.59 74.48 -24.31 57.35 76.42 -22.43 56.76 coo 10.53 5.51 -42.28 10.30 3.78 -41.11 76.52 -29.94 52.39 75.18 -30.89 53.68 ULMN 3 2f9z_c01 PROTEIN (CHEMOTAXIS METHYLATION PROTuser 2 3 # 2 D 21 THR B 105 THR^? 37.87 MG MG B 701 D 27 CYH B 93 CYH~? 42.85 MG MG B 701 D 44 HIS B 104 HIS^? 43.18 MG MG B 701 coo 8.10 8.69 -37.60 9.58 7.79 -38.92 73.55 -30.07 49.09 72.87 -30.65 47.12 coo 15.06 1.75 -41.51 12.66 0.75 -42.59 74.48 -24.31 57.35 76.42 -22.43 56.76 coo 10.53 5.51 -42.28 10.30 3.78 -41.11 76.52 -29.94 52.39 75.18 -30.89 53.68 2f9z_c01 source 2f9z PROTEIN (CHEMOTAXIS METHYLATION PROTEIN) : 2 hits 2f9z_c01 naa= 3 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 1 3 # 1 A 177 PHE A 142 PHE~? 13.47 MG MG B 701 A 263 ASP B 161 ASP^? 15.44 MG MG B 701 A 292 LYS A 175 LYS~? 16.95 MG MG B 701 coo 51.51 50.32 16.39 52.13 49.68 13.75 62.78 -0.55 30.89 63.67 -3.12 31.49 coo 54.43 44.82 23.74 55.21 45.06 21.80 63.88 -11.38 34.74 64.49 -9.36 34.64 coo 63.95 45.30 16.71 59.11 49.15 16.05 54.19 -7.18 37.22 54.81 -12.82 38.86 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 2 3 # 2 A 177 PHE A 179 PHE~? 15.24 MG MG B 701 A 263 ASP A 165 ASP^? 19.82 MG MG B 701 A 292 LYS A 172 LYS~? 6.12 MG MG B 701 coo 51.51 50.32 16.39 52.13 49.68 13.75 59.12 -2.16 37.53 58.98 -3.05 34.90 coo 54.43 44.82 23.74 55.21 45.06 21.80 49.47 0.04 38.38 48.02 -0.73 39.68 coo 63.95 45.30 16.71 59.11 49.15 16.05 50.20 -3.67 28.72 53.15 -8.47 28.45 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 3 3 # 3 A 177 PHE B 179 PHE~? 33.79 MG MG B 701 A 263 ASP B 165 ASP^? 26.59 MG MG B 701 A 292 LYS B 172 LYS~? 42.28 MG MG B 701 coo 51.51 50.32 16.39 52.13 49.68 13.75 80.09 -2.55 42.63 80.83 -1.68 45.20 coo 54.43 44.82 23.74 55.21 45.06 21.80 71.61 -6.68 45.38 69.65 -6.30 44.66 coo 63.95 45.30 16.71 59.11 49.15 16.05 75.30 -2.84 54.33 79.74 -2.40 56.36 2oat_c03 source 2oat ORNITHINE AMINOTRANSFERASE : 3 hits 2oat_c03 naa= 3 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 1 3 # 1 B 177 PHE A 179 PHE~? 15.24 MG MG B 701 B 263 ASP A 165 ASP^? 19.82 MG MG B 701 B 292 LYS A 172 LYS~? 6.12 MG MG B 701 coo 49.99 26.05 6.28 51.46 26.87 8.49 59.12 -2.16 37.53 58.98 -3.05 34.90 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 49.47 0.04 38.38 48.02 -0.73 39.68 coo 60.53 31.67 0.97 57.79 27.51 3.63 50.20 -3.67 28.72 53.15 -8.47 28.45 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 2 3 # 2 B 177 PHE B 179 PHE~? 33.79 MG MG B 701 B 263 ASP B 165 ASP^? 26.59 MG MG B 701 B 292 LYS B 172 LYS~? 42.28 MG MG B 701 coo 49.99 26.05 6.28 51.46 26.87 8.49 80.09 -2.55 42.63 80.83 -1.68 45.20 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 71.61 -6.68 45.38 69.65 -6.30 44.66 coo 60.53 31.67 0.97 57.79 27.51 3.63 75.30 -2.84 54.33 79.74 -2.40 56.36 2oat_c04 source 2oat ORNITHINE AMINOTRANSFERASE : 2 hits 2oat_c04 naa= 3 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 1 3 # 1 C 177 PHE A 142 PHE~? 13.47 MG MG B 701 C 263 ASP B 161 ASP^? 15.44 MG MG B 701 C 292 LYS A 175 LYS~? 16.95 MG MG B 701 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 62.78 -0.55 30.89 63.67 -3.12 31.49 coo 19.84 12.02 9.33 18.68 11.23 7.75 63.88 -11.38 34.74 64.49 -9.36 34.64 coo 12.82 3.49 4.98 17.80 5.59 1.90 54.19 -7.18 37.22 54.81 -12.82 38.86 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 2 3 # 2 C 177 PHE A 179 PHE~? 15.24 MG MG B 701 C 263 ASP A 165 ASP^? 19.82 MG MG B 701 C 292 LYS A 172 LYS~? 6.12 MG MG B 701 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 59.12 -2.16 37.53 58.98 -3.05 34.90 coo 19.84 12.02 9.33 18.68 11.23 7.75 49.47 0.04 38.38 48.02 -0.73 39.68 coo 12.82 3.49 4.98 17.80 5.59 1.90 50.20 -3.67 28.72 53.15 -8.47 28.45 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 3 3 # 3 C 177 PHE B 179 PHE~? 33.79 MG MG B 701 C 263 ASP B 165 ASP^? 26.59 MG MG B 701 C 292 LYS B 172 LYS~? 42.28 MG MG B 701 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 80.09 -2.55 42.63 80.83 -1.68 45.20 coo 19.84 12.02 9.33 18.68 11.23 7.75 71.61 -6.68 45.38 69.65 -6.30 44.66 coo 12.82 3.49 4.98 17.80 5.59 1.90 75.30 -2.84 54.33 79.74 -2.40 56.36 2oat_c05 source 2oat ORNITHINE AMINOTRANSFERASE : 3 hits 2oat_c05 naa= 3 ULMN 3 2oat_c06 ORNITHINE AMINOTRANSFERASE user 1 3 # 1 A 178 TRP B 180 TRP~? 24.13 MG MG B 701 A 263 ASP B 165 ASP^? 26.59 MG MG B 701 A 292 LYS B 172 LYS~? 42.28 MG MG B 701 coo 48.96 45.07 19.49 48.62 41.39 18.16 74.18 -4.52 37.27 75.71 -6.65 34.39 coo 54.43 44.82 23.74 55.21 45.06 21.80 71.61 -6.68 45.38 69.65 -6.30 44.66 coo 63.95 45.30 16.71 59.11 49.15 16.05 75.30 -2.84 54.33 79.74 -2.40 56.36 2oat_c06 source 2oat ORNITHINE AMINOTRANSFERASE : 1 hits 2oat_c06 naa= 3 ULMN 3 2oat_c07 ORNITHINE AMINOTRANSFERASE user 1 3 # 1 B 178 TRP B 180 TRP~? 24.13 MG MG B 701 B 263 ASP B 165 ASP^? 26.59 MG MG B 701 B 292 LYS B 172 LYS~? 42.28 MG MG B 701 coo 45.83 31.15 4.65 45.88 34.74 6.24 74.18 -4.52 37.27 75.71 -6.65 34.39 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 71.61 -6.68 45.38 69.65 -6.30 44.66 coo 60.53 31.67 0.97 57.79 27.51 3.63 75.30 -2.84 54.33 79.74 -2.40 56.36 2oat_c07 source 2oat ORNITHINE AMINOTRANSFERASE : 1 hits 2oat_c07 naa= 3 ULMN 3 2oat_c08 ORNITHINE AMINOTRANSFERASE user 1 3 # 1 C 178 TRP B 180 TRP~? 24.13 MG MG B 701 C 263 ASP B 165 ASP^? 26.59 MG MG B 701 C 292 LYS B 172 LYS~? 42.28 MG MG B 701 coo 20.52 16.65 4.15 17.32 18.91 4.39 74.18 -4.52 37.27 75.71 -6.65 34.39 coo 19.84 12.02 9.33 18.68 11.23 7.75 71.61 -6.68 45.38 69.65 -6.30 44.66 coo 12.82 3.49 4.98 17.80 5.59 1.90 75.30 -2.84 54.33 79.74 -2.40 56.36 2oat_c08 source 2oat ORNITHINE AMINOTRANSFERASE : 1 hits 2oat_c08 naa= 3 ULMN 3 2tps_c00 THIAMIN PHOSPHATE SYNTHASE user 1 3 # 1 A 59 ARG A 178 ARG~? 13.19 MG MG B 701 A 130 SER B 162 SER^? 20.48 MG MG B 701 A 159 LYS A 175 LYS~? 16.95 MG MG B 701 coo 18.35 45.84 20.99 16.20 47.83 21.89 60.75 -6.17 35.55 62.65 -6.30 33.15 coo 15.14 43.67 10.77 15.61 44.43 13.04 67.92 -11.32 37.08 69.18 -13.29 36.33 coo 11.57 48.49 22.18 13.51 49.99 17.21 54.19 -7.18 37.22 54.81 -12.82 38.86 2tps_c00 source 2tps THIAMIN PHOSPHATE SYNTHASE : 1 hits 2tps_c00 naa= 3 ULMN 3 2tps_c01 THIAMIN PHOSPHATE SYNTHASE user 1 3 # 1 B 59 ARG A 178 ARG~? 13.19 MG MG B 701 B 130 SER A 147 SER^? 16.30 MG MG B 701 B 159 LYS A 175 LYS~? 16.95 MG MG B 701 coo 58.72 31.58 20.45 60.80 29.39 20.94 60.75 -6.17 35.55 62.65 -6.30 33.15 coo 61.66 35.17 10.39 61.29 34.14 12.56 59.94 3.92 28.83 60.06 6.29 28.37 coo 65.38 28.77 21.17 63.49 28.03 16.12 54.19 -7.18 37.22 54.81 -12.82 38.86 2tps_c01 source 2tps THIAMIN PHOSPHATE SYNTHASE : 1 hits 2tps_c01 naa= 3 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 1 1 # 1 A 461 ASN A 90 ASN~? 26.35 MG MG B 701 coo 5.80 63.03 55.85 5.52 65.03 56.45 39.76 12.43 23.01 37.74 11.92 22.68 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 2 1 # 2 A 461 ASN A 121 ASN^? 29.95 MG MG B 701 coo 5.80 63.03 55.85 5.52 65.03 56.45 52.20 18.76 34.12 54.15 19.63 34.02 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 3 1 # 3 A 461 ASN A 123 ASN~? 26.30 MG MG B 701 coo 5.80 63.03 55.85 5.52 65.03 56.45 57.01 15.83 33.37 58.33 16.35 31.78 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 4 1 # 4 A 461 ASN B 90 ASN~? 42.88 MG MG B 701 coo 5.80 63.03 55.85 5.52 65.03 56.45 72.19 -20.15 61.00 72.72 -18.20 60.27 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 5 1 # 5 A 461 ASN B 121 ASN~? 40.01 MG MG B 701 coo 5.80 63.03 55.85 5.52 65.03 56.45 80.51 -24.09 47.29 82.46 -24.55 46.48 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 6 1 # 6 A 461 ASN B 123 ASN~? 41.71 MG MG B 701 coo 5.80 63.03 55.85 5.52 65.03 56.45 84.46 -20.26 46.14 86.41 -20.49 46.97 1kbk_p00 source 1kbk ALPHA-AMYLASE, PANCREATIC : 6 hits 1kbk_p00 naa= 1 ULMN 4 2cl8_p00 DECTIN-1 user 1 4 # 1 A 145 ARG A 258 ARG~? 19.65 MG MG B 701 A 148 SER B 162 SER^? 20.48 MG MG B 701 A 152 ALA B 160 ALA~? 17.20 MG MG B 701 A 194 GLU B 134 GLU^? 26.11 MG MG B 701 coo -29.52 -1.51 -10.80 -29.25 -1.07 -13.87 65.98 -2.88 40.97 66.14 -4.57 38.35 coo -35.30 0.90 -4.91 -36.19 -1.20 -5.57 67.92 -11.32 37.08 69.18 -13.29 36.33 coo -37.81 4.22 -2.30 -36.99 5.43 -2.37 64.13 -15.84 33.51 65.33 -16.77 33.15 coo -43.25 5.44 -9.45 -44.36 4.89 -7.68 69.63 -18.91 41.63 70.61 -19.62 39.97 2cl8_p00 source 2cl8 DECTIN-1 : 1 hits 2cl8_p00 naa= 4 ULMN 3 2qv4_p00 PANCREATIC ALPHA-AMYLASE user 1 3 # 1 A 459 ASN B 123 ASN~? 41.71 MG MG B 701 A 460 GLY B 101 GLY~? 43.78 MG MG B 701 A 461 ASN B 121 ASN~? 40.01 MG MG B 701 coo 15.00 94.38 6.97 13.00 93.59 6.99 84.46 -20.26 46.14 86.41 -20.49 46.97 coo 19.48 94.04 5.03 19.26 94.00 5.78 85.46 -26.82 47.74 85.02 -27.36 48.17 coo 20.23 95.69 9.16 21.55 97.37 9.20 80.51 -24.09 47.29 82.46 -24.55 46.48 2qv4_p00 source 2qv4 PANCREATIC ALPHA-AMYLASE : 1 hits 2qv4_p00 naa= 3 ULMN 3 1b01_d00 GENE REGULATION/DNA user 1 3 # 1 B 4 ARG A 126 ARG^? 30.85 MG MG B 701 B 6 THR A 117 THR^? 34.97 MG MG B 701 B 8 THR A 115 THR^? 37.56 MG MG B 701 coo 40.52 16.08 100.90 37.97 16.41 102.60 48.08 15.54 42.27 50.77 14.42 43.32 coo 36.11 13.64 95.03 34.54 14.86 95.91 39.68 17.15 38.48 39.65 17.82 40.51 coo 32.72 8.05 92.39 31.25 9.11 91.35 33.37 14.79 39.55 32.77 15.85 41.27 ULMN 3 1b01_d00 GENE REGULATION/DNA user 2 3 # 2 B 4 ARG A 178 ARG~? 13.19 MG MG B 701 B 6 THR B 208 THR~? 10.07 MG MG B 701 B 8 THR A 169 THR~? 12.09 MG MG B 701 coo 40.52 16.08 100.90 37.97 16.41 102.60 60.75 -6.17 35.55 62.65 -6.30 33.15 coo 36.11 13.64 95.03 34.54 14.86 95.91 60.49 -3.20 26.65 60.84 -1.10 26.85 coo 32.72 8.05 92.39 31.25 9.11 91.35 53.69 2.67 26.96 55.61 3.43 26.29 ULMN 3 1b01_d00 GENE REGULATION/DNA user 3 3 # 3 B 4 ARG A 226 ARG^? 38.22 MG MG B 701 B 6 THR A 228 THR~? 36.57 MG MG B 701 B 8 THR A 232 THR~? 41.53 MG MG B 701 coo 40.52 16.08 100.90 37.97 16.41 102.60 52.39 10.28 54.33 53.57 13.12 54.39 coo 36.11 13.64 95.03 34.54 14.86 95.91 49.57 5.80 57.73 48.75 6.14 55.73 coo 32.72 8.05 92.39 31.25 9.11 91.35 44.58 4.76 62.81 45.31 3.27 61.38 ULMN 3 1b01_d00 GENE REGULATION/DNA user 4 3 # 4 B 4 ARG B 126 ARG^? 29.16 MG MG B 701 B 6 THR B 117 THR^? 33.70 MG MG B 701 B 8 THR B 115 THR^? 33.84 MG MG B 701 coo 40.52 16.08 100.90 37.97 16.41 102.60 72.93 -22.54 42.02 74.52 -21.06 39.83 coo 36.11 13.64 95.03 34.54 14.86 95.91 67.56 -26.21 48.19 67.67 -27.81 46.75 coo 32.72 8.05 92.39 31.25 9.11 91.35 61.14 -26.63 49.14 61.60 -28.67 48.58 ULMN 3 1b01_d00 GENE REGULATION/DNA user 5 3 # 5 B 4 ARG B 226 ARG^? 21.45 MG MG B 701 B 6 THR B 228 THR~? 14.18 MG MG B 701 B 8 THR B 232 THR~? 7.39 MG MG B 701 coo 40.52 16.08 100.90 37.97 16.41 102.60 70.51 -17.10 28.75 72.04 -19.70 28.19 coo 36.11 13.64 95.03 34.54 14.86 95.91 65.45 -13.65 27.45 65.67 -14.19 29.51 coo 32.72 8.05 92.39 31.25 9.11 91.35 58.56 -14.33 25.39 59.44 -12.56 26.33 1b01_d00 source 1b01 GENE REGULATION/DNA : 5 hits 1b01_d00 naa= 3 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 1 3 # 1 I 303 TYR A 167 TYR^? 14.87 MG MG B 701 I 306 VAL A 151 VAL^? 20.34 MG MG B 701 I 308 VAL A 135 VAL^? 25.39 MG MG B 701 coo 26.18 35.24 6.87 24.33 35.18 8.97 50.02 0.16 32.66 47.75 0.13 34.22 coo 23.55 29.53 9.81 23.15 27.39 10.24 50.63 4.98 38.04 48.87 4.93 36.68 coo 16.43 30.18 9.35 15.05 30.67 11.01 45.58 8.75 40.29 44.61 7.55 38.70 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 2 3 # 2 I 303 TYR A 211 TYR~? 36.27 MG MG B 701 I 306 VAL A 159 VAL~? 37.39 MG MG B 701 I 308 VAL A 155 VAL^? 31.70 MG MG B 701 coo 26.18 35.24 6.87 24.33 35.18 8.97 46.06 1.29 56.07 43.74 -0.16 56.67 coo 23.55 29.53 9.81 23.15 27.39 10.24 42.82 5.67 55.50 44.03 3.92 56.06 coo 16.43 30.18 9.35 15.05 30.67 11.01 42.44 6.08 48.31 41.99 4.00 48.73 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 3 3 # 3 I 303 TYR B 167 TYR^? 33.00 MG MG B 701 I 306 VAL B 151 VAL^? 30.14 MG MG B 701 I 308 VAL B 135 VAL^? 28.27 MG MG B 701 coo 26.18 35.24 6.87 24.33 35.18 8.97 74.51 -6.62 50.39 71.88 -7.09 49.71 coo 23.55 29.53 9.81 23.15 27.39 10.24 74.01 -11.29 45.17 72.94 -11.49 47.06 coo 16.43 30.18 9.35 15.05 30.67 11.01 69.75 -16.57 44.71 69.22 -15.25 46.34 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 4 3 # 4 I 303 TYR B 211 TYR~? 10.12 MG MG B 701 I 306 VAL B 159 VAL~? 12.57 MG MG B 701 I 308 VAL B 155 VAL~? 19.23 MG MG B 701 coo 26.18 35.24 6.87 24.33 35.18 8.97 61.93 -10.14 30.57 59.39 -9.09 31.01 coo 23.55 29.53 9.81 23.15 27.39 10.24 60.71 -15.88 31.76 61.27 -14.93 29.83 coo 16.43 30.18 9.35 15.05 30.67 11.01 63.08 -15.31 38.87 61.29 -14.21 39.32 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 5 3 # 5 I 303 TYR B 252 TYR^? 25.41 MG MG B 701 I 306 VAL B 251 VAL^? 27.32 MG MG B 701 I 308 VAL B 263 VAL~? 29.80 MG MG B 701 coo 26.18 35.24 6.87 24.33 35.18 8.97 79.70 -7.64 31.83 77.94 -6.02 30.43 coo 23.55 29.53 9.81 23.15 27.39 10.24 80.44 -11.64 29.06 81.80 -13.34 28.83 coo 16.43 30.18 9.35 15.05 30.67 11.01 84.43 -7.53 23.68 84.88 -5.37 23.73 1cqt_d00 source 1cqt GENE REGULATION/DNA : 5 hits 1cqt_d00 naa= 3 ULMN 3 1emh_d00 HYDROLASE/DNA user 1 3 # 1 A 271 PRO A 82 PRO~? 23.75 MG MG B 701 A 272 LEU A 81 LEU~? 21.91 MG MG B 701 A 276 ARG A 89 ARG~? 21.03 MG MG B 701 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 36.86 2.32 34.28 37.81 4.18 33.45 coo 10.97 0.43 16.73 11.31 2.11 18.06 42.12 4.62 33.97 42.77 5.70 35.72 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 41.91 10.07 29.06 41.51 7.36 27.58 ULMN 3 1emh_d00 HYDROLASE/DNA user 2 3 # 2 A 271 PRO A 141 PRO^? 19.57 MG MG B 701 A 272 LEU A 140 LEU^? 19.96 MG MG B 701 A 276 ARG A 138 ARG^? 25.45 MG MG B 701 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 64.19 7.07 33.07 62.46 5.89 32.23 coo 10.97 0.43 16.73 11.31 2.11 18.06 59.84 5.65 35.10 59.22 6.19 37.08 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 56.09 11.79 37.51 58.92 12.66 36.83 ULMN 3 1emh_d00 HYDROLASE/DNA user 3 3 # 3 A 271 PRO A 173 PRO^? 11.37 MG MG B 701 A 272 LEU A 174 LEU^? 10.87 MG MG B 701 A 276 ARG A 178 ARG~? 13.19 MG MG B 701 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 48.29 -5.70 32.10 50.03 -4.35 31.76 coo 10.97 0.43 16.73 11.31 2.11 18.06 54.71 -4.40 33.74 55.61 -4.00 31.77 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 60.75 -6.17 35.55 62.65 -6.30 33.15 ULMN 3 1emh_d00 HYDROLASE/DNA user 4 3 # 4 A 271 PRO B 183 PRO~? 20.23 MG MG B 701 A 272 LEU B 250 LEU^? 21.79 MG MG B 701 A 276 ARG B 226 ARG^? 21.45 MG MG B 701 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 73.67 -5.83 30.03 73.11 -3.66 30.27 coo 10.97 0.43 16.73 11.31 2.11 18.06 76.93 -9.56 26.97 75.85 -8.43 25.40 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 70.51 -17.10 28.75 72.04 -19.70 28.19 1emh_d00 source 1emh HYDROLASE/DNA : 4 hits 1emh_d00 naa= 3 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 1 3 # 1 E 40 ARG A 195 ARG~? 43.32 MG MG B 701 E 41 TYR A 200 TYR~? 45.60 MG MG B 701 E 83 ARG A 71 ARG~? 17.45 MG MG B 701 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 61.44 -7.15 66.34 63.04 -4.84 65.03 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 56.79 -4.41 69.25 56.84 -5.83 66.87 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 52.94 11.11 20.93 55.28 9.38 22.01 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 2 3 # 2 E 40 ARG A 195 ARG~? 43.32 MG MG B 701 E 41 TYR A 204 TYR~? 43.42 MG MG B 701 E 83 ARG A 71 ARG~? 17.45 MG MG B 701 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 61.44 -7.15 66.34 63.04 -4.84 65.03 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 52.40 -7.49 67.00 53.03 -9.24 64.93 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 52.94 11.11 20.93 55.28 9.38 22.01 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 3 3 # 3 E 40 ARG B 195 ARG~? 17.65 MG MG B 701 E 41 TYR B 200 TYR~? 13.23 MG MG B 701 E 83 ARG B 71 ARG~? 47.78 MG MG B 701 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 67.86 1.55 15.86 69.38 1.19 18.53 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 64.00 -2.37 14.81 64.76 -0.92 17.07 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 84.61 -16.28 59.56 86.63 -14.84 57.69 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 4 3 # 4 E 40 ARG B 195 ARG~? 17.65 MG MG B 701 E 41 TYR B 204 TYR~? 10.93 MG MG B 701 E 83 ARG A 195 ARG~? 43.32 MG MG B 701 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 67.86 1.55 15.86 69.38 1.19 18.53 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 60.36 -0.30 19.04 61.29 1.75 20.68 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 61.44 -7.15 66.34 63.04 -4.84 65.03 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 5 3 # 5 E 40 ARG B 195 ARG~? 17.65 MG MG B 701 E 41 TYR B 204 TYR~? 10.93 MG MG B 701 E 83 ARG B 71 ARG~? 47.78 MG MG B 701 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 67.86 1.55 15.86 69.38 1.19 18.53 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 60.36 -0.30 19.04 61.29 1.75 20.68 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 84.61 -16.28 59.56 86.63 -14.84 57.69 1id3_d00 source 1id3 STRUCTURAL PROTEIN/DNA : 5 hits 1id3_d00 naa= 3 ULMN 4 1kqq_d00 TRANSCRIPTION/DNA user 1 4 # 1 A 92 THR A 117 THR^? 34.97 MG MG B 701 A 93 SER A 107 SER^? 37.91 MG MG B 701 A 96 LEU A 108 LEU^? 33.24 MG MG B 701 A 131 ARG A 89 ARG~? 21.03 MG MG B 701 coo 3.35 5.93 10.54 2.79 5.49 12.55 39.68 17.15 38.48 39.65 17.82 40.51 coo 3.53 2.76 8.43 3.13 1.02 10.05 37.40 19.71 36.06 36.29 21.61 37.11 coo 5.64 -0.49 6.46 5.57 -2.53 7.21 35.07 16.75 33.56 34.37 15.98 31.67 coo 12.62 -3.51 13.26 13.87 -0.97 14.34 41.91 10.07 29.06 41.51 7.36 27.58 ULMN 4 1kqq_d00 TRANSCRIPTION/DNA user 2 4 # 2 A 92 THR A 222 THR^? 29.73 MG MG B 701 A 93 SER A 217 SER~? 30.46 MG MG B 701 A 96 LEU A 216 LEU~? 25.22 MG MG B 701 A 131 ARG A 126 ARG^? 30.85 MG MG B 701 coo 3.35 5.93 10.54 2.79 5.49 12.55 62.04 9.47 43.12 63.32 11.19 43.65 coo 3.53 2.76 8.43 3.13 1.02 10.05 57.85 13.16 42.60 59.76 14.69 42.27 coo 5.64 -0.49 6.46 5.57 -2.53 7.21 55.34 9.26 42.09 56.47 8.47 40.48 coo 12.62 -3.51 13.26 13.87 -0.97 14.34 48.08 15.54 42.27 50.77 14.42 43.32 ULMN 4 1kqq_d00 TRANSCRIPTION/DNA user 3 4 # 3 A 92 THR B 117 THR^? 33.70 MG MG B 701 A 93 SER B 107 SER^? 37.85 MG MG B 701 A 96 LEU B 108 LEU^? 38.32 MG MG B 701 A 131 ARG B 89 ARG~? 39.23 MG MG B 701 coo 3.35 5.93 10.54 2.79 5.49 12.55 67.56 -26.21 48.19 67.67 -27.81 46.75 coo 3.53 2.76 8.43 3.13 1.02 10.05 67.06 -28.86 51.54 65.90 -30.87 50.74 coo 5.64 -0.49 6.46 5.57 -2.53 7.21 64.83 -26.80 55.02 64.92 -24.61 55.22 coo 12.62 -3.51 13.26 13.87 -0.97 14.34 70.16 -17.97 55.88 70.89 -15.54 57.64 ULMN 4 1kqq_d00 TRANSCRIPTION/DNA user 4 4 # 4 A 92 THR B 222 THR^? 32.47 MG MG B 701 A 93 SER B 217 SER~? 33.42 MG MG B 701 A 96 LEU B 216 LEU~? 29.67 MG MG B 701 A 131 ARG B 126 ARG^? 29.16 MG MG B 701 coo 3.35 5.93 10.54 2.79 5.49 12.55 83.36 -13.27 35.32 84.56 -14.62 34.12 coo 3.53 2.76 8.43 3.13 1.02 10.05 80.79 -17.73 37.60 83.05 -18.57 37.26 coo 5.64 -0.49 6.46 5.57 -2.53 7.21 77.72 -14.51 39.15 79.26 -13.29 40.12 coo 12.62 -3.51 13.26 13.87 -0.97 14.34 72.93 -22.54 42.02 74.52 -21.06 39.83 1kqq_d00 source 1kqq TRANSCRIPTION/DNA : 4 hits 1kqq_d00 naa= 4 ULMN 3 1mjo_d00 TRANSCRIPTION/DNA user 1 3 # 1 D 23 LYS A 172 LYS~? 6.12 MG MG B 701 D 25 THR A 168 THR^? 7.86 MG MG B 701 D 27 SER A 147 SER^? 16.30 MG MG B 701 coo 86.60 33.38 44.00 87.05 39.52 42.71 50.20 -3.67 28.72 53.15 -8.47 28.45 coo 81.20 31.58 48.03 79.23 32.24 47.54 54.22 -0.54 28.99 53.77 -2.31 27.85 coo 79.09 29.82 54.20 77.17 28.90 53.05 59.94 3.92 28.83 60.06 6.29 28.37 ULMN 3 1mjo_d00 TRANSCRIPTION/DNA user 2 3 # 2 D 23 LYS A 172 LYS~? 6.12 MG MG B 701 D 25 THR A 169 THR~? 12.09 MG MG B 701 D 27 SER A 147 SER^? 16.30 MG MG B 701 coo 86.60 33.38 44.00 87.05 39.52 42.71 50.20 -3.67 28.72 53.15 -8.47 28.45 coo 81.20 31.58 48.03 79.23 32.24 47.54 53.69 2.67 26.96 55.61 3.43 26.29 coo 79.09 29.82 54.20 77.17 28.90 53.05 59.94 3.92 28.83 60.06 6.29 28.37 ULMN 3 1mjo_d00 TRANSCRIPTION/DNA user 3 3 # 3 D 23 LYS B 172 LYS~? 42.28 MG MG B 701 D 25 THR B 168 THR^? 39.79 MG MG B 701 D 27 SER B 146 SER~? 44.57 MG MG B 701 coo 86.60 33.38 44.00 87.05 39.52 42.71 75.30 -2.84 54.33 79.74 -2.40 56.36 coo 81.20 31.58 48.03 79.23 32.24 47.54 79.61 -4.74 52.17 79.36 -3.15 53.62 coo 79.09 29.82 54.20 77.17 28.90 53.05 87.67 -4.57 51.59 87.26 -2.47 52.75 ULMN 3 1mjo_d00 TRANSCRIPTION/DNA user 4 3 # 4 D 23 LYS B 172 LYS~? 42.28 MG MG B 701 D 25 THR B 168 THR^? 39.79 MG MG B 701 D 27 SER B 147 SER^? 42.22 MG MG B 701 coo 86.60 33.38 44.00 87.05 39.52 42.71 75.30 -2.84 54.33 79.74 -2.40 56.36 coo 81.20 31.58 48.03 79.23 32.24 47.54 79.61 -4.74 52.17 79.36 -3.15 53.62 coo 79.09 29.82 54.20 77.17 28.90 53.05 85.67 -7.01 49.55 87.33 -8.74 49.65 ULMN 3 1mjo_d00 TRANSCRIPTION/DNA user 5 3 # 5 D 23 LYS B 172 LYS~? 42.28 MG MG B 701 D 25 THR B 169 THR~? 41.74 MG MG B 701 D 27 SER B 146 SER~? 44.57 MG MG B 701 coo 86.60 33.38 44.00 87.05 39.52 42.71 75.30 -2.84 54.33 79.74 -2.40 56.36 coo 81.20 31.58 48.03 79.23 32.24 47.54 80.90 -7.97 53.82 83.02 -8.15 53.47 coo 79.09 29.82 54.20 77.17 28.90 53.05 87.67 -4.57 51.59 87.26 -2.47 52.75 ULMN 3 1mjo_d00 TRANSCRIPTION/DNA user 6 3 # 6 D 23 LYS B 172 LYS~? 42.28 MG MG B 701 D 25 THR B 169 THR~? 41.74 MG MG B 701 D 27 SER B 147 SER^? 42.22 MG MG B 701 coo 86.60 33.38 44.00 87.05 39.52 42.71 75.30 -2.84 54.33 79.74 -2.40 56.36 coo 81.20 31.58 48.03 79.23 32.24 47.54 80.90 -7.97 53.82 83.02 -8.15 53.47 coo 79.09 29.82 54.20 77.17 28.90 53.05 85.67 -7.01 49.55 87.33 -8.74 49.65 ULMN 3 1mjo_d00 TRANSCRIPTION/DNA user 7 3 # 7 D 23 LYS B 238 LYS~? 10.43 MG MG B 701 D 25 THR B 230 THR~? 11.71 MG MG B 701 D 27 SER B 246 SER~? 19.29 MG MG B 701 coo 86.60 33.38 44.00 87.05 39.52 42.71 60.37 -14.95 16.47 59.84 -17.17 21.39 coo 81.20 31.58 48.03 79.23 32.24 47.54 63.14 -13.74 22.31 64.62 -14.39 20.89 coo 79.09 29.82 54.20 77.17 28.90 53.05 71.01 -12.18 18.97 73.33 -12.81 19.38 1mjo_d00 source 1mjo TRANSCRIPTION/DNA : 7 hits 1mjo_d00 naa= 3 ULMN 5 1puf_d01 TRANSCRIPTION/DNA user 1 5 # 1 B 237 ARG B 126 ARG^? 29.16 MG MG B 701 B 282 ASN B 121 ASN~? 40.01 MG MG B 701 B 286 ASN B 123 ASN~? 41.71 MG MG B 701 B 289 ILE B 139 ILE^? 39.53 MG MG B 701 B 290 ARG B 138 ARG^? 35.64 MG MG B 701 coo -5.10 15.13 5.71 -4.91 12.17 6.50 72.93 -22.54 42.02 74.52 -21.06 39.83 coo 2.51 20.44 4.28 1.26 22.15 4.11 80.51 -24.09 47.29 82.46 -24.55 46.48 coo 5.06 16.69 8.21 3.26 17.85 8.47 84.46 -20.26 46.14 86.41 -20.49 46.97 coo 9.09 18.34 13.23 8.90 18.41 14.03 83.27 -12.61 48.94 83.55 -12.47 50.31 coo 5.43 13.66 11.60 2.60 14.79 11.13 81.28 -15.50 42.88 84.08 -15.53 41.69 1puf_d01 source 1puf TRANSCRIPTION/DNA : 1 hits 1puf_d01 naa= 5 ULMN 4 1v15_d00 HYDROLASE user 1 4 # 1 D 5 ARG B 89 ARG~? 39.23 MG MG B 701 D 51 ASP B 91 ASP~? 46.73 MG MG B 701 D 54 ARG B 94 ARG~? 47.57 MG MG B 701 D 96 ARG B 71 ARG~? 47.78 MG MG B 701 coo 26.68 123.37 35.42 27.02 123.02 38.47 70.16 -17.97 55.88 70.89 -15.54 57.64 coo 28.85 117.12 30.52 26.97 118.21 30.78 69.68 -24.93 62.08 69.33 -24.21 64.01 coo 27.03 113.91 36.12 26.66 115.85 33.77 76.29 -23.20 63.54 75.68 -20.19 63.65 coo 15.69 117.00 39.50 16.92 119.48 40.82 84.61 -16.28 59.56 86.63 -14.84 57.69 1v15_d00 source 1v15 HYDROLASE : 1 hits 1v15_d00 naa= 4 ULMN 4 1zme_d00 TRANSCRIPTION/DNA user 1 4 # 1 D 41 HIS A 192 HIS~? 50.82 MG MG B 701 D 67 LYS B 172 LYS~? 42.28 MG MG B 701 D 69 ILE B 149 ILE^? 36.12 MG MG B 701 D 70 VAL B 148 VAL^? 36.96 MG MG B 701 coo 33.21 28.24 12.68 34.93 27.24 13.36 68.48 1.80 70.19 70.40 2.63 70.21 coo 43.60 24.24 -2.92 40.98 22.76 -1.01 75.30 -2.84 54.33 79.74 -2.40 56.36 coo 45.09 17.16 -5.36 44.78 17.47 -6.67 78.40 -9.76 49.57 78.00 -10.64 50.68 coo 48.05 14.52 -3.67 47.42 13.00 -2.17 82.04 -6.86 48.43 82.12 -5.42 46.76 1zme_d00 source 1zme TRANSCRIPTION/DNA : 1 hits 1zme_d00 naa= 4 ULMN 4 2bgw_d00 HYDROLASE user 1 4 # 1 A 86 ALA A 160 ALA~? 35.52 MG MG B 701 A 87 GLU A 231 GLU~? 40.57 MG MG B 701 A 123 TYR A 211 TYR~? 36.27 MG MG B 701 A 182 ARG A 226 ARG^? 38.22 MG MG B 701 coo 33.66 63.14 16.62 34.95 63.46 15.91 45.30 6.87 52.88 46.13 8.16 52.95 coo 28.97 64.99 12.92 27.92 64.06 11.28 46.37 8.02 59.96 46.65 9.30 58.33 coo 38.40 63.73 13.00 38.79 62.53 10.47 46.06 1.29 56.07 43.74 -0.16 56.67 coo 29.35 67.59 19.60 30.93 68.47 17.09 52.39 10.28 54.33 53.57 13.12 54.39 2bgw_d00 source 2bgw HYDROLASE : 1 hits 2bgw_d00 naa= 4 ULMN 3 2bsq_d00 TRANSCRIPTION user 1 3 # 1 E 3 SER A 110 SER~? 31.15 MG MG B 701 E 5 VAL A 84 VAL~? 27.83 MG MG B 701 E 7 ARG A 89 ARG~? 21.03 MG MG B 701 coo -3.82 -25.91 35.53 -5.28 -27.06 37.10 31.60 12.76 34.14 32.49 10.59 33.52 coo -8.42 -21.09 33.22 -10.34 -21.69 33.92 35.85 9.55 32.37 37.25 11.34 32.29 coo -12.01 -17.19 33.96 -11.18 -17.21 36.88 41.91 10.07 29.06 41.51 7.36 27.58 ULMN 3 2bsq_d00 TRANSCRIPTION user 2 3 # 2 E 3 SER A 111 SER~? 32.12 MG MG B 701 E 5 VAL A 84 VAL~? 27.83 MG MG B 701 E 7 ARG A 89 ARG~? 21.03 MG MG B 701 coo -3.82 -25.91 35.53 -5.28 -27.06 37.10 28.64 11.17 32.36 29.60 10.10 30.40 coo -8.42 -21.09 33.22 -10.34 -21.69 33.92 35.85 9.55 32.37 37.25 11.34 32.29 coo -12.01 -17.19 33.96 -11.18 -17.21 36.88 41.91 10.07 29.06 41.51 7.36 27.58 ULMN 3 2bsq_d00 TRANSCRIPTION user 3 3 # 3 E 3 SER A 162 SER^? 29.38 MG MG B 701 E 5 VAL A 214 VAL~? 28.87 MG MG B 701 E 7 ARG A 226 ARG^? 38.22 MG MG B 701 coo -3.82 -25.91 35.53 -5.28 -27.06 37.10 48.41 3.59 47.69 49.51 5.75 47.96 coo -8.42 -21.09 33.22 -10.34 -21.69 33.92 53.00 6.92 48.32 53.81 5.31 47.11 coo -12.01 -17.19 33.96 -11.18 -17.21 36.88 52.39 10.28 54.33 53.57 13.12 54.39 ULMN 3 2bsq_d00 TRANSCRIPTION user 4 3 # 4 E 3 SER B 110 SER~? 33.08 MG MG B 701 E 5 VAL B 84 VAL~? 35.81 MG MG B 701 E 7 ARG B 89 ARG~? 39.23 MG MG B 701 coo -3.82 -25.91 35.53 -5.28 -27.06 37.10 59.95 -23.29 54.22 59.15 -22.24 52.19 coo -8.42 -21.09 33.22 -10.34 -21.69 33.92 63.86 -18.76 55.66 65.27 -20.12 54.64 coo -12.01 -17.19 33.96 -11.18 -17.21 36.88 70.16 -17.97 55.88 70.89 -15.54 57.64 ULMN 3 2bsq_d00 TRANSCRIPTION user 5 3 # 5 E 3 SER B 111 SER~? 36.45 MG MG B 701 E 5 VAL B 84 VAL~? 35.81 MG MG B 701 E 7 ARG B 89 ARG~? 39.23 MG MG B 701 coo -3.82 -25.91 35.53 -5.28 -27.06 37.10 56.74 -22.11 55.96 57.39 -19.94 56.97 coo -8.42 -21.09 33.22 -10.34 -21.69 33.92 63.86 -18.76 55.66 65.27 -20.12 54.64 coo -12.01 -17.19 33.96 -11.18 -17.21 36.88 70.16 -17.97 55.88 70.89 -15.54 57.64 ULMN 3 2bsq_d00 TRANSCRIPTION user 6 3 # 6 E 3 SER B 215 SER~? 26.70 MG MG B 701 E 5 VAL B 152 VAL^? 26.04 MG MG B 701 E 7 ARG B 163 ARG^? 22.33 MG MG B 701 coo -3.82 -25.91 35.53 -5.28 -27.06 37.10 75.07 -16.26 35.49 76.05 -18.46 35.16 coo -8.42 -21.09 33.22 -10.34 -21.69 33.92 72.25 -12.29 41.96 73.36 -12.62 40.07 coo -12.01 -17.19 33.96 -11.18 -17.21 36.88 66.22 -8.44 41.95 64.50 -6.02 42.66 2bsq_d00 source 2bsq TRANSCRIPTION : 6 hits 2bsq_d00 naa= 3 ULMN 3 2ky8_d00 TRANSCRIPTION/DNA user 1 3 # 1 A 24 ARG B 178 ARG~? 37.59 MG MG B 701 A 32 LYS B 175 LYS~? 34.92 MG MG B 701 A 46 ARG B 258 ARG^? 33.01 MG MG B 701 coo -8.00 4.27 27.74 -7.09 2.66 30.09 79.48 2.47 45.22 81.37 1.59 47.51 coo -5.15 8.65 26.69 -4.26 5.48 32.02 75.00 1.45 45.20 75.48 7.65 46.06 coo -0.17 -5.20 27.14 -1.15 -5.34 29.97 83.96 -0.40 36.39 82.47 1.91 37.80 2ky8_d00 source 2ky8 TRANSCRIPTION/DNA : 1 hits 2ky8_d00 naa= 3 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 1 3 # 1 B 34 SER A 100 SER~? 32.62 MG MG B 701 B 37 ASN A 121 ASN^? 29.95 MG MG B 701 B 45 THR A 117 THR^? 34.97 MG MG B 701 coo -19.49 41.97 71.08 -17.37 40.80 71.17 53.58 21.63 28.64 52.67 23.81 29.19 coo -23.05 39.62 69.74 -22.86 39.59 67.61 52.20 18.76 34.12 54.15 19.63 34.02 coo -30.87 34.84 80.57 -28.94 34.51 81.49 39.68 17.15 38.48 39.65 17.82 40.51 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 2 3 # 2 B 34 SER B 100 SER~? 45.77 MG MG B 701 B 37 ASN B 121 ASN~? 40.01 MG MG B 701 B 45 THR B 117 THR^? 33.70 MG MG B 701 coo -19.49 41.97 71.08 -17.37 40.80 71.17 84.70 -26.50 51.42 84.08 -28.81 51.12 coo -23.05 39.62 69.74 -22.86 39.59 67.61 80.51 -24.09 47.29 82.46 -24.55 46.48 coo -30.87 34.84 80.57 -28.94 34.51 81.49 67.56 -26.21 48.19 67.67 -27.81 46.75 2z3x_d00 source 2z3x DNA BINDING PROTEIN/DNA : 2 hits 2z3x_d00 naa= 3 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 1 3 # 1 A 18 SER A 100 SER~? 32.62 MG MG B 701 A 20 HIS A 104 HIS^? 33.98 MG MG B 701 A 22 LEU A 92 LEU~? 29.77 MG MG B 701 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 53.58 21.63 28.64 52.67 23.81 29.19 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 45.13 22.80 31.21 43.22 23.40 30.59 coo -14.55 2.62 13.63 -14.94 2.66 11.50 39.61 16.69 28.94 40.79 16.87 30.80 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 2 3 # 2 A 18 SER B 100 SER~? 45.77 MG MG B 701 A 20 HIS B 104 HIS^? 43.18 MG MG B 701 A 22 LEU B 92 LEU~? 40.63 MG MG B 701 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 84.70 -26.50 51.42 84.08 -28.81 51.12 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 76.52 -29.94 52.39 75.18 -30.89 53.68 coo -14.55 2.62 13.63 -14.94 2.66 11.50 70.15 -25.59 56.83 70.23 -26.19 54.69 3gxq_d00 source 3gxq DNA BINDING PROTEIN/DNA : 2 hits 3gxq_d00 naa= 3 ULMN 3 3s57_d00 OXIDOREDUCTASE/DNA user 1 3 # 1 A 101 VAL A 148 VAL^? 13.75 MG MG B 701 A 102 PHE A 166 PHE^? 17.85 MG MG B 701 A 169 CYH A 72 CYH~? 15.35 MG MG B 701 coo -0.48 2.03 12.21 0.64 0.32 12.97 57.35 2.46 31.20 58.46 0.97 32.40 coo 0.51 5.20 15.97 0.26 4.09 18.50 55.48 -0.21 37.25 56.90 1.01 39.28 coo 4.56 -7.03 18.26 5.32 -4.76 16.88 49.96 7.59 26.24 52.51 6.56 26.61 ULMN 3 3s57_d00 OXIDOREDUCTASE/DNA user 2 3 # 2 A 101 VAL A 151 VAL^? 20.34 MG MG B 701 A 102 PHE A 136 PHE^? 26.98 MG MG B 701 A 169 CYH A 72 CYH~? 15.35 MG MG B 701 coo -0.48 2.03 12.21 0.64 0.32 12.97 50.63 4.98 38.04 48.87 4.93 36.68 coo 0.51 5.20 15.97 0.26 4.09 18.50 51.01 11.36 40.52 53.20 13.02 39.90 coo 4.56 -7.03 18.26 5.32 -4.76 16.88 49.96 7.59 26.24 52.51 6.56 26.61 ULMN 3 3s57_d00 OXIDOREDUCTASE/DNA user 3 3 # 3 A 101 VAL B 148 VAL^? 36.96 MG MG B 701 A 102 PHE B 166 PHE^? 30.39 MG MG B 701 A 169 CYH B 72 CYH~? 41.54 MG MG B 701 coo -0.48 2.03 12.21 0.64 0.32 12.97 82.04 -6.86 48.43 82.12 -5.42 46.76 coo 0.51 5.20 15.97 0.26 4.09 18.50 77.21 -5.09 44.06 77.80 -6.03 41.49 coo 4.56 -7.03 18.26 5.32 -4.76 16.88 79.11 -13.84 55.95 80.97 -12.20 54.68 3s57_d00 source 3s57 OXIDOREDUCTASE/DNA : 3 hits 3s57_d00 naa= 3 ULMN 3 2odj_o00 PORIN D user 1 3 # 1 A 156 HIS B 157 HIS~? 18.79 MG MG B 701 A 208 ASP A 177 ASP~? 19.64 MG MG B 701 A 296 SER B 217 SER~? 33.42 MG MG B 701 coo 12.72 17.48 24.71 12.80 19.37 23.81 58.96 -20.41 35.42 60.06 -22.12 34.89 coo 18.47 29.19 29.68 19.30 29.17 27.75 57.48 -8.32 42.16 55.62 -9.31 42.19 coo 6.89 17.22 46.63 5.08 16.21 47.91 80.79 -17.73 37.60 83.05 -18.57 37.26 2odj_o00 source 2ODJ PORIN D : 1 hits 2odj_o00 naa= 3 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 1 3 # 1 A 130 SER A 143 SER~? 15.64 MG MG B 701 A 166 PHE A 179 PHE~? 15.24 MG MG B 701 A 182 PHE A 259 PHE^? 23.41 MG MG B 701 coo -46.28 37.24 81.97 -44.96 39.32 82.40 66.42 2.53 29.16 66.03 2.11 26.82 coo -36.62 39.62 84.60 -38.76 41.24 85.25 59.12 -2.16 37.53 58.98 -3.05 34.90 coo -36.55 45.66 79.22 -38.34 43.94 80.53 60.86 3.12 42.58 59.55 5.17 41.16 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 2 3 # 2 A 130 SER A 145 SER~? 15.87 MG MG B 701 A 166 PHE B 189 PHE~? 14.75 MG MG B 701 A 182 PHE B 188 PHE~? 17.15 MG MG B 701 coo -46.28 37.24 81.97 -44.96 39.32 82.40 65.62 4.84 24.49 66.57 2.65 23.80 coo -36.62 39.62 84.60 -38.76 41.24 85.25 69.85 -4.50 18.58 67.45 -3.45 19.57 coo -36.55 45.66 79.22 -38.34 43.94 80.53 71.48 -8.55 24.27 72.09 -8.90 26.93 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 3 3 # 3 A 130 SER A 147 SER^? 16.30 MG MG B 701 A 166 PHE A 166 PHE^? 17.85 MG MG B 701 A 182 PHE A 259 PHE^? 23.41 MG MG B 701 coo -46.28 37.24 81.97 -44.96 39.32 82.40 59.94 3.92 28.83 60.06 6.29 28.37 coo -36.62 39.62 84.60 -38.76 41.24 85.25 55.48 -0.21 37.25 56.90 1.01 39.28 coo -36.55 45.66 79.22 -38.34 43.94 80.53 60.86 3.12 42.58 59.55 5.17 41.16 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 4 3 # 4 A 130 SER A 147 SER^? 16.30 MG MG B 701 A 166 PHE A 179 PHE~? 15.24 MG MG B 701 A 182 PHE A 259 PHE^? 23.41 MG MG B 701 coo -46.28 37.24 81.97 -44.96 39.32 82.40 59.94 3.92 28.83 60.06 6.29 28.37 coo -36.62 39.62 84.60 -38.76 41.24 85.25 59.12 -2.16 37.53 58.98 -3.05 34.90 coo -36.55 45.66 79.22 -38.34 43.94 80.53 60.86 3.12 42.58 59.55 5.17 41.16 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 5 3 # 5 A 130 SER A 210 SER~? 36.07 MG MG B 701 A 166 PHE A 188 PHE~? 35.84 MG MG B 701 A 182 PHE A 189 PHE~? 41.84 MG MG B 701 coo -46.28 37.24 81.97 -44.96 39.32 82.40 49.99 -1.69 57.23 51.51 -3.29 58.19 coo -36.62 39.62 84.60 -38.76 41.24 85.25 57.53 2.90 57.96 56.98 3.16 55.25 coo -36.55 45.66 79.22 -38.34 43.94 80.53 59.77 -0.70 63.73 57.68 -2.54 63.82 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 6 3 # 6 A 130 SER A 215 SER~? 31.75 MG MG B 701 A 166 PHE A 259 PHE^? 23.41 MG MG B 701 A 182 PHE A 166 PHE^? 17.85 MG MG B 701 coo -46.28 37.24 81.97 -44.96 39.32 82.40 53.96 10.22 46.63 54.01 12.63 46.67 coo -36.62 39.62 84.60 -38.76 41.24 85.25 60.86 3.12 42.58 59.55 5.17 41.16 coo -36.55 45.66 79.22 -38.34 43.94 80.53 55.48 -0.21 37.25 56.90 1.01 39.28 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 7 3 # 7 A 130 SER A 217 SER~? 30.46 MG MG B 701 A 166 PHE A 259 PHE^? 23.41 MG MG B 701 A 182 PHE A 166 PHE^? 17.85 MG MG B 701 coo -46.28 37.24 81.97 -44.96 39.32 82.40 57.85 13.16 42.60 59.76 14.69 42.27 coo -36.62 39.62 84.60 -38.76 41.24 85.25 60.86 3.12 42.58 59.55 5.17 41.16 coo -36.55 45.66 79.22 -38.34 43.94 80.53 55.48 -0.21 37.25 56.90 1.01 39.28 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 8 3 # 8 A 130 SER A 220 SER~? 30.23 MG MG B 701 A 166 PHE A 124 PHE^? 29.34 MG MG B 701 A 182 PHE A 136 PHE^? 26.98 MG MG B 701 coo -46.28 37.24 81.97 -44.96 39.32 82.40 62.66 13.66 39.67 62.74 13.68 42.09 coo -36.62 39.62 84.60 -38.76 41.24 85.25 53.10 15.90 36.97 52.63 18.53 37.74 coo -36.55 45.66 79.22 -38.34 43.94 80.53 51.01 11.36 40.52 53.20 13.02 39.90 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 9 3 # 9 A 130 SER A 224 SER^? 34.13 MG MG B 701 A 166 PHE A 136 PHE^? 26.98 MG MG B 701 A 182 PHE A 124 PHE^? 29.34 MG MG B 701 coo -46.28 37.24 81.97 -44.96 39.32 82.40 58.45 8.88 49.16 58.56 10.38 51.09 coo -36.62 39.62 84.60 -38.76 41.24 85.25 51.01 11.36 40.52 53.20 13.02 39.90 coo -36.55 45.66 79.22 -38.34 43.94 80.53 53.10 15.90 36.97 52.63 18.53 37.74 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 10 3 # 10 A 130 SER A 256 SER~? 22.42 MG MG B 701 A 166 PHE A 259 PHE^? 23.41 MG MG B 701 A 182 PHE A 166 PHE^? 17.85 MG MG B 701 coo -46.28 37.24 81.97 -44.96 39.32 82.40 68.19 1.16 36.27 69.40 -0.26 37.83 coo -36.62 39.62 84.60 -38.76 41.24 85.25 60.86 3.12 42.58 59.55 5.17 41.16 coo -36.55 45.66 79.22 -38.34 43.94 80.53 55.48 -0.21 37.25 56.90 1.01 39.28 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 11 3 # 11 A 130 SER B 143 SER~? 44.45 MG MG B 701 A 166 PHE B 179 PHE~? 33.79 MG MG B 701 A 182 PHE B 259 PHE^? 29.88 MG MG B 701 coo -46.28 37.24 81.97 -44.96 39.32 82.40 90.48 -3.13 47.60 89.69 -2.19 49.67 coo -36.62 39.62 84.60 -38.76 41.24 85.25 80.09 -2.55 42.63 80.83 -1.68 45.20 coo -36.55 45.66 79.22 -38.34 43.94 80.53 80.60 -7.36 37.01 80.46 -9.35 38.95 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 12 3 # 12 A 130 SER B 145 SER~? 46.81 MG MG B 701 A 166 PHE B 142 PHE~? 39.32 MG MG B 701 A 182 PHE B 179 PHE~? 33.79 MG MG B 701 coo -46.28 37.24 81.97 -44.96 39.32 82.40 91.16 -3.94 52.87 90.08 -1.82 52.87 coo -36.62 39.62 84.60 -38.76 41.24 85.25 86.08 -2.81 46.36 85.54 -0.20 45.70 coo -36.55 45.66 79.22 -38.34 43.94 80.53 80.09 -2.55 42.63 80.83 -1.68 45.20 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 13 3 # 13 A 130 SER B 147 SER^? 42.22 MG MG B 701 A 166 PHE B 166 PHE^? 30.39 MG MG B 701 A 182 PHE B 259 PHE^? 29.88 MG MG B 701 coo -46.28 37.24 81.97 -44.96 39.32 82.40 85.67 -7.01 49.55 87.33 -8.74 49.65 coo -36.62 39.62 84.60 -38.76 41.24 85.25 77.21 -5.09 44.06 77.80 -6.03 41.49 coo -36.55 45.66 79.22 -38.34 43.94 80.53 80.60 -7.36 37.01 80.46 -9.35 38.95 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 14 3 # 14 A 130 SER B 147 SER^? 42.22 MG MG B 701 A 166 PHE B 179 PHE~? 33.79 MG MG B 701 A 182 PHE B 259 PHE^? 29.88 MG MG B 701 coo -46.28 37.24 81.97 -44.96 39.32 82.40 85.67 -7.01 49.55 87.33 -8.74 49.65 coo -36.62 39.62 84.60 -38.76 41.24 85.25 80.09 -2.55 42.63 80.83 -1.68 45.20 coo -36.55 45.66 79.22 -38.34 43.94 80.53 80.60 -7.36 37.01 80.46 -9.35 38.95 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 15 3 # 15 A 130 SER B 210 SER~? 12.60 MG MG B 701 A 166 PHE B 188 PHE~? 17.15 MG MG B 701 A 182 PHE B 189 PHE~? 14.75 MG MG B 701 coo -46.28 37.24 81.97 -44.96 39.32 82.40 63.63 -6.43 28.51 65.51 -5.02 28.70 coo -36.62 39.62 84.60 -38.76 41.24 85.25 71.48 -8.55 24.27 72.09 -8.90 26.93 coo -36.55 45.66 79.22 -38.34 43.94 80.53 69.85 -4.50 18.58 67.45 -3.45 19.57 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 16 3 # 16 A 130 SER B 215 SER~? 26.70 MG MG B 701 A 166 PHE B 259 PHE^? 29.88 MG MG B 701 A 182 PHE B 166 PHE^? 30.39 MG MG B 701 coo -46.28 37.24 81.97 -44.96 39.32 82.40 75.07 -16.26 35.49 76.05 -18.46 35.16 coo -36.62 39.62 84.60 -38.76 41.24 85.25 80.60 -7.36 37.01 80.46 -9.35 38.95 coo -36.55 45.66 79.22 -38.34 43.94 80.53 77.21 -5.09 44.06 77.80 -6.03 41.49 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 17 3 # 17 A 130 SER B 217 SER~? 33.42 MG MG B 701 A 166 PHE B 259 PHE^? 29.88 MG MG B 701 A 182 PHE B 166 PHE^? 30.39 MG MG B 701 coo -46.28 37.24 81.97 -44.96 39.32 82.40 80.79 -17.73 37.60 83.05 -18.57 37.26 coo -36.62 39.62 84.60 -38.76 41.24 85.25 80.60 -7.36 37.01 80.46 -9.35 38.95 coo -36.55 45.66 79.22 -38.34 43.94 80.53 77.21 -5.09 44.06 77.80 -6.03 41.49 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 18 3 # 18 A 130 SER B 256 SER~? 38.63 MG MG B 701 A 166 PHE B 259 PHE^? 29.88 MG MG B 701 A 182 PHE B 166 PHE^? 30.39 MG MG B 701 coo -46.28 37.24 81.97 -44.96 39.32 82.40 89.21 -2.78 38.72 90.41 -2.19 36.69 coo -36.62 39.62 84.60 -38.76 41.24 85.25 80.60 -7.36 37.01 80.46 -9.35 38.95 coo -36.55 45.66 79.22 -38.34 43.94 80.53 77.21 -5.09 44.06 77.80 -6.03 41.49 2r11_o00 source 2R11 CARBOXYLESTERASE NP : 18 hits 2r11_o00 naa= 3 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 1 3 # 1 B 130 SER A 110 SER~? 31.15 MG MG B 701 B 166 PHE A 118 PHE^? 29.09 MG MG B 701 B 182 PHE A 73 PHE~? 23.31 MG MG B 701 coo -19.94 46.29 97.83 -22.38 46.56 97.60 31.60 12.76 34.14 32.49 10.59 33.52 coo -29.59 43.40 95.66 -28.22 45.54 94.50 41.62 15.66 34.45 39.96 13.55 33.81 coo -32.72 50.15 98.46 -30.32 48.85 97.77 46.15 11.22 29.51 44.01 12.03 31.08 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 2 3 # 2 B 130 SER A 143 SER~? 15.64 MG MG B 701 B 166 PHE A 179 PHE~? 15.24 MG MG B 701 B 182 PHE A 259 PHE^? 23.41 MG MG B 701 coo -19.94 46.29 97.83 -22.38 46.56 97.60 66.42 2.53 29.16 66.03 2.11 26.82 coo -29.59 43.40 95.66 -28.22 45.54 94.50 59.12 -2.16 37.53 58.98 -3.05 34.90 coo -32.72 50.15 98.46 -30.32 48.85 97.77 60.86 3.12 42.58 59.55 5.17 41.16 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 3 3 # 3 B 130 SER A 145 SER~? 15.87 MG MG B 701 B 166 PHE B 189 PHE~? 14.75 MG MG B 701 B 182 PHE B 188 PHE~? 17.15 MG MG B 701 coo -19.94 46.29 97.83 -22.38 46.56 97.60 65.62 4.84 24.49 66.57 2.65 23.80 coo -29.59 43.40 95.66 -28.22 45.54 94.50 69.85 -4.50 18.58 67.45 -3.45 19.57 coo -32.72 50.15 98.46 -30.32 48.85 97.77 71.48 -8.55 24.27 72.09 -8.90 26.93 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 4 3 # 4 B 130 SER A 147 SER^? 16.30 MG MG B 701 B 166 PHE A 166 PHE^? 17.85 MG MG B 701 B 182 PHE A 259 PHE^? 23.41 MG MG B 701 coo -19.94 46.29 97.83 -22.38 46.56 97.60 59.94 3.92 28.83 60.06 6.29 28.37 coo -29.59 43.40 95.66 -28.22 45.54 94.50 55.48 -0.21 37.25 56.90 1.01 39.28 coo -32.72 50.15 98.46 -30.32 48.85 97.77 60.86 3.12 42.58 59.55 5.17 41.16 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 5 3 # 5 B 130 SER A 147 SER^? 16.30 MG MG B 701 B 166 PHE A 179 PHE~? 15.24 MG MG B 701 B 182 PHE A 259 PHE^? 23.41 MG MG B 701 coo -19.94 46.29 97.83 -22.38 46.56 97.60 59.94 3.92 28.83 60.06 6.29 28.37 coo -29.59 43.40 95.66 -28.22 45.54 94.50 59.12 -2.16 37.53 58.98 -3.05 34.90 coo -32.72 50.15 98.46 -30.32 48.85 97.77 60.86 3.12 42.58 59.55 5.17 41.16 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 6 3 # 6 B 130 SER A 210 SER~? 36.07 MG MG B 701 B 166 PHE A 188 PHE~? 35.84 MG MG B 701 B 182 PHE A 189 PHE~? 41.84 MG MG B 701 coo -19.94 46.29 97.83 -22.38 46.56 97.60 49.99 -1.69 57.23 51.51 -3.29 58.19 coo -29.59 43.40 95.66 -28.22 45.54 94.50 57.53 2.90 57.96 56.98 3.16 55.25 coo -32.72 50.15 98.46 -30.32 48.85 97.77 59.77 -0.70 63.73 57.68 -2.54 63.82 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 7 3 # 7 B 130 SER A 215 SER~? 31.75 MG MG B 701 B 166 PHE A 259 PHE^? 23.41 MG MG B 701 B 182 PHE A 166 PHE^? 17.85 MG MG B 701 coo -19.94 46.29 97.83 -22.38 46.56 97.60 53.96 10.22 46.63 54.01 12.63 46.67 coo -29.59 43.40 95.66 -28.22 45.54 94.50 60.86 3.12 42.58 59.55 5.17 41.16 coo -32.72 50.15 98.46 -30.32 48.85 97.77 55.48 -0.21 37.25 56.90 1.01 39.28 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 8 3 # 8 B 130 SER A 217 SER~? 30.46 MG MG B 701 B 166 PHE A 259 PHE^? 23.41 MG MG B 701 B 182 PHE A 166 PHE^? 17.85 MG MG B 701 coo -19.94 46.29 97.83 -22.38 46.56 97.60 57.85 13.16 42.60 59.76 14.69 42.27 coo -29.59 43.40 95.66 -28.22 45.54 94.50 60.86 3.12 42.58 59.55 5.17 41.16 coo -32.72 50.15 98.46 -30.32 48.85 97.77 55.48 -0.21 37.25 56.90 1.01 39.28 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 9 3 # 9 B 130 SER A 220 SER~? 30.23 MG MG B 701 B 166 PHE A 124 PHE^? 29.34 MG MG B 701 B 182 PHE A 136 PHE^? 26.98 MG MG B 701 coo -19.94 46.29 97.83 -22.38 46.56 97.60 62.66 13.66 39.67 62.74 13.68 42.09 coo -29.59 43.40 95.66 -28.22 45.54 94.50 53.10 15.90 36.97 52.63 18.53 37.74 coo -32.72 50.15 98.46 -30.32 48.85 97.77 51.01 11.36 40.52 53.20 13.02 39.90 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 10 3 # 10 B 130 SER A 224 SER^? 34.13 MG MG B 701 B 166 PHE A 136 PHE^? 26.98 MG MG B 701 B 182 PHE A 124 PHE^? 29.34 MG MG B 701 coo -19.94 46.29 97.83 -22.38 46.56 97.60 58.45 8.88 49.16 58.56 10.38 51.09 coo -29.59 43.40 95.66 -28.22 45.54 94.50 51.01 11.36 40.52 53.20 13.02 39.90 coo -32.72 50.15 98.46 -30.32 48.85 97.77 53.10 15.90 36.97 52.63 18.53 37.74 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 11 3 # 11 B 130 SER A 224 SER^? 34.13 MG MG B 701 B 166 PHE A 259 PHE^? 23.41 MG MG B 701 B 182 PHE A 166 PHE^? 17.85 MG MG B 701 coo -19.94 46.29 97.83 -22.38 46.56 97.60 58.45 8.88 49.16 58.56 10.38 51.09 coo -29.59 43.40 95.66 -28.22 45.54 94.50 60.86 3.12 42.58 59.55 5.17 41.16 coo -32.72 50.15 98.46 -30.32 48.85 97.77 55.48 -0.21 37.25 56.90 1.01 39.28 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 12 3 # 12 B 130 SER A 256 SER~? 22.42 MG MG B 701 B 166 PHE A 259 PHE^? 23.41 MG MG B 701 B 182 PHE A 166 PHE^? 17.85 MG MG B 701 coo -19.94 46.29 97.83 -22.38 46.56 97.60 68.19 1.16 36.27 69.40 -0.26 37.83 coo -29.59 43.40 95.66 -28.22 45.54 94.50 60.86 3.12 42.58 59.55 5.17 41.16 coo -32.72 50.15 98.46 -30.32 48.85 97.77 55.48 -0.21 37.25 56.90 1.01 39.28 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 13 3 # 13 B 130 SER B 143 SER~? 44.45 MG MG B 701 B 166 PHE B 179 PHE~? 33.79 MG MG B 701 B 182 PHE B 259 PHE^? 29.88 MG MG B 701 coo -19.94 46.29 97.83 -22.38 46.56 97.60 90.48 -3.13 47.60 89.69 -2.19 49.67 coo -29.59 43.40 95.66 -28.22 45.54 94.50 80.09 -2.55 42.63 80.83 -1.68 45.20 coo -32.72 50.15 98.46 -30.32 48.85 97.77 80.60 -7.36 37.01 80.46 -9.35 38.95 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 14 3 # 14 B 130 SER B 145 SER~? 46.81 MG MG B 701 B 166 PHE B 142 PHE~? 39.32 MG MG B 701 B 182 PHE B 179 PHE~? 33.79 MG MG B 701 coo -19.94 46.29 97.83 -22.38 46.56 97.60 91.16 -3.94 52.87 90.08 -1.82 52.87 coo -29.59 43.40 95.66 -28.22 45.54 94.50 86.08 -2.81 46.36 85.54 -0.20 45.70 coo -32.72 50.15 98.46 -30.32 48.85 97.77 80.09 -2.55 42.63 80.83 -1.68 45.20 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 15 3 # 15 B 130 SER B 147 SER^? 42.22 MG MG B 701 B 166 PHE B 166 PHE^? 30.39 MG MG B 701 B 182 PHE B 259 PHE^? 29.88 MG MG B 701 coo -19.94 46.29 97.83 -22.38 46.56 97.60 85.67 -7.01 49.55 87.33 -8.74 49.65 coo -29.59 43.40 95.66 -28.22 45.54 94.50 77.21 -5.09 44.06 77.80 -6.03 41.49 coo -32.72 50.15 98.46 -30.32 48.85 97.77 80.60 -7.36 37.01 80.46 -9.35 38.95 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 16 3 # 16 B 130 SER B 147 SER^? 42.22 MG MG B 701 B 166 PHE B 179 PHE~? 33.79 MG MG B 701 B 182 PHE B 259 PHE^? 29.88 MG MG B 701 coo -19.94 46.29 97.83 -22.38 46.56 97.60 85.67 -7.01 49.55 87.33 -8.74 49.65 coo -29.59 43.40 95.66 -28.22 45.54 94.50 80.09 -2.55 42.63 80.83 -1.68 45.20 coo -32.72 50.15 98.46 -30.32 48.85 97.77 80.60 -7.36 37.01 80.46 -9.35 38.95 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 17 3 # 17 B 130 SER B 206 SER~? -2.06 MG MG B 701s B 166 PHE A 142 PHE~? 13.47 MG MG B 701 B 182 PHE A 179 PHE~? 15.24 MG MG B 701 coo -19.94 46.29 97.83 -22.38 46.56 97.60 58.11 -6.07 22.68 56.48 -7.41 21.42 coo -29.59 43.40 95.66 -28.22 45.54 94.50 62.78 -0.55 30.89 63.67 -3.12 31.49 coo -32.72 50.15 98.46 -30.32 48.85 97.77 59.12 -2.16 37.53 58.98 -3.05 34.90 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 18 3 # 18 B 130 SER B 210 SER~? 12.60 MG MG B 701 B 166 PHE B 188 PHE~? 17.15 MG MG B 701 B 182 PHE B 189 PHE~? 14.75 MG MG B 701 coo -19.94 46.29 97.83 -22.38 46.56 97.60 63.63 -6.43 28.51 65.51 -5.02 28.70 coo -29.59 43.40 95.66 -28.22 45.54 94.50 71.48 -8.55 24.27 72.09 -8.90 26.93 coo -32.72 50.15 98.46 -30.32 48.85 97.77 69.85 -4.50 18.58 67.45 -3.45 19.57 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 19 3 # 19 B 130 SER B 215 SER~? 26.70 MG MG B 701 B 166 PHE B 259 PHE^? 29.88 MG MG B 701 B 182 PHE B 166 PHE^? 30.39 MG MG B 701 coo -19.94 46.29 97.83 -22.38 46.56 97.60 75.07 -16.26 35.49 76.05 -18.46 35.16 coo -29.59 43.40 95.66 -28.22 45.54 94.50 80.60 -7.36 37.01 80.46 -9.35 38.95 coo -32.72 50.15 98.46 -30.32 48.85 97.77 77.21 -5.09 44.06 77.80 -6.03 41.49 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 20 3 # 20 B 130 SER B 217 SER~? 33.42 MG MG B 701 B 166 PHE B 259 PHE^? 29.88 MG MG B 701 B 182 PHE B 166 PHE^? 30.39 MG MG B 701 coo -19.94 46.29 97.83 -22.38 46.56 97.60 80.79 -17.73 37.60 83.05 -18.57 37.26 coo -29.59 43.40 95.66 -28.22 45.54 94.50 80.60 -7.36 37.01 80.46 -9.35 38.95 coo -32.72 50.15 98.46 -30.32 48.85 97.77 77.21 -5.09 44.06 77.80 -6.03 41.49 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 21 3 # 21 B 130 SER B 224 SER^? 24.32 MG MG B 701 B 166 PHE B 259 PHE^? 29.88 MG MG B 701 B 182 PHE B 166 PHE^? 30.39 MG MG B 701 coo -19.94 46.29 97.83 -22.38 46.56 97.60 77.48 -13.89 31.52 77.07 -15.32 29.51 coo -29.59 43.40 95.66 -28.22 45.54 94.50 80.60 -7.36 37.01 80.46 -9.35 38.95 coo -32.72 50.15 98.46 -30.32 48.85 97.77 77.21 -5.09 44.06 77.80 -6.03 41.49 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 22 3 # 22 B 130 SER B 256 SER~? 38.63 MG MG B 701 B 166 PHE B 259 PHE^? 29.88 MG MG B 701 B 182 PHE B 166 PHE^? 30.39 MG MG B 701 coo -19.94 46.29 97.83 -22.38 46.56 97.60 89.21 -2.78 38.72 90.41 -2.19 36.69 coo -29.59 43.40 95.66 -28.22 45.54 94.50 80.60 -7.36 37.01 80.46 -9.35 38.95 coo -32.72 50.15 98.46 -30.32 48.85 97.77 77.21 -5.09 44.06 77.80 -6.03 41.49 2r11_o01 source 2R11 CARBOXYLESTERASE NP : 22 hits 2r11_o01 naa= 3 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 1 3 # 1 C 130 SER A 143 SER~? 15.64 MG MG B 701 C 166 PHE A 179 PHE~? 15.24 MG MG B 701 C 182 PHE A 259 PHE^? 23.41 MG MG B 701 coo -2.19 64.27 51.12 -3.34 62.10 50.60 66.42 2.53 29.16 66.03 2.11 26.82 coo -11.14 61.91 46.89 -9.88 60.30 48.76 59.12 -2.16 37.53 58.98 -3.05 34.90 coo -7.71 55.92 42.70 -7.18 57.60 44.85 60.86 3.12 42.58 59.55 5.17 41.16 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 2 3 # 2 C 130 SER A 145 SER~? 15.87 MG MG B 701 C 166 PHE B 189 PHE~? 14.75 MG MG B 701 C 182 PHE B 188 PHE~? 17.15 MG MG B 701 coo -2.19 64.27 51.12 -3.34 62.10 50.60 65.62 4.84 24.49 66.57 2.65 23.80 coo -11.14 61.91 46.89 -9.88 60.30 48.76 69.85 -4.50 18.58 67.45 -3.45 19.57 coo -7.71 55.92 42.70 -7.18 57.60 44.85 71.48 -8.55 24.27 72.09 -8.90 26.93 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 3 3 # 3 C 130 SER A 147 SER^? 16.30 MG MG B 701 C 166 PHE A 166 PHE^? 17.85 MG MG B 701 C 182 PHE A 259 PHE^? 23.41 MG MG B 701 coo -2.19 64.27 51.12 -3.34 62.10 50.60 59.94 3.92 28.83 60.06 6.29 28.37 coo -11.14 61.91 46.89 -9.88 60.30 48.76 55.48 -0.21 37.25 56.90 1.01 39.28 coo -7.71 55.92 42.70 -7.18 57.60 44.85 60.86 3.12 42.58 59.55 5.17 41.16 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 4 3 # 4 C 130 SER A 147 SER^? 16.30 MG MG B 701 C 166 PHE A 179 PHE~? 15.24 MG MG B 701 C 182 PHE A 259 PHE^? 23.41 MG MG B 701 coo -2.19 64.27 51.12 -3.34 62.10 50.60 59.94 3.92 28.83 60.06 6.29 28.37 coo -11.14 61.91 46.89 -9.88 60.30 48.76 59.12 -2.16 37.53 58.98 -3.05 34.90 coo -7.71 55.92 42.70 -7.18 57.60 44.85 60.86 3.12 42.58 59.55 5.17 41.16 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 5 3 # 5 C 130 SER A 210 SER~? 36.07 MG MG B 701 C 166 PHE A 188 PHE~? 35.84 MG MG B 701 C 182 PHE A 189 PHE~? 41.84 MG MG B 701 coo -2.19 64.27 51.12 -3.34 62.10 50.60 49.99 -1.69 57.23 51.51 -3.29 58.19 coo -11.14 61.91 46.89 -9.88 60.30 48.76 57.53 2.90 57.96 56.98 3.16 55.25 coo -7.71 55.92 42.70 -7.18 57.60 44.85 59.77 -0.70 63.73 57.68 -2.54 63.82 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 6 3 # 6 C 130 SER A 215 SER~? 31.75 MG MG B 701 C 166 PHE A 259 PHE^? 23.41 MG MG B 701 C 182 PHE A 166 PHE^? 17.85 MG MG B 701 coo -2.19 64.27 51.12 -3.34 62.10 50.60 53.96 10.22 46.63 54.01 12.63 46.67 coo -11.14 61.91 46.89 -9.88 60.30 48.76 60.86 3.12 42.58 59.55 5.17 41.16 coo -7.71 55.92 42.70 -7.18 57.60 44.85 55.48 -0.21 37.25 56.90 1.01 39.28 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 7 3 # 7 C 130 SER A 217 SER~? 30.46 MG MG B 701 C 166 PHE A 259 PHE^? 23.41 MG MG B 701 C 182 PHE A 166 PHE^? 17.85 MG MG B 701 coo -2.19 64.27 51.12 -3.34 62.10 50.60 57.85 13.16 42.60 59.76 14.69 42.27 coo -11.14 61.91 46.89 -9.88 60.30 48.76 60.86 3.12 42.58 59.55 5.17 41.16 coo -7.71 55.92 42.70 -7.18 57.60 44.85 55.48 -0.21 37.25 56.90 1.01 39.28 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 8 3 # 8 C 130 SER A 220 SER~? 30.23 MG MG B 701 C 166 PHE A 124 PHE^? 29.34 MG MG B 701 C 182 PHE A 136 PHE^? 26.98 MG MG B 701 coo -2.19 64.27 51.12 -3.34 62.10 50.60 62.66 13.66 39.67 62.74 13.68 42.09 coo -11.14 61.91 46.89 -9.88 60.30 48.76 53.10 15.90 36.97 52.63 18.53 37.74 coo -7.71 55.92 42.70 -7.18 57.60 44.85 51.01 11.36 40.52 53.20 13.02 39.90 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 9 3 # 9 C 130 SER A 224 SER^? 34.13 MG MG B 701 C 166 PHE A 136 PHE^? 26.98 MG MG B 701 C 182 PHE A 124 PHE^? 29.34 MG MG B 701 coo -2.19 64.27 51.12 -3.34 62.10 50.60 58.45 8.88 49.16 58.56 10.38 51.09 coo -11.14 61.91 46.89 -9.88 60.30 48.76 51.01 11.36 40.52 53.20 13.02 39.90 coo -7.71 55.92 42.70 -7.18 57.60 44.85 53.10 15.90 36.97 52.63 18.53 37.74 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 10 3 # 10 C 130 SER A 256 SER~? 22.42 MG MG B 701 C 166 PHE A 259 PHE^? 23.41 MG MG B 701 C 182 PHE A 166 PHE^? 17.85 MG MG B 701 coo -2.19 64.27 51.12 -3.34 62.10 50.60 68.19 1.16 36.27 69.40 -0.26 37.83 coo -11.14 61.91 46.89 -9.88 60.30 48.76 60.86 3.12 42.58 59.55 5.17 41.16 coo -7.71 55.92 42.70 -7.18 57.60 44.85 55.48 -0.21 37.25 56.90 1.01 39.28 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 11 3 # 11 C 130 SER B 143 SER~? 44.45 MG MG B 701 C 166 PHE B 179 PHE~? 33.79 MG MG B 701 C 182 PHE B 259 PHE^? 29.88 MG MG B 701 coo -2.19 64.27 51.12 -3.34 62.10 50.60 90.48 -3.13 47.60 89.69 -2.19 49.67 coo -11.14 61.91 46.89 -9.88 60.30 48.76 80.09 -2.55 42.63 80.83 -1.68 45.20 coo -7.71 55.92 42.70 -7.18 57.60 44.85 80.60 -7.36 37.01 80.46 -9.35 38.95 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 12 3 # 12 C 130 SER B 147 SER^? 42.22 MG MG B 701 C 166 PHE B 166 PHE^? 30.39 MG MG B 701 C 182 PHE B 259 PHE^? 29.88 MG MG B 701 coo -2.19 64.27 51.12 -3.34 62.10 50.60 85.67 -7.01 49.55 87.33 -8.74 49.65 coo -11.14 61.91 46.89 -9.88 60.30 48.76 77.21 -5.09 44.06 77.80 -6.03 41.49 coo -7.71 55.92 42.70 -7.18 57.60 44.85 80.60 -7.36 37.01 80.46 -9.35 38.95 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 13 3 # 13 C 130 SER B 147 SER^? 42.22 MG MG B 701 C 166 PHE B 179 PHE~? 33.79 MG MG B 701 C 182 PHE B 259 PHE^? 29.88 MG MG B 701 coo -2.19 64.27 51.12 -3.34 62.10 50.60 85.67 -7.01 49.55 87.33 -8.74 49.65 coo -11.14 61.91 46.89 -9.88 60.30 48.76 80.09 -2.55 42.63 80.83 -1.68 45.20 coo -7.71 55.92 42.70 -7.18 57.60 44.85 80.60 -7.36 37.01 80.46 -9.35 38.95 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 14 3 # 14 C 130 SER B 210 SER~? 12.60 MG MG B 701 C 166 PHE B 188 PHE~? 17.15 MG MG B 701 C 182 PHE B 189 PHE~? 14.75 MG MG B 701 coo -2.19 64.27 51.12 -3.34 62.10 50.60 63.63 -6.43 28.51 65.51 -5.02 28.70 coo -11.14 61.91 46.89 -9.88 60.30 48.76 71.48 -8.55 24.27 72.09 -8.90 26.93 coo -7.71 55.92 42.70 -7.18 57.60 44.85 69.85 -4.50 18.58 67.45 -3.45 19.57 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 15 3 # 15 C 130 SER B 215 SER~? 26.70 MG MG B 701 C 166 PHE B 259 PHE^? 29.88 MG MG B 701 C 182 PHE B 166 PHE^? 30.39 MG MG B 701 coo -2.19 64.27 51.12 -3.34 62.10 50.60 75.07 -16.26 35.49 76.05 -18.46 35.16 coo -11.14 61.91 46.89 -9.88 60.30 48.76 80.60 -7.36 37.01 80.46 -9.35 38.95 coo -7.71 55.92 42.70 -7.18 57.60 44.85 77.21 -5.09 44.06 77.80 -6.03 41.49 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 16 3 # 16 C 130 SER B 217 SER~? 33.42 MG MG B 701 C 166 PHE B 259 PHE^? 29.88 MG MG B 701 C 182 PHE B 166 PHE^? 30.39 MG MG B 701 coo -2.19 64.27 51.12 -3.34 62.10 50.60 80.79 -17.73 37.60 83.05 -18.57 37.26 coo -11.14 61.91 46.89 -9.88 60.30 48.76 80.60 -7.36 37.01 80.46 -9.35 38.95 coo -7.71 55.92 42.70 -7.18 57.60 44.85 77.21 -5.09 44.06 77.80 -6.03 41.49 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 17 3 # 17 C 130 SER B 256 SER~? 38.63 MG MG B 701 C 166 PHE B 142 PHE~? 39.32 MG MG B 701 C 182 PHE B 166 PHE^? 30.39 MG MG B 701 coo -2.19 64.27 51.12 -3.34 62.10 50.60 89.21 -2.78 38.72 90.41 -2.19 36.69 coo -11.14 61.91 46.89 -9.88 60.30 48.76 86.08 -2.81 46.36 85.54 -0.20 45.70 coo -7.71 55.92 42.70 -7.18 57.60 44.85 77.21 -5.09 44.06 77.80 -6.03 41.49 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 18 3 # 18 C 130 SER B 256 SER~? 38.63 MG MG B 701 C 166 PHE B 259 PHE^? 29.88 MG MG B 701 C 182 PHE B 166 PHE^? 30.39 MG MG B 701 coo -2.19 64.27 51.12 -3.34 62.10 50.60 89.21 -2.78 38.72 90.41 -2.19 36.69 coo -11.14 61.91 46.89 -9.88 60.30 48.76 80.60 -7.36 37.01 80.46 -9.35 38.95 coo -7.71 55.92 42.70 -7.18 57.60 44.85 77.21 -5.09 44.06 77.80 -6.03 41.49 2r11_o02 source 2R11 CARBOXYLESTERASE NP : 18 hits 2r11_o02 naa= 3 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 1 3 # 1 D 130 SER A 110 SER~? 31.15 MG MG B 701 D 166 PHE A 118 PHE^? 29.09 MG MG B 701 D 182 PHE A 73 PHE~? 23.31 MG MG B 701 coo -32.42 55.27 46.18 -30.51 54.94 47.67 31.60 12.76 34.14 32.49 10.59 33.52 coo -23.62 58.20 50.84 -23.76 56.14 48.96 41.62 15.66 34.45 39.96 13.55 33.81 coo -23.08 51.44 54.96 -24.43 52.71 52.88 46.15 11.22 29.51 44.01 12.03 31.08 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 2 3 # 2 D 130 SER A 143 SER~? 15.64 MG MG B 701 D 166 PHE A 179 PHE~? 15.24 MG MG B 701 D 182 PHE A 259 PHE^? 23.41 MG MG B 701 coo -32.42 55.27 46.18 -30.51 54.94 47.67 66.42 2.53 29.16 66.03 2.11 26.82 coo -23.62 58.20 50.84 -23.76 56.14 48.96 59.12 -2.16 37.53 58.98 -3.05 34.90 coo -23.08 51.44 54.96 -24.43 52.71 52.88 60.86 3.12 42.58 59.55 5.17 41.16 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 3 3 # 3 D 130 SER A 145 SER~? 15.87 MG MG B 701 D 166 PHE B 189 PHE~? 14.75 MG MG B 701 D 182 PHE B 188 PHE~? 17.15 MG MG B 701 coo -32.42 55.27 46.18 -30.51 54.94 47.67 65.62 4.84 24.49 66.57 2.65 23.80 coo -23.62 58.20 50.84 -23.76 56.14 48.96 69.85 -4.50 18.58 67.45 -3.45 19.57 coo -23.08 51.44 54.96 -24.43 52.71 52.88 71.48 -8.55 24.27 72.09 -8.90 26.93 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 4 3 # 4 D 130 SER A 147 SER^? 16.30 MG MG B 701 D 166 PHE A 166 PHE^? 17.85 MG MG B 701 D 182 PHE A 259 PHE^? 23.41 MG MG B 701 coo -32.42 55.27 46.18 -30.51 54.94 47.67 59.94 3.92 28.83 60.06 6.29 28.37 coo -23.62 58.20 50.84 -23.76 56.14 48.96 55.48 -0.21 37.25 56.90 1.01 39.28 coo -23.08 51.44 54.96 -24.43 52.71 52.88 60.86 3.12 42.58 59.55 5.17 41.16 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 5 3 # 5 D 130 SER A 147 SER^? 16.30 MG MG B 701 D 166 PHE A 179 PHE~? 15.24 MG MG B 701 D 182 PHE A 259 PHE^? 23.41 MG MG B 701 coo -32.42 55.27 46.18 -30.51 54.94 47.67 59.94 3.92 28.83 60.06 6.29 28.37 coo -23.62 58.20 50.84 -23.76 56.14 48.96 59.12 -2.16 37.53 58.98 -3.05 34.90 coo -23.08 51.44 54.96 -24.43 52.71 52.88 60.86 3.12 42.58 59.55 5.17 41.16 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 6 3 # 6 D 130 SER A 210 SER~? 36.07 MG MG B 701 D 166 PHE A 188 PHE~? 35.84 MG MG B 701 D 182 PHE A 189 PHE~? 41.84 MG MG B 701 coo -32.42 55.27 46.18 -30.51 54.94 47.67 49.99 -1.69 57.23 51.51 -3.29 58.19 coo -23.62 58.20 50.84 -23.76 56.14 48.96 57.53 2.90 57.96 56.98 3.16 55.25 coo -23.08 51.44 54.96 -24.43 52.71 52.88 59.77 -0.70 63.73 57.68 -2.54 63.82 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 7 3 # 7 D 130 SER A 215 SER~? 31.75 MG MG B 701 D 166 PHE A 259 PHE^? 23.41 MG MG B 701 D 182 PHE A 166 PHE^? 17.85 MG MG B 701 coo -32.42 55.27 46.18 -30.51 54.94 47.67 53.96 10.22 46.63 54.01 12.63 46.67 coo -23.62 58.20 50.84 -23.76 56.14 48.96 60.86 3.12 42.58 59.55 5.17 41.16 coo -23.08 51.44 54.96 -24.43 52.71 52.88 55.48 -0.21 37.25 56.90 1.01 39.28 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 8 3 # 8 D 130 SER A 217 SER~? 30.46 MG MG B 701 D 166 PHE A 259 PHE^? 23.41 MG MG B 701 D 182 PHE A 166 PHE^? 17.85 MG MG B 701 coo -32.42 55.27 46.18 -30.51 54.94 47.67 57.85 13.16 42.60 59.76 14.69 42.27 coo -23.62 58.20 50.84 -23.76 56.14 48.96 60.86 3.12 42.58 59.55 5.17 41.16 coo -23.08 51.44 54.96 -24.43 52.71 52.88 55.48 -0.21 37.25 56.90 1.01 39.28 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 9 3 # 9 D 130 SER A 220 SER~? 30.23 MG MG B 701 D 166 PHE A 124 PHE^? 29.34 MG MG B 701 D 182 PHE A 136 PHE^? 26.98 MG MG B 701 coo -32.42 55.27 46.18 -30.51 54.94 47.67 62.66 13.66 39.67 62.74 13.68 42.09 coo -23.62 58.20 50.84 -23.76 56.14 48.96 53.10 15.90 36.97 52.63 18.53 37.74 coo -23.08 51.44 54.96 -24.43 52.71 52.88 51.01 11.36 40.52 53.20 13.02 39.90 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 10 3 # 10 D 130 SER A 224 SER^? 34.13 MG MG B 701 D 166 PHE A 136 PHE^? 26.98 MG MG B 701 D 182 PHE A 124 PHE^? 29.34 MG MG B 701 coo -32.42 55.27 46.18 -30.51 54.94 47.67 58.45 8.88 49.16 58.56 10.38 51.09 coo -23.62 58.20 50.84 -23.76 56.14 48.96 51.01 11.36 40.52 53.20 13.02 39.90 coo -23.08 51.44 54.96 -24.43 52.71 52.88 53.10 15.90 36.97 52.63 18.53 37.74 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 11 3 # 11 D 130 SER A 224 SER^? 34.13 MG MG B 701 D 166 PHE A 259 PHE^? 23.41 MG MG B 701 D 182 PHE A 166 PHE^? 17.85 MG MG B 701 coo -32.42 55.27 46.18 -30.51 54.94 47.67 58.45 8.88 49.16 58.56 10.38 51.09 coo -23.62 58.20 50.84 -23.76 56.14 48.96 60.86 3.12 42.58 59.55 5.17 41.16 coo -23.08 51.44 54.96 -24.43 52.71 52.88 55.48 -0.21 37.25 56.90 1.01 39.28 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 12 3 # 12 D 130 SER A 256 SER~? 22.42 MG MG B 701 D 166 PHE A 259 PHE^? 23.41 MG MG B 701 D 182 PHE A 166 PHE^? 17.85 MG MG B 701 coo -32.42 55.27 46.18 -30.51 54.94 47.67 68.19 1.16 36.27 69.40 -0.26 37.83 coo -23.62 58.20 50.84 -23.76 56.14 48.96 60.86 3.12 42.58 59.55 5.17 41.16 coo -23.08 51.44 54.96 -24.43 52.71 52.88 55.48 -0.21 37.25 56.90 1.01 39.28 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 13 3 # 13 D 130 SER B 143 SER~? 44.45 MG MG B 701 D 166 PHE B 179 PHE~? 33.79 MG MG B 701 D 182 PHE B 259 PHE^? 29.88 MG MG B 701 coo -32.42 55.27 46.18 -30.51 54.94 47.67 90.48 -3.13 47.60 89.69 -2.19 49.67 coo -23.62 58.20 50.84 -23.76 56.14 48.96 80.09 -2.55 42.63 80.83 -1.68 45.20 coo -23.08 51.44 54.96 -24.43 52.71 52.88 80.60 -7.36 37.01 80.46 -9.35 38.95 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 14 3 # 14 D 130 SER B 147 SER^? 42.22 MG MG B 701 D 166 PHE B 166 PHE^? 30.39 MG MG B 701 D 182 PHE B 259 PHE^? 29.88 MG MG B 701 coo -32.42 55.27 46.18 -30.51 54.94 47.67 85.67 -7.01 49.55 87.33 -8.74 49.65 coo -23.62 58.20 50.84 -23.76 56.14 48.96 77.21 -5.09 44.06 77.80 -6.03 41.49 coo -23.08 51.44 54.96 -24.43 52.71 52.88 80.60 -7.36 37.01 80.46 -9.35 38.95 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 15 3 # 15 D 130 SER B 147 SER^? 42.22 MG MG B 701 D 166 PHE B 179 PHE~? 33.79 MG MG B 701 D 182 PHE B 259 PHE^? 29.88 MG MG B 701 coo -32.42 55.27 46.18 -30.51 54.94 47.67 85.67 -7.01 49.55 87.33 -8.74 49.65 coo -23.62 58.20 50.84 -23.76 56.14 48.96 80.09 -2.55 42.63 80.83 -1.68 45.20 coo -23.08 51.44 54.96 -24.43 52.71 52.88 80.60 -7.36 37.01 80.46 -9.35 38.95 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 16 3 # 16 D 130 SER B 206 SER~? -2.06 MG MG B 701s D 166 PHE A 142 PHE~? 13.47 MG MG B 701 D 182 PHE A 179 PHE~? 15.24 MG MG B 701 coo -32.42 55.27 46.18 -30.51 54.94 47.67 58.11 -6.07 22.68 56.48 -7.41 21.42 coo -23.62 58.20 50.84 -23.76 56.14 48.96 62.78 -0.55 30.89 63.67 -3.12 31.49 coo -23.08 51.44 54.96 -24.43 52.71 52.88 59.12 -2.16 37.53 58.98 -3.05 34.90 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 17 3 # 17 D 130 SER B 210 SER~? 12.60 MG MG B 701 D 166 PHE B 188 PHE~? 17.15 MG MG B 701 D 182 PHE B 189 PHE~? 14.75 MG MG B 701 coo -32.42 55.27 46.18 -30.51 54.94 47.67 63.63 -6.43 28.51 65.51 -5.02 28.70 coo -23.62 58.20 50.84 -23.76 56.14 48.96 71.48 -8.55 24.27 72.09 -8.90 26.93 coo -23.08 51.44 54.96 -24.43 52.71 52.88 69.85 -4.50 18.58 67.45 -3.45 19.57 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 18 3 # 18 D 130 SER B 215 SER~? 26.70 MG MG B 701 D 166 PHE B 259 PHE^? 29.88 MG MG B 701 D 182 PHE B 166 PHE^? 30.39 MG MG B 701 coo -32.42 55.27 46.18 -30.51 54.94 47.67 75.07 -16.26 35.49 76.05 -18.46 35.16 coo -23.62 58.20 50.84 -23.76 56.14 48.96 80.60 -7.36 37.01 80.46 -9.35 38.95 coo -23.08 51.44 54.96 -24.43 52.71 52.88 77.21 -5.09 44.06 77.80 -6.03 41.49 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 19 3 # 19 D 130 SER B 217 SER~? 33.42 MG MG B 701 D 166 PHE B 259 PHE^? 29.88 MG MG B 701 D 182 PHE B 166 PHE^? 30.39 MG MG B 701 coo -32.42 55.27 46.18 -30.51 54.94 47.67 80.79 -17.73 37.60 83.05 -18.57 37.26 coo -23.62 58.20 50.84 -23.76 56.14 48.96 80.60 -7.36 37.01 80.46 -9.35 38.95 coo -23.08 51.44 54.96 -24.43 52.71 52.88 77.21 -5.09 44.06 77.80 -6.03 41.49 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 20 3 # 20 D 130 SER B 220 SER~? 36.00 MG MG B 701 D 166 PHE B 124 PHE~? 35.62 MG MG B 701 D 182 PHE B 136 PHE^? 30.83 MG MG B 701 coo -32.42 55.27 46.18 -30.51 54.94 47.67 86.25 -17.21 37.74 86.54 -18.84 36.01 coo -23.62 58.20 50.84 -23.76 56.14 48.96 79.51 -21.13 44.47 79.25 -23.80 43.75 coo -23.08 51.44 54.96 -24.43 52.71 52.88 75.25 -17.57 42.31 77.88 -18.52 41.97 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 21 3 # 21 D 130 SER B 224 SER^? 24.32 MG MG B 701 D 166 PHE B 136 PHE^? 30.83 MG MG B 701 D 182 PHE B 124 PHE~? 35.62 MG MG B 701 coo -32.42 55.27 46.18 -30.51 54.94 47.67 77.48 -13.89 31.52 77.07 -15.32 29.51 coo -23.62 58.20 50.84 -23.76 56.14 48.96 75.25 -17.57 42.31 77.88 -18.52 41.97 coo -23.08 51.44 54.96 -24.43 52.71 52.88 79.51 -21.13 44.47 79.25 -23.80 43.75 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 22 3 # 22 D 130 SER B 224 SER^? 24.32 MG MG B 701 D 166 PHE B 259 PHE^? 29.88 MG MG B 701 D 182 PHE B 166 PHE^? 30.39 MG MG B 701 coo -32.42 55.27 46.18 -30.51 54.94 47.67 77.48 -13.89 31.52 77.07 -15.32 29.51 coo -23.62 58.20 50.84 -23.76 56.14 48.96 80.60 -7.36 37.01 80.46 -9.35 38.95 coo -23.08 51.44 54.96 -24.43 52.71 52.88 77.21 -5.09 44.06 77.80 -6.03 41.49 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 23 3 # 23 D 130 SER B 256 SER~? 38.63 MG MG B 701 D 166 PHE B 259 PHE^? 29.88 MG MG B 701 D 182 PHE B 166 PHE^? 30.39 MG MG B 701 coo -32.42 55.27 46.18 -30.51 54.94 47.67 89.21 -2.78 38.72 90.41 -2.19 36.69 coo -23.62 58.20 50.84 -23.76 56.14 48.96 80.60 -7.36 37.01 80.46 -9.35 38.95 coo -23.08 51.44 54.96 -24.43 52.71 52.88 77.21 -5.09 44.06 77.80 -6.03 41.49 2r11_o03 source 2R11 CARBOXYLESTERASE NP : 23 hits 2r11_o03 naa= 3 ULMN 3 3hde_o00 LYSOZYME user 1 3 # 1 A 35 GLU A 218 GLU~? 32.55 MG MG B 701 A 44 ASP A 221 ASP~? 23.86 MG MG B 701 A 50 THR A 222 THR^? 29.73 MG MG B 701 coo 3.19 -22.62 -21.80 4.26 -21.93 -23.46 54.56 16.53 40.79 53.76 18.19 41.81 coo -3.28 -18.53 -28.91 -2.33 -19.01 -30.75 63.27 9.05 38.25 62.91 9.80 36.26 coo -4.91 -24.14 -27.53 -3.37 -22.71 -27.06 62.04 9.47 43.12 63.32 11.19 43.65 ULMN 3 3hde_o00 LYSOZYME user 2 3 # 2 A 35 GLU A 219 GLU~? 34.01 MG MG B 701 A 44 ASP A 221 ASP~? 23.86 MG MG B 701 A 50 THR A 222 THR^? 29.73 MG MG B 701 coo 3.19 -22.62 -21.80 4.26 -21.93 -23.46 59.27 18.40 40.08 59.60 20.33 40.74 coo -3.28 -18.53 -28.91 -2.33 -19.01 -30.75 63.27 9.05 38.25 62.91 9.80 36.26 coo -4.91 -24.14 -27.53 -3.37 -22.71 -27.06 62.04 9.47 43.12 63.32 11.19 43.65 ULMN 3 3hde_o00 LYSOZYME user 3 3 # 3 A 35 GLU B 218 GLU~? 32.37 MG MG B 701 A 44 ASP B 221 ASP~? 37.75 MG MG B 701 A 50 THR B 222 THR^? 32.47 MG MG B 701 coo 3.19 -22.62 -21.80 4.26 -21.93 -23.46 79.74 -21.86 40.41 79.27 -22.32 38.45 coo -3.28 -18.53 -28.91 -2.33 -19.01 -30.75 87.06 -12.52 38.62 87.72 -12.86 40.65 coo -4.91 -24.14 -27.53 -3.37 -22.71 -27.06 83.36 -13.27 35.32 84.56 -14.62 34.12 ULMN 3 3hde_o00 LYSOZYME user 4 3 # 4 A 35 GLU B 219 GLU~? 39.54 MG MG B 701 A 44 ASP B 221 ASP~? 37.75 MG MG B 701 A 50 THR B 222 THR^? 32.47 MG MG B 701 coo 3.19 -22.62 -21.80 4.26 -21.93 -23.46 85.46 -21.90 40.90 85.71 -22.21 42.97 coo -3.28 -18.53 -28.91 -2.33 -19.01 -30.75 87.06 -12.52 38.62 87.72 -12.86 40.65 coo -4.91 -24.14 -27.53 -3.37 -22.71 -27.06 83.36 -13.27 35.32 84.56 -14.62 34.12 3hde_o00 source 3HDE LYSOZYME : 4 hits 3hde_o00 naa= 3 ULMN 3 3hde_o01 LYSOZYME user 1 3 # 1 B 35 GLU A 186 GLU~? 38.23 MG MG B 701 B 44 ASP A 194 ASP~? 51.94 MG MG B 701 B 50 THR A 193 THR~? 45.93 MG MG B 701 coo -10.34 -10.51 -29.93 -8.23 -10.47 -29.91 60.82 -4.60 59.58 62.03 -6.27 60.12 coo -0.99 -14.50 -23.89 0.18 -12.74 -23.86 62.72 -3.55 72.77 62.75 -5.34 73.88 coo -5.24 -12.06 -20.18 -4.96 -12.24 -22.31 63.13 -0.94 68.76 61.50 -0.74 67.46 ULMN 3 3hde_o01 LYSOZYME user 2 3 # 2 B 35 GLU A 218 GLU~? 32.55 MG MG B 701 B 44 ASP A 221 ASP~? 23.86 MG MG B 701 B 50 THR A 222 THR^? 29.73 MG MG B 701 coo -10.34 -10.51 -29.93 -8.23 -10.47 -29.91 54.56 16.53 40.79 53.76 18.19 41.81 coo -0.99 -14.50 -23.89 0.18 -12.74 -23.86 63.27 9.05 38.25 62.91 9.80 36.26 coo -5.24 -12.06 -20.18 -4.96 -12.24 -22.31 62.04 9.47 43.12 63.32 11.19 43.65 ULMN 3 3hde_o01 LYSOZYME user 3 3 # 3 B 35 GLU A 219 GLU~? 34.01 MG MG B 701 B 44 ASP A 221 ASP~? 23.86 MG MG B 701 B 50 THR A 222 THR^? 29.73 MG MG B 701 coo -10.34 -10.51 -29.93 -8.23 -10.47 -29.91 59.27 18.40 40.08 59.60 20.33 40.74 coo -0.99 -14.50 -23.89 0.18 -12.74 -23.86 63.27 9.05 38.25 62.91 9.80 36.26 coo -5.24 -12.06 -20.18 -4.96 -12.24 -22.31 62.04 9.47 43.12 63.32 11.19 43.65 ULMN 3 3hde_o01 LYSOZYME user 4 3 # 4 B 35 GLU B 186 GLU~? 15.37 MG MG B 701 B 44 ASP B 194 ASP~? 20.07 MG MG B 701 B 50 THR B 193 THR~? 17.32 MG MG B 701 coo -10.34 -10.51 -29.93 -8.23 -10.47 -29.91 69.45 -0.46 21.54 67.97 0.05 22.96 coo -0.99 -14.50 -23.89 0.18 -12.74 -23.86 67.87 -2.29 9.08 66.66 -1.03 7.91 coo -5.24 -12.06 -20.18 -4.96 -12.24 -22.31 70.69 -3.40 12.79 69.76 -4.18 14.57 ULMN 3 3hde_o01 LYSOZYME user 5 3 # 5 B 35 GLU B 218 GLU~? 32.37 MG MG B 701 B 44 ASP B 221 ASP~? 37.75 MG MG B 701 B 50 THR B 222 THR^? 32.47 MG MG B 701 coo -10.34 -10.51 -29.93 -8.23 -10.47 -29.91 79.74 -21.86 40.41 79.27 -22.32 38.45 coo -0.99 -14.50 -23.89 0.18 -12.74 -23.86 87.06 -12.52 38.62 87.72 -12.86 40.65 coo -5.24 -12.06 -20.18 -4.96 -12.24 -22.31 83.36 -13.27 35.32 84.56 -14.62 34.12 3hde_o01 source 3HDE LYSOZYME : 5 hits 3hde_o01 naa= 3 ULMN 3 3hde_o02 LYSOZYME user 1 3 # 1 C 35 GLU A 186 GLU~? 38.23 MG MG B 701 C 44 ASP A 194 ASP~? 51.94 MG MG B 701 C 50 THR A 193 THR~? 45.93 MG MG B 701 coo 15.89 -0.52 0.58 15.91 1.38 -0.35 60.82 -4.60 59.58 62.03 -6.27 60.12 coo 24.21 6.79 -4.52 23.75 8.67 -3.70 62.72 -3.55 72.77 62.75 -5.34 73.88 coo 25.48 4.87 1.60 23.90 4.95 0.15 63.13 -0.94 68.76 61.50 -0.74 67.46 ULMN 3 3hde_o02 LYSOZYME user 2 3 # 2 C 35 GLU A 218 GLU~? 32.55 MG MG B 701 C 44 ASP A 221 ASP~? 23.86 MG MG B 701 C 50 THR A 222 THR^? 29.73 MG MG B 701 coo 15.89 -0.52 0.58 15.91 1.38 -0.35 54.56 16.53 40.79 53.76 18.19 41.81 coo 24.21 6.79 -4.52 23.75 8.67 -3.70 63.27 9.05 38.25 62.91 9.80 36.26 coo 25.48 4.87 1.60 23.90 4.95 0.15 62.04 9.47 43.12 63.32 11.19 43.65 ULMN 3 3hde_o02 LYSOZYME user 3 3 # 3 C 35 GLU A 219 GLU~? 34.01 MG MG B 701 C 44 ASP A 221 ASP~? 23.86 MG MG B 701 C 50 THR A 222 THR^? 29.73 MG MG B 701 coo 15.89 -0.52 0.58 15.91 1.38 -0.35 59.27 18.40 40.08 59.60 20.33 40.74 coo 24.21 6.79 -4.52 23.75 8.67 -3.70 63.27 9.05 38.25 62.91 9.80 36.26 coo 25.48 4.87 1.60 23.90 4.95 0.15 62.04 9.47 43.12 63.32 11.19 43.65 ULMN 3 3hde_o02 LYSOZYME user 4 3 # 4 C 35 GLU B 186 GLU~? 15.37 MG MG B 701 C 44 ASP B 194 ASP~? 20.07 MG MG B 701 C 50 THR B 193 THR~? 17.32 MG MG B 701 coo 15.89 -0.52 0.58 15.91 1.38 -0.35 69.45 -0.46 21.54 67.97 0.05 22.96 coo 24.21 6.79 -4.52 23.75 8.67 -3.70 67.87 -2.29 9.08 66.66 -1.03 7.91 coo 25.48 4.87 1.60 23.90 4.95 0.15 70.69 -3.40 12.79 69.76 -4.18 14.57 ULMN 3 3hde_o02 LYSOZYME user 5 3 # 5 C 35 GLU B 218 GLU~? 32.37 MG MG B 701 C 44 ASP B 221 ASP~? 37.75 MG MG B 701 C 50 THR B 222 THR^? 32.47 MG MG B 701 coo 15.89 -0.52 0.58 15.91 1.38 -0.35 79.74 -21.86 40.41 79.27 -22.32 38.45 coo 24.21 6.79 -4.52 23.75 8.67 -3.70 87.06 -12.52 38.62 87.72 -12.86 40.65 coo 25.48 4.87 1.60 23.90 4.95 0.15 83.36 -13.27 35.32 84.56 -14.62 34.12 3hde_o02 source 3HDE LYSOZYME : 5 hits 3hde_o02 naa= 3 ULMN 3 3tu8_o00 BURKHOLDERIA LETHAL FACTOR 1 (BLF1) user 1 3 # 1 A 88 THR A 103 THR~? 32.91 MG MG B 701 A 94 CYH A 93 CYH~? 25.81 MG MG B 701 A 106 HIS A 104 HIS^? 33.98 MG MG B 701 coo 29.73 -7.52 13.32 29.45 -5.70 12.17 50.29 22.50 34.59 50.45 21.47 36.44 coo 31.46 -1.21 4.47 31.00 -3.95 4.28 42.80 17.19 26.05 43.95 14.89 27.02 coo 27.96 -4.35 8.55 29.78 -5.07 7.70 45.13 22.80 31.21 43.22 23.40 30.59 ULMN 3 3tu8_o00 BURKHOLDERIA LETHAL FACTOR 1 (BLF1) user 2 3 # 2 A 88 THR A 105 THR^? 36.48 MG MG B 701 A 94 CYH A 93 CYH~? 25.81 MG MG B 701 A 106 HIS A 104 HIS^? 33.98 MG MG B 701 coo 29.73 -7.52 13.32 29.45 -5.70 12.17 43.83 22.53 35.56 43.67 23.24 37.59 coo 31.46 -1.21 4.47 31.00 -3.95 4.28 42.80 17.19 26.05 43.95 14.89 27.02 coo 27.96 -4.35 8.55 29.78 -5.07 7.70 45.13 22.80 31.21 43.22 23.40 30.59 ULMN 3 3tu8_o00 BURKHOLDERIA LETHAL FACTOR 1 (BLF1) user 3 3 # 3 A 88 THR B 103 THR~? 38.15 MG MG B 701 A 94 CYH B 93 CYH~? 42.85 MG MG B 701 A 106 HIS B 104 HIS^? 43.18 MG MG B 701 coo 29.73 -7.52 13.32 29.45 -5.70 12.17 79.49 -28.27 47.31 78.51 -27.23 45.65 coo 31.46 -1.21 4.47 31.00 -3.95 4.28 74.48 -24.31 57.35 76.42 -22.43 56.76 coo 27.96 -4.35 8.55 29.78 -5.07 7.70 76.52 -29.94 52.39 75.18 -30.89 53.68 ULMN 3 3tu8_o00 BURKHOLDERIA LETHAL FACTOR 1 (BLF1) user 4 3 # 4 A 88 THR B 105 THR^? 37.87 MG MG B 701 A 94 CYH B 93 CYH~? 42.85 MG MG B 701 A 106 HIS B 104 HIS^? 43.18 MG MG B 701 coo 29.73 -7.52 13.32 29.45 -5.70 12.17 73.55 -30.07 49.09 72.87 -30.65 47.12 coo 31.46 -1.21 4.47 31.00 -3.95 4.28 74.48 -24.31 57.35 76.42 -22.43 56.76 coo 27.96 -4.35 8.55 29.78 -5.07 7.70 76.52 -29.94 52.39 75.18 -30.89 53.68 3tu8_o00 source 3TU8 BURKHOLDERIA LETHAL FACTOR 1 (BLF1) : 4 hits 3tu8_o00 naa= 3 ULMN 3 3uao_o00 PUTATIVE ISOCHORISMATASE user 1 3 # 1 A 29 ASP A 165 ASP^? 19.82 MG MG B 701 A 117 LYS A 172 LYS~? 6.12 MG MG B 701 A 150 CYH A 150 CYH^? 20.80 MG MG B 701 coo 37.97 47.82 5.46 38.65 48.02 7.40 49.47 0.04 38.38 48.02 -0.73 39.68 coo 41.02 51.33 13.36 40.18 47.06 9.99 50.20 -3.67 28.72 53.15 -8.47 28.45 coo 39.17 42.30 8.54 40.94 44.26 7.78 54.05 4.31 36.56 55.14 4.53 39.16 ULMN 3 3uao_o00 PUTATIVE ISOCHORISMATASE user 2 3 # 2 A 29 ASP A 165 ASP^? 19.82 MG MG B 701 A 117 LYS A 175 LYS~? 16.95 MG MG B 701 A 150 CYH A 150 CYH^? 20.80 MG MG B 701 coo 37.97 47.82 5.46 38.65 48.02 7.40 49.47 0.04 38.38 48.02 -0.73 39.68 coo 41.02 51.33 13.36 40.18 47.06 9.99 54.19 -7.18 37.22 54.81 -12.82 38.86 coo 39.17 42.30 8.54 40.94 44.26 7.78 54.05 4.31 36.56 55.14 4.53 39.16 ULMN 3 3uao_o00 PUTATIVE ISOCHORISMATASE user 3 3 # 3 A 29 ASP B 165 ASP^? 26.59 MG MG B 701 A 117 LYS B 172 LYS~? 42.28 MG MG B 701 A 150 CYH B 150 CYH^? 29.89 MG MG B 701 coo 37.97 47.82 5.46 38.65 48.02 7.40 71.61 -6.68 45.38 69.65 -6.30 44.66 coo 41.02 51.33 13.36 40.18 47.06 9.99 75.30 -2.84 54.33 79.74 -2.40 56.36 coo 39.17 42.30 8.54 40.94 44.26 7.78 77.46 -9.77 45.05 77.37 -9.94 42.24 ULMN 3 3uao_o00 PUTATIVE ISOCHORISMATASE user 4 3 # 4 A 29 ASP B 165 ASP^? 26.59 MG MG B 701 A 117 LYS B 175 LYS~? 34.92 MG MG B 701 A 150 CYH B 150 CYH^? 29.89 MG MG B 701 coo 37.97 47.82 5.46 38.65 48.02 7.40 71.61 -6.68 45.38 69.65 -6.30 44.66 coo 41.02 51.33 13.36 40.18 47.06 9.99 75.00 1.45 45.20 75.48 7.65 46.06 coo 39.17 42.30 8.54 40.94 44.26 7.78 77.46 -9.77 45.05 77.37 -9.94 42.24 3uao_o00 source 3UAO PUTATIVE ISOCHORISMATASE : 4 hits 3uao_o00 naa= 3 ULMN 3 3uao_o01 PUTATIVE ISOCHORISMATASE user 1 3 # 1 B 29 ASP A 165 ASP^? 19.82 MG MG B 701 B 117 LYS A 172 LYS~? 6.12 MG MG B 701 B 150 CYH A 150 CYH^? 20.80 MG MG B 701 coo 33.94 43.16 45.29 35.02 43.05 43.47 49.47 0.04 38.38 48.02 -0.73 39.68 coo 38.53 39.60 38.22 36.76 43.89 41.37 50.20 -3.67 28.72 53.15 -8.47 28.45 coo 35.77 48.61 42.57 37.40 46.62 43.48 54.05 4.31 36.56 55.14 4.53 39.16 ULMN 3 3uao_o01 PUTATIVE ISOCHORISMATASE user 2 3 # 2 B 29 ASP A 165 ASP^? 19.82 MG MG B 701 B 117 LYS A 175 LYS~? 16.95 MG MG B 701 B 150 CYH A 150 CYH^? 20.80 MG MG B 701 coo 33.94 43.16 45.29 35.02 43.05 43.47 49.47 0.04 38.38 48.02 -0.73 39.68 coo 38.53 39.60 38.22 36.76 43.89 41.37 54.19 -7.18 37.22 54.81 -12.82 38.86 coo 35.77 48.61 42.57 37.40 46.62 43.48 54.05 4.31 36.56 55.14 4.53 39.16 ULMN 3 3uao_o01 PUTATIVE ISOCHORISMATASE user 3 3 # 3 B 29 ASP B 165 ASP^? 26.59 MG MG B 701 B 117 LYS B 172 LYS~? 42.28 MG MG B 701 B 150 CYH B 150 CYH^? 29.89 MG MG B 701 coo 33.94 43.16 45.29 35.02 43.05 43.47 71.61 -6.68 45.38 69.65 -6.30 44.66 coo 38.53 39.60 38.22 36.76 43.89 41.37 75.30 -2.84 54.33 79.74 -2.40 56.36 coo 35.77 48.61 42.57 37.40 46.62 43.48 77.46 -9.77 45.05 77.37 -9.94 42.24 ULMN 3 3uao_o01 PUTATIVE ISOCHORISMATASE user 4 3 # 4 B 29 ASP B 165 ASP^? 26.59 MG MG B 701 B 117 LYS B 175 LYS~? 34.92 MG MG B 701 B 150 CYH B 150 CYH^? 29.89 MG MG B 701 coo 33.94 43.16 45.29 35.02 43.05 43.47 71.61 -6.68 45.38 69.65 -6.30 44.66 coo 38.53 39.60 38.22 36.76 43.89 41.37 75.00 1.45 45.20 75.48 7.65 46.06 coo 35.77 48.61 42.57 37.40 46.62 43.48 77.46 -9.77 45.05 77.37 -9.94 42.24 3uao_o01 source 3UAO PUTATIVE ISOCHORISMATASE : 4 hits 3uao_o01 naa= 3 ULMN 3 3uao_o02 PUTATIVE ISOCHORISMATASE user 1 3 # 1 C 29 ASP A 165 ASP^? 19.82 MG MG B 701 C 117 LYS A 172 LYS~? 6.12 MG MG B 701 C 150 CYH A 150 CYH^? 20.80 MG MG B 701 coo 54.62 -9.81 68.84 52.97 -9.23 67.61 49.47 0.04 38.38 48.02 -0.73 39.68 coo 46.74 -10.34 64.36 51.80 -7.96 65.19 50.20 -3.67 28.72 53.15 -8.47 28.45 coo 55.78 -5.03 64.48 55.52 -7.79 64.07 54.05 4.31 36.56 55.14 4.53 39.16 ULMN 3 3uao_o02 PUTATIVE ISOCHORISMATASE user 2 3 # 2 C 29 ASP A 165 ASP^? 19.82 MG MG B 701 C 117 LYS A 175 LYS~? 16.95 MG MG B 701 C 150 CYH A 150 CYH^? 20.80 MG MG B 701 coo 54.62 -9.81 68.84 52.97 -9.23 67.61 49.47 0.04 38.38 48.02 -0.73 39.68 coo 46.74 -10.34 64.36 51.80 -7.96 65.19 54.19 -7.18 37.22 54.81 -12.82 38.86 coo 55.78 -5.03 64.48 55.52 -7.79 64.07 54.05 4.31 36.56 55.14 4.53 39.16 ULMN 3 3uao_o02 PUTATIVE ISOCHORISMATASE user 3 3 # 3 C 29 ASP B 165 ASP^? 26.59 MG MG B 701 C 117 LYS B 172 LYS~? 42.28 MG MG B 701 C 150 CYH B 150 CYH^? 29.89 MG MG B 701 coo 54.62 -9.81 68.84 52.97 -9.23 67.61 71.61 -6.68 45.38 69.65 -6.30 44.66 coo 46.74 -10.34 64.36 51.80 -7.96 65.19 75.30 -2.84 54.33 79.74 -2.40 56.36 coo 55.78 -5.03 64.48 55.52 -7.79 64.07 77.46 -9.77 45.05 77.37 -9.94 42.24 ULMN 3 3uao_o02 PUTATIVE ISOCHORISMATASE user 4 3 # 4 C 29 ASP B 165 ASP^? 26.59 MG MG B 701 C 117 LYS B 175 LYS~? 34.92 MG MG B 701 C 150 CYH B 150 CYH^? 29.89 MG MG B 701 coo 54.62 -9.81 68.84 52.97 -9.23 67.61 71.61 -6.68 45.38 69.65 -6.30 44.66 coo 46.74 -10.34 64.36 51.80 -7.96 65.19 75.00 1.45 45.20 75.48 7.65 46.06 coo 55.78 -5.03 64.48 55.52 -7.79 64.07 77.46 -9.77 45.05 77.37 -9.94 42.24 3uao_o02 source 3UAO PUTATIVE ISOCHORISMATASE : 4 hits 3uao_o02 naa= 3 ULMN 3 3uao_o03 PUTATIVE ISOCHORISMATASE user 1 3 # 1 D 29 ASP A 165 ASP^? 19.82 MG MG B 701 D 117 LYS A 172 LYS~? 6.12 MG MG B 701 D 150 CYH A 150 CYH^? 20.80 MG MG B 701 coo 25.05 13.27 54.10 26.66 12.10 53.60 49.47 0.04 38.38 48.02 -0.73 39.68 coo 33.45 10.03 51.76 28.31 9.37 53.37 50.20 -3.67 28.72 53.15 -8.47 28.45 coo 24.32 7.20 55.59 24.80 8.07 53.08 54.05 4.31 36.56 55.14 4.53 39.16 ULMN 3 3uao_o03 PUTATIVE ISOCHORISMATASE user 2 3 # 2 D 29 ASP A 165 ASP^? 19.82 MG MG B 701 D 117 LYS A 175 LYS~? 16.95 MG MG B 701 D 150 CYH A 150 CYH^? 20.80 MG MG B 701 coo 25.05 13.27 54.10 26.66 12.10 53.60 49.47 0.04 38.38 48.02 -0.73 39.68 coo 33.45 10.03 51.76 28.31 9.37 53.37 54.19 -7.18 37.22 54.81 -12.82 38.86 coo 24.32 7.20 55.59 24.80 8.07 53.08 54.05 4.31 36.56 55.14 4.53 39.16 ULMN 3 3uao_o03 PUTATIVE ISOCHORISMATASE user 3 3 # 3 D 29 ASP B 165 ASP^? 26.59 MG MG B 701 D 117 LYS B 172 LYS~? 42.28 MG MG B 701 D 150 CYH B 150 CYH^? 29.89 MG MG B 701 coo 25.05 13.27 54.10 26.66 12.10 53.60 71.61 -6.68 45.38 69.65 -6.30 44.66 coo 33.45 10.03 51.76 28.31 9.37 53.37 75.30 -2.84 54.33 79.74 -2.40 56.36 coo 24.32 7.20 55.59 24.80 8.07 53.08 77.46 -9.77 45.05 77.37 -9.94 42.24 ULMN 3 3uao_o03 PUTATIVE ISOCHORISMATASE user 4 3 # 4 D 29 ASP B 165 ASP^? 26.59 MG MG B 701 D 117 LYS B 175 LYS~? 34.92 MG MG B 701 D 150 CYH B 150 CYH^? 29.89 MG MG B 701 coo 25.05 13.27 54.10 26.66 12.10 53.60 71.61 -6.68 45.38 69.65 -6.30 44.66 coo 33.45 10.03 51.76 28.31 9.37 53.37 75.00 1.45 45.20 75.48 7.65 46.06 coo 24.32 7.20 55.59 24.80 8.07 53.08 77.46 -9.77 45.05 77.37 -9.94 42.24 3uao_o03 source 3UAO PUTATIVE ISOCHORISMATASE : 4 hits 3uao_o03 naa= 3 ULMN 3 3uao_o04 PUTATIVE ISOCHORISMATASE user 1 3 # 1 E 29 ASP A 165 ASP^? 19.82 MG MG B 701 E 117 LYS A 172 LYS~? 6.12 MG MG B 701 E 150 CYH A 150 CYH^? 20.80 MG MG B 701 coo 54.17 11.77 49.20 52.64 11.40 50.63 49.47 0.04 38.38 48.02 -0.73 39.68 coo 45.83 11.66 53.42 50.97 10.25 52.77 50.20 -3.67 28.72 53.15 -8.47 28.45 coo 55.28 7.50 53.67 54.71 10.14 54.01 54.05 4.31 36.56 55.14 4.53 39.16 ULMN 3 3uao_o04 PUTATIVE ISOCHORISMATASE user 2 3 # 2 E 29 ASP A 165 ASP^? 19.82 MG MG B 701 E 117 LYS A 175 LYS~? 16.95 MG MG B 701 E 150 CYH A 150 CYH^? 20.80 MG MG B 701 coo 54.17 11.77 49.20 52.64 11.40 50.63 49.47 0.04 38.38 48.02 -0.73 39.68 coo 45.83 11.66 53.42 50.97 10.25 52.77 54.19 -7.18 37.22 54.81 -12.82 38.86 coo 55.28 7.50 53.67 54.71 10.14 54.01 54.05 4.31 36.56 55.14 4.53 39.16 ULMN 3 3uao_o04 PUTATIVE ISOCHORISMATASE user 3 3 # 3 E 29 ASP B 165 ASP^? 26.59 MG MG B 701 E 117 LYS B 172 LYS~? 42.28 MG MG B 701 E 150 CYH B 150 CYH^? 29.89 MG MG B 701 coo 54.17 11.77 49.20 52.64 11.40 50.63 71.61 -6.68 45.38 69.65 -6.30 44.66 coo 45.83 11.66 53.42 50.97 10.25 52.77 75.30 -2.84 54.33 79.74 -2.40 56.36 coo 55.28 7.50 53.67 54.71 10.14 54.01 77.46 -9.77 45.05 77.37 -9.94 42.24 ULMN 3 3uao_o04 PUTATIVE ISOCHORISMATASE user 4 3 # 4 E 29 ASP B 165 ASP^? 26.59 MG MG B 701 E 117 LYS B 175 LYS~? 34.92 MG MG B 701 E 150 CYH B 150 CYH^? 29.89 MG MG B 701 coo 54.17 11.77 49.20 52.64 11.40 50.63 71.61 -6.68 45.38 69.65 -6.30 44.66 coo 45.83 11.66 53.42 50.97 10.25 52.77 75.00 1.45 45.20 75.48 7.65 46.06 coo 55.28 7.50 53.67 54.71 10.14 54.01 77.46 -9.77 45.05 77.37 -9.94 42.24 3uao_o04 source 3UAO PUTATIVE ISOCHORISMATASE : 4 hits 3uao_o04 naa= 3 ULMN 3 3uao_o05 PUTATIVE ISOCHORISMATASE user 1 3 # 1 F 29 ASP A 165 ASP^? 19.82 MG MG B 701 F 117 LYS A 172 LYS~? 6.12 MG MG B 701 F 150 CYH A 150 CYH^? 20.80 MG MG B 701 coo 41.67 65.37 28.64 40.76 63.70 27.74 49.47 0.04 38.38 48.02 -0.73 39.68 coo 38.34 58.97 23.05 39.26 61.42 28.02 50.20 -3.67 28.72 53.15 -8.47 28.45 coo 39.64 61.25 32.92 38.08 62.62 31.22 54.05 4.31 36.56 55.14 4.53 39.16 ULMN 3 3uao_o05 PUTATIVE ISOCHORISMATASE user 2 3 # 2 F 29 ASP A 165 ASP^? 19.82 MG MG B 701 F 117 LYS A 175 LYS~? 16.95 MG MG B 701 F 150 CYH A 150 CYH^? 20.80 MG MG B 701 coo 41.67 65.37 28.64 40.76 63.70 27.74 49.47 0.04 38.38 48.02 -0.73 39.68 coo 38.34 58.97 23.05 39.26 61.42 28.02 54.19 -7.18 37.22 54.81 -12.82 38.86 coo 39.64 61.25 32.92 38.08 62.62 31.22 54.05 4.31 36.56 55.14 4.53 39.16 ULMN 3 3uao_o05 PUTATIVE ISOCHORISMATASE user 3 3 # 3 F 29 ASP B 165 ASP^? 26.59 MG MG B 701 F 117 LYS B 172 LYS~? 42.28 MG MG B 701 F 150 CYH B 150 CYH^? 29.89 MG MG B 701 coo 41.67 65.37 28.64 40.76 63.70 27.74 71.61 -6.68 45.38 69.65 -6.30 44.66 coo 38.34 58.97 23.05 39.26 61.42 28.02 75.30 -2.84 54.33 79.74 -2.40 56.36 coo 39.64 61.25 32.92 38.08 62.62 31.22 77.46 -9.77 45.05 77.37 -9.94 42.24 ULMN 3 3uao_o05 PUTATIVE ISOCHORISMATASE user 4 3 # 4 F 29 ASP B 165 ASP^? 26.59 MG MG B 701 F 117 LYS B 175 LYS~? 34.92 MG MG B 701 F 150 CYH B 150 CYH^? 29.89 MG MG B 701 coo 41.67 65.37 28.64 40.76 63.70 27.74 71.61 -6.68 45.38 69.65 -6.30 44.66 coo 38.34 58.97 23.05 39.26 61.42 28.02 75.00 1.45 45.20 75.48 7.65 46.06 coo 39.64 61.25 32.92 38.08 62.62 31.22 77.46 -9.77 45.05 77.37 -9.94 42.24 3uao_o05 source 3UAO PUTATIVE ISOCHORISMATASE : 4 hits 3uao_o05 naa= 3 ULMN 3 3uao_o06 PUTATIVE ISOCHORISMATASE user 1 3 # 1 G 29 ASP A 165 ASP^? 19.82 MG MG B 701 G 117 LYS A 172 LYS~? 6.12 MG MG B 701 G 150 CYH A 150 CYH^? 20.80 MG MG B 701 coo 26.53 -14.13 63.27 28.07 -12.63 63.49 49.47 0.04 38.38 48.02 -0.73 39.68 coo 34.28 -10.03 65.81 29.08 -9.98 63.85 50.20 -3.67 28.72 53.15 -8.47 28.45 coo 25.24 -8.30 61.46 25.55 -9.17 63.98 54.05 4.31 36.56 55.14 4.53 39.16 ULMN 3 3uao_o06 PUTATIVE ISOCHORISMATASE user 2 3 # 2 G 29 ASP A 165 ASP^? 19.82 MG MG B 701 G 117 LYS A 175 LYS~? 16.95 MG MG B 701 G 150 CYH A 150 CYH^? 20.80 MG MG B 701 coo 26.53 -14.13 63.27 28.07 -12.63 63.49 49.47 0.04 38.38 48.02 -0.73 39.68 coo 34.28 -10.03 65.81 29.08 -9.98 63.85 54.19 -7.18 37.22 54.81 -12.82 38.86 coo 25.24 -8.30 61.46 25.55 -9.17 63.98 54.05 4.31 36.56 55.14 4.53 39.16 ULMN 3 3uao_o06 PUTATIVE ISOCHORISMATASE user 3 3 # 3 G 29 ASP B 165 ASP^? 26.59 MG MG B 701 G 117 LYS B 172 LYS~? 42.28 MG MG B 701 G 150 CYH B 150 CYH^? 29.89 MG MG B 701 coo 26.53 -14.13 63.27 28.07 -12.63 63.49 71.61 -6.68 45.38 69.65 -6.30 44.66 coo 34.28 -10.03 65.81 29.08 -9.98 63.85 75.30 -2.84 54.33 79.74 -2.40 56.36 coo 25.24 -8.30 61.46 25.55 -9.17 63.98 77.46 -9.77 45.05 77.37 -9.94 42.24 ULMN 3 3uao_o06 PUTATIVE ISOCHORISMATASE user 4 3 # 4 G 29 ASP B 165 ASP^? 26.59 MG MG B 701 G 117 LYS B 175 LYS~? 34.92 MG MG B 701 G 150 CYH B 150 CYH^? 29.89 MG MG B 701 coo 26.53 -14.13 63.27 28.07 -12.63 63.49 71.61 -6.68 45.38 69.65 -6.30 44.66 coo 34.28 -10.03 65.81 29.08 -9.98 63.85 75.00 1.45 45.20 75.48 7.65 46.06 coo 25.24 -8.30 61.46 25.55 -9.17 63.98 77.46 -9.77 45.05 77.37 -9.94 42.24 3uao_o06 source 3UAO PUTATIVE ISOCHORISMATASE : 4 hits 3uao_o06 naa= 3 ULMN 3 3uao_o07 PUTATIVE ISOCHORISMATASE user 1 3 # 1 H 28 VAL A 148 VAL^? 13.75 MG MG B 701 H 117 LYS A 172 LYS~? 6.12 MG MG B 701 H 150 CYH A 150 CYH^? 20.80 MG MG B 701 coo 45.82 27.58 23.40 45.30 28.87 21.66 57.35 2.46 31.20 58.46 0.97 32.40 coo 38.01 32.08 28.20 39.46 29.85 23.57 50.20 -3.67 28.72 53.15 -8.47 28.45 coo 41.19 29.62 18.76 39.21 28.51 20.32 54.05 4.31 36.56 55.14 4.53 39.16 ULMN 3 3uao_o07 PUTATIVE ISOCHORISMATASE user 2 3 # 2 H 28 VAL A 148 VAL^? 13.75 MG MG B 701 H 117 LYS A 175 LYS~? 16.95 MG MG B 701 H 150 CYH A 150 CYH^? 20.80 MG MG B 701 coo 45.82 27.58 23.40 45.30 28.87 21.66 57.35 2.46 31.20 58.46 0.97 32.40 coo 38.01 32.08 28.20 39.46 29.85 23.57 54.19 -7.18 37.22 54.81 -12.82 38.86 coo 41.19 29.62 18.76 39.21 28.51 20.32 54.05 4.31 36.56 55.14 4.53 39.16 ULMN 3 3uao_o07 PUTATIVE ISOCHORISMATASE user 3 3 # 3 H 28 VAL B 148 VAL^? 36.96 MG MG B 701 H 117 LYS B 172 LYS~? 42.28 MG MG B 701 H 150 CYH B 150 CYH^? 29.89 MG MG B 701 coo 45.82 27.58 23.40 45.30 28.87 21.66 82.04 -6.86 48.43 82.12 -5.42 46.76 coo 38.01 32.08 28.20 39.46 29.85 23.57 75.30 -2.84 54.33 79.74 -2.40 56.36 coo 41.19 29.62 18.76 39.21 28.51 20.32 77.46 -9.77 45.05 77.37 -9.94 42.24 ULMN 3 3uao_o07 PUTATIVE ISOCHORISMATASE user 4 3 # 4 H 28 VAL B 148 VAL^? 36.96 MG MG B 701 H 117 LYS B 175 LYS~? 34.92 MG MG B 701 H 150 CYH B 150 CYH^? 29.89 MG MG B 701 coo 45.82 27.58 23.40 45.30 28.87 21.66 82.04 -6.86 48.43 82.12 -5.42 46.76 coo 38.01 32.08 28.20 39.46 29.85 23.57 75.00 1.45 45.20 75.48 7.65 46.06 coo 41.19 29.62 18.76 39.21 28.51 20.32 77.46 -9.77 45.05 77.37 -9.94 42.24 3uao_o07 source 3UAO PUTATIVE ISOCHORISMATASE : 4 hits 3uao_o07 naa= 3